{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "90be358e",
   "metadata": {},
   "source": [
    "## PERC Rule for Pulmonary Embolism"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0377d46e",
   "metadata": {},
   "source": [
    "### Seven Criteria of PERC Rule\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "62833d68",
   "metadata": {},
   "source": [
    "\n",
    "1. Age < 50 years\n",
    "2. Heart rate < 100 bpm\n",
    "3. Oxygen saturation ≥ 95% \n",
    "4. No hemoptysis\n",
    "5. No estrogen use\n",
    "6. No prior venous thromboembolism (VTE)\n",
    "7. No unilateral leg swelling"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b205b060",
   "metadata": {},
   "source": [
    "### Quick Overview"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "id": "f2d04e23",
   "metadata": {},
   "outputs": [],
   "source": [
    "from datasets import load_dataset\n",
    "import pandas as pd\n",
    "import ast\n",
    "import json\n",
    "import matplotlib.pyplot as plt\n",
    "import os\n",
    "import requests\n",
    "import sys\n",
    "import re\n",
    "import numpy as np\n",
    "import asyncio\n",
    "import aiohttp\n",
    "from typing import List\n",
    "import seaborn as sns\n",
    "import builtins \n",
    "\n",
    "# Load dataset\n",
    "dataset = load_dataset(\"ncbi/MedCalc-Bench-v1.0\")\n",
    "df = dataset[\"train\"].to_pandas()  # or \"test\"\n",
    "df_test = dataset[\"test\"].to_pandas()  # or \"test\"\n",
    "# Filter for calculator name \"PERC\"\n",
    "\n",
    "perc_df = df[df[\"Calculator Name\"] == \"PERC Rule for Pulmonary Embolism\"]\n",
    "\n",
    "perc_df_test = df_test[df_test[\"Calculator Name\"] == \"PERC Rule for Pulmonary Embolism\"]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1f5acee9",
   "metadata": {},
   "source": [
    "### Function to calculate PERC Score"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "5feb6c6c",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Testing calcualtor\n",
    "def perc_score(\n",
    "    age,\n",
    "    heart_rate,\n",
    "    oxygen_saturation,\n",
    "    has_hemoptysis=False,\n",
    "    on_estrogen=False,\n",
    "    history_dvt_pe=False,\n",
    "    unilateral_leg_swelling=False,\n",
    "    recent_trauma_or_surgery=False\n",
    "):\n",
    "    \"\"\"\n",
    "    Calculate the PERC rule score.\n",
    "    Returns the number of failed criteria (0 = all passed, 8 = all failed).\n",
    "    \"\"\"\n",
    "    score = 0\n",
    "    if age >= 50:\n",
    "        score += 1\n",
    "    if heart_rate >= 100:\n",
    "        score += 1\n",
    "    if oxygen_saturation < 95:\n",
    "        score += 1\n",
    "    if has_hemoptysis:\n",
    "        score += 1\n",
    "    if on_estrogen:\n",
    "        score += 1\n",
    "    if history_dvt_pe:\n",
    "        score += 1\n",
    "    if unilateral_leg_swelling:\n",
    "        score += 1\n",
    "    if recent_trauma_or_surgery:\n",
    "        \n",
    "        score += 1\n",
    "    return score\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "677f4d81",
   "metadata": {},
   "source": [
    "### Function to safely parse the \"Relevant Entities\" column"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "id": "ff16e8eb",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/y5/cg9ckmtx691dkg8sg071p0qw0000gq/T/ipykernel_91983/1491001109.py:11: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  perc_df[\"Parsed Entities\"] = perc_df[\"Relevant Entities\"].apply(safe_parse)\n"
     ]
    }
   ],
   "source": [
    "\n",
    "''''This function safely parses a string representation (val) of a dictionary or list similar to to_dict()'''\n",
    "def safe_parse(val):\n",
    "    if isinstance(val, dict):\n",
    "        return val\n",
    "    try:\n",
    "        return ast.literal_eval(val)\n",
    "    except (ValueError, SyntaxError):\n",
    "        return None\n",
    "\n",
    "# Using perc_df[\"Relevant Entities\"].to_dict() to parse the \"Relevant Entities\" column produces the same result as perc_df[\"Parsed Entities\"].\n",
    "perc_df[\"Parsed Entities\"] = perc_df[\"Relevant Entities\"].apply(safe_parse)\n",
    "\n",
    "\n",
    "entities_df = pd.json_normalize(perc_df[\"Parsed Entities\"])\n",
    "\n",
    "\n",
    "def get_value(item):\n",
    "    if isinstance(item, list) and item:\n",
    "        return item[0]\n",
    "    return item\n",
    "\n",
    "entities_cleaned = entities_df.map(get_value)\n",
    "\n",
    "'''This function extracts the first element from a list or returns the item itself if it's not a list.\n",
    "Mainly to account for values with units such as [\"73\",\"years]'''\n",
    "def extract_number(val):\n",
    "    if isinstance(val, list) and len(val) > 0:\n",
    "        return val[0]\n",
    "    elif isinstance(val, (int, float)):\n",
    "        return val\n",
    "    else:\n",
    "        return None\n",
    "    \n",
    "def calculate_perc_score_from_entities(entities):\n",
    "    \"\"\"Extracts values from entity dict and returns the computed PERC score.\"\"\"\n",
    "    age = extract_number(get_value(entities.get(\"age\")))\n",
    "    heart_rate = extract_number(get_value(entities.get(\"Heart Rate or Pulse\")))\n",
    "    o2_sat = extract_number(get_value(entities.get(\"O₂ saturation percentage\")))\n",
    "\n",
    "    hemoptysis = get_value(entities.get(\"Hemoptysis\"), False)\n",
    "    hormone_use = get_value(entities.get(\"Hormone use\"), False)\n",
    "    prior_pe_dvt = get_value(entities.get(\"Previously documented Deep Vein Thrombosis\"), False) or \\\n",
    "                   get_value(entities.get(\"Previously Documented Pulmonary Embolism\"), False)\n",
    "    leg_swelling = get_value(entities.get(\"Unilateral Leg Swelling\"), False)\n",
    "    recent_surgery_trauma = get_value(entities.get(\"Recent surgery or trauma\"), False)\n",
    "\n",
    "    return perc_score(age, heart_rate, o2_sat, hemoptysis, hormone_use, prior_pe_dvt, leg_swelling, recent_surgery_trauma)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "aaa7a2a9",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "bae7b5b2",
   "metadata": {},
   "source": [
    "### Testing the Calculator "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "20172be2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 Incorrect answers out of <built-in function all>\n"
     ]
    }
   ],
   "source": [
    "\n",
    "#Quick test to see if the function works\n",
    "wrong = 0\n",
    "all_vals = 1000\n",
    "\n",
    "for i in range(all_vals):\n",
    "    sample_row = perc_df.sample(1).iloc[0]\n",
    "    entities = sample_row[\"Parsed Entities\"]\n",
    "\n",
    "    if entities is None:\n",
    "        # You can choose to skip or count this as wrong\n",
    "        continue  # Skip this sample, or use: wrong += 1; continue\n",
    "\n",
    "    def get_value(val, default=False):\n",
    "        return val if val is not None else default\n",
    "\n",
    "    try:\n",
    "        score = calculate_perc_score_from_entities(entities)\n",
    "    except Exception as e:\n",
    "        print(f\"❌ Error in sample {i}: {e}\")\n",
    "        print(\"Entities:\", entities)\n",
    "        wrong += 1\n",
    "        continue\n",
    "\n",
    "    if score != sample_row[\"Ground Truth Answer\"]:\n",
    "        print(\"Sample Entities:\", entities)\n",
    "        print(\"PERC Score with calculator:\", score)\n",
    "        print(\"Actual Ground Truth Answer:\", sample_row[\"Ground Truth Answer\"])\n",
    "        print(\"-------\" * 50)\n",
    "        wrong += 1\n",
    "\n",
    "print(wrong, \"Incorrect answers out of\", all)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "065c010f",
   "metadata": {},
   "source": [
    "### Functions to run models"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "e9cc1055",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Available models \n",
    "model_ids = [\n",
    "    \"Llama-3.3-70B-Instruct\",#\n",
    "    \"Llama3-Med42-70B\",#\n",
    "    \"Llama3-Med42-70B-32k\",\n",
    "    \"Llama3-Med42-70B-DGX\",\n",
    "    \"Llama3-Med42-DPO-70B\",\n",
    "    \"Med42-Qwen2.5-72B-v3-bi\",#\n",
    "    \"Med42-R1-Qwen3-4B\",#\n",
    "    \"Meta-Llama-3-70B-Instruct\",\n",
    "    \"Meta-Llama-3-70b-Instruct\",\n",
    "    # \"gliner-gte-small\",\n",
    "    # \"gliner-multitask-large-v0.5\",\n",
    "    # \"gte-small\",\n",
    "    # \"thenlper/gte-small\",\n",
    "    # \"whisper-large-v3-turbo\",\n",
    "    # \"whisper-large-v3-turbo-vllm\"\n",
    "]\n",
    "#Models that I will be using\n",
    "model_ids = [\n",
    "    \"Llama-3.3-70B-Instruct\",#\n",
    "    \"Llama3-Med42-70B\",#\n",
    "    \"Med42-Qwen2.5-72B-v3-bi\"\n",
    "]\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "21c2bf2a",
   "metadata": {},
   "source": [
    "### Function to run models with different prompts among other params and plot the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "0de1665f",
   "metadata": {},
   "outputs": [],
   "source": [
    "'''extracts a JSON object from a text string. Assues only one JSON object is present in the text.'''\n",
    "def extract_json_from_text(text: str):\n",
    "    try:\n",
    "        start = text.index('{')\n",
    "        end = text.rindex('}') + 1\n",
    "        json_str = text[start:end]\n",
    "        return json.loads(json_str)\n",
    "    except (ValueError, json.JSONDecodeError):\n",
    "        return None\n",
    "    \n",
    "\n",
    "\n",
    "'''Attempts to extract a PERC score from a text string.\n",
    "Returns a dictionary with \"Answer\" and optional \"Note\" keys.'''\n",
    "def extract_score_from_text(text):\n",
    "    if not isinstance(text, str):\n",
    "        return None\n",
    "\n",
    "    text = text.strip().lower()\n",
    "\n",
    "    # Early rejection: misunderstood task\n",
    "    rejection_keywords = [\n",
    "        \"not applicable\", \"cannot calculate\", \"not appropriate\", \"not designed\",\n",
    "        \"does not apply\", \"score is not valid\", \"wrong score\",\n",
    "        \"perc is not for\", \"perc (percutaneous|pneumonia|coronary|emergency)\"\n",
    "    ]\n",
    "    if any(re.search(kw, text) for kw in rejection_keywords):\n",
    "        return {\"Answer\": None, \"Note\": \"LLM misunderstood or refused to calculate PERC score\"}\n",
    "\n",
    "    # Ensure correct PERC context\n",
    "    if \"pulmonary embolism\" not in text and \"perc criteria\" in text:\n",
    "        return {\"Answer\": None, \"Note\": \"PERC criteria mentioned but not in PE context\"}\n",
    "\n",
    "    # Match known phrasing\n",
    "    patterns = [\n",
    "        r'\\bperc\\s*score\\s*(?:is|=|of|:)?\\s*(\\d{1,2})\\b',\n",
    "        r'\\btotal\\s*score\\s*(?:is|=|:)?\\s*(\\d{1,2})\\b',\n",
    "        r'\\bscore\\s*(?:is|=|:)?\\s*(\\d{1,2})\\b',\n",
    "        r'\\banswer\\s*(?:is|=|:)?\\s*(\\d{1,2})\\b',\n",
    "        r'\\bmeets\\s*(\\d{1,2})\\s+criteria',\n",
    "        r'\\b(\\d{1,2})\\s+criteria\\s+met',\n",
    "        r'\\b(\\d{1,2})\\s+out\\s+of\\s+8\\s+criteria',\n",
    "        r'\\b(\\d{1,2})\\s*/\\s*8\\s+criteria'\n",
    "    ]\n",
    "    for pattern in patterns:\n",
    "        match = re.search(pattern, text, re.IGNORECASE)\n",
    "        if match:\n",
    "            try:\n",
    "                return {\"Answer\": int(match.group(1))}\n",
    "            except ValueError:\n",
    "                continue\n",
    "\n",
    "    # Fallback 1: binary checklist count\n",
    "    checklist_matches = re.findall(r':\\s*([01])\\b', text)\n",
    "    if checklist_matches and len(checklist_matches) <= 8:\n",
    "        try:\n",
    "            score = sum(int(x) for x in checklist_matches)\n",
    "            return {\"Answer\": score}\n",
    "        except Exception:\n",
    "            pass\n",
    "\n",
    "    # Fallback 2: checklist-like marks\n",
    "    checkbox_like = re.findall(r'-\\s*\\[(x|1)\\]', text, re.IGNORECASE)\n",
    "    if checkbox_like:\n",
    "        return {\"Answer\": len(checkbox_like)}\n",
    "\n",
    "    # Fallback 3: keyword-based approximate tally\n",
    "    yes_count = len(re.findall(r'\\b(yes|1|true|present)\\b', text, re.IGNORECASE))\n",
    "    no_count = len(re.findall(r'\\b(no|0|false|absent)\\b', text, re.IGNORECASE))\n",
    "    if 0 < yes_count <= 8 and yes_count + no_count >= 5:\n",
    "        return {\"Answer\": yes_count, \"Note\": \"Heuristically inferred from 'yes' counts\"}\n",
    "\n",
    "    return {\"Answer\": None, \"Note\": \"No identifiable score\"}\n",
    "\n",
    "'''Plots a bar chart comparing the counts of correct, wrong, and invalid answers for each model.'''\n",
    "def plot_df(results_df):\n",
    "    x = np.arange(len(results_df))  # label locations\n",
    "    width = 0.25  # narrower bar width to fit 3 bars per group\n",
    "\n",
    "    fig, ax = plt.subplots(figsize=(12, 6))\n",
    "    \n",
    "    bars1 = ax.bar(x - width,     results_df[\"correct\"], width, label='Correct', color='mediumseagreen')\n",
    "    bars2 = ax.bar(x,             results_df[\"wrong\"],   width, label='Wrong',   color='tomato')\n",
    "    bars3 = ax.bar(x + width,     results_df[\"invalid\"], width, label='Invalid', color='slategray')\n",
    "\n",
    "    ax.set_title(\"Correct, Wrong, and Invalid Answer Count per Model\")\n",
    "    ax.set_xlabel(\"Model\")\n",
    "    ax.set_ylabel(\"Count\")\n",
    "    ax.set_xticks(x)\n",
    "    ax.set_xticklabels(results_df[\"model_id\"], rotation=45, ha=\"right\")\n",
    "    ax.legend()\n",
    "    ax.grid(axis=\"y\", linestyle='--', alpha=0.5)\n",
    "\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "'''Plots a pie chart for each model showing the distribution of correct, wrong, and invalid answers.'''\n",
    "def plot_df_pie(results_df):\n",
    "    num_models = len(results_df)\n",
    "    ncols = 2\n",
    "    nrows = (num_models + 1) // ncols\n",
    "\n",
    "    fig, axes = plt.subplots(nrows, ncols, figsize=(12, 5 * nrows))\n",
    "    axes = axes.flatten()\n",
    "\n",
    "    for i, row in results_df.iterrows():\n",
    "        # Prepare label, value, color triplets\n",
    "        all_labels = ['Correct', 'Incorrect', 'Invalid']\n",
    "        all_counts = [row['correct'], row['wrong'], row['invalid']]\n",
    "        all_colors = ['mediumseagreen', 'tomato', 'slategray']\n",
    "\n",
    "        # Filter out zero-counts\n",
    "        filtered = [(label, count, color) for label, count, color in zip(all_labels, all_counts, all_colors) if count > 0]\n",
    "        if not filtered:\n",
    "            continue  # skip completely empty pie\n",
    "\n",
    "        labels, counts, colors = zip(*filtered)\n",
    "\n",
    "        ax = axes[i]\n",
    "        ax.pie(counts, labels=labels, autopct='%1.1f%%', colors=colors, startangle=140)\n",
    "        ax.set_title(f\"Model: {row['model_id']}\")\n",
    "\n",
    "    # Hide unused subplots\n",
    "    for j in range(i + 1, len(axes)):\n",
    "        axes[j].axis('off')\n",
    "\n",
    "    plt.suptitle(\"Prediction Outcome Breakdown per Model\", fontsize=16)\n",
    "    plt.tight_layout(rect=[0, 0, 1, 0.95])\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f10f4a0f",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# Configuration\n",
    "BASE_URL = \"https://hive.g42healthcare.ai/v1/chat/completions\"\n",
    "HEADERS = {\"Content-Type\": \"application/json\"}\n",
    "CONCURRENT_REQUESTS = 10  # Limit the number of parallel requests\n",
    "\n",
    "# Async function to get LLM response\n",
    "'''Async function to get chat completion from the LLM API. Takes in a session, semaphore, model ID, system instruction, and user instruction.\n",
    "Returns the content of the first choice in the response.'''\n",
    "async def get_chat_completion(session, sem, model: str, system_instruction: str, user_instruction: str) -> str:\n",
    "    payload = {\n",
    "        \"model\": model,\n",
    "        \"messages\": [\n",
    "            {\"role\": \"system\", \"content\": system_instruction},\n",
    "            {\"role\": \"user\", \"content\": user_instruction}\n",
    "        ],\n",
    "        \"temperature\": 0.0,\n",
    "        \"stream\": False,\n",
    "        \"max_tokens\": 2000\n",
    "    }\n",
    "\n",
    "    async with sem:\n",
    "        async with session.post(BASE_URL, headers=HEADERS, json=payload) as response:\n",
    "            response.raise_for_status()\n",
    "            result = await response.json()\n",
    "            return result[\"choices\"][0][\"message\"][\"content\"]\n",
    "\n",
    "''' A function that runs a batch of prompts concurrently using asyncio and aiohttp.\n",
    "It takes a model ID, system instruction, and a list of prompts, and returns the results.\n",
    "It uses a semaphore to limit the number of concurrent requests.'''\n",
    "async def run_batch(model: str, system_instruction: str, prompts: List[str]):\n",
    "    sem = asyncio.Semaphore(CONCURRENT_REQUESTS)\n",
    "    async with aiohttp.ClientSession() as session:\n",
    "        tasks = [\n",
    "            get_chat_completion(session, sem, model, system_instruction, prompt)\n",
    "            for prompt in prompts\n",
    "        ]\n",
    "\n",
    "        results = []\n",
    "        total = len(tasks)\n",
    "        completed = 0\n",
    "\n",
    "        for coro in asyncio.as_completed(tasks):\n",
    "            result = await coro\n",
    "            results.append(result)\n",
    "            completed += 1\n",
    "            progress = (completed / total) * 100\n",
    "            print(f\"\\rBatch Progress: {progress:.1f}% ({completed}/{total})\", end=\"\", flush=True)\n",
    "\n",
    "        print()  # newline after completion\n",
    "        return results\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d5331536",
   "metadata": {},
   "outputs": [],
   "source": [
    "''' A function that runs models with output.\n",
    "It takes a system instruction, a list of model IDs, and optional parameters for including relevant entities,\n",
    "sampling, and full DataFrame usage.\n",
    "It returns invalid outputs, wrong outputs, a summary DataFrame, and parsed results per model.'''\n",
    "async def run_models_with_output_with_jinja(\n",
    "    sys_instruct,\n",
    "    model_ids: List[str],\n",
    "    include_relevant_entities=True,\n",
    "    sample=10,\n",
    "    full_df=False,\n",
    "    prompt=\"Calculate PERC score for this patient.\"\n",
    "):\n",
    "    results = []\n",
    "    wrong_outputs = []\n",
    "    invalid_outputs = []\n",
    "    parsed_results_per_model = {model_id: [] for model_id in model_ids}\n",
    "\n",
    "    subset_df = perc_df.head(sample)\n",
    "    iterate_df = perc_df if full_df else subset_df\n",
    "\n",
    "    for model_id in model_ids:\n",
    "        print(f\"\\n=== Evaluating model: {model_id} ===\\n\")\n",
    "        wrong = invalid = correct = 0\n",
    "        total = len(iterate_df)\n",
    "        prompts = []\n",
    "\n",
    "        for idx, row in iterate_df.iterrows():\n",
    "            entities = entities = ast.literal_eval(row[\"Relevant Entities\"]) if include_relevant_entities else None\n",
    "            user_instruction = template.render(\n",
    "                note=row[\"Patient Note\"],\n",
    "                entities=row[\"Parsed Entities\"],\n",
    "                include_relevant_entities=include_relevant_entities,\n",
    "                prompt=prompt\n",
    "            )\n",
    "            prompts.append(user_instruction)\n",
    "\n",
    "\n",
    "        results_async = await run_batch(\n",
    "            model=model_id,\n",
    "            system_instruction=sys_instruct,\n",
    "            prompts=prompts\n",
    "        )\n",
    "\n",
    "        for i, reply in enumerate(results_async):\n",
    "            progress = (i + 1) / len(results_async) * 100\n",
    "            print(f\"\\rParsing: {progress:.1f}% ({i + 1}/{len(results_async)})\", end=\"\", flush=True)\n",
    "\n",
    "            row = iterate_df.iloc[i]\n",
    "            entities = row[\"Parsed Entities\"]\n",
    "            ground_truth = row[\"Ground Truth Answer\"]\n",
    "\n",
    "            parsed = extract_json_from_text(reply)\n",
    "            if parsed is None or \"Answer\" not in parsed:\n",
    "                # parsed = extract_score_from_text(reply) \n",
    "                if parsed is None or \"Answer\" not in parsed:\n",
    "                    invalid += 1\n",
    "                    invalid_outputs.append({\n",
    "                        \"model\": model_id,\n",
    "                        \"note\": row[\"Patient Note\"],\n",
    "                        \"entities\": entities if include_relevant_entities else None,\n",
    "                        \"reply\": reply,\n",
    "                        \"reason\": \"Invalid JSON or missing 'Answer'\"\n",
    "                    })\n",
    "                    parsed_results_per_model[model_id].append({\n",
    "                        \"note\": row[\"Patient Note\"],\n",
    "                        \"entities\": entities if include_relevant_entities else None,\n",
    "                        \"ground_truth\": ground_truth,\n",
    "                        \"parsed_criteria\": None,\n",
    "                        \"predicted\": None,\n",
    "                        \"raw_reply\": reply,\n",
    "                        \"valid\": False,\n",
    "                        \"correct\": False\n",
    "                    })\n",
    "                    continue\n",
    "\n",
    "            predicted_score = parsed.get(\"Answer\")\n",
    "\n",
    "            # Extract all criteria booleans except the 'Answer'\n",
    "            criteria = {k: v for k, v in parsed.items() if k != \"Answer\"}\n",
    "\n",
    "            if predicted_score == ground_truth:\n",
    "                correct += 1\n",
    "            else:\n",
    "                wrong += 1\n",
    "                wrong_outputs.append({\n",
    "                    \"model\": model_id,\n",
    "                    \"note\": row[\"Patient Note\"],\n",
    "                    \"entities\": entities if include_relevant_entities else None,\n",
    "                    \"reply\": reply,\n",
    "                    \"expected\": ground_truth,\n",
    "                    \"predicted\": predicted_score\n",
    "                })\n",
    "\n",
    "            parsed_results_per_model[model_id].append({\n",
    "                \"note\": row[\"Patient Note\"],\n",
    "                \"entities\": entities if include_relevant_entities else None,\n",
    "                \"ground_truth\": ground_truth,\n",
    "                \"parsed_criteria\": criteria,\n",
    "                \"predicted\": predicted_score,\n",
    "                \"raw_reply\": reply,\n",
    "                \"valid\": True,\n",
    "                \"correct\": predicted_score == ground_truth\n",
    "            })\n",
    "\n",
    "        valid = correct + wrong\n",
    "        accuracy = correct / valid if valid > 0 else 0\n",
    "\n",
    "        results.append({\n",
    "            \"model_id\": model_id,\n",
    "            \"wrong\": wrong,\n",
    "            \"correct\": correct,\n",
    "            \"invalid\": invalid,\n",
    "            \"total\": total,\n",
    "            \"accuracy\": round(accuracy, 3)\n",
    "        })\n",
    "\n",
    "        print(\"\\nDone ✅\")\n",
    "\n",
    "    results_df = pd.DataFrame(results)\n",
    "    print(\"\\n=== Summary Table ===\")\n",
    "    print(results_df)\n",
    "\n",
    "    return invalid_outputs, wrong_outputs, results_df, parsed_results_per_model\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e8ac3c6b",
   "metadata": {},
   "source": [
    "### Testing Function with different prompts"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a7a921cd",
   "metadata": {},
   "source": [
    "#### Simple prompt (includes all relevant entites in prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "804a2e9c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Evaluating model: Llama-3.3-70B-Instruct ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Llama3-Med42-70B ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Med42-Qwen2.5-72B-v3-bi ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Summary Table ===\n",
      "                  model_id  wrong  correct  invalid  total  accuracy\n",
      "0   Llama-3.3-70B-Instruct    118       15        0    133     0.113\n",
      "1         Llama3-Med42-70B    103       30        0    133     0.226\n",
      "2  Med42-Qwen2.5-72B-v3-bi    106       27        0    133     0.203\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x1000 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invalid_outputs, wrong_outputs, results_df,parsed_json = await run_models_with_output(\n",
    "    sys_instruct=(\n",
    "        \"You are a helpful Medical Assistant. After you calculate the PERC score, provide an explanation of how \"\n",
    "        \"you arrived at that score along with the score in JSON format. \\n\"\n",
    "        \"The JSON should be in the format: {\\\"Explanation\\\": \\\"<explanation>\\\", \\\"Answer\\\": <score>}\"\n",
    "    ),\n",
    "    model_ids=model_ids,\n",
    "    include_relevant_entities=True,\n",
    "    full_df=True\n",
    ")\n",
    "plot_df_pie(results_df)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ffbfc157",
   "metadata": {},
   "source": [
    "#### Simple prompt (does not include relevant entites in prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "a14e3fc4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Evaluating model: Llama-3.3-70B-Instruct ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Llama3-Med42-70B ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Med42-Qwen2.5-72B-v3-bi ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Summary Table ===\n",
      "                  model_id  wrong  correct  invalid  total  accuracy\n",
      "0   Llama-3.3-70B-Instruct    115       18        0    133     0.135\n",
      "1         Llama3-Med42-70B    108       25        0    133     0.188\n",
      "2  Med42-Qwen2.5-72B-v3-bi    107       26        0    133     0.195\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x1000 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "invalid_outputs, wrong_outputs, results_df,parsed_json = await run_models_with_output(\n",
    "    sys_instruct=(\n",
    "        \"You are a helpful Medical Assistant. After you calculate the PERC score, provide an explanation of how \"\n",
    "        \"you arrived at that score along with the score in JSON format. \\n\"\n",
    "        \"The JSON should be in the format: {\\\"Explanation\\\": \\\"<explanation>\\\", \\\"Answer\\\": <score>}\"\n",
    "    ),\n",
    "    model_ids=model_ids,\n",
    "    include_relevant_entities=False,\n",
    "    full_df=True\n",
    ")\n",
    "plot_df_pie(results_df)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ed4364ae",
   "metadata": {},
   "source": [
    "#### Troubleshooting wrong/invalid replies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "e0896c2d",
   "metadata": {},
   "outputs": [],
   "source": [
    "def print_outputs(wrong_outputs,invalid_outputs):\n",
    "    for i, entry in enumerate(wrong_outputs):\n",
    "        print(f\"\\n--- Wrong Reply {i+1} ---\")\n",
    "        print(f\"Expected: {entry['expected']} | Predicted: {entry['predicted']}\")\n",
    "        print(f\"Reply:\\n{entry['reply']}\")\n",
    "\n",
    "    # Extract invalid replies with metadata\n",
    "    for i, entry in enumerate(invalid_outputs):\n",
    "        print(f\"\\n--- Invalid Reply {i+1} ---\")\n",
    "        print(f\"Expected: {entry['expected']} | Predicted: {entry['predicted']}\")\n",
    "        print(f\"Reply:\\n{entry['reply']}\")\n",
    "\n",
    "# invalid_replies = [entry['reply'] for entry in invalid_outputs if 'reply' in entry]\n",
    "# for i, reply in enumerate(invalid_replies):\n",
    "#     print(f\"\\n--- Invalid Reply {i+1} ---\\n{reply}\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "64ed6447",
   "metadata": {},
   "source": [
    "#### More detailed system instruction (includes relevant entities in prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "f6880241",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Evaluating model: Llama-3.3-70B-Instruct ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Llama3-Med42-70B ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Med42-Qwen2.5-72B-v3-bi ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Summary Table ===\n",
      "                  model_id  wrong  correct  invalid  total  accuracy\n",
      "0   Llama-3.3-70B-Instruct    103       30        0    133     0.226\n",
      "1         Llama3-Med42-70B     95       38        0    133     0.286\n",
      "2  Med42-Qwen2.5-72B-v3-bi     99       34        0    133     0.256\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABG0AAAPZCAYAAACrktcqAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjkuNCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8ekN5oAAAACXBIWXMAAA9hAAAPYQGoP6dpAAD3n0lEQVR4nOzdBXhc1dbG8TcuTVN3dxdKvdAiFRxaKFD4cIeLy8Xd7QIXvXBxd5diLVaou7t72qZtGp3vWSd3QpImbXyP/H/PM5SMrpk5M7PPOmuvHeHz+XwCAAAAAABAQIl0HQAAAAAAAAD2RtIGAAAAAAAgAJG0AQAAAAAACEAkbQAAAAAAAAIQSRsAAAAAAIAARNIGAAAAAAAgAJG0AQAAAAAACEAkbQAAAAAAAAIQSRsAAAAAAIAARNIGQEho2bKlIiIiCpzi4uLUvHlznXLKKfr1118VKO68804vPvs3v1dffdU7/+yzz670GJYvX+49lr1uwSAzM1MvvviijjzySDVq1EixsbGqU6eO+vXrp7vuukubN292HSLybcOFTzExMd77duyxx+qrr75SMBg3bpwX+yGHHBLQ94nK+R258sor93ndRx55JO+60dHRVRJfRX9vV+VvDgCg7EjaAAgpgwYN0llnneWdbAc/JydH77//voYMGaLHH39c4bbzYYP8YDdv3jx16dJFF154ob7//nu1adNGJ510kvr27etdZskvO+/jjz+u0Mdlh6bsqlWrlvc5tNNxxx2nGjVq6Msvv9Qxxxyjm266yXWIwD699dZbysjIKPbyl19+uUrjAQCEr6o5NAAAVeT8888vsJO9Z88eXXTRRXr99dd1ww03eDuM7du3VyAaOXKk+vfv7+3cVrYmTZp4CQ+rgAhky5Yt00EHHaStW7dq6NCh+u9//+tVT/mlpaXp9ttv16OPPqrRo0fro48+0gknnOA0Zkh169b1kl6F/etf/9I111yjhx56SKeddpq6devmJD5gX3r37q3Jkyfrs88+875XCvvjjz80f/589enTR5MmTXISIwAgfFBpAyCkxcfH65lnnvGO/GdnZ1d4NUZFsmRNx44dvWkklc2SNfZYVqESyM444wwvYWPJLKvSyJ+wMQkJCd40heuuu86rqrKE3ZYtW5zFi327+uqr1bRpU/l8Pv3000+uwwGKdO655+6zmsaSx/mvBwBAZSJpAyDkJSUlqUOHDt7/558u5O9HYF555RUNGDDAS5wUnla0du1arzqgU6dOSkxMVPXq1b0jrE8//bSysrKKfEyrALFpO+3atfN661gixqaJrFy5sszTcdasWaPrr7/eq06wGCwRZVVDdn078pv/PlasWOH93apVqwK9RaynRkl6I6xevVqXX365F78lvux1salnL7zwgpf82lfsu3bt8qa/tG3b1nvuDRs29J67xV8a48eP1++//+79v73Wdl/Fueeee1S/fn1t377du25+1j8k/3MvSY8he13OOecc7/9fe+21Aq9h4X4kloCwZKBVcdlztX479q9VCFlFiW0Lhb377rs6/PDDVbt2be95tWjRwtsBXLhw4X6nu33zzTdeDPae1KpVy3vcWbNm5V337bff9rZl20Zq1qypUaNGacmSJcW+dmXZvsujQYMG3r+F7zt/v5fdu3d7FVT+mApvp1OmTNHpp5/uJfHs9bPXccSIEfr666+LfMy5c+fqjjvu8LZhqzLz90Sy6i2bPllamzZt0sCBA714rWdWenp6gcutss9eQ4vdYjviiCNK1Fdr4sSJOvnkk9W4cWMvRtumrQ+QTQsszN4ze/yipn127tzZu8ymEBZ29913e5fZ61uZn9/83zH2Xj/88MPeNEdLtFollj1Pq1Ypjn1uHnvsMS9ha9uxfQ/Z97hVTBaVmM3/HCzRe9VVV3lJaXsOpe0hZN+xVm0zduzYvZ73zp07vW3Gko/Dhw/f5/1YHDfffLP3vP2frQMPPNB7LYr6XvCzBLVN6bXr2+f84IMP9qp+9iclJcXbznv27Ond1h7Tnsu9997rfaYAAEHKBwAhoEWLFj77SnvllVeKvLxt27be5VdccUXeefa3nf7xj3/4IiMjfQcddJBvzJgxvn79+vmWL1/uXWf8+PG+WrVqeddr2bKl77jjjvONGDEi77zhw4f7MjIyCjzWrl27fP379/cur1atmu+YY47xjR492tegQQNfnTp1fGeeeaZ32R133FHgdha7nX/WWWftFf8PP/zgq1mzpnd5/fr1fccff7x3n3369PHFxMTk3ebXX3/1/t8e16574oknen/7T/PmzfOut2zZMu9ye90Kmzhxoq927dre5c2bN/edcsopviOOOMIXHx/vnWfPPz09vcjYTzjhBF/37t29WI899lgvTovX/1jbtm0r8Xt61VVXebfr0qVLia5v76Ndv1evXgXOHzJkiHf+zz//XOTt7H0o/H5ce+21vkGDBnnnt2nTpsBr+MADD+Rdz977UaNGedezbcjed9uGhg0b5mvSpIl3vr3Wfjk5OXnvf3R0tO+www7znXrqqb727dt75yUmJvq++eabYrfvG2+80RcREeHFdvLJJ+fdzl7vxYsX+66//vq8+z3ppJN8zZo18y5v3Lixb+vWrXvdb1m2733xbwdFbVfG3v+kpCTvOoWfp70/dr59/my7tm34yCOP9La/oUOH5l3viSee8F5ru27Pnj2952mf3djYWO+8u+66a6/HPe+887zLOnbs6D0/u88BAwbk3c/VV1+912388dj2k9+CBQu8bcIuu+GGG7z3ND/7jvFvD4MHD/be386dO3t/X3nllUXep/nPf/6TF88BBxzgbUcDBw7M+5668847C1z/q6++8s631yi/NWvW5N3G7i8lJaXA5QcffLB3mb33lfn5zf8dY58R+56y99Fej9atW3uX2bbwxx9/7HVbew7dunXzrmPfRXa7kSNH5n0ObFv1f0cXfg5HH320r1WrVt42bNuzfU+efvrpJYrZf//2Pfrss896/3/vvfcWuM5///tf7/xbbrkl7zlGRUXtdV9LlizJu7969ep538UWT/Xq1fO+p4r6TD7++ON571/fvn297aB3797e39dcc02xn685c+bkfd4bNWrkfWfbe2i/O/7PSuH3b1+/OQCAwEHSBkDIJ21mzJiRtzP08ssv553vHxgnJyf7JkyYsNft1q1b5yVZbCfZBvDZ2dl5l23evNnbMS5qJ/G6667L20G0nY/8yRzbCfI/bkmTNitXrvTVqFEjb6e9cMJkw4YN3k5GUa9H/oRBfsUlbfbs2ZN324svvrjADrvthNjOkl128803Fxm7P6mzffv2vMtsx8R2GOyy+++/31dS/p3Lc845p0TXf+211/J2VDMzM8uVtCnpDo1/J8pel+nTpxe4zHbmLdmWf0fpueee865ft25d37Rp0wpc1x+H7TBv3LixwH3535O4uDjvPv2ysrK8nVK7rGvXrt72mj8O2+b8O/6Fdz7Lun2XJWmTmprq+/PPP32HHnqod7klTAonO/xJEjtZ4sDiK+zbb7/14rXXL3/SwcycOdPXtGlT7/bjxo0rcJn9bdtvYfPnz8+7zV9//VVkPPkTLL/88ouXRLCd9Oeff36v+/vyyy/zkrV23fxs2/c/v8JJG4vdkm323F5//fUCl3399dd5CamxY8fmnb9z504vEWKPlf87wf85sNfQ/v3oo4+KvE3+z3ZlfH793zH+7d2+h/Nvt5dffnnetmLfO362XfgTppZs27FjR95l9rm2hKpdZttSfvmfw+GHH17gOZRU/qSNfW4TEhK8hH9+Fpu9T7Y97StpY8lHu8wSNfa6+9ln2xI2dtlpp51W4Db2Gtl92XfYBx98UOCyN99803vcoj5fu3fvzksk3nrrrQW2B/sOsMRPUd+lJG0AIDiQtAEQskkbG3Tb0Wj/YNaqDfIPnv0D/LvvvrvI+/znP//pXW4VHEVZvXq1twNkR1H9O6A2ePYfSS2qYsJ2RP0VKyVNEvgrTuyoaWlfj9Imbd5444281yr/jpTfhx9+6F1uzzEtLW2v2G1ncO3atXvd7t133/Uut0RASVnSy5+oKgnbofe/p5bIquykjT2Gf2d68uTJJYrRvy0+9dRTe11m25B/R/u+++4r8v20SprCpk6dmve8n3nmmb0ut532onZyy7J970/+HeeiTpZ0uu2227wdycLyJ20KJzwK7wjbdliU999/37vcqhpK6oUXXijytS2ctHn77be9+K06xBIpRbGKELuNvbZF8Sc/Cidt/JVAVpGyryoyq+AqKrGZP0l1xhlneOf5K3Es+bq/6pzK+PzmT9pYdVRh9v3ir0Z766238s63701/ZUj+5KufJRctQWnXmTVr1l7PwbbZohJ0pU3aGKvQyf/6WpLP/j7kkEMKPMfCSRu7vb9ybv369Xs9jn1f+BPMq1atyjv//PPP9863SrCi+JP+hb+3/clgq+osiiVNrWLKEoP5q3tI2gBAcKCnDYCQYn1I/L1HrA/C0Ucf7fXzsN4G1u/C+sAUZstHF+Wrr77y/rWeFUWx3hjW88X6WyxatMg7b+rUqUpNTfV6Nlgfi8KsP8T++iAU9u2333r/2pLXlc3f9+XUU08tsoeM9UexPir2HK2vSGHWB6KoRsrWm8SUti9GaeTm4arOzz//7C0JbD0q7LQ/1ifI31vGeoQUZtusv4+O3XdRjjrqqL3Os22wJJdb75rybt9lXfJ7zJgxXo8f621iPVieeOKJYm9rfVysh0dhmzdv9nq+WE8U6/NSFH/vEn+Pp8K9SD744AOvx4h9lqz3iZ1sxTGzYMGCYmO6//77vR461gfHetMceeSRe13Hnttvv/3m/f///d//FXk/Z5555j4/d8X1szrvvPO8f+2x8/eUsp485ocffsg778cff/T60di2YL1x8l/m/3//7arq81vU9m7fL/5tL3+/Kf92eeKJJyo6eu9FTiMjIzV48OBi3+cDDjhArVu3VmU0JPb/u78GxP7nY78B/h5O+dn3RY8ePbzm6da7q/Dtitt+inodS/JZtr5u9t7aNspqVwAQfFjyG0BIsUajtsNi/I08rZGlDZ6L2gEwxTXjXbp0qfdvUTuQhdmOrTUFth3zfd2nvzlwafibCttqT5XNv1NWXIyWWLDLrOFlUTtwhVd38ktOTs5bgr2kLPFlNmzYUKLrb9y4MW+nzpq/VrbSvi/+18t2/P2vR2H+1byK2zku6vW1HbJ9XW4NSYt67cuyfZd3yW9L/lhi5ZZbbvF22q+99tq9rlPcZ8eWf7fEnDVw3VdTan+8+X3xxRdeQmxfK4vt2LGjyPOtGbbtWFsj3F9++aXYFdfsvv2vcXGfn+LO39/nzv+Ydv/2OPa95k++WONZS8ZYM25ruGzJuUsuucS73Jpdv/HGG962as2u95e0qcjPr58lz+1UFP/z9X9v5t8ub7vtNu9Umvd5f9+9pXXooYd6MX744YdeotEaTNtrUVyiv6Tvp/89nTFjRoHPuv91KO3243/NbLU9O5X2NQMABDaSNgBCyvnnn1/s0eri2JH7othRUGMD9KIqdPKzHXHkJkwqih2NtsqFv/76q0TXtyoMY0ewi0vQ7et9DoXXtzSvv4vt2yp3brzxRl1xxRV68MEHi0za7O/zaEkqq8IoKdsptgoES/bYykNWMWM79nY/9nrZCkG28lRxlVq28k9MTIwmT57srahmlTnFxVjVbHUoSyJY9YStnOZPygwbNiwvOWNJG1t96rjjjtPs2bO9hI+tKFTZn9/SyP/a+99nq8wqLkGW/70prCLfG/9qVJYYsyqX9evXe1VagfL+F37Niqvsyc+SdwCA4ELSBgCK0axZM68y4J///KdXWl4SNqXE5F8yvLB9XVbc0W+bumHL4/qriCqLP37/kdviKh7yX7eyHH/88XryySe96gGbirWvKUhWAeBfutl2TvOziitjU7r2VTFTWv6qhH0tW5yf//WySgmr6iiq2sb/ulf2a1vW7bsi+Keu2HQnO/krqkoSr39H2qaplDTBYFU2lrAZOXKktwR7Yfub+mVVIp9//rm3tLott25To2xJ5vwVTv7EllUA2fLf9hkvKqFQ3Gff3m+bOmfvf9euXYvdLqzaJ38VmSUnbWloe442pc6SNlFRUV6FSOHpU7b8syVHrPrGXsOqsm3bNu9UVLWN//Ww5bMLv8/2+b/uuuvkmiVt7rrrLu81LsnUqJJ+jxb1WfdvB6Xdfuw1s+8hm0a3vyogAEDwoacNABTD37fCnwwoCUss2M6c7YzaEfzCbKpPUefvi783zosvvlji2/gTFdbDoDT8PUHee++9IqdCfPLJJ97UKJtyU5I+LuVhO542tc1cdtll3s5wcWwahZX9WyLErpuff6do3rx5e91u9+7dxfaP2d9reNhhh3nXsYSS9TLaH9sx9VcOFDV1yHao/ef7d7oDbfuuCP6+PpZ0KU3FgvVn6d69u5d88/d5KomtW7cWW2Fgr/nbb7+93/uw7coe0/pR2VQpS4bY5yA/S6DY9Ezz1ltvFXk/VvWyr89dUdtF/l4qNpWtcBWZPzFjCSWLzRJw/gSJvWbWj8b63Fi1Tf7rV6Winrf1g7LvmfzPP/92af2HqrpPVXHJWUsgWVLOvo/69eu339v4n49tM0VN75w2bZqmT59eoD+PsQTcvrYfm54VSJ9lAEDVIGkDAMW4/vrrvZ0fa5z62GOPeTsZRVWdvPnmm3l/206ov2Hw1VdfrXXr1uVdZkf7rdeE/Vsa11xzjZcksaP9t956qzIzM/fq5eJvgOrnP3I9Z86cUj3W6NGjvZ0U64thj5s/YWHP1T+dxaaJ2FH/ymavrb0HNkXKKh1WrVpV4HL/lJdHH300rwKjXr16Ba7j30l95plnCvSP2LVrl/deFb7Pwq+hVfoUxaaZ+HuH2OtmU0/ysx3On376yZu24uevHLD+I9bPIv917733Xm9Hzp7vBRdcoEDcvsvLqlr81S72vuxvWlZh9hoZ60/jr3zIz15H21byJ0b9TXStL0n+z6M19L399tuLbGZbFKtUsce0Ztz2GLZjXniH/KqrrvL+/fe//73X/T788MPFJveuvPJKLxnz6aef7vV623N54YUXvP8vqvLEv33bDr1VcPmnRuW/3JLI7777boHrVyXb3vN/Pmw6j1V4WQ8XqxLJP93NEiR9+vTxpjva+1xUDxZLmD3//POlTkqX1ccff+y9hhMmTCjR9W1qlyV37Pvpoosu8pLDfnY/dp6/4bu/ssj/vWqVUpZ8sQR5fvb+2fZRFPses6SkJbrsdS2qqtCmdpUm8Q8ACCCul68CgMpa8nt//MvR7sv48eN9devW9a5nS6bakre2DKwtrepfvtmWIc7PlhXv27evd5ktD2xLdY8ePdrXsGFDX506dXxnnnlmqZeY/u677/KWEm/QoIHvhBNO8O7THseWuC18m6effjrv8W0ZYVtS2E62ZO2+lvw2EydO9NWuXTvvclt+9qijjspbqnzEiBG+9PT0Ese+v8fbn9mzZ+e91rZk7UEHHeQbM2aMt2xxcnJy3vO05Z6LkpGR4evdu7d3vRo1aviOPvpo77a2lLUtOXzuuecW+X7Yc7Slz+2yAw44wHvf7DV8+OGHC1znuOOOy1u+d8CAAb7TTjvNN3z48LzljPMvu25LZ/uXZLbncvjhh3vPpUOHDt55CQkJRS4nvb8l3Pe1Le/rtS/L9r0v+ZeOtm3Bf7LnaO+bLY1slzdv3nyvZZkLL7FdnCeffNJ77ey6bdu29d5Pe81tOWx7DoWX3LZlow888MC87cSuf/LJJ3uvh312/EufF37c4uLJysrKew/bt2/vW7lyZYHLL7vssrztwZaGtufepUsX7+8rr7yy2OdoS4/bdezyXr16ec9p0KBBvoiICO+8O++8s9jXxL+d2sne0/w+++yzvMvatWtX5O0r4/Prv4291yNHjvRea3uPTj311Lxty7YT//La+a1ZsyZveXS7zsCBA73b2XeZne/fjtLS0kr8HMqy5HdJn2PhJb+Nbd/++7Pt8qSTTvKW7PZ/Z9l7nH/5bT/7fvG/X/bZs+2gT58+3t9XX311se+DfU+2bNnSu7xmzZq+wYMHe7e134rOnTt725H9duTHkt8AEBxI2gAICZWVtDEbNmzw3Xbbbd4g2xInsbGxvqZNm3o7ErajP3PmzL1us2vXLu82tnNi17fBsu0M2yDfblPapI1ZsWKFt9NnO/iWQLEdUNtptKTDhAkTClw3Ozvb98ADD3g7i/5ki51sR7QkO2G2I2o7n61bt/bit+dtCYnnnnvO2wkurDKTNv7kiO3UWjLEXkvbAaxVq5aXjLn99tt9Gzdu3OftU1JSfP/4xz+8981uawmVCy+80Htvi3s/zKxZs7ykjCV4/DvUhXe4LRHz9ttve7FZUs7u3xJ0Bx98sO+RRx4psGPpZ9e3HXrbubLrN2vWzHf22WfnJdWqKmlT1u27OP7toPDJdhgtYWZJxnvvvde3ffv2vW5b0qSN/32x98+SELZ9JyYmetuqJRSfeuopb6c/v9TUVN/NN9+c99mxnWjbmZ08eXKxj7uveOw9v+SSS/Je10WLFhW4/OWXX/YSRfZY9ryHDh3q3d/+nuOff/7p7dzb9mOJKdueLMk0duzYfb4e/iSSJTgsSZmfvdb+JJfFXNVJG7uNfWfcd999vo4dO/ri4uK8pPCJJ57omzNnTrG337Nnj+/555/3HXrood7rYM/B3jdL2th3kyWyS/McqjppY7Zs2eK76aabfJ06dcrbTi0B/OCDD/p2795d7P1aos2SnPZ+2ve8fRY//PDD/b4PO3bs8JI+9l3t/25p1KiRl/S5/vrrfX/88UeB65O0AYDgEGH/cV3tAwAAgNBhTXNtiWqbtlPa5usAAOBv9LQBAAAAAAAIQCRtAAAAAAAAAhBJGwAAAAAAgABETxsAAAAAAIAARKUNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjYAAAAAAAABiKQNAAAAAABAACJpAwAAAAAAEIBI2gAAAAAAAAQgkjaocBEREbrzzjtLfbvly5d7t3311VdVWcaNG+c9hv0LAAAQKhh/ha+qeA8BuEPSJkTZl7Z9edvpt99+2+tyn8+nZs2aeZcfc8wxCgU2ULHns3nzZoWitWvX6v/+7//UoUMHVa9eXTVr1lTfvn312muvee/n/syZM0ejR49W69atlZiYqLp162rw4MH64osvSjUgKO50wQUXFLh+enq6/vnPf6px48ZKSEhQv3799P333+91vy1btixwP/Hx8WrXrp2uv/56bd26tUSxnX322UpKSlJl+frrr8s0EA61GAAA+8b4K3ilpaXpvPPOU9euXVWjRg1vXNGjRw89+eSTyszMLPF4xF6L5ORk7/4KW7RoUd728eijj6oq2TitqO1uy5YteuSRR7wxYb169bzxZf/+/fXee++V+L4POeSQYseHMTExe13/888/V69evbwxX/PmzXXHHXcoKyuryO3Kf4qMjFSjRo28+P/8889yvBJA8Il2HQAql30Zvv322zrooIMKnD9+/HitXr1acXFxzmJD6dhgyN6zk046yfuBswGEJUFsgLBgwQLdf//9+7z9ihUrlJqaqrPOOstLpOzevVsfffSRjjvuOL3wwgu68MIL93l7+yF/44039jr/22+/1VtvvaXhw4cXON/i+vDDD3XVVVd5SRgbyB511FH6+eef99oee/bsqWuvvdb7/z179mjKlCl64oknvO104sSJcs0SJs8884zTpEkgxAAAKBnGX8HHkix2gMvGKnZAyZIEf/zxh66++mr99ddf3vtZEtHR0d4Yyw6KnXzyyQUus/GSbRs21qlKkydP9sZh9tiFTZgwQbfccov3vG+99VYvfhsfnnrqqZo7d67uuuuu/d6/3f78888vcN6uXbt08cUX7zU+/Oabb3TCCSd4iZ5///vfmjVrlu69915t3LhRzz333F73bedZAi0nJ0erVq3Siy++6CWYbHxo40cgHJC0CXH2BfzBBx/oqaee8r6E/eyH58ADDwz6oyLhpHv37nuVFf/jH//Qscce672/99xzj6Kiova5Ldip8O1tO3j88cf3m7SpVq2aV+lTmA0C7IiSxeFnP6Tvvvuud+Tmuuuu884788wzvaNXN9xwgzcIyq9JkyYF7tt++O0H2o5C2VEpS/oECztSZAOL2NhY16EAABxh/BV8ateuvVcFhyUdrOrm6aef9sZKDRs23O/9WEJu0KBBeuedd/ZK2tj7f/TRR3tJkapi1V1XXHGFNw778ccf97q8S5cu3lirRYsWeeddeumlGjp0qB566CFv3GZjwH0ZNmzYXue9+eab3r+nn356gfNtXGhj2rFjx+Z9NmwcaQcfr7zySnXs2LHA9e1gpVWH+1nCx8aT9vkiaYNwwfSoEDdmzBiv7DH/tJSMjAyvAuK0004r8jaWGbeqByvftR8em45jO8+Fp+DY9Bc7+mAVGDZdxyo27OhRUdasWaNzzz1XDRo08O7TfiBefvnl/cZv1STz58/XunXrVFl+/fVXb9qQVa9YbPa87XkVLmv1T8FZuXKlV5pp/2/JBqt+MHak4LDDDvN+2OyHr/ARGZvqYz9U3bp1825rP1BHHnmkZsyYUa747WiQHdGx97W0LMljz3fbtm1lemx7X6xyZtSoUQWO3tj2ZfedPxFkl1vZsR3RsSMl++MfGOUf7Jb2dbH3ycrTbRqZPb5NDXv99df32sbsKJIlhuw6derU8Y6M+j8z9r773+P8Zbr5p4zZ58Mqg9q0aeNtQ3Zkyl8ib9cpybx+O4png/xatWp525ANaKwke38xAAACD+Ov0Bl/2XjClGasZO+xVZTkv82kSZO85Ehx779d16qT/e9/27ZtvaSJHQgqfD17TSyZZFOZrIJ6X7FZlfTs2bN13333FXl5q1atCiRsjI0xLDli29rSpUtVFvY+2Hty/PHH551n4yM72fgw//jOkkS2ndvno7LHh0AwYmsPcfZDM2DAAC/bbz9Qxn5Etm/f7pU92hGg/OwL0378bUfcdrAtg/3dd995/UXsh/9f//pXgWoIy6Lbj8/AgQP1008/eUcPCtuwYYM3N9Z+AKyywwYZFoPd/44dO7wfqOLYY3bq1Mn7Qaqs5mqWqbekxyWXXOLtsFuViJVr2gDILssvOzvbex2tLPPhhx/2ylztOdmPkpWG2tEES2A8//zz3hENe+3tx9DYj96nn37qDVDsPHtdbFrSkCFDvB8wm7JUEjaYsYHdzp07vTLrV155xXsc6xtTEnZbuw/bBmxOsb0Xp5xyShleOXnVNDaYKHwUZdq0aWrfvr03MMrPkidm+vTp3qAk/+DQf9TRSobt9nZEy15n/+tXFosXL/aO0Ni2ZtuQDVRtoGNHOW3gamy60QMPPOBtzxafbZNWRjx16lTvyNFFF13k9ROygXdR08OMvQcWtw1CbKBlR+tKw+7bBqI2V9uOMtmAZN68efryyy+9v0sSAwAgcDD+Ct7xlyXX7PWxsZKNByxxZkkNS6KUlMViVToff/yxlzTzJzGsisR6uRRmr4PFY6+7/eZbIsuqkm+66SYvcWYHhvzbiSVB7ICU3b+9R5988on3PhXFpsVbf8Gbb765RFVC+a1fv977N3+VS0lt2rTJG7PY+DJ/lY6N70zv3r0LXN/eg6ZNm+Zdnp+/v6GNN+31scpyO8hWuIoJCGk+hKRXXnnFDsv4Jk2a5Hv66ad91atX9+3evdu7bPTo0b5DDz3U+/8WLVr4jj766Lzbffrpp97t7r333gL3d9JJJ/kiIiJ8ixcv9v6ePn26d71LL720wPVOO+007/w77rgj77zzzjvP16hRI9/mzZsLXPfUU0/11ahRIy+uZcuWebe12P3855111ln7fc72mHbdTZs2FXudn3/+2buO/evnf/z8HnjgAe/5rlixIu88i8Fue//99+edl5KS4ktISPCu++677+adP3/+/L1ehz179viys7MLPI49v7i4ON/dd9+93+eXPza7b//p8MMP961cubLEt7/ooovybhsZGem9t1u3bvWVxYEHHui9t4WfV5cuXXyHHXbYXtefM2eO97jPP/983nm2DeZ/Pv7ToEGD9tpmimPvTbVq1Qqc57/fX375Je+8jRs3eq/3tddem3dejx49CnwGinLZZZd591WYf/tMTk727ruoz6BdZ1/bYFZWlq9Vq1ZevLY95ZeTk7PfGAAAgYPxV/CPv955550C45HevXv7Zs6cud/XofB4xN47G6MZe/yGDRv67rrrrrzX9pFHHsm73T333OPdbuHChQXu78Ybb/RFRUXljfP828nDDz+cdx0bRxx88MF7vYfmuuuu88YY9hoUtd0VZ8uWLb769et791sW//73v714vv766wLn23O284sat/bp08fXv3//vbarwqeaNWv6vv322zLFBQQrpkeFActE29ECO2pvGXf7t7jSTGt2atNabO5rflaua9l9O0Ljv54pfL3CR23sNjZv1/qd2P9bNYX/NGLECO+Ik1U07OtIld2uMpcwzF+hYlUoFpsdubLHLSrjn7/RmpWlWvmyHUXIn/G38+yy/CWlVoFhTe38R4ysbNrKdO26+3oNiiq5tqMXdsTG/z4WtUJBcew9stvbqlN21MpiKcvUqoULF3oNg+2Iof95+Vk8RTVZ9E+hKhyvf2UpO9n2aSW81gzQjjqW5rkV1rlzZx188MF5f9tRRnu9878v9j7ZY1nJclmdeOKJ3n2XhW1jy5Yt894XiyU/pkABQPBi/BWc469DDz3UG49YtY9Vs9jqRxZfadl7bVOhrWLFqqHs3+Lef3ssG6/YFOn875X1lbGYf/nll7z336YFWXWSn203l19+eZHjNJtmbf0FS9P42l9BbVOurPKpLGyMauOiwr1u/GO64saIRY35bDu298N64Fhls1Vy27ircH9EIJQxPSoM2JemfenbF6iVX9qXv00ZKW6FIStRtDnS+Vn5pf9y/7/2A2g9PPKzH8DC5ZH2pf+f//zHOxXFusW7ZHOkb7/9dm+qUEpKSoHLbFBT+Ael8M65zSm2ks7CO9h2fv77sx9B+/F89tlnvZ10ex/8rCy4cDlq/vvJP7CxEl3/3GNL4NiUHHt/bQWpkkyRstJcf5M3KyG2rv42qLOeKvYc7Dnn/9G0hrpFTfex0mRTeGqUsThsHnRh/tUSCsdppbf2HPyszNu2JdtOX3rpJW8w4p/Sld/+Sn2tvLgwGxDlf1/uvvtur9TYBgHW2O6II47QGWec4fWUKanyTOFasmSJ9689NgAgdDD+Cq7xl5/1/7GTsffLGuRa8sEO7ti4o6TjEetTZ++nLZ1t08L79OnjTbEq3OvO2H3PnDmz2ANA/vfK3n+bSm1Jp329/8amV1sSzBIcpWFjLlsZ1HoA2pLnfnaAzz9Vyc/iLbwIhiXMrH+hTV8r3HfGP/4rboxY1DjWpsTln6Jl74n1IbQ47eAhEA5I2oQJy+xfcMEFXkLAqisKH9GvLP7mabYyUHHzbUuzc1zR7IfbfojtR8jm/Foyw47a2JxZ631SuPlbcaszFXd+/uaB9qN/2223eXObbT6uJUJs4GVHx/I/jv0Y52dHFSyW4tiPly1/aEdh7OhZadntbf60HZGxH337kbcqHD+bY124aa6xQahd3/rDFGbPwV7DwvwNDUvSv+fwww/3/rXnZT/MNug555xzClyncHPGsrwvNhiwxMlnn33mHcWxJJH1DrB58YWXryxOUYOM4qpk8g8WAQChjfFX8Iy/9jVOsr45Nk6w8VJJxyNWTWK9bWxMZYkM66FXHIvDXg9bqakodmCpNKyyxxIv1lMnf5LIVri0pJOdZ69D4d6DtjCDJbcefPBB7wBWflbZYlVI+VkSzN+o2c/fCLqog3r+Ma6NB/P3NvSf5+99uC+WsLIKbXs/rAJqfytbAaGApE2YGDlypPdDY0sZ2o9NcayC44cffvDKePMf7bEVBPyX+/+1Hxjb2c2f3bdqj/z8KxvYj3P+SopAYSsOWLLCflCt6sQv/2oPFcU64tuP3X//+98C59uRsPxHEAo/tr9hbnH8VTGFj/qUVOHb24Ah//LbVplSmFXlWJNfq1IpijVQtGaK1sgv/4DAbue/fH9sYGGs4bKxhFRlvC/GBi42ALOTPZ4lcmxw5U/alGWakv91K7yig/9oqZ//aKmt7LCvzwhTpQAg+DD+Cp7xV0nHSaUZj1jSzhZBsCSRTScvjo0FbPyxv/fK3n9bttuum7/apvD7b1VMxpJGhVlizCqE7QBV/ml1thqXjX3sPEukFWZVN4Wfd1EVRpa0sedjTbAL84//rMFz/gSNLbZgDajzrzpa0jEiSRuEA3rahAn7Yn/uuee8L2ObClMcK+W0H/inn366wPn2xW47jf4VEPz/Fl79wN/dPv8RECvLtPmotlNamJXv7ktlLznpP0KT/wiJ/b9/qeWKfqzCR2JsDnPhihT7wc5/8h+VKO61skGIvTf5VyOwedD2ulk59r7KoO31tfJXqxSx/i/G/s3/+EVV0viPohQ3N9uOStl2lL8k20phrWrIjo4UPrpSlC+++ML711+aa69D4demItjc9sKfFStfzl+66x8QlGa5T38yxj8P3RR+TYy9bzZ4ss9O4fvPv72UJQYAgFuMv4Jn/GVjp6IqZqwCN/+KR6UZj1iyyKp77H3d15Ru68tjU4psxbDC7Hffn6Sw7cT+37YpP9tuCveesSXQbVWpwidL5tnzsP/Pvz1aQtH6JFl1jK3eWdzBqMLP29+r0M96Ednql8WND+1ApFVV2Vgof+WxPR/bzoubPpifVWdZ1Y+9nvXr19/v9YFQQKVNGCmuPDY/+wK3HxgrA7XSSdthtikjVoJomXf/jqhlyq2fipVQ2pEHmzNrmX+rvijMSiyt6sJ21q1E2JIC9oVrzd/sqFLh+bHlXXLSfmwSExMLnGdHOGy5w8Lsh8Oe03XXXec9llWF2ACn8NzqimBLOltlilVz2OtlR5msL0zr1q1LdHtrzvv77797PVesV4u9bhbrpEmTvOlD+ZeitMGBlbja637IIYd459mRPqt8sSqSJk2aeKXa9vg2KHvsscf2mh9dHPuRtR93O4JSeE69n73XtrSmLVVpySKLzY6m2TZV+EiXsdfeli/1z5meMWOGtxynHQErqrleRbLt0V4jS05ZxY0d/bGjcjYX28+fuLIBjR1hswHgvo6Y+Qcm9hrZa2Dvld23LZHuH3jl3zZtsGKfPftc2fZhA0J7X6xBsn8AV5YYAADuMf4KjvGXjUNsavQJJ5zgXWZVT/YbbNUl9v5YIqS07Pnfeuut+72eLe1uvX0sVpseZr/5NvXHYrUxiW0TNiayOAYNGqQbb7zRO8/eU5sCVbja2saJRfX1s23J+vXYc/Szpdat2sn6+9jUdH/PQj97zUo6Vt1Xv0M/a4xsC01YT0Ubx1hS0catVt3s7+GUnz1/G6NaQs0qcmwcaduJvVdUISNsuF6+CpW/5OS+FLX0X2pqqu/qq6/2NW7c2BcTE+Nr166dt0Rf/uWHTVpamu+KK67w1alTx1um8Nhjj/WtWrVqr6UWzYYNG7wli5s1a+bdpy17aMsg/uc//8m7TkUtOVnUyZZLLG7Jyblz5/qGDh3qS0pK8tWtW9d3wQUX+GbMmLFXLEUtK22GDBniLXG9v9fWllu0paZt+U1bptKWtJ4wYYJ3ezvtz9ixY33HHHNM3vtiy4jafViMhd8b/2uR/3naEpb2PBs0aOCLjo721apVy/v7s88+85WGLbNo9/3UU0/t83q2fdhSk/Ze27KatpRjUUs0Fl7y25Yht2Umx4wZk7fEaVmX/C5qWcvCr7ctr9q3b19vCUl7Xzp27Oi77777fBkZGQWW07z88st99erV85YX9X91FrVsZ35LlizxXmN7/va633zzzb7vv/9+r/fG/Pbbb75hw4Z576s9l+7du3tLZu4vBgBA4GD8FbzjL3vPbFn25s2be7/b9pi9evXyPf74477MzMz9vg77ijW/4sYO9v7fdNNNvrZt2/piY2O912TgwIG+Rx99tMCYxJbjPuOMM3zJycne0u32/9OmTStyye/9vTb5t9niTvu7Tz9b1rxJkybea7Y/n3zyia9nz57e69y0aVPfrbfeWuA5Frdd2Ws7YMAA3/vvv1+imIBQEWH/cZ04AgAAAAAAQEH0tAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIACRtAEAAAAAAAhAJG0AAAAAAAACEEkbAAAAAACAAETSBgAAAAAAIABFuw4AQDEy0qWMDCnT/v3fKTOj0P/v+d91MqTISCk6RoqJkaJj//7/2DgpPkGKS5QSEnP/384DAAAIRdnZ0u6df4+b7N/MTCnrf2Mm/9/+/8/OkqKicsdHsfH/+zf/6X/nxf3v78go188QQBghaQO4GEhs2yxt3SylbJK2/u+Usvnv/9+5XfL5Ki8GG5gkVpdq1ZXq1Jdq15Nq+/+tl3tejdpSRETlxQAAAFAaOTnSjhRp21Zp+1Zp25bcU/7/t8tSbRyVU3lxxCVIterkjqP8p5r/+7f2//6tXrPyHh9AWInw+SpzzxAI40HFhjXSysXSqqXSpnV/J2W2p1TuQKKiWKVOzToFEzlNWkrN20oNmpDQAQAAlcOqX9atlNYsl9askFYvl9atyB1L2RgrGMTE5o6jLIHTuIXUtJXUrJXUpFVu1TMAlBBJG6AiBhY2qFi5JPe0aom0epmUvkchKz4xd+BhCRw7tWgrNWqeW8EDAABQEjnZ0oa1/0vOLJfWWoJmWe7BrmBJzpSWHfSq2zA3ieM/NWst1WvEATEARSJpA5Q2QbNsgbR8UW4FjVXSrF+VO+Up3NkRJavEsQRO8za5yZxmbaRoZmECAADlHtBaOk9aMEtaOCt3TGVjK+ROuWrSQmrZXmrfVWrXTapRy3VUAAIASRtgX7KycgcU86dL82dIS+ZJWZmuowquAUiH7lKXXrmnhs1cRwQAAKrKnjRp8ZzcBI0lapYvzG36i5Kx6ejtu+WeOvXMnW4FIOyQtAEKs8qZWZOlOVOkRbNDe5pTVbO+OF0OlDr3kjofICUmuY4IAABUZJJm4cy/K2msIplq5IpjU9Ft/NTpAKlj99zp6gBCHkkbwJIy86ZLsyfnnjavdx1ReLAlyq0E2J/Ead2RnjgAAAQbW7lp+gRp2p+5lclUJFcNGzO16SwdeFDuiSocIGSRtEF4svnTMydKf/4kzZrEACMQJFSTuvWW+gyRuvbO7ZEDAAACjzUPnvJrbrLGppGzO+GWNTBu00nqPVjqNSh31U8AIYOkDcKHrUKwYIb058/S1N+ltF2uI8K+EjgHDJD6HpJbAkwFDgAAbtmKTpN+kSb/krtaJgI3gWPVywceLPU+mAQOEAJI2iD02UpPf/2UO9DYtsV1NCitpBpSn4OlAcOk1h1cRwMAQPjYlSpN+DH3tGKR62hQlgROqw65CZw+g0ngAEGKpA1C08a10l8/S3+Ny20sjNBpwDdwqNT/MKlWXdfRAAAQmhbNkX75Wpr8K0tyh4qISKlbH+mQo3OnoVtvQQBBgaQNQoetTmDzq3/8XFoy13U0qOyBR+ee0iHHSj36MfAAAKC8du/MragZ/7W0doXraFCZ6jaUhhwlHTRcql7TdTQA9oOkDUJjkDH+G+nnz6Wtm1xHg6rWoIl0+PHSoOFSXLzraAAACC52oGv8/6pqMtJdR4OqFB2Tu/LUIcdI7bq4jgZAMUjaILhXLvjxU+n3sbnLdiO8Vauee9TosONY9hIAgH2xcZONn375Rlq9zHU0CARNWuYmbwYcJsUnuo4GQD4kbRB8FsyUvv9YmjFR8uW4jgaBeNTIlg0fPkpq1tp1NAAABA5bOfOnL6TvP5F2bncdDQKRJWwOHiEdMVqqUdt1NABI2iBoZGVJk8blDjJYZhIl1bFnbvLGGu/ZCgoAAISjnanSD59IP32eO60c2J/YOGnwkbnJGyqYAadI2iCwZWVK476Svv2A5bpRvlWnRpwkDTxcioxyHQ0AAFVjxzZp7Ee5Y6k9u11Hg2AUEysdfIR05Mms3Ak4QtIGgSknR/rrJ+mzN6TNG1xHg1DRuLk08hzpgAGuIwEAoPLYgS474GU9a2gujIqafm7Tpo48Rapdz3U0QFghaYPAM3Oi9PErNMZD5bEVEk48T2rb2XUkAABUHFtF86t3c5sMW7UyUBnJm0HDpKNOlerUdx0NEBZI2iBwLJ0vffhfaeEs15EgXBwwUBp1jtSometIAAAo32pQ37yfOxWKyhpUhajo3GlTx58hVa/hOhogpJG0gXvrVuVW1kz7w3UkCEeRkdJBI6Tj/o9GewCA4GLD+L9+lj56WUrZ7DoahKPEpNzEzaHH0DcQqCQkbeCODS6sZ80f3+f2sAFcr5IwdKR05GgpoZrraAAA2LdlC6R3n5eWzHMdCSA1aSmNuUTq2MN1JEDIIWmDqpeZIX39nvTdh5TwIvAkJedW3RxiR4wiXUcDAMDeTYY/ekX688fcShsgkBx4kHTyhfS7ASoQSRtUrXnTpTf/LW1Y4zoSYN9ad5TOuir3yBEAAIFw0Gvsx7kHvtLTXEcD7Lt6+YjRucuE25LhAMqFpA2qRuo26b3/SH/+5DoSoHQrJNiA4+hTc/8fAAAXZvwlvfOctHm960iAkqvbQBp9QW71DYAyI2mDyvfrt9IHL0m7d7qOBCibxs1zq27asEQ4AKAK2djpneelCT+4jgQouy4HSmdfLdWq6zoSICiRtEHlsaNBrz0pzZvmOhKg/CIic1dGsCXC4xNcRwMACHWzJkmvP8mqUAidVaasUfGAw11HAgQdkjaoeLZJ/fxFbpM85lwj1NSuL51xudStj+tIAAChKG2X9N4L0m9jXUcCVLxeg6QzrpCq13AdCRA0SNqgYm1YK732L2nhLNeRAJWr36HSqRcz6AAAVJw5U3PHUVs3uY4EqDzVa0pnXikdMMB1JEBQIGmDivPHD9JbT0vpe1xHAlSNpBq5vW4YdAAAymNPmvTBi9L4r11HAlSdgUOlUy+REqu5jgQIaCRtUH6WpHnrGemP711HArhx2HHS6PNZ1hIAUHrzZ0ivPi5t3uA6EqDq1a4nnXON1OkA15EAAYukDcpn7Urp+fuktStcRwK41byNdNHNUoMmriMBAASDnBzp8zelr97J7QcIhKuICOnQYzkABhSDpA3KzpaffJPpUECeuATp//7ByggAgH3bmSq9+KA0Z4rrSIDA0aKddOltUp36riMBAgpJG5ReRrr09jOsagAU5+AjpNMu5WgRAGBvyxdJz90jbdnoOhIgMPsFXnQj06WAfEjaoHTWr5Keu09as9x1JEAQHC26VarTwHUkAIBA8cs30tvPSlmZriMBAldkpDTqHOmI0a4jAQICSRuU3J8/SW/8W0pPcx0JEByqVZcu+KfUtbfrSAAALmVm5C7a8Nt3riMBgkfvwblNiuPiXUcCOEXSBvuXlZU7HcqODgEonYhI6djTpGNPz220BwAIL5vXS8/eK61c7DoSIPg0aSldervUoLHrSABnSNpg39J25Q405k1zHQkQ/EeLzruOPjcAEE5mT5ZefEjaleo6EiB4JVSTLrhB6t7PdSSAEyRtULyUzdKTt0mrl7mOBAgN7btJl92eO20KABDafvxMevcFyZfjOhIg+Fm1slUtU7mMMETSBkWzRI0lbCxxA6DiNG4uXXkvy1kCQCj78GXp2/ddRwGEnv6HSedcK0VFuY4EqDIkbbA3mwr17D1S2m7XkQChqWYd6cp7pGatXUcCAKhI2dnSa/+S/vjBdSRA6OraR7rkFhoUI2yQtEFBNsh47QkpO8t1JEBoi0/MXRK8cy/XkQAAKkL6Hum5e3P72ACoXK07SlfcIyUx5Ryhj6QN/vbl29Knr7uOAggfUdHS2VdJA4a6jgQAUB6p26Qnb5eWL3QdCRBeU86vuk+qXc91JEClImmD3FLet55mSW/AlZFnS0ef6joKAEBZbFovPXGLtGGN60iA8GMJm6vvlxo1cx0JUGlI2oQ7r5T3Pmn2JNeRAOFtyNHS6ZdKkTTWA4CgsXJx7sIN21NcRwKEr6Tk3KlSrTu4jgSoFCRtwj1hYwONhbNcRwLAHHiQdOFNrIgAAMFg3nTpmbulPSzcADhnTYkvuVXq2tt1JECFI2kTrjIzpKduzx1wAAgcfYdI5/9Tiox0HQkAoDjzZ+SOozLSXUcCIH+vwPOuk/oe4joSoEKxVxCuCZun7yJhAwSiieOlVx+XyKcDQGBaNEf69x0kbIBAY6vfvvRw7lgKCCEkbcJNVmbucpRzpriOBEBx/vhBeuMpEjcAEGiWLZCeui13ijmAwJOTI/33YWnKb64jASoMSZtwWyXqhQekmRNdRwJgf2w1t3eecx0FAMBv5RLpX7dIafSwAQJ+n+c/D0oz/nIdCVAhSNqEixz78npAmvaH60gAlNRPn0vvv+g6CgDAmuXS4zdLu3e6jgRASadK2eyC2ZNdRwKUG0mbcEnYvPQIZYJAMBr7kfTxq66jAIDwtX619PhN0s7triMBUNq2EM/eIy2a7ToSoFxI2oTDvM5X/iVNHOc6EgBl9fW70hdvuY4CAMLPpvXSYzdK21NcRwKgLKxh+FN35E5vBIIUSZtQZk1MX39SmvCD60gAlNdnb0jffOA6CgAIH1s3SY/9U0rZ7DoSAOWRtiu3H9WGNa4jAcqEpE0o++x16bfvXEcBoKJ89N/cBsUAgMq1MzV3StTmDa4jAVARUrflfqZJwiIIkbQJVb+Plb58x3UUACraW89I82e4jgIAQrwPxt25vWwAhI4tG6UnbpX2sAIcggtJm1A0b7r0+lOuowBQWashPH+ftHGt60gAIDS99oS0cJbrKABU1kpwLz6U2/cTCBIkbULN2pW5y9vZjh2A0LRzh/TvO6Xdu1xHAgCh5fM3pQk/uo4CQGWa8Zf0CStzIniQtAkhKek7lfHa49Luna5DAVDZ1q2U/vOAlJPtOhIACAkrFkyS74u3XYcBoCp8877050+uowBKhKRNiMjKydZtU17VRV0Slda0hetwAFSF2ZOl9190HQUABL25KSt07pIP9N6wAfLFxrkOB0BVTYVcusB1FMB+kbQJEU/M+UQzti7V4sg9OvHAZG3s0s11SACqwg+fsqIUAJTD5j3bdcvkV5SRk6VnElN07/ADlF2jluuwAFS2zAzpmbtYUQoBj6RNCPhsxR/eyS81Ilsntc3W9AH9nMYFoIqwohQAlEl6dqZunvSyNqfvyDtvbPQOXTSklfY0be40NgBVYPvW3MRNRrrrSIBikbQJcjO2LNUTsz/Z63xfhHR5g1R9PHSQfDGxTmIDUEWs8bg1IGdFKQAolcdnf6R521ftdf6CyD066cCa2tS5q5O4AFSh5YukV//lOgqgWCRtgtiGtBSvj02Wr/hGpP9KStHDw3opp3qNKo0NQBXblcqKUgBQCt+unqSvV00s9vLtEVk6sV2OZlK5DIS+ieOkr951HQVQJJI2Qdx4+NbJryolY/8rRX0Zu0OXHtpO6Y2aVklsAByuKPX6E66jAICAtzx1gx6f9dF+r2eVy5c1SNWnVrkcHVMlsQFw5NPXpLlTXUcB7IWkTZB6ZeF3ml9EOW9x5kTu1ui+tbW1Y+dKjQuAY5N/pTExAOxDenaG7pj6mtKyM0p8m8eSUvTo8N5ULgOhzOeTXn5M2vl3jysgEJC0CUKzti7TW0t+KvXtUiKyNKqDNLdf30qJC0CAePd5ae0K11EAQED61+yPtTR1falv93nsdl12aFsql4FQtm1L7lLgQAAhaRNkdmel697pbyvbl1Om22dHSBc12qmvDx8kX1R0hccHIADYCggvPJC7lCUAIM93qyfrq330sdmf2ZFpOsUqlztQuQyErGl/SOO/dh0FkIekTZB5as6nWrt7S7nv54HqKXpiRB/lVKteIXEBCDBrlkvv/cd1FAAQMFbs3KDHZn1Y7vvZYpXLHaX5fftUSFwAAtB7L0jrSt6KAqhMJG2CyG/rZ+urVX9V2P19HLtdVx/WQRkNGlfYfQIIIOO+lKb/6ToKAHAuIztLt095vVR9bPZXuXxB41365jAql4GQrVp+8UEpK9N1JABJm2CRkp6qh2e+X+H3OzVqt8b0r6ft7TpW+H0DCACvPymlbnMdBQA49fLCb7U0dV2F3+/9ySn6t1e5nFTh9w3AsZVLpE9ecx0FQNImWDw08/0SLe9dFhsjMjWyS5SW9O5dKfcPwKEdKdLrT7mOAgCcmb9tld5dOq7S7v+D2O265rBOyqzfqNIeA4AjYz+S5k1zHQXCHEmbIPD5ign6fcOcSn2MTPl0dtPd+vGQgfJFRlXqYwFw0FDv97GuowCAKpeZk6X7Z7xT5gUcSmpK1C6NGVBfO9p2qNTHAeBgGfD/Psoy4HCKpE2AW7Nrs56e+1mVPd6dNbfpheH95EtIrLLHBFBFy4BvLv0StwAQzF5dOFbLyrC8d1ls8CqXo7X0wAOr5PEAVOEy4G9QtQx3SNoEMDsqdM+0tyqsaV5JvRW/TTcM7aKsuvWr9HEBVKK03UyTAhBWFmxfrbeW/FSlj5kR4dNZzdL0s1e5zDAbCBlTfpNmVNyCMEBp8GsSwN5Y9IPmbFvh5LH/jNqlMwY2UWrrtk4eH0AlmDtVmvyr6ygAoNJl5WTr/umVPy2qOLfX3KaXhveXL57KZSBkvPOslL7HdRQIQyRtAtTSHev06iK3PShWR6ZrZLd4rep5gNM4AFSg915gwAEg5NkYqjJWiyqN1+O36cahXZVVh8plICRs3iB99Y7rKBCGSNoEqKfmfurs6FB+6RE5Oq1lun4fPEC+CDYXIOilbJa+eMt1FABQaayHzZuLf1Qg+CN6p848qLF2tqJyGQgJ330krV3pOgqEGfbCA9Cv62dryuZFCiQ31t6u14cPkC8u3nUoAMrr+08YcAAIWU/O+SQgDnz5rYrI0KgecVpN5TIQ/LKzpLeedh0FwgxJmwBcmvLZuZ8rEL2UkKLbhnVXdq26rkMBUN4Bx9vPuo4CACrcuHUzAu7Al0mTT2NapuuPg6lcBoLegpnShB9cR4Ewwq9GgPlw2a9avXuzAtX46J06Z3Bz7W7R2nUoAMpj/nRp4jjXUQBAhUnPztAzAXrgy++fdbbrDSqXgeD3/kvSrlTXUSBMkLQJICnpqXpt0fcKdMsi9mhUz0St69bDdSgAyuP9F6U9u11HAQAV4u0lP2t9WooC3YsJKbpjWA9l16rjOhQAZZW6Tfr4VddRIEyQtAkgLy74RruygmNVl10ROTq5TaYmH2RlvhGuwwFQFtu2SJ+96ToKACi3DWkpemvxTwoWP0en6tyDm2t381auQwFQVr98Iy1d4DoKhAGSNgFi8Y41+mrlXwo2V9fdrveHDZQvJtZ1KADK4qfPpDXLXUcBAOVi06LSczIVTJZGpmvUAdW0vmt316EAKAtreP7205LP5zoShDiSNgHiqTmfKkfB+YF/OjFF9w3vpewatVyHAqC0srOlt55xHQUAlNm0zYv187oZCkZWuTy6bZamDuxP5TIQjJYvkqb+7joKhDiSNgFg/LqZmrZliYLZdzE7dNGQVtrTtLnrUACU1sJZ0szgq/QDAJ/Pp3/P/UzB7sr6O/TBUCqXgaD02etSTo7rKBDCSNo4lpGdpWfnfaFQsCByj046sKY2de7qOhQApfU5vW0ABOcS34t2rFEo+He1FD0wvJdykmu6DgVAaaxdKf0ZPD21EHxI2jj2wbLxWrt7i0LF9ogsndguRzMH9HMdCoDSlvdO/9N1FABQYjm+HL288DuFkm+scvmQNtrTuJnrUACU9uBXVpbrKBCiSNo4tDU9Va8v/kGhxhchXdYgVZ8NHSRfdIzrcACUFNU2AILID2umafnODQo18yPTdHKfmtrcqYvrUACU1Ob10m+hlURG4CBp45AtTbk7K12h6tGkFD06vLdyqtdwHQqAkli5WJo2wXUUALBfWTnZemXRWIWqlIhsjWrv0+z+fV2HAqCkvnpHysxwHQVCEEkbR1Iz0/TFytCfivB57HZddmhbZTRs4joUACWttmHpSgAB7rvVk7V61yaFMqtcvqThTn1+uFUuR7sOB8D+pGyWfg6NXqUILCRtHPlk+e9Kyw7dKpv8ZluZb7862tqhs+tQAOzPqiXStD9cRwEAxcrMydKrIVxlU9gj1VP0r+F9lJOU7DoUAPvz9fvSnt2uo0CIIWnjaMWoj5b/qnCyJSJLozpKC/r2cR0KgP2h2gZAAPty5V9an5aicPJJ7HZdflh7KpeBQLdzu/T9J66jQIghaePAt6sneU2Iw012hHR+41369rBB8kVR5gsErNXLpKm/u44CAIrsZfPm4h8VjmZG7tap/eoqpX0n16EA2JexH0u7d7qOAiGEpI2D5SnfXTpO4ey+5BQ9PbyvcqoluQ4FQHGotgEQgH5YO1Ub92xTuNoUkakTO0dqYR8ql4GAlbZL+vVb11EghJC0qWK/rp+tVSHeOK8k3o/bpmsP66TM+o1chwKgKGuWS1PCaxongMD3/tJfFO4y5dN5TXZp7KGD5IuMch0OgKL89LmUk+06CoQIkjZV7O0lP7kOIWBMjtqlMQPqa0fb9q5DAVCUbz9wHQEA5Jm6eZEW7VjjOoyAcU+NFD07op98iVQuAwFny0Zp2gTXUSBEkLSpQtO3LNHcbStdhxFQNkRkamSXGC078EDXoQAobPkiadkC11EAgOe9peNdhxBw3rXK5cM7KbNeQ9ehACjsx89cR4AQQdKmCr295GfXIQSkjAifzmyWpnFDBsoXySYJBJRxX7mOAAC0cudGTdg4z3UYAWlS1C7938CGSm3dznUoAPJbOEtaudh1FAgB7CFXkWWp6/Ung419uq3WNr00vL988YmuQwHgN2m8tCv8VrsDEFg+WPaLfKI5enHWRmRoZLc4LT+gl+tQAOT3w6euI0AIIGlThVU2DDb27/X4bbpxaFdl1annOhQAJiNd+v1711EACGM7Mnbp29WTXYcR8NIjcnRGiz36xSqXIxjiAwFh4nhpR/iueIeKwTd6FdiUtk0/rJnqOoyg8Uf0Tp15UBPtbNXWdSgAzPivWP4bgDOfrZygPdkZrsMIGrfU2qaXR1jlcoLrUABkZUrjvnQdBYIcSZsqGmxk+VjyrTRWRWRoVI84re55gOtQAGxYI82b5joKAGHI5/PpixV/ug4j6Lwav003D+umrNpULgMB0R/QkjdAGZG0qYLBxtg1U1yHEZTS5NOYlumacPAAynwB12hIDMCBqVsWa13aVtdhBKXfonbqrIOaalfLNq5DAcLbjpTcHoFAGbEnXMlmpSzTut0MNsrjhjrb9cbwAfLFxbsOBQhfM/6UUja7jgJAmPl61UTXIQS1lZHpOrFHgtZ07+k6FCC8jfvadQQIYiRtKtlYetlUiBcTUnTnsJ7KrlXHdShAeMrOln75xnUUAMLIrsw9+mX9LNdhBL1dETk6tXWG/vIqlyNchwOEpyVzpU3rXUeBIEXSphJl5WTr57XTXYcRMn6K3qFzD26utGYtXYcChKdfv81N3gBAFfhp3XQaEFeg6+ps1zvDBsoXG+c6FCA8/fWz6wgQpEjaVKIJG+dpR+Zu12GElKWR6RrZK0kbunZ3HQoQfrZtyZ0mBQBVgKlRFe+5xBTdZZXLNWu7DgUIPxNJ2qBsSNpUou9pQFxpZb4ntc3S1IH9XYcChB+OEgGoAit3btTslOWuwwhJP8ak6vzBLZXWtIXrUIDwsnaltHKJ6ygQhEjaVOI87N83zHEdRki7sv4OvT9skHwxsa5DAcLHrEnSnjTXUQAIcVTZVK7FkXt04oHJ2tilm+tQgPDy10+uI0AQImlTScatm6GMnCzXYYS8f1dL0QPDeyknuabrUIDwkJHOFCkAlSrHl6OxVCtXutSIbJ3UNlvTB/RzHQoQPiaOl3JyXEeBIEPSppKwalTV+SZmhy4e0kZ7GjdzHQoQHiaNdx0BgBA2J2WFNu3Z7jqMsOCLkC5vkKqPh1K5DFSJlM3SQlbFQ+mQtKkEm9K2afqWxa7DCCvzotJ0cp+a2typi+tQgNA3e4q0e5frKACEKJb5rnr/SkrRw8N6Kad6DdehAKFv4jjXESDIkLSpBD+snaYc+VyHEXZSrMy3vU9z+vV1HQoQ2rIypekTXEcBIET9tn626xDC0pexO3Tpoe2U3qip61CA0Db519yxFFBCJG0qAfOw3cmOkC5utFOfHz5Ivuho1+EAoWvaH64jABCClu5Yp9W7N7sOI2zNidyt0X1ra2vHzq5DAULX7p3SrMmuo0AQIWlTwZalrtfiHWtdhxH2Hqmeon8N76OcpGTXoQChac6U3KbEAFCBmBrlXkpElkZ1kOZSuQxUnqm/u44AQYSkTQX7bQMlvYHik9jtuvyw9spo0Nh1KEDosYTNXBquA6hYJG0Cp3L5okY79bVVLkdRuQxUuLlTJB/tNFAyJG0q2NTNNCAOJDMjd+vU/vW0rX1H16EAoWcafW0AVJz1u7dq0Y41rsNAPg9UT9ETI/oop1p116EAoWV7irR6mesoECRI2lSgjOwszdrKhy/QbIrI1KjOUVrUp7frUIDQMuMvKSfbdRQAQsSvNCAOSB/HbtfVh3WgchmojNU4gRIgaVOBZqcsU3oOncADUaZ8OrfJbn1/6CD5IqNchwOEhp3bpSXzXEcBIET8tmGO6xBQjKlRuzWmfz1tb0flMlCh/QGBEiBpU4GmbF7kOgTsx901UvT8iH7yJVRzHQoQGubPcB0BgBCwJzvDO/iFwLUxIlMju0RpSW8ql4EKsXiOlL7HdRQIAiRtKhBJm+Dwdtw2XT+0izLrNnAdChD8FtI0FED5zdiyVBk5Wa7DQAkql89uuls/HjKQymWgvLIypQUzXUeBIEDSpoLsytyj+dtXuQ4DJfRX1E7936BGSm3dznUoQHCz6VFZ7GgBKJ/Jmxe6DgGlcGfNbXphuFUuJ7oOBQhuTJFCCZC0qSDTty5Rti/HdRgohbURGRrZLU7LD+jlOhQguJf+XkGVIYDyoVo5+LwVv003DO2irLr1XYcCBK8KTtqcffbZOuGEExSKDjnkEF111VUKRyRtKsgUjhAFpfSIHJ3RYo9+HTJQvgg+DkCZLGTFFwBll5qxW4t3rHUdBsrgz6hdOmNgE6W2bus6FCA4rV8tbdmgUJGRkbHXednZ2crJobihPNhLrSAcIQpuN9fapldGDJAvPsF1KEDwWch8bABlN2PrUvnkcx0Gymh1ZLpGdovXqp4HuA4FCE6VtPS3VaZcccUVuuGGG1S7dm01bNhQd955Z4HrbNu2TRdddJEaNGig+Ph4de3aVV9++WXe5R999JG6dOmiuLg4tWzZUo899liB29t599xzj84880wlJyfrwgsv1KuvvqqaNWvq888/V+fOnb3brly5Uunp6bruuuvUpEkTVatWTf369dO4ceMK3N/vv//uxZ2YmKhatWppxIgRSklJ8SqIxo8fryeffFIRERHeafny5QoXJG0qwNb0VC1NXe86DJTTK/EpumVoN2XVruc6FCC4LJ4rcQQFQDmmmCP4K5dPa5mu3wdTuQwE0kqcr732mpcg+euvv/Twww/r7rvv1vfff+9dZtUvRx55pJcoefPNNzV37lw9+OCDiorKbTI+ZcoUnXzyyTr11FM1a9YsL+Fz2223eUmZ/B599FH16NFD06ZN8y43u3fv1kMPPaSXXnpJc+bMUf369fWPf/xDEyZM0LvvvquZM2dq9OjROuKII7RoUW7xw/Tp03X44Yd7iR673m+//aZjjz3Wq9SxZM2AAQN0wQUXaN26dd6pWbNmChcRPp+PQxvl9MOaqbpr2puuw0AFaZ4Tp//M2K5qK5a6DgUIHrc/LTWnPB5A6Z3/6+NasH216zBQQc5Pq6Uzx01RBEsZAyVTp7700OsVcldWkWLVM59++qlXsWIJj19//TXv8r59++qwww7zkjNjx471kjbz5s1T+/bt97qv008/XZs2bfKu52dVO1999ZWXiPFX2hxwwAH65JNP8q5jSZ1zzjnHS8JYMsdYpU3r1q29fxs3bpx33aFDh3ox3X///TrttNO8yy1ZU5RDDjlEPXv21BNPPKFwQyq8AkxmalRIWRmZrhN7Jmpt99wvGQAlQF8bAGWQlpVOP5sQ81JCim4b1l3Zteq6DgUIDls2SttTKuWuu3fvXuDvRo0aaePGjd7/W1KladOmRSZsjCVzBg0aVOA8+9sqYywZ5Ne7d++9bhsbG1vgsa1Sx25jj5WUlJR3silPS5YsKVBpg71FF3EeSmkqSZuQsysiR6e0ztFjyf3V5/e/rCTNdUhAYFswUxoamqsVAKg8i3asYfXNEDQ+eqfOGdxcz09PViKVy8D+LZsv9RxQ4XcbExNT4G/rBeNvCpyQUDG9PG36VWF23/ZYfjt37vSmXdmUK//0Kz9L3lRkPKGISptySklP1bq0ra7DQCW5tu4OvTNsoHyxca5DAQLbotwyWQAojYVMiwpZyyL2aFTPRK3rRuUysF9LF1T5Q1olzOrVq7VwYdGrIHfq1Mnrd5Of/W3VMoUTL/tjU6is0saqfNq2bVvgZA2S/fH8+OOPxd5HbGxsgQqfcELSppyW0YA45D2XmKK7hx+g7Jq1XYcCBK6d26W1K11HASDILNi+xnUIqOTK5ZPbZGryQQPky3fUHUARlTZVbMiQIRo8eLBOPPFErznxsmXL9M033+jbb7/1Lr/22mu9JIqtDmWJHWtq/PTTT3srQJWWJXqsR46tMvXxxx97jzVx4kQ98MADXo8cc9NNN2nSpEm69NJLvUbF8+fP13PPPafNmzfn9c+xhsq2apSdF07LiJO0KSeSNuHhh+gdumBwS6U1beE6FCBwrWIFGAClQ6VNeLi67na9b5XLMbGuQwEC04rFTh7WlvTu06ePxowZ463aZI2G/dUsvXr10vvvv++t9mRLgd9+++3e6lPW7LgsXnnlFS9pY8mgDh066IQTTvCSNM2bN89L7FjT4xkzZnjNiW21qM8++0zR0bkdXSxZZBU+Fme9evW8psXhgtWjyunRmR/os5UTXIeBKlLdF6VXF0v158xyHQoQeI4+VRpZth9yAOEnPTtTI769iZ42YWREZrJu+m2Boiqp6SoQ1B58VaqbO1UIyI9Km3JatpNKm3CSGpGtk9pma8aA/q5DAQIP06MAlMKSHWtJ2ISZ72J26KIhrbSnae6RdQD5rKRiGUUjaVNOTI8KP74I6R8NdujjoYPkiy7YkR0Ia+tI2gAouYU76GcTjhZE7tFJB9bUps5dXYcCBJZVrLSGopG0KYfNe3YoNTPNdRhw5F9JKXp4+IHKqV7DdShAYNi0TsrKdB0FgCBBP5vwtT0iSye2y9HMAf1chwIEjpVu+tog8JG0KYdlqetchwDHvozdoUsPbaf0Rk1dhwK4Z43rNnDkHEDJLGblKIV75fJlDVL1KZXLQC4qbVAMkjblwNQomDmRuzW6b21t7djZdSiAe/S1AVBCq3bnLuOK8PZYUooeHd6bymUgZbOUmeE6CgQgkjblQNIGfikRWRrVQZrXr6/rUAC31q5wHQGAILA9Y5d2MsUc//N57HZddmhbZTRs4joUlEDL98Yr4r/f7XW67I+53uX/mb9Kh3w1Ucmv/+Cdvy29dFOnH5yx1LvdVX/OK3D+NX/OV+03flSzd8frrcVrC1z2wbL1OnbsVAU1W9R58wbXUSAAkbQph+U7+VDhb9kR0oWNdurrwwfJFxXtOhzADZoRAyiBNbuoskFBsyPTdHK/OtragcrlQDfpuAFaN+aQvNP3R/T2zh/dKne56t1Z2TqiaV3d3KN16e9703a9MH+1utdOKnD+Fys36u2l6zT2iN56uE97nf/bHG3ek1uVsj0jU7dMXqRnBnZS0NtMUQD2RtKmHKi0QVEeqJ6ip4b3UU616q5DAaoe06MAlMAapkahCFuscrmjtKBvH9ehYB/qJcSqYWJc3unLVRvVpnqChjSs5V1+VdeWurFHa/WvX7NU97szM0unj5upFw/qolqxBfsczdu2S4c0rK3e9WpoTJtGSo6J1rLU3Gq9GyYu1CWdmql5UoKCHkkbFIGkTRltSEvRrqw9rsNAgPowbruuPqyDMus3ch0KULU2rs1tSAwA+7Bm1xbXISCAK5fPb7xL3x5G5XIwyMjO0ZuL1+nc9k0VERFRrvu67I95OrpZPQ1tUmevy3rUrq7Jm7crJT1TUzZvV1p2ttomJ+q39SmaumWHrujcQiGBpA2KQNKmjJZTZYP9mBq1W2MG1Nf2th1chwJUHVvy2xI3ALAPa3aTtMG+3ZecoqeH91VOtYLTZBBYPl2xUdsysnR2u8blup93l6zzki8P9G5X5OUjmtbV/7VtrD6fTdDZv8zWa4O7qVp0lC75Y66eH9RZz81fqQ4f/qpBX/ylOSk7FbToaYMikLQpo5U7N7kOAUFgQ0SmRnWJ1pLeuXN9gbCwiaQNgH2jpw1K4v24bbr2sE5ULgew/y5crSOb1lXjavFlvo9VO9N05Z/z9dYh3RUfHVXs9e7s1VaLTx6sWaMGaWTLBnpgxlINbVxHMZGRunf6Uv12dD+d36Gpzhw/S0Fr0zrXESAAkbQpo60Zqa5DQJDIiPDp7Ka79dMhA+WL5COHMLBju+sIAAQ4etqgpCZH7fIql3e0be86FBSyIjVNP6zd4iVKymPK5h3auCdDvT6doOiXx3qn8etT9NScld7/Z+f49rrN/G079eaSdbrnwLYat26rBjes5fXaOblVA69iJzUjS0GJShsUgYmi5ViqEiiNO2pu08IR/XXRuOmKSNvtOhyg8uxIcR0BgAC2JztDW9M5+IXSVS6P7BKjl2ocqFZTprgOB//zyqI1qh8fq6Ob1S3X/RzeuI5mjRxY4Lxzfp2tjjWq6Z/dWykqsmCvHJ/Pp4t+n6vH+3VQUky0sn0+Zf4vseP/184LSrt35p4SmRaIv3HYv4xI2qAs3orbpn8O7aqsuvVdhwJUntRtriMAEMC27iFhg7JVLp/ZLE3jhlC5HAhyfD69snCNzmrXRNGF3o/1u9M1fcsOLd6Re5ByVspO7++t6blLdJvDv56kp+eu8P6/emy0utauXuBk/WrqxMd4/1/YSwtWq158rI5tnjueHtSgpn5au1V/btymf81Zoc41q6lmXMHVp4IKzYhRCN94ZUTSBmU1IWqnzhjYRDtbtXUdClA5dpC0AVC8lIwgbhIK526rtU0vDe8vX3yi61DC2g9rtmjlrj06t32TvS57fv4qHfDpBF3w2xzv78FfTfT+/nzF3z1Bl6Tu1uY9maV+3A1p6bpvxlI91b9j3nl969XUtd1a6OixU/X+0vV6ZXBXBbVNJG1QUITP6stQav837iGt2MmcQ5RdgiL03+WxajZ9mutQgIrVuZd0zf2uowAQoH7fMEc3Tvqv6zAQ5AZmJem+CcsVvWWj61CAinXqxdLQE1xHgQBCpU0ZUWmD8kqTT6e1TNfvgwfIF8FHESGEnjYA9mEbYyhUgD+id+rMgxpTuYzQk8Z3JApiT7EMcnw5Ss2kkSwqxo21t+v14QPkiyv7UolAQKGnDYB92M70KFSQVREZGtUjTqt7HuA6FKDisGAJCiFpUwapmWnK9uW4DgMh5KWEFN02rLuya5Wv+z4QEHbusKUdXEcBIEBtS+coMiq2cnlMy3RNOJjKZYQIKm1QCN9sZcDUKFSG8dE7dc7g5trdvJXrUIDyyc6WdrE6DICibaPSBpXghjrb9QaVywgFJG1QCEmbMmAuNirLsog9GnVANa3r1sN1KED50NcGQDE4+IXK8mJCiu4c1lPZteq4DgUoO5I2KISkTRkw2EBl2hWRo5PbZGryoP7yRUS4DgcoG5b9BlAMKm1QmX6K3qFzD26utGYtXYcClA09bVAISZsyYLCBqnB1vR16f9hA+WJiXYcClN7O7a4jABCgdmeluw4BIW5pZLpG9krShq7dXYcClN5uCgRQEEmbMqDSBlXl6cQU3T+8l7KTa7kOBSidjIwKuZuzzz5bJ5xwgkLRIYccoquuusp1GECVy8rJdh0CwqRy+aS2WZo6sL/rUIDSYXoUCokufAb2j6QNqtK3MTu07JBWenpKdcWvWek6nJDT8r3xWrFzz17nX9qpma7v1kqt3v+lyNu9f1gPjW7VcL/3f/Hvc/TC/NX6V78Ouqprbql2enaOzv91tj5buVENE+L07MDOGtrk7/n3j8xcppW79ujfAzopaGVlKhRkZGQoNrZgtVt2drYiIiIUGclxD6AsMnKyXIeAMHJl/R26fNggjR43SRGZFXNAAahUJG1QCCPOMtiTzRc+qtaCyD06qXdNbe7U1XUoIWfScQO0bswheafvj+jtnW8JmWbV4gtcZqe7erVRUkyUjmy6/+XZP1m+QX9u3K7GiXEFzv/P/FWasmWHJhzbXxd2bKrTxs2U739LZC9L3a0XF6zWfQe2U1DLzqqUypQrrrhCN9xwg2rXrq2GDRvqzjvvLHCdbdu26aKLLlKDBg0UHx+vrl276ssvv8y7/KOPPlKXLl0UFxenli1b6rHHHitwezvvnnvu0Zlnnqnk5GRdeOGFevXVV1WzZk19/vnn6ty5s3fblStXKj09Xdddd52aNGmiatWqqV+/fho3blyB+/v999+9uBMTE1WrVi2NGDFCKSkpXgXR+PHj9eSTT3oJIDstX768wl8zIBBl+ai0QdX6d7UUPTC8l3KSa7oOBdi/jHQpi+Q2/kalTRn4d66CyaoPJmrLH4uVtmarImOjVb1jY7U8+yAlNq3tXZ6Zukcr356gbdNWKH3TDsUkJ6p2/zZq8X8DFV2t4A5nYbtXbdHyV3/T9tmr5cvOUWKzOup40zGKr5/sXb70pfHa+OMcRcbHqOVZB6n+IX9XD2z+baE2/DRXXW4PzekPFWl7RJZGtZeeqdlP3Sb85TqckFEvoWAVxYMzl6pN9QQNaVjL25FuWCjh8snyjTq5VUMlxez763PNrj26fMI8fXdEbx09dkqBy+Zt26XjmtdXl1pJal09QddPXKjNezK9WC75fa4e6tNeybFB/vVcSYON1157Tddcc43++usvTZgwwUt+DBo0SMOGDVNOTo6OPPJIpaam6s0331SbNm00d+5cRUVFebedMmWKTj75ZC/Rc8opp+iPP/7QpZdeqjp16nj34/foo4/q9ttv1x133OH9/euvv2r37t166KGH9NJLL3nXr1+/vv7xj3949//uu++qcePG+uSTT3TEEUdo1qxZateunaZPn67DDz9c5557rpeciY6O1s8//+xV6tjfCxcu9JJKd999t/c49erVq5TXDAg0mVTawIFvYnZo+ZA2emrKRsWvXeU6HGDf9uyWknL3pYAy7RWsX79e9913n7766iutWbPGG7z27NnTm5tvA9RAYkdILS47+lpRfAq+pI0lVBod3UNJ7RrIl+PTitd/15zbP1avZ89SVHyMMrbuVMaWnWp57sFe0iV94w4tfvZH7/xONx1b7P2mrdummf98Xw2GdVHz0wYoKjFWu1du8RJDZsvEJdo0fr663D1Ke9Zu06KnxqrWAS0VUyNBWbvStfyN39X1nhOr8JUIbr4I6dIGqbpu6CAdN26iIkJkCkqgyMjO0ZuL1+mari29hE1hUzZv1/StqXpm4L6nLeX4fDpj/CxvepUlZgrrUae63li8VmlZ2fpu9WY1SoxT3fgYvbV4reKjojSyZQMFvUpK2nTv3j0vmWKJkaefflo//vijl7T54YcfNHHiRM2bN0/t27f3rtO6deu82z7++OPeb9Rtt93m/W3XsaTLI488UiBpc9hhh+naa6/N+9uSNpmZmXr22WfVo0cP7zyrtHnllVe8fy1hY6zq5ttvv/XOv//++/Xwww+rd+/e3u38rMrHz6ZdWQWOVQwB4SSTnjZwZF5Umk7uU1MvL0xW3XlzXIcDFM+X4zoCBHPSxsq37aimlYrbQLdbt27eYPa7777TZZddpvnz51dIzwBj9xsTE6NAE3wpG6nrXaMK/N3+quH66/9e0M7FG1Sja1NVa1FXnW7+OzmT0KimWp4xSAse+9arnomIKnom3Yo3fletA1uq1TmDC9zWL23VVtXo1lTV2zX0TlZ1s2fDdi9ps/yVX9XoyB55FTkouUeTUrRoeG9d88scRe7c4TqckPHpio3alpGls9vl7oQX9t8Fa9SpZjUNbLDvxtAPzVym6IgIXdGleZGXn9u+iWZuTVXnj373kjXvH9pDKRmZun3qYo07qo9unbxI7y5dpzbJiXr54K5qUi1eQSc7s9KSNvk1atRIGzdu9P7fKluaNm2al7ApzJI5xx9/fIHz7PfsiSee8Kpf/BU5lmgpzH6j8j+2VdPYbQo/lk2ZskocfzyjR48u83MFQhWVNnApJSLbq1x+rkZfdflzoutwgKJF5I5JgDL1tLFScjsCbUczTzzxRG/AakcOrVz9zz//9K5jRx5tYJyUlOT1BLBy9A0bNuTdh5WmW2WOlZm3atXK6ztg7H6fe+45HXfccV5/AKvmMZ999pl69erlXc+Omt51113KyncUt7geBtZb4JxzztH27dvzegYU7n9QFnYUPdhl7crtyxNdvfidQauEscqZ4hI2VrGTMnmZEprU0uzbP9Zf//e8pl/7jrZMWJx3nWqt6nmJoayde7x/c9KzlNC4prbPWaOdSzaq8bE9K+HZhYfPYrfr8kPbK6NhE9ehhIz/Llzt9appXESSxKpi3l66Tue1b7rP+7BqnCfnrNCrg7sWWa1jYiIj9czAzlp2ymBNOn6ADmpYS9f+tUBXdG6haVtSveTRjJED1b9+TV3x5zwFpUr6niycyLfX2KZFmYSEhAp5DPv9KczuO//7uXPnTi/JY1OuLDnjP1liyKY+VWQ8QCjJ8eUomyPICIDK5Ysb7tTnhw+SLzrIpyMjNLHYAfIp1dawdetWr/TbKmqKGtRa9Y0Nni1hY9e1Jovff/+9li5d6vUPyG/x4sVeQ8iPP/7YG+j6WVJl5MiR3lFM6wNgZenWEPLKK6/0ythfeOEFb8qTP6Hj72FgzR6th4Fd58EHH/QG0wMHDvSOoFriaN26dd7JytfLL7iTNpZsWfriOCV3auxV2BQlc3uaVr33lxqO6Fbs/WRu363stEyt/nCSavVq6U2BqtO/jeY98IW2z1rtXcfOr3dIJ02/5m0tfOI7tbt6hCLjYrTkuR/V9rLDte6bmZpy8auaccO72rVic6U951A1M2q3Tu5XRxkNiq4MQcmtSE3TD2u36PwORSdlPly2QbuzsnVm232/1r+uT9HGtAw1f+8XRb881jvZ6lTXTlzgrVRVlJ/XbtGclJ36R+fmGrduq45qVlfVYqK93jnj1qVUyPMLB1YJs3r1aq9XTFE6derk/VbkZ3/bwQd/lU1JHXDAAV6ljVX5tG3btsDJP93J4rGpW8Wx6h27DyCcMDUKgeSR6in69/A+rsMA9kbSBvmUKrVsiRZrwtuxY8dir2MDVEu4LFu2TM2aNfPOe/31171qnEmTJqlPnz55U6Ls/MKNF0877TSvOsbPEjc33nijzjrrLO9vq7SxlT1s9RDra7C/HgY1atTIbSZagT0DgjtlIy15/iev70z3h04u8vKs3emac/enXm+b5qf132fyx9Tp10ZNTujl/X9S6/pKnb9O676d6U2LMi1OG+Cd/Fa+M0E1ezT3KngsMdTr6TO0ddIyLfzXdzrgidMr+NmGvrs3Jih2w1rXYQS9VxatUf34WB3drG6xVTjWPLhw4+LCzmjbWEMb/718txnx3RTv/HPa7V0VtScrW5dNmKe3hnRXVGSEsn2+vGnMmTl2RDrYv3GqzpAhQzR48GCvCtT611gCxabs2m+ANQi2PjX2G2S/IXYgwRoZW0+c/D1nSsp+b04//XTvoIKtQGVJnE2bNnm/gZasOfroo3XTTTd5U4itQvXiiy/2kjTWiNimTNWtW9dbqcoaKtu0Y6tMtRWxWEYcoY/vNASWtul87yIAMR5APpEVvWqSJU8sWeNP2BhbItWqcOwyvxYtWhS5UkbhXgIzZszwVtawAa3/dMEFF3hVM7aax/56GGDvhM3WSUvV7b6TFFe3+l6XZ+3O0Jw7PlFUQow63XKsIqOLP/ock5zgJV4SmhfcQU1oVttbgaoou1dt1caf53urUlk1To0uTRRTI1F1D2qvXUs2eo+PkonzRerdpbHqzkpSFTLl8ZWFa3RWuyaKLuJHcvGOXfplfYrO71D0VLSOH/7mLe9t6sTHqmvt6gVOMZERapgQqw41965QvGf6Uh3VtJ4OqJvb22lQg1r6ePkGr+fN03NXalD9IF2etJipYZXNKjgtMTNmzBjvt8cS/P5qFptm+/7773urPdk0Wlshyn5f8jchLg1rOGxJG0sGdejQQSeccIJ3cKJ589xeRva7NHbsWO93rG/fvhowYIA33ddWkTJW+WkVPhan/R7a1GIg1MVEMhUFgSNBERoxbYHrMICAGUchMJXql9NW6rAjlmVpNlxYUdOrijrf+gZYD5tRowo20jXWv8ZFz4CYIGwMZQm3pS/87PWb6fbAaMU3rFF0hc3tnygiJkqdbz0+bwWo4kTGRHmrUaWt3lrg/LQ1KYqvl1xkDIuf+UGtzh+sqIRYr1InJzu3pMCX9b9y6f/1psC+1ffF6JXZaUpeMtt1KCHhhzVbtHLXHq9BcFFeXrhGTavFa3iToqtwFmzfpe0ZpW+sOXtrqt5ftl7TT/i7Eu2kVg28KVIHfzlRHWok6u1DCzbeDR4VM9iw6bB+1qessE8//bTA31at8vLLLxd7f1aFY6fiWNVLYZbUKSqxY/117PfJTvuq/ik8JcvPkjpW7QOEk8iISEVHRCnLxzQpuHfD9hqK2soqUghAkcG3v4kASdrYYHjEiBF65plndMUVV+yVYLGGwNYzYNWqVd7JX21jfWbsMjuaWFp2ZHTBggVemfv+ehgUVW1TGT0DgvEo0ZLnftKmXxao8y3HeQmTjJRd3vlRiXGKiov+X8LmY2WnZ6nTtUcoOy3DO+WvqDHWf6bFWQep7oDc96PJqN5a8PBX3gpUNbo1U8rU5do6cam63b/3iikbxs72Vo2q07eN93dy58beVKkd89cpZcoyJTarreikIFwlp4p1yk7Q05PWK3b9GtehhIzhTevKd96IYi+/v3d771Scfd3WLD9lSJHnWxXOotEHFzgvMiJCzw7q7J0AIBTFRkUry3+wBnCkmi9Sh04r/4FooFIwPQr5lDr7YAkbWyLVSr2trNySJraSkzUctpWfLEFjc/htrr81AbbLbD6/HW0sahnV/bHy9WOOOcYrNz/ppJO8+f5Waj579mzde++9++1hYD0DrFrH+gz06NFDiYmJ3qk8ooMw87n+m5nev7Nu/qDA+e2uHK4GQ7t4KzmlLljvnTflwlcKXKf3S+cqvkGNvCqa7F3peZdZ8ibr0sO1+oNJWvqfn5XQpLY63XSsN+0pP0sSrXp/oro//HdD6urtG6rJCQdq7t2felOk2l+97x1fSIdlJev2XxcoajvNaRHgWI0DQDFiI2O0W3+PJQAXbtqWrKhtVCwjQKdGMT0K+ZR6VG1NfqdOneqt3mTz+K23jM3FP/DAA72kjSVLbM7+5Zdf7iVTLMliyZN///vfKgur7LHluy1B9NBDD3nl6NYI+fzzzy/Qw8B6A1gPg127dnmJG1tBytgKUtYA0ppObtmyxWteXN5lv2ODsNLmoC+u3uflNbs12+91irufhsO6eqd9ia1VTX3+e95e5zcf0987Yf/O2FNTF4ybpog9aa5DAfYvMcl1BAACVDCOoxBaaviidfBUpkUhQFFlg0IifCXpLowCXl04Vv9d+K3rMBBGbkqtpSN//lMRLJWKYHHxLVLvglO/AMCM+fkBrd61yXUYCGMPb6mhAb/SUwwBKjpGev4L11EggHCoowxignB6FILX0xuqq8eEohuZAgGrGpU2AIpGpQ1cquOLVr+pTItCAIuJcR0BAgy/mmWciw1UxZLery2PVpMZLOmNIMT0KADFiCNpA4du3VJNkbtSXYcBFC9p71V+Ed741SyD5NjyNTIG9qeeL0avzklT8mKOBCFIkbQBUIyE6DjXISBMNfDF6MApuYtzAAGrOkkbFETSpgzqxvNBQuXpmGNLem9Q3LrVrkMByo6kDYBi1Iit5joEhKnbNiYoIm2X6zCAfaPSBoXQmroM6sQluw4BIerQrOp6/pdlJGwQ3GyZygR2ygAUrVYsSV1UvaY5ceo+bYbrMID9o9IGhVBpUwZ140naoOKdnl5TF/3Mkt4IAZawYblKAMWoFVfddQgIQ7duiGGMheBA0gaFkLQpg6SYBMVHxWpPdobrUBAiWNIbIYWpUQD2oVZc8H5HrPpgorb8sVhpa7YqMjZa1Ts2VsuzD1Ji09p518lI2aVlL/+ibdNXKjstQwlNaqvZyX1Vd1C7fd53+padWv7qr0qZslw56ZmKb1RT7a4crurtGnqXr/54stZ8PNn7/yYn9lHTkQfm3TZ1wTotfu4n9XxsjCKiSJoX1soXr85U2SBYJFEggIJI2pRRnbjqWrN7i+swEAKe2lhdB/zBkt4IIYlMjQIQmtOjts9erUZH91BSuwby5fi04vXfNef2j9Xr2bMUFZ+7uujCx79V1q50db7teMUkx2vj+AWa//BX6vn4aUpqU7/I+83auUczb3hPNbo1VZc7RyomOUFpa7cpOineu3zXsk1a+dYEdb79eO/vuXd/qloHtFC1lnXly87R4md/VNvLhpKwKcata6MUkZHuOgygZKi0QSF8s5cRzYhREUt6v7MsTgf8wZLeCDGJTH0AEJrTo7reNUoNhnZRtRZ1ldSqntpfNVzpm1K1c/GGvOvsmL9OjY/pqertGyq+YU01P6WfoqvFFbhOYas/nKS4uklqf9WI/92uhmr1aqGERjW9y3ev3qpqreqqZo/m3imxZT2lrd6ae9uPJyu5SxPvdthbh5x4tZs23XUYQMmRtEEhVNqUEc2IUf4lvfewpDdCU7XgPYoOoPIF8/SowrJ25U6Vj66eWxFjkjs20qZfF6pWn9ZesmbzbwuVk5GlGt2aFXs/WyYu9Spn5j34pXbMXq3YOklqdFQPNRzRzbvcKmrS1qRoz8Yd3t/2/4kt6iht3TZt+GGOev7r9Ep/rsHq5jURisjKdB0GUHJJuclawI+kTRnVoRkxyoglvRHy6jRwHQGAAFYrNngrbfKz6VFLXxyn5E6Nvcobv47/PFrzH/5af532nDddKTIuWp1uPk4JjYvfEduzfrvWfTNTTU7opWaj+2rnovVa+p+fFREdqQaHd1FiszpqceYgbyqWaXnWIO+8Wbd+qFZnH6xt05Zr5dt/etdvfcEhqtG1aZW8BoGue3aiWs2gygZBpjr7mSiIpE0ZUWmDshiSlaS7flusqG25Jc1ASKrf2HUEAAJYtZh4xUXGKD0nuKsfljz/k3av3KLuD51c4PwVb03wetp0vfdERScnaOufi72eNt0fPNmrmCmSz6ektg3U8syDvD+t982uFVu0/ptZXtLGNDqyh3fy2/DjHEUlxKp6x0aacslr6vn4GKVv3qkFj3yt3i+dq8gYhvk3rspWRFaW6zCA0mF6FAqhp00Zsew3Suv0PTV1zw+zSdgg9DUgaQNg3xpXq6NgT9hsnbRU3e47SXF1/64csulK676crnZXDPN6z1jfm+ZjBiipbX2t+6r4io/YWtW8ypn8EpvVVvqm3OlQhWVuT9PKd/5Um4sOVerC9V4VT0LjWqrZvZlysnKUtmabwt2B2dXUdOZM12EApZNUQ4pPdB0FAgxJmzJiehRK44bUWrro+4mK2LPbdShA5aPSBsB+NE0spuIkwPl8Pi9hs2XCYi9hYw2D88tJz63qiIiMKHB+RGSkd9vi2BQrW0Y8P+tbE1e/6PHm0pfGqcnxvbyEkU3TshWk8mLMzpEv5++/w9UNKzIUkZPtOgygdBo2cR0BAhBJmzKqG0fZGkrmqY3JOvbH3xWRTXkuwkB0jFSrnusoAAS4ptWC83tiyXM/aeO4+epw3VHe1KSMlF3eKft/yZqEprUU36imFj/zo1cBY5U3qz+Zom3TV6hO/7Z59zPrlg+19su/K28aH99LqQvWa9X7E72lvu0x1n83y1tevLCUaSu86zQ6uqf3d/V2DbyVpLZOXqb13870EkYJTWornA3ITlKjWbNchwGUXkP6UWFvTHYtIyptUJIlvV9dEaOm0/90HQpQdeo1kiI5HgBg35pWC85Km/Xf5E63mXXzBwXOb3flcG8p8MjoKHW58wQtf/U3zb3nM2WnZXhJHFvKu3bvVgUaD2fuSMv725br7nTzsVr++m9a+e6fim9Qw2soXP+QTgUex5JDS1/4WR1uOCqvmseqbVpfeKgWPTlWkTFRan/1CEXFhfcQ/7qlaYrwUW2EINSg+FXmEL4ifPuq1cQ+HfHtzdqVtcd1GAjQJb1fmbNHNRYvcB0KULV69JMuv8t1FAAC3LTNi3XFn8+6DgMh6NCs6rrrq4m2k+M6FKD0LrtDOmCA6ygQYDgcWg5tk+nbgL11yInXOxO3kLBBeKrPXGwAoVtpg8B3xZKdJGwQvJgehSKQtCmHdsnsnGDvJb1f+GW54tatdh0K4AZNiAGUQN34GoqPinUdBkLMiMxk1Z03x3UYQNlEReVOMwcKIWlTDu1qkLTB305LZ0lvgOW+AZRERESEmiQG97LfCDz/WMRS5whidRtK0eHdjwpFI2lTDlTaIP+S3hePZUlvgEobAKG+ghQC03EZNVRz4XzXYQBl14B9SxSNpE05tKreUDGRUa7DgGNPsqQ38Pdy37Xru44CQJBok8w0AFScixZscR0CUD4N6GeDopG0KYfoyCi1TGroOgw4EuuL0NvL49TrD5b0BjyNmrHcN4ASo2IZFeXk9JpKXrLQdRhA+dCEGMVgdF1O7elrE5bq+KL18dxsNZs+zXUoQOBo3cl1BEDQWb9+vS6//HK1bt1acXFxatasmY499lj9+OOPCjSvvvqqatasWWH3R29AVJRz521wHQJQfk1buo4AAYpOR+XEUaLwXNL7mcmbFLd2letQgMDShqQNUBrLly/XoEGDvETII488om7duikzM1PfffedLrvsMs2fX/r+HBkZGYqN3XtVJrvfmJgYBZIGCbVUI6aatmfuch0KgtgZe2qq2vI/XIcBlH+KefO2rqNAgKLSppw4ShReBmdVz13Sm4QNsLfWHV1HAASVSy+91FtFaeLEiTrxxBPVvn17denSRddcc43+/DN36u3KlSt1/PHHKykpScnJyTr55JO1YcPfVQV33nmnevbsqZdeekmtWrVSfHy8d77d73PPPafjjjtO1apV03333eed/9lnn6lXr17e9ay656677lJW1t892bZt26aLLrpIDRo08K7TtWtXffnllxo3bpzOOeccbd++3btvO9ljlxcVyyivM+asdR0CUH4t2koxeyfcAUOlTTm1TW6sCEXIJ5/rUFAFS3pf/PN0VogCipKUzFxsoBS2bt2qb7/91kumWFKlMKu+ycnJyUvYjB8/3kuuWAXOKaec4iVR/BYvXqyPPvpIH3/8saKi/l4gwZIqDz74oJ544glFR0fr119/1ZlnnqmnnnpKBx98sJYsWaILL7zQu+4dd9zhPd6RRx6p1NRUvfnmm2rTpo3mzp3r3efAgQO9+7n99tu1YMEC7zYWV3l1qtlckzbTiwRlc35aLSWsmus6DKD8mGKOfSBpU06J0fFqUq2uVu/a5DoUVKLrU2vp2HF/sUIUUJxWHVxHAAQVS7T4fD517Fh8hZr1tZk1a5aWLVvm9boxr7/+uleNM2nSJPXp0ydvSpSdX69ewSW0TzvtNK86xu/cc8/VjTfeqLPOOsv72ypt7rnnHt1www1e0uaHH37wqn7mzZvnVf34r+NXo0YNr8KmYcOKW4TBkjZAWUT4pFNnrXQdBlAx2nZ2HQECGEmbCtA+uQlJmxD2xKZkHfj7767DAAIb/WyAUrGEzf5Y8sSSNf6EjencubNXhWOX+ZM2LVq02CthY3r37l3g7xkzZuj333/PmyplsrOztWfPHu3evVvTp09X06ZN8xI2VYGkDcrq0rRailtLlQ1CBOMo7ANJmwrqa/PTuumuw0AlLOn96opYNZvOkt7AftHPBiiVdu3aeVUrZWk2XFhR06uKOn/nzp1eD5tRo0btdV3rX5OQkKCqVic+2WtIvCEtpcofG8EryieNmrHMdRhAxahTX6pZx3UUCGA0Iq4A7WvQxyHUsKQ3UAoRkSRtgFKqXbu2RowYoWeeeUa7du29epI1BO7UqZNWrVrlnfysx4xdZhU3pWUNiK0fTdu2bfc6RUZGqnv37lq9erUWLiy6x4ytSmWVORWtR+2/p2ABJXHFrlqK3UADYoQIqmywHyRtKkC3Wi0VG0nRUqholxOv9yalqMai8h/9BMJC4+ZSfKLrKICgYwkbS4L07dvXayS8aNEib9qTNQoeMGCAhg4d6i0Dfvrpp2vq1KlevxlrJDxkyJC9pj6VhDURtt43Vm0zZ84c77Heffdd3Xrrrd7ldr+DBw/2VrL6/vvvvV4633zzjdcw2bRs2dKr1rFeO5s3b/amVFWEA+u2q5D7QXiIUYSOnbHEdRhAxWlDPxvsG0mbCpAQHafuHCUKCQdnJenFX1ewpDdQGhwhAsrEmvxaMubQQw/Vtdde6y2vPWzYMC8pYst12/QpW6K7Vq1aXjLFkjh2m/fee69Mj2eVPbZ899ixY71+OP3799e//vUvryeOnyWP7LIxY8Z41TzWpNhfXWMrSF188cXe6lXWQ+fhhx+ukNeBpA1K45rUmorZtN51GEDFYRyF/YjwlaQTHvbr3SXj9My8z12HgXI4Jb2mLhs3XRFpLOkNlMrZ10gHDXcdBYAgNuan+7V692bXYSDAxfki9e2vGxS9lQVAECJi46R/fyxFRbmOBAGMSpsK0q8+/RyC2fU7a+mysRNJ2ABl0a6L6wgABDmqbVAS/9yRTMIGocV6ApKwwX6QtKkgrao39FY/QPD516ZkHffD74rIznIdChB86jWSGjRxHQWAIEfSBvtTzRepw6bRbxAhpltf1xEgCJC0qUD961FtE2xLer+1Ik69f2dJb6DMupa+GSoAFHZA3baKUITrMBDAbtyWrKhtW12HAVSsHiRtsH8kbSpQX6ZIBdWS3h/NzVbzaSzpDZRLtz6uIwAQAmrGJqltcmPXYSBAVfdFafC0ua7DACqWVSo3bOY6CgQBkjYVqHfddoqOYE5iMCzp/e6kFNVkSW+g/M3zOvZwHQWAEMEUKRTn1q1JityxzXUYQMXq3s91BAgSJG0qUGJ0vLrXbuU6DJRgSe94lvQGyq9999zEDQBUgIH1O7sOAQGoli9a/afNcR0GUPF6kLRByZC0qWCsIhW4Tk6vqft+nK2olC2uQwFCQ3emRgGoON3rtPamSQH53balmiJ37nAdBlCxEpOkdl1dR4EgQdKmgvWjGXFAunZnLf3je5b0BipMRIR0wEDXUQAIIVERkTqoQRfXYSCA1PfFqPfUWa7DACpe1wNZ6hslRtKmgrVJbqz68TVdh4FCS3qfYEt6Z7GkN1BhWraXatV1HQWAEHNIo+6uQ0AAuW1jvCJ273QdBlDx6GeDUiBpUwn61uvgOgT8b0nvN1fEs6Q3UBmosgFQCQ6s215J0fGuw0AAaJoTpx7TZroOA6h4kZFSV6aYo+RI2lSCAfU7uQ4h7FnTuo/mZavFtKmuQwFCE0kbAJUgOjJKA5kiBVsxamOMIvakuQ4DqHhtu0hJ1V1HgSBC0qYS9K/fWdVjElyHEbba5sTr/cnbVHMhS3oDlaJhM6lRM9dRAAhRQxp2cx0CHGuZE6fOVNkgVPXo7zoCBBmSNpUgNipaQxv3ch1GWDooO0kv/bpS8WtWug4FCF29D3IdAYAQX4kzISrWdRhw6NZ10YpI3+M6DKDiRURKfYe4jgJBhqRNJTm6WV/XIYTlkt73/zBHUSmbXYcChPaqUYOGu44CQAiLi4pVf6aah60OOfFqP32G6zCAytGxBws5oNRI2lSSDjWbqW1yY9dhhI2r85b03uU6FCC0degu1WvkOgoAIW5E096uQ4AjN6+JVERmhuswgMox4HDXESAIkbSpREc1pdqmKjy+uYZGsaQ3UDUOGuE6AgBhwCpt6sYluw4DVaxLTqJazZjuOgygcsTFSwcyxRylR9KmEg1r2ksxkVGuwwjpJb3fWBGvPr9NcB0KEB4SkxhsAKgSURGRVNuEoZtWZXMQDqG98qYlboBSImlTiWrGJmlgfZatrKwlvT+cl6OWLOkNVJ1+h0oxNAcFUDWObtbPdQioQr2yE9V8BitGIYTRExBlRNKmktGQuPKW9K61cJ7rUIDwcjBTowBUnWZJ9dSjdmvXYaCK3LAiSxE52a7DACqH9QO0JsRAGZC0qWR963dUvfgarsMIGQOzkvTSbyzpDVS55m2k5m1dRwEgzBzTnGqbcNA/u5oaz6LKBiHeE9BW4ATKgKRNJWNOdsUZnVFDD/44R1FbWdIbqHI0IAbgwCGNeqhaND0gQt11y/YowpfjOgygckRFSYOGuY4CQYykTRVgFamKWdL78rGTWNIbcMH62PQ/zHUUAMJQfFSsDm/c03UYqERDspJUf85s12EAladbH6lmHddRIIiRtKmiOdnda7dyHUbQemxzskb++AerCQCu9BqUu3IUADhwXIuBrkNAJbpqyS5F+HyuwwAqz+CjXEeAIEfSpoocxQoIpRajCL2xMl59f/uTH3PApYOPcB0BgDDWoUZT9azdxnUYqATDs5JVd94c12EAladxi9xKG6AcSNpUkcMa9VByTKLrMIJGLV+UPpqbo5ZTWdIbcD7Y6NDddRQAwtypbQ5xHQIqwT8WbnMdAlC5RpxIA2KUG0mbKpIQHaeTWh3sOoyg0DonTu9P2cGS3kAgOOoUBhsAnBtYv7NaJNV3HQYq0LGZNVRr4XzXYQCVp1ZdqR89AVF+JG2q0EmtBrMCwn4MyE7Sy7+tUvzqFa5DAVCvkdR3iOsoAEARERE6uRXfR6Hk4gVbXIcAVK6hJ0jR0a6jQAggaVOFqsckaFTLg1yHEbBOSq+hh35gSW8gYBwxWoqMch0FAHhGNO2tWrE0RQ+VMV/y4oWuwwAqT0I1aQgNiFExSNpUsZNbD1ZCVKzrMALOVbtq6YrvWdIbCBi2NOWgYa6jAIA8cVExGtlykOswUAHOm7/JdQhA5RpytBRPP1NUDJI2VaxmbJKOZ+nKAh7ZXEOjfmBJbyCgDB8lRce4jgIACrCkTVwk303B7PT0mkpatth1GEDlsfHT0ONdR4EQQtLGgVNbH6LYSOY32pLer69MUP/fJrCkNxBIkpJzjxABQAAe/DqyGcvnBrOzZq91HQJQufoflluxDFQQkjYO1IlP1rHN+yvcl/T+cJ5PraZOcR0KgMIOP16Ko2k6gMD0f20P5+BXkDo3raYSVi13HQZQeWzFzSNOch0FQgxJG0dOa3OYYsK0wad/Se/aC+a6DgVAYTb/2pI2ABCgGiTU0nHNB7gOA6UU4ZPGzF7tOgygcvXoLzVs5joKhBiSNo7UT6ipI5v2Ccslvf/722qW9AYC1SHHSImszgIgsJ3RbqjiWdghqFycVkvxa1a6DgOo3Cqb4053HQVCEEkbh05ve7iiIsLnLRiVUUMP/ThX0VtZMQAISLFxuQ2IASDA1Y6rrhNbHuQ6DJRQlE86aSbTohAGvWyat3UdBUJQ+GQMAlDjxDoa1uRAhcuS3leNnayI3TtdhwKgOIOPlJJruo4CAErk9DaHKSma/lvB4PLdtRS7fo3rMIDKExMrnXCW6ygQokjaOHZG28MVqQiFx5Lema5DAVCcatWlYyjpBRA8qscm6tQ2h7oOAyVYLfS46UtchwFULusHWKe+6ygQokjaONY8qX7IVtt4S3qvYklvICgcf4aUVN11FABQKqNbDfaWAUfgujq1pmI2rXcdBlB5kpKlo051HQVCGEmbAHBxp2NULcTKe/OW9J7Ckt5AwGvcXBpytOsoAKDUEqPjdHrbw1yHgWLE+SJ15PSFrsMAKtfRY6TEaq6jQAgjaRMA6sYn65z2IxQqWvni9R5LegPB45SLpKgo11EAQJmManGQmibWdR0GinB9arKit7AABUJYvUbSoce4jgIhjqRNgLAVEFpXb6Rg1z+7ml7+dZUSWNIbCA7d+0ldQnOKJoDwEBsVrSu6nOA6DBRSzRepodMWuA4DqFwjz5aiY1xHgRBH0iZAREdG6ZquJyrYl/R++Md5LOkNBIuoaOmUC11HAQDlNqBBZw2s39l1GMjnn9uTFZWyxXUYQOVp1UHqO8R1FAgDJG0CSI86rTU8SJsSX86S3kBwrnTQoInrKACgQlzZZaRiI6NdhwFb2csXpSFTmSaPEDf6fNcRIEyQtAkwl3U+TklB1pT44S01NJolvYHgUr2GdMxprqMAgArTuFodjWEJ8IBwS0p1Re7Y5joMoPL0GSK17+Y6CoQJkjYBpnZcdZ3b/ggFy5Ler61K1IBfWdIbCDonnMVKBwBCzhltD1fDhFquwwhrtXzRGjB1tuswgMpTrbo05hLXUSCMkLQJQKNaHaQ2Ad6UuIYvWh/O96n1lMmuQwFQWs1aSwcHR3IYAEojLirWq1qGO7duqabInTtchwFUnpMvlJJruo4CYYSkTQCKiojUNd1OVIQiFKhLen8wZbtqz2euMhB0IiKkMZdKkXz9AwhNhzTqoT5127sOIyzV98Woz9RZrsMAKk+XXtKgYa6jQJhh1B6gutdurRFNA68pcb/sJL38G0t6A0Hr0GOl9l1dRwEAleq6bqOVEBXrOoywc+umBBalQOiKi5fOuMJ1FAhDJG0C2KWdjg2opsTekt4/zVX0Fpb0BoJSvUbSiee6jgIAqqQp8cWdjnEdRlhp7ItVz6kzXYcBVG4/wLoNXUeBMETSJoDViquu8zscqUBa0jtyF0dPgKCdFnXWVblHiQAgDIxsMUi96rRzHUbYuG1DnCL27HYdBlA5WnWQDj/edRQIUyRtAtzIljbgaOs0hodY0hsIfkOOljr2cB0FAFSZiIgI3dTjFCVGx7kOJeS1zIlTl2kzXIcBVI6o6NwDX/QDhCNseQEuMiJStx1wumrEVnO2pPdAlvQGgpuV8p50nusoAKDKNUysrcs6sZpUZbtlfbQi0ve4DgOoHEeeLDVt5ToKhDGSNkGgbnwN3dTj1Cpf0vuD+WJJbyDYRURK510nxSe4jgQAnDiuxQD1qdfBdRghq11OvDpQZYNQ1ai5dMwY11EgzJG0CRKDGnTRSS0PrrIS1w+m7lCd+XOq5PEAVKIjR0vtWC0KQHi7sfspAbW4Qyi5ZW2kIjIzXIcBVLyYWOnCG6XoGNeRIMyRtAkil3Q6Vu2Sm1T6kt6v/L5aCauWV+rjAKgCzdtKx53hOgoAcK5+Qk1d3uUE12GEnC45iWo9fbrrMIDKccpFUrPWrqMASNoEk9ioaN3Z6wwlRMVWyv2PZElvIHTExknn3yBFR7uOBAACwlHN+mpY416uwwgpN67KUURWluswgIrXZ4h0yNGuowA8JG2CTPOk+rqy66hKWdL7apb0BkKHNR5u3Nx1FAAQUK7rPlpNq9VzHUZI6JWdqBYz6GWDEFS/sXTWla6jAPKQtAlCRzfrq6GND6iw+3twK0t6AyGl36HSYayWAgCF2fLfd/c6U7GRVCGW1w0rsxSRk+06DKBiWf+ai2+R4hNdRwLkIWkTpK7rNlqNE+uU6z6ifNIrqxM16BeW9AZCRrM20pkcHQKA4rSr0UT/6Hy86zCCmvVAbDxrpuswgIp3yoVS8zauowAKIGkTpKrFxOuOA/5P0RFRZV7S+6MFEWo7mSW9gZCRlCxddpsUxwopALAvI1sO0vAmB7oOI2hdt2yPInJyXIcBVKzeB0uHHus6CmAvJG2CWOdaLXR+hyNKfTuW9AZCUGRk7rKUdRu6jgQAgsL13UerdXW+M0trcFZ1NZgzy3UYQMWq10g66yrXUQBFImkT5E5rc5j61OtQ4uv3ya6mV35fw5LeQKg58VypM6uiAEBJxUfF6p4Dz/b63KDkrl6yi2n1CME+NjdLCdVcRwIUiaRNkIuIiNBdB5yhZiVYCeH4jBp69Kf5it6ysUpiA1BF+g6RRpzkOgoACMpVOe844AxFRTAkLomhWcmqO2+26zCAinXG5VKLdq6jAIrFL1QIqB6bqIf7nq8aMcVnhy/bXUvXfj9FkbtSqzQ2AJWsaSvprKtdRwEAQWtgg866rBMr7pXE5Yt2uA4BqFjHjJEGDXcdBbBPJG1CRNNq9XRv77MVE7l3Y+IHt9bUKd//oYjMDCexAagk1apLl91B42EAKKfRrQdrZItBrsMIaMdkJKv2grmuwwAqTr9DpRPOch0FsF8kbUJIzzptdH23kwss6f2yt6T3H8w9BkKy8fBNUj2aaAJARbiy60j1LUWfwHBzycIU1yEAFaddV+lsKpURHEjahJgjm/XRGW2HqrovSh8ujFA7lvQGQtNJ50ldaDwMABXF+trc3esstWJFqb2Myqih5MULXIcBVIwGTXIrlWNiXUcClAhJmxB0QYcj9c6eNqo7jyW9gZB0xGhp+ImuowCAkFMtJl4P9zlfteOquw4loFwwb5PrEICKkVRDuvIeKYnPOIIHSZsQXVGqxsjzpI49XIcCoKINPjK3ygYAUCkaJtbW/b3PUWxktOtQAsJpe2oqadli12EA5WeVNf+4Q6rf2HUkQKmQtAlV0THSZbdLzVq7jgRARek9WPq/y11HAQAhr0utlrqr15ksBS7prLnrXIcAlF9EhHTudVLbzq4jAUqNX6JQllAtt/yvbgPXkQAor669pfNvyG1ADACodAc17Kpbe56mSEUoXJ2zp5YSVy5zHQZQfiPPlvoMdh0FUCaM/kNdzTrSVfflzt8EEJzsqNAlt0rRlOoDQFUa2qSXrus+WhHhmLjx+XTa7FWuowDK76hTpaNOcR0FUGYkbcJBw6bS1fdK1Wi4BQQdm+J4xd1SXLzrSAAgLB3bvL8u73y8ws3FabUVv3ql6zCA8jnyZGnU2a6jAMqFpE24aNFOuu4hKm6AYFuS8ur7pcQk15EAQFgb3Xqwzu9wpMJFlE8aPXO56zCA8jniZOnEc11HAZQbSZtwO2J//UNS9ZquIwGwP7XqStfcLyXzeQWAQHBWu2E6vc1hCgf/2F1LsevXuA4DKLsRJ0knkbBBaCBpE26atJSuf1iqUct1JACKU71GboVNHZqIA0AgubjTMRrV8iCFshhF6PgZS12HAZTd8BOl0ee7jgKoMCRtwlHj5tL1j+QeyQcQWOrUl/75WO7nFAAQcK7uOkqntj5Eoeqq1JqK2cgy3whSw0ZKJ1/gOgqgQkX4fD5fxd4lgsbGtdKj/5S2bnIdCQBjiRqrsCGhCgAB7/VF3+vFBd8olMT6IvTdb5sUvWWj61CA0ht6gnTqxa6jACoclTbhrH7j3IobO7IPwK3WHaUbHiNhAwBB4sx2w3Rll5EhtRz49ak1SdggOB1+PAkbhCwqbSDZj7NV3GyiFBZwonMv6bLbWdYbAILQt6sn6cEZ7ynbl6NglqAIfTN+g6JSNrsOBSidY06TTjjTdRRApaHSBrmVNtac2JYXBlC1eh8sXXEXCRsACFJHNO2ju3udqZjIKAWzG7fVIGGD4BIVJZ19NQkbhDwqbfC31O3Ss/dIi2a7jgQID0OOkk7/hxRJ/hwAgt2kTQt0y+RXlJadoWBT3RelL35eragdKa5DAUomPlG65Bapy4GuIwEqHXsKKLjM8LUPSAOHuY4ECH1HnSqdcQUJGwAIEX3qddCTAy5V7bjqCjY3b6tOwgbBw/r//fNREjYIG1TaoGjfvC99/IrE5gFUrIgIafQF0vBRriMBAFSCjWnbdOOk/2rRjjUKBrV8Ufr0xxWK3LnDdSjA/jVpKV15j1S7nutIgCpD0gbFm/aH9NLDUvoe15EAoSE2Lnfudd9DXEcCAKhEaVnpumfaW/p1Q+BPOX90c7L6/fan6zCA/evUU7rkNimxmutIgCpF0gb7tnKx9O87JRrTAeVjR4RshagW7VxHAgCoAjbEfmH+V3pryU8KVPV8MfrwhyWK3LXTdSjAvg0cKp15lRQd7ToSoMqRtMH+bdsiPX2ntHyR60iA4NSuq3TJrVJyTdeRAACq2DerJumRWe8rMydbgebJjcnq9QdVNgjwaeW2pPfxZ7iOBHCGpA1KJiNd+u8j0pTfXEcCBJchR0tjLuHIEACEsZlbl+rmya9oe8YuBYpGvhi9N3aRItJ2uw4FKFpCNem866SeA1xHAjhF0gYlZ5vKZ69LX77jOhIg8MXE5iZrBh/pOhIAQADYkJaiO6a8rjnbVigQPLu+urr9+ZfrMICiNWudW6Vcv7HrSADnSNqg9Gb8Jb3yuLRzu+tIgMBUr5F0yS1S87auIwEABJCsnGyvz817S8fLJ3dD8OY5cXrzu3mKYLEJBKIBQ6UzLs9dwAEASRuUo8/Ny49Jc6e6jgQILD37S+deJyUmuY4EABCg/tgwV/dPf0fbM91Ml3pxbZI6Tpzo5LGBYlmS5pSLpCFHuY4ECCgkbVB2tumM/Uj65DUpK9N1NIBbkZHSCWdJR56c2zQPAID9TJe6c+obmp2yvEoft21OvF7+ZrYiMjOq9HGBfWrUXLr4ZqlJS9eRAAGHpA3Kb8Ui6T8PShvWuI4EcKNBk9zqmjadXEcCAAiy6VIvLfhGby/5ucqmS72yOlFtJ0+ukscCSuSg4dKYS6W4eNeRAAGJpA0qhs2Jfuc56bfvXEcCVJ2ISGno8dLIs5l3DQAosz83ztMDM97V1vTUSn2cTtkJeuGbmYqgQhqBICFROv0fUv/DXEcCBDSSNqhYk3+RXn9K2r3TdSRA5TcbPudaqX1X15EAAELAjoxdemL2J/p+beX1C3xjZbxaTqUfIQJA9365zYZr1XUdCRDwSNqg4m3ZKL30sLRotutIgIpn/WoOPVY68VzKeAEAFe7X9bP16KwPKrzqpntOop7+aroisrMq9H6BUkmqIY25WOp3qOtIgKBB0gaVIydbGvux9PmbUka662iAilG3gXT2NVLHHq4jAQCEsNSM3Xpizicau2ZKhd3nO8ti1XTG9Aq7P6DU+gyRTrtEql7TdSRAUCFpg8q1eb305tPSbBreIcgNPlI6+QIpPtF1JACAMPH7hjl6dOYH2py+o1z30y87SY98NVkROTkVFhtQYjXr5PauOWCA60iAoETSBlVj4jjp3RekHSmuIwFKx+Zan3211OVA15EAAMJQamaanp77mb5ZNanMK0x9sCRaDWfNrPDYgP06aETuQa/EJNeRAEGLpA2qjjUn/uhl6ZdvJR9HehDgYmKlYSOlo06V4hNcRwMACHOzti7Tk3M+0YLtq0t1u4Oyk3T/l5MVwdgLVT2l/Mwrpc69XEcCBD2SNqh6yxdJbz8jLZ3vOhKgaL0HS6PPk+o0cB0JAAB5cnw5+nLlX3pxwTfallGylTo/XhipenNZHAJVJC5BOuIkafiJLNgAVBCSNnDDNrs/vpc+eoUpUwgcLdtLp1wkteviOhIAAPY5ZerlBd/qkxW/K3sfFTSHZ1bXHV9PtAF/lcaHMBQZmTsV6vgzpBq1XUcDhBSSNnArbVfuClM/fSGxBCVc9q0ZdbbU//DcJb0BAAgCy1LXe1OmpmxeVOTln82Tai+YW+VxIcx07S2NPl9q0tJ1JEBIImmDwLBlg/TF29KEH6TsbNfRIFzExkkjTpKOGE0JLwAgaP2ybqb+s+Brrdi5Me+8ozKTddNXfzqNCyGuaStp9AVSF/rWAJWJpA0Cy8a1ucmbv36SWJYSlcWqafodKo06R6pdz3U0AACUm02T+nb1ZL2y8DttSEvRl7OzVWPxAtdhIVSX8D7hTGngsNxpUQAqFUkbBKb1q6TP35Im/cJKU6jYZM0BA3NXhGrZznU0AABUuMycLE1YPEGDX3hO2r7VdTgIJQnVclfWtCplKpSBKkPSBoFtzfLcnjdTf89tXgyURVR0bmXNkSdLjZq5jgYAgMqXmSGN/1r69gNp2xbX0SCYWWNhS9YMOSo3cQOgSpG0QXBYuUT6/A1pOnOzUcqeNYOPzF12kmlQAIBwTd788o30zfskb1A6DZrkVtUMOFyKiXUdDRC2SNoguCxfmDvomD6BhsUoXmKSdNhx0uHHS9VruI4GAIDASN789bP04+fSqiWuo0Ega9FOOnK01OsgetYAAYCkDYJTyubckt9fv5G2p7iOBoHUGM9fvhuf6DoaAAAC08LZ0k+fSdP+4CAY/tapZ+5U8s6sBgUEEpI2CG5ZWdLU36Sfv5QWzXYdDVwuOWmVNZTvAgBQcls3SeO/yp0+lbrddTRwwcZNtkjD8FFSy/auowFQBJI2CB2rlkrjvpT+/ElK3+M6GlQ2W7Wgz5DcnjWtO7qOBgCA4J46NXG89NPn0opFrqNBVWjeRjpoRO5CDdWqu44GwD6QtEHo2b1L+uN7adxXuUuHI/TmWQ8+IneQwRQoAAAq1pK50k9f5E6dykh3HQ0quuefjZ8OHiE1b+s6GgAlRNIGoW3edGniuNyBx84drqNBeXrV2CBj4FCpSUvX0QAAEPr2pEkz/pT+GifNmSJlZ7mOCGURESF17CkdNFzqNYhp5EAQImmD8GBN9ubPkKb8Kk21BA7ztoNiuW6bY22Jmk4HsHoBAACu7EqVpvwmTRovzZ8p+XJcR4SSLNfd9xBp0DCpbkPX0QAoB5I2CD852dKCmdLk/yVwUre5jgh+NWpL3fpIPfrlrlxgfWsAAEDg2L5VmvRLbgJnyTzX0cAvIlJq3UHqOSD31KiZ64jw/+3dBXzc9eHG8efi2kjd3d1pCxRKBRlWaHEdNmAMBhvwH87QCYzR4cN96MpwKW2pu1J3b9M0aTy5/+v7uyYkbdpG7vL93d3n/Xrdkpz87jkpyz35CuAnlDYIb6bAMdteOgXOVGkf24fX+ZBdM6e61yBfUWPWqzHnAQAA99u1zfc71OI50qolUlGh7UThNyq5W1+p9zG+U71U24kABAClDVCqpERatVRaOse3Fs66Fb5pVfAvM3rGTHcyRY05mfVqAABAcDM7d65cLC2dJy2dK21eJ/Exw/+SU6Xeg3yjacyoZFPcAAhplDbA4eTul35eJC2f7ytxtqznl4+aiIyUmreVOnTzlTSde7EIHgAAoS4zQ1p2oMAxRc7e3bYTBae0BlKH7r7fozp2l1q0Y50/IMxQ2gBVlZ3lG/prTiuXSOtXMgy4MukNpXZdpLZdfHOrzZQn/goEAEB4M3/8MuXN2p+l9auk7ZtZ0LiydWmat/aVNB0PFDX1G9tOBcAyShugpgoLfFOoNqz2/SJiTpvXSznZChux8VKbjr6Cpr0pajoz3QkAAFRtOpX5HWrDKl+JY75u3RBeU9PNKJqmrXx/5DJFTbuuUkKi7VQAXIbSBvA3M/zXlDdlRc463y8huTkKSmZhYLOrU8OmUqNmB742lZq1lpq1kiIibScEAACh8gexTWt/KXLM70+7d0gZu4N3VI6ZJm623DbljNnRqexrSykuwXY6AEGA0gaoK3t2+kocMxzY7FJl5nrv2yvt23Pg6157060io3zTmkwpYwoZU8w0LPc905sAAIAtRUVSxk5fgbNru7T7wKn0+4xdvg0lbDDry5jFgc1IY/NHrtR03+9UpeWM+d0qKtpONgAhgdIGcJP9Wb7yJrO0yDlQ7Ji/PJntyc3JDBs2v5hU+v2Br2ZOdFycb/qS2a3J/CUn7sDXxGQpqZ7va2I9KSlZimcoLgAACFLm95+9e3ybSJiRzXkHTrkHTvm5h55vfl8yo4UjI3x/vHK+P3CKKP81yvd9YtKB35sOOpnChoWBAQQQpQ0AAAAAAIALUQsDAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNAAAAAACAC1HaAAAAAAAAuBClDQAAAAAAgAtR2gAAAAAAALgQpQ0AAAAAAIALUdoAAAAAAAC4EKUNDuHxeHTfffdV+3br1q1zbvvKK68oXB4z4Jb374033njU65l/m+a65t8qAAAAAPejtHGp0g9X5jRlypRDLvd6vWrZsqVz+a9+9SuFAlOamMcTERGhjRs3HnL5vn37FB8fX+UPqP700EMPOffbo0ePCufn5ORowoQJGj16tJo2bark5GT17dtXzzzzjIqLi6t1H+Y1ff3113X88ccrNTVVCQkJ6tmzp/785z879+NWs2bNcl6P7t27KzExUa1atdL48eO1YsWKar/XDz5t27atVrc3pzfffLPsuh9++KHOO+88tWvXznl+O3furFtvvVV79+495LgHH8c8tm7duvn99ViyZInGjRtXlqlBgwbOe+C///2v3+4DAAAAQHCKsh0ARxYXF6e33npLxx57bIXzJ02apE2bNik2NtZatkAxj+ntt9/WH//4xwrnmw/cNpjn+eGHH3Y+tB9szZo1+u1vf6uTTjpJv//971WvXj19+eWXuv766zV9+nS9+uqrVboPU/BceOGFeu+993Tcccc5BZb5AD958mTde++9zvnffPONGjVqJLd57LHHNHXqVKd46NWrl1O0PP300+rXr5/zHBxcdB3OAw88oLZt21Y4z5RXR2MKDlN2HeyJJ57QggULnNem1DXXXKNmzZrp4osvdsqlRYsWOVn/97//ae7cuU4pWN6oUaN06aWXOt9nZ2c7r8fdd9/tHPf999+XP6xfv15ZWVm67LLLnGymEPrggw90xhln6LnnnnMy+8sll1yi888/PyT/uwEAAACEJC9c6eWXX/aal2fs2LHeBg0aeAsLCytcfvXVV3v79+/vbd26tfe0007z632b+7333nurfbu1a9c6tzXZa8LcZ+lj7tOnzyGXjxo1ynvOOec417nhhhu8dfWYzzvvPO+IESO8w4cP93bv3r3CZTt37vQuXrz4kNtcccUVzjFXrlxZpft/+OGHnevfdttth1z26aefeiMiIrynnnqq142mTp3qzc/Pr3DeihUrvLGxsd6LLrqoyu/1WbNm+S1TTk6ONzk52XnPlPf9998fct1XX33Vuf8XXnihwvmHe5+de+65zuuRm5vrDZSioiJv7969vZ07d67S9QPxbwIAAACAfUyPcrkLLrhAu3fv1tdff112XkFBgf7zn/84IzMqs3//fmfKh5k+Zf6ibqaA/PWvf3Wm35SXn5+vW265RQ0bNnSm9Zi/7JtRJZXZvHmzrrzySjVu3Ng5ppkK8+9///uo+QsLC7V8+XJt3bq1yo/ZPK758+c7tytlRm989913h33M5rGYESkdOnRw8pnHbkbqmPNr+piNH3/80Xmun3zyyUovN1NZzHNxsLPPPtv5umzZsqM+3tzcXP3lL39Rp06d9Mgjjxxy+emnn+6MwjCjQWbOnOmcZ0b11K9fv8Jrakb8mGk8Tz31VNl527dvd84z07Wq+1yVTkP7+OOPndEypa/7F198UeF6Q4cOVUxMTIXzOnbs6Fy3Ko+/PDPipLrTyipjphaZY1100UUVzj/hhBNq9VoZTZo0cZ6bqKjDD1ScPXu2c53KRlqZkVjmsokTJx729pGRkc7rUtm0rSMxU8HMv3czQq9///7O+7c81rQBAAAAgguljcu1adNGQ4YMcaYLlfr888+VmZnpTHM4mPkQb4oIMzXk5JNP1t///nfnQ9wf/vAH54N+eVdddZVTRpj1WB599FFFR0frtNNOO+SY5oP/Mccc40zPMR/i//GPfzgf+H/9618ftswoX/Z07dpVd955Z5Ufs5nu0qJFC2daWKl3331XSUlJleYrKSlxHrMppkzB8c9//lNnnXWW8xyY9Utq8pgNUx6YIsTcxqwtUx2la7GYUudozJpFGRkZTiF1uCKgdIpO6TonZgrVnj17nPVQSpmpO2Y9IPO1/Hmlz2l1n6vSbGaql3mvPf7448rLy9M555zjFIlHYt6H5n1Tlcdf6sQTT3Sml5lpYSbjypUrVVOmvDBTncaOHVur18o83l27djknM43JvCdNEXOk18oYMGCAs0aNmdZ2MPNeTktL05gxYw4pW839rF692nk9zL/z8lO7jsZMmbz55pudqV9mqpl5jcx/AxYvXlzlYwAAAABwGdtDfXD0KSNPP/20M9XDTPkwxo0b5z3xxBOd7w+eHvXxxx87t/vzn/98yJQOj8fjXbVqlfPz/Pnznetdf/31Fa534YUXHjJV6Ne//rW3adOm3l27dlW47vnnn+9NSUkpy1XZ9KjS8y677LIqT48yU47MNKEOHTqUXTZw4EBnylFlU0Fef/11Z7rK5MmTKxzv2Wefda5rpu9U9zEb5nk3j2/Hjh3Oz5VNj6qMmSrUrVs3b9u2bQ+Z1laZJ5980rn/jz766LDX2bNnT9nUMcNkMj//61//cn7eu3ev8xyY90bjxo3LbnfTTTd509PTvSUlJdV6rgzzc0xMTNl7xliwYIFz/j//+c8jPiZzP+Z6L7300lEf/7vvvuu9/PLLnWlK5jm46667vAkJCc60wA0bNnira/fu3U7u8ePHV+n65v0dGRnpTOkqz+Sv7HTWWWd58/LyjnrcO++80xsdHe28duXfG6mpqd4rr7zykOtfe+21ZfdhXiPzb7b8bY+k9HazZ88uO2/9+vXeuLg479lnn33If1fMv0sAAAAA7sdImyBgduIxU2jMdAoz5cN8Pdw0ITOFxkytuOmmmyqcb6ZLmc925q/3pdczDr6e+Ut9eeY2ZlFUMyrDfF866sCczEgBM+LHLOB6pJFC5nbV3QbcPL5Vq1Y5OxOVfj3cYzYLwprRPF26dKmQb8SIEc7l33//fbUes2FGKdxzzz3OorNmKlV1mNFIS5cudRa4PdJojFLmNTXMdK3DKb2s9Lomk3m8pdNfzELA5nU3I6rMCJfSUSpmpI1ZxNpMianOc1Vq5MiRat++fdnPZqFhMxrGLMB8OGZa2w033OCMEDPTuqry/n755Zed0URm1M+DDz7oTCEyr4HZtau6zHQ2M4Xw4KlRlTEjZ1566SXn34eZ0nWwM88805maaE6ffPKJM2LMTA8z78WDpxsezIxcMtMDyy+g/dVXXzlTniob1WTeh+Z+zEieU045xRnpZR5HVZnn20yJKmUWWjb5zXPpjylnAAAAAOoeu0cFAfMB3Xx4Nh8wzc4y5gPYueeeW+l1zRQOswPNwQWA+aBeennpVzOVpvwHcsNMpSpv586dzofM559/3jlVZseOHfI3s222KRbMYzY7CJl1REqLhYOZgsKsR3K4cqU0X1Ufs3HXXXcpPT3dmR5VHWZtmhdeeMEpHk499dSy881rZp7L8szxzVowBxcylSm9rPzuUWaKVGkRZcoZMyXHnMxxzc9m/SGzy1H5squqz1X5D/4HM1N7zHSuw001MtPNUlJSnPLEFEk1YYqmwYMHO1PySpnnr3z5YKbLmVNlU6PMc2CKjyMxz5GZ4mfKx8OVQ2aanvm3V8pM2zJrCd12221OeWrKTLOrlDmVMo/ZPL+9e/d23sNmOpS5H8N8b6ZhVfZeNtc1J8MUWGYKnzn+jBkznNLNFKSmvC1l3jvmcZaqrHQy6ySZ/2aY5878GwIAAAAQXChtgoT54H311Vc7H4rNh9GqbIXsD2YNFMOsk3G4URNm9EWgHrNZQNeUGmZkgilcDpfRrDlj1u+pjFnQtTpMsWEKKrP2zZYtWyqsb2JGTphFXM1ok/IfmA0zmuj222/Xdddd55Q+5W3cuPGQ7azNqBazMG63bt2cnxcuXOiMNKmMucww66SULzZMQWRGvZgCwpQ45sO9Od/8bMo789yY82v6XB2udKlslIkpFcx705R8pfdfGybLzz//XPbzwIEDy0pHwyymbLZGL2/Dhg3OfZttss16RYdjyixTwJgFlk25VJURUaVK15kxo5xMqWLWB7r//vvLLm/dunXZQr/mfWsKITOaybyPP/30U2dx8arcnylmr732Wq1YscIpFn/3u99VWNh4+PDh+uGHH6qcGwAAAEDwobQJEmaHG/MBbvr06c5f6w/HfGA0oxPMyIzyo21Kd2Iyl5d+NR/gzaKn5UealP+QbJTusmRGOJQfcVAXTGljpiiZnadef/31w17PjJwxH8LNh+nSaUCVqepjNosnm+uZaVQHT6UyTPliPkCXX4TZTJ0xCxabhW8nTJhwyG3MKIfyO4AZZiSGMWzYMKeEM6OK/vSnP1ValLz22mvO13HjxpWdV1rGmOOa6WN33HFH2aLDpuwypUliYmKFKTNVfa6qyxRapsAwBYN5/5UWUbVhyqjyI4LMCJryI03KF1ilzILdplA60tQo8/qbBXrNqCUzUqmy0TpHUlRU5HwtHV1jRsWYoqyUWQC5lCltTKFjphiakU/79u2rdAHxypQ+VlOGGWaHL1Oelh/xVF5lCzeb18Ms7FzdKX4AAAAAXML2ojo4+kLEpV555RXvfffdV7bw75EWIn744YcrHO+8886rsBDxvHnzqrwor1kk1izsumjRokNyli7Se7iFiAsKCrzLli3zbtmypVoLEZdfpPeRRx6pcL2DFyI2z4s577nnnjvkmOa5ys7OrtZjNvdvFsQ9+GQWIW7VqpXz/cKFC8tuP2nSJGfBV7M4dFUWqK2Meb1Mhttvv/2QyyZOnOgsTHv66acfclnz5s29nTt3dl7b0kVrZ8yY4RyrU6dO3pNOOqnC9av6XFX2PJd/z5VfWLqoqMh7xhlneKOioryfffbZER+neR+Y94N5X1T2HipljmPu3yykXB29evVyXqPShZcPtnXrVm+7du28zZo1O+pivId7/Pfcc49z2TPPPFOlTD179nTeG2bhbrOgd3FxcYXLt2/ffshtzPPTr18/b3x8vDcrK6vKCxHPmTOn7DyziLN5X5qFk0uxEDEAAAAQXBhpE0SqsqirGe1gtk42IzbMFA0zmsMsfmpGgpiFTkvXc+nTp48zTeNf//qX85f8oUOH6ttvv3UW/T2Y2RrbTOUxa4yYKVpmFIXZbtosQGxGVZjvj7blt8le3cWIDTOi5WguueQSZ2tlMy3J5DQjV8zIIDO6yJxvFmI1a71U9TGbNUcqm6ZUOrKm/GVmuo6ZZmNGrZjpLGah34OnjlVl+pgZRTF//nw99thjmjZtmrOtthmxYbbcfuONN9S9e/dKnz8z2uadd95xpjyVjrzo16+fM8LGjLI4ePHmqj5X1WEW8TXTfsx7z7wXTN7yyo8OMQv5mik+a9eudRapNszrYNYwMvdr1sIx76t///vfzvSo//u//6tyDrO1tZlGZkYcHW4UkRlhY0bwmOfbPLfmVMqMhBk1alSF65vnsPTxmLVhzEg3k99seW+ey6owo23MiLG4uDhnbZuDp/mZEXRmBI4ZIdW8eXNnCqQZVWRek7/97W9VHglkpnqZ9XnM6LDY2FjnfW6Un7oFAAAAIMjYbo1Q9ZE2lTl4pI1h/jJ/yy23OKMJzJbDHTt29P7lL385ZPRBbm6uM5Khfv363sTERGckx8aNGyvd/tqMBjCjDlq2bOkcs0mTJs4ojueff77sOv7c8ru6IyDMyITHHnvMGQ0TGxvrTUtL8/bv3997//33ezMzM2v0mA9W2Zbf33///WG3hq7KMcszr48ZCTNs2DBni/fSY4wcOdLZKroyEyZMcK7zm9/8psL55jbm/G+//faQ21T1uarqSBvzvBzpOSjP3O7gkR5/+tOfvH369HG2VzfvLTNSxjyebdu2eavjjjvucI5dfhTUwY6U0zyOI13XbAveokUL7zXXXFPp6JjDWblyZdkxpkyZcsjlb7/9tvN6ma3azWgl83qYnz/55JMq30fpa/XGG284/97N69q3b1/n/VkeI20AAACA4OIx/2O7OAJwKLPosRm9YkYD/fe//3VGiQAAAAAAwgelDeBi+/fvd3aYMlNlJk2a5Ex9AgAAAACEB0obAAAAAAAAF6q4IiYAAAAAAABcgdIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIUobQAAAAAAAFyI0gYAAAAAAMCFKG0AAAAAAABciNIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIUobQAAAAAAAFyI0gYAAAAAAMCFKG0AAAAAAABciNIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIUobQAAAAAAAFyI0gYAAAAAAMCFKG0AAAAAAABciNIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIUobQAAAAAAAFyI0gYAAAAAAMCFKG0AAAAAAABciNIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIUobQAAAAAAAFyI0gYAAAAAAMCFKG0AAAAAAABciNIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIUobQAAAAAAAFyI0gYAAAAAAMCFKG0AAAAAAABciNIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIUobQAAAAAAAFyI0gYAAAAAAMCFKG0AAAAAAABciNIGAAAAAADAhShtAAAAAAAAXIjSBgAAAAAAwIWibAcAcASFBdL+rHKnbKkgz3eZJ0LyeCSP84Pve+fb0u8PXBYdIyXWk5LrSUkpUmyczUcEAAAAAKgiShugrhUVSru2Sdu3SDu2SHt2+gqZnHLFjPNztq+08beYWCkx2VfgJJV+NYWOKXZSpNT6UuPmUqNmvsIHAAAAAGCFx+v1eu3cNRDixcxOU8xs9hUzZafNvpKmpESuFxEh1W/sK3CatJAatzjwtbmU3tB2OgAAAAAIeZQ2QG3l50nrV0qrl0trl0sbVku7d0jeIChmaspMsWp0oMxp2U5q31Vq29k3igcAAAAA4BeUNkB1bdskrVl+4LRM2rxOKi62ncq+yCipZVupfTepQ3epQzcprYHtVAAAAAAQtChtgCMpyJdWLpFWL/WVNGt/9q03g6ox06hMiWNG4pgSp2V7KTLSdioAAAAACAqUNsDBtm2UFs+RFs2SViwKzGLA4cpMq+rUU+o1yHcya+YAAAAAACpFaQMUFUk/L5DmT/cVNWZnJ9SNZq2kngcKnI7dpQhG4QAAAABAKUobhKec/dKimb6iZvEsKTfHdiKYrcf7DJb6DpO69WW7cQAAAABhj9IG4cNMc1owXZr6tbR0nlRcZDsRDicuQeo5UBpwnNR7sBQVbTsRAAAAANQ5ShuEvnUrpalfSTN/YBHhYB2BM2SEdOwYqXkb22kAAAAAoM5Q2iA0Ze2Vpn3nK2vMltwIDe26+MqbQcN9o3EAAAAAIIRR2iB0FBdLC2f6ihqzoDDTn0J7F6oBx/sKHLOAMQAAAACEIEobBL89O6VvP5F++sY3wgbhpUlL6djR0tBRUr1U22kAAAAAwG8obRC8zLSnL/7jW6uGUTUwixUfc6J08nipSQvbaQAAAACg1ihtEHxWLpY+f9+3ZTdvXxzMEyH1Hyader7Uqr3tNAAAAABQY5Q2CA7mbTp/uvTF+9LqpbbTIFj0GOArbzr1sJ0EAAAAAKqN0gbuVlQoTf9e+vI/0tYNttMgWJnFik85T+o1yHYSAAAAAKgyShu4t6z5fqL01QdSxi7baRAqWraXThkvDThOioiwnQYAAAAAjojSBu4zc5L04cvSrm22kyBUNW4unXuV1HeI7SQAAAAAcFiUNnCPVUul956X1iy3nQThoksf6bxrpJbtbCcBAAAAgENQ2sC+HVukD/4tzZliOwnCdbepYaOksy+XUtJspwEAAACAMpQ2sCc7S5r4lvTDRN8aNoBNcQnSqeOlUWOl6BjbaQAAAACA0gYWmILmu0+liW9LOdm20wAVNWgsjb1SGjTcdhIAAAAAYY7SBnVr8WzpzQnSzq22kwBH1qGbdN61UtvOtpMAAAAACFOUNqgb+7Okd56Tpn1jOwlQdR6PdPwp0rirfNOnAAAAAKAOUdog8Ob9JL3xTykzw3YSoGbqN5Iuv0Xq2td2EgAAAABhhNIGgZO1V3rzX9LsH20nAfw06ubUA6Nu4m2nAQAAABAGKG0QGDO+l95+VsrOtJ0E8P9CxZeZUTd9bCcBAAAAEOIobeBfe3f7pkLNn247CRDYUTfDT5PO/TWjbgAAAAAEDKUN/GfKl9J7L7CNN8JHgya+tW669LadBAAAAEAIorRB7eXul17+uzR3qu0kgJ1RNyeYUTdXSbFxttMAAAAACCGUNqidjWukZ/4s7dhiOwlgV/M20vV3S42b204CAAAAIERQ2qB206HenCAVFthOArhDfIJ05W1S36G2kwAAAAAIAZQ2qL6CfF9ZM/Ur20kAd06XOnmcdPZlUkSk7TQAAAAAghilDapn+2bfdKhNa20nAdytSx/p2juk5FTbSQAAAAAEKUobVN2cKdIrf5dyc2wnAYJDWgPpuj9J7bvaTgIAAAAgCFHa4OiKiqT/vCR985HtJEDwiYqWxl8tjTjDdhIAAAAAQYbSBkeWnSVNuE9aucR2EiC4HTNCuuQmtgUHAAAAUGWUNji8XdukJ++Stm2ynQQIDa3aS797UEpJt50EAAAAQBCgtEHlNqyS/nG3lJlhOwkQWho0kW55SGrc3HYSAAAAAC5HaYNDLZkjPfOQlMeCw0BAJKf4Rty06WQ7CQAAAAAXo7RBRT99I736pFRcZDsJENpi46Xr75K697edBAAAAIBLUdrgF5+9I330iu0UQPiIjJKu+L1vkWIAAAAAOAilDaSSYumtZ6QfJtpOAoQfj0cad5U0+hzbSQAAAAC4DKVNuCvIl55/VJo/zXYSILyNOUc69ypfiQMAAAAAlDZhLi9X+sdd0soltpMAMIacJF3+eyky0nYSAAAAAC5AaROu8vN8W3qvWGQ7CYDyeg2Wrr9bioqynQQAAACAZRG2A8CCwgLp6fsobAA3WjhDeuFR31pTAAAAAMIapU24KSqUJjwoLZtvOwmAw5kzRXr5CYmBkAAAAEBYo7QJJ0VF0rMPS4tn2U4C4GimfSO98bTtFAAAAAAsorQJF2aqhZlywS5RQPCY9Jn07vO2UwAAAACwhNImHJSUSC/91TflAkBw+fpD6ZPXbacAAAAAYAGlTagza2K8+qQ043vbSQDU1H/flD5/33YKAAAAAHWM0ibUvfFPaepXtlMAqK0PXpK++9R2CgAAAAB1iNImlH38qjTpf7ZTAPCXt5+RplDCAgAAAOGC0iZUmdE1E9+2nQKAv6c7vvaktHCm7SQAAAAA6gClTShaNl967SnbKQAEamHx5x+VNq21nQQAAABAgFHahJotG6Rn/iwVF9lOAiBQ8nKkp+6VMjNsJwEAAAAQQJQ2ISQjP1sFr/5dysm2HQVAoO3ZIU24XyossJ0EAAAAQIBQ2oSIwpIi3TXnZV3bPUG5LVrbjgOgLqxZLr30V9spAAAAAAQIpU2I+NuiD7Rwz1qtisjTOf3raUf3nrYjAagLs3+U/veO7RQAAAAAAoDSJgT8Z+1kfbZxRtnPWZ5induhWPOHDLaaC0Ad+eg1adEs2ykAAAAA+BmlTZBbtGetnl76ySHnez3Sbxtn6cORw+SNjrGSDUAd8ZZILzwmbd9sOwkAAAAAP6K0CWJ7C7J139zXVWw+sB3GE0kZenxUP5Ukp9RpNgB1zCxAbhYmNjtLAQAAAAgJlDZByuv16s/z3tKOvL1Hve7EmH26/sSOym/aok6yAbBkywbp5b/bTgEAAADATyhtgtTrq77RjJ3Lq3z9JRE5GjcoXXu6dAtoLgCWzZkiTfnSdgoAAAAAfkBpE4Tm7Vqlf6+o/oeyDE+RxnaWlg4eFJBcAFzi7Wel7VtspwAAAABQS5Q2QWZPfpbun/fGEdexOZJij3Rt02z976Rh8kZG+T0fABfIz5VeelwqLradBAAAAEAtUNoE3To2b2p3/r5aH+uR5Aw9OWagShKT/ZINgMusWS79903bKQAAAADUAqVNEPlw3RTN2rXCf8eLydQtIzqroHEzvx0TgIv87x1p5RLbKQAAAADUEKVNkNi0f6eeXf6Z3487NzJHFxzTUJkdu/j92AAsKymRXvqLlLvfdhIAAAAANUBpEwRKvCV6aP7byisuCMjxd3gKdXb3SK0eMCAgxwdg0a5t0lv/sp0CAAAAQA1Q2gSBt1d/r8UZ6wJ6H4Xy6vIWOfr2hKHyRkQG9L4A1LFp30ozJ9lOAQAAAKCaKG1cbs2+rTXa3rum7kvdq+dGD5Y3PqHO7hNAHXjjn9KenbZTAAAAAKgGShsXKyop1kML3lZBSVGd3u+bcXv1x5HdVdSgUZ3eL4AAysmWXnnCdgoAAAAA1UBp42Jvrf5OKzI3Wbnv6ZH7dcnQ5spq18HK/QMIgKVzpVk/2k4BAAAAoIoobVxqy/7denXl11YzbIrI19k947SxT1+rOQD40XvPS3m5tlMAAAAAqAJKG5d6cslHdT4tqjL5nhJd2CZfU48fIq+HtwsQ9DJ2Sf9903YKAAAAAFXAp3AX+nHrQk3bsVRuckd6pl4bPUTe2DjbUQDU1jcfS1vW204BAAAA4CgobVwmtyhfTy39RG70YnyG7h7VS8VpDWxHAVAbxUXSmxNspwAAAABwFJQ2LvPKyq+0PTdDbjUpKltXHN9KOa3b2Y4CoDZ+XijN+N52CgAAAABHQGnjImuztum9Ne7f2WWtJ09j+yRoa8/etqMAqI33XpBy99tOAQAAAOAwKG1c5B9LPlKRt1jBYL+nROPbF2r2sWaBYo/tOABqInOP9MkbtlMAAAAAOAxKG5eYsWOZ5uxaqWBzS4NMvTdqqLzRMbajAKiJ7z+VNq21nQIAAABAJShtXKDEW6Jnlk1UsHo6IUMPje6n4pQ021EAVFdxsfTWv2ynAAAAAFAJShsX+GrzHK3O2qpg9mX0Pl07vK3yWrSyHQVAda1YJC2ebTsFAAAAgINQ2lhWUFykF3/+QqHg54g8nds/VTu79bAdBUB1ffK67QQAAAAADkJpY9kH6ya7eovv6sr0FOmcjiVaOGSw7SgAqmPtz9KCGbZTAAAAACiH0sairIIcvb7qG4Uar0e6oXGWPhk5TN6oaNtxAFQVo20AAAAAV6G0sejN1d8pqzBXoeqvSRn66+gBKklOsR0FQFVsWCXN+8l2CgAAAAAHUNpYsq9gvz5cN1Wh7tOYTN1wYgcVNGluOwqAqvj0DcnrtZ0CAAAAAKWNPe+vnazc4nyFg8URuRo/uL72dO5mOwqAo9m4RpozxXYKAAAAAJQ2duQU5TkLEIeT3Z4ije0i/TxooO0oAKoy2qakxHYKAAAAIOxR2ljw0bqfQnotm8Mp9khXNduvL0YMkzcyynYcAIezZb00+0fbKQAAAICwR2lTx/KLC/Xe2kkKZw/Vy9DTowepJDHJdhQAh/Ppm4y2AQAAACyjtKljEzdM1578LIW792L36tYRXVXYqKntKAAqs20ja9sAAAAAllHa1KGikmK9tfp72zFcY3bkfl0wpJH2dehkOwqAynz3ie0EAAAAQFijtKlD32+drx15e23HcJXtnkKd3T1aa/v3tx0FwMFWLvHtJgUAAADACkqbOvThuqm2I7hSgcerS1vm6ofhQ+WN4C0JuMr3/7WdAAAAAAhbfEKuIysyN2lxxjrbMVzt7rS9enH0MfLGJdiOAqDU9O+knGzbKQAAAICwRGlTRxhlUzWvxe3VHSN7qKh+Q9tRABgF+dLUr22nAAAAAMISpU0dyCrI0Teb59qOETR+isrWpcc2V3bbDrajADB+mCh5vbZTAAAAAGGH0qYOfLZxpvJLCm3HCCobPQUa2ztWm/r0tR0FwPbN0pI5tlMAAAAAYYfSJsC8Xq8+Xs/UqJrIlVcXtMnXtOOGyOvhrQpY9R0LEgMAAAB1jU/CATZz53JtztltO0ZQ+2P9TL0+eoi8sXG2owDha9Esadc22ykAAACAsEJpE2D/2zjLdoSQ8EJ8hu4b1UfFafVtRwHCk7dE+n6i7RQAAABAWKG0CaD9hXmasn2x7Rgh47uofbryuFbKbdnGdhQgPE39Sioqsp0CAAAACBuUNgH0w9YFKijhA44/rYnI19n9krS9Ry/bUYDwk71PWjbPdgoAAAAgbFDaBNBXm9ltJRD2e0p0bocizR16jO0oQPiZ9aPtBAAAAEDYoLQJkO25GZq3e7XtGCHtd4326b1Rw+SNjrEdBQgf86dJRYW2UwAAAABhgdImQL7ZPFdeeW3HCHn/TMzQI6P7qaRequ0oQHjIyZaWzrWdAgAAAAgLlDYB8iVTo+rM59H7dN3w9spr1tJ2FCA8zJpsOwEAAAAQFihtAmDVvi1am7XNdoywsiwyV+MHpmpX1+62owDhMUWqsMB2CgAAACDkUdoEwKStC21HCEsZnmKd28mrJYMH2Y4ChLbc/dISRhMCAAAAgUZpEwCTty2yHSFsFXuk65pm69OThskbFWU7DhC62EUKAAAACDhKGz/bsn+3VmdttR0j7P0lOUNPjB6okqR6tqMAoWnBDKZIAQAAAAFGaeNnk7cvth0BB3wUk6nfjuikgsbNbEcBQk9ejrR4tu0UAAAAQEijtPGzn7YvsR0B5SyMyNH5xzTU3k5dbEcBQs9sdpECAAAAAonSxo+yC3O1cM9a2zFwkJ2eQo3tFqmVAwfYjgKEFrMYsddrOwUAAAAQsiht/GjWzp9V5C22HQOVKJRXVzbP0dcnDpM3ItJ2HCA0ZO+TNlFUAwAAAIFCaeNH03cutx0BR/FASoaeHTNY3vhE21GA0LBsvu0EAAAAQMiitPGjubtW2o6AKngrdq/+MLK7Chs0th0FCH7LF9hOAAAAAIQsShs/2ZKzW9tyM2zHQBXNiMzWxcOaKqtdR9tRgOC2cpFUwrRQAAAAIBAobfxk3u7VtiOgmrZ4CnR2z1it69vPdhQgeOXmSOtW2U4BAAAAhCRKGz+Zt4sPLcEo31OiS1rnafLwofJ6+OcA1Mhy1rUBAAAAAoFPqX4ybzelTTD7v7S9ennMEHnj4m1HAYIP69oAAAAAAUFp4web9+/Sjry9tmOgll6Oy9CfRvZUUXpD21GA4LJqiVRUaDsFAAAAEHIobfyAUTahY3JUti47toX2t25nOwoQPArypTXLbacAAAAAQg6ljR8s2LPGdgT40YaIfJ3TJ0FbevW2HQUIHkyRAgAAAPyO0sYPlu/daDsC/Gy/p0TntSvUzGOPkdfjsR0HcL8Vi2wnAAAAAEIOpU0t5Rbla0P2DtsxECC3Ntint0cNlTcm1nYUwN02MuIQAAAA8DdKm1pauW+LSuS1HQMB9ExChh4Y3VfFqem2owDutT9L2rPTdgoAAAAgpFDa1NKKTKZGhYNvovbp6uPbKLdFa9tRAPfaxGgbAAAAwJ8obWrp58xNtiOgjqyMyNM5/etpR/eetqMA7rRpre0EAAAAQEihtKmlFZQ2YSXLU6xzOxRrwZBjbEcB3IfSBgAAAPArSptayCsu0HoWIQ47Xo90Y+N9+nDkMHmjom3HAdyD0gYAAADwK0qbWli9b6uKvSW2Y8CSJ5Iy9Pjo/ipJTrEdBXCH7ZulwgLbKQAAAICQQWlTC+uzt9uOAMsmxuzT9Sd2VH7TFrajAPYVF0tbN9hOAQAAAIQMSpta2Lif7W0hLYnI0bhB6drTpZvtKIB9G5kiBQAAAPgLpU0tbNq/y3YEuESGp0hjO0vLBg+yHQWwi3VtAAAAAL+htKmFjSxCjHKKPdI1TbP1v5OGyRsZZTsOYMemNX471OWXX66zzjpLoeiEE07QzTffbDsGAAAAXI7Spoa8Xq825+y2HQMu9Ehyhp4aPVAlicm2owB1b0vorGlTUHDoosrFxcUqKWEBegAAANQNSpsa2pmX6Wz5DVTmP7GZumVEZxU2amo7ClC39mUEZAcpMzLlpptu0h//+Eelp6erSZMmuu+++ypcZ+/evbr22mvVuHFjxcXFqUePHpo4cWLZ5R988IG6d++u2NhYtWnTRn/7298q3N6c9+CDD+rSSy9VvXr1dM011+iVV15RamqqPv30U3Xr1s257YYNG5Sfn6/bbrtNzZs3V2JiogYPHqwffvihwvGmTp3q5E5ISFBaWprGjBmjjIwMZwTRpEmT9I9//EMej8c5rVu3zu/PGQAAAIIfpU0NsQgxjmZuZI4uGNJImR06244C1B2vV9oTmPW+Xn31VacgmTFjhh5//HE98MAD+vrrr53LzOiXU045xSlK3njjDS1dulSPPvqoIiMjncvnzJmj8ePH6/zzz9eiRYucwufuu+92Spny/vrXv6p3796aN2+ec7mRk5Ojxx57TC+++KKWLFmiRo0a6cYbb9S0adP0zjvvaOHChRo3bpxOPvlkrVy50rnN/PnzddJJJzlFj7nelClTdPrppzsjdUxZM2TIEF199dXaunWrc2rZsmVAnjMAAAAEN4/XzPNBtX26fpr+suh92zEQBGK8Hj2/OV7tZ8+2HQWoG7c+KnXtU+vDmBEpZvTMxx9/7IxYMYXH5MmTyy4fNGiQRowY4ZQzX331lVPaLFu2TJ06dTrkWBdddJF27tzpXK+UGbXz2WefOUVM6Uibvn376qOPPiq7jil1rrjiCqeEMWWOYUbatGvXzvnarFmzsuuOHDnSyfTwww/rwgsvdC43ZU1lzOPp06ePnnzyyVo/TwAAAAhdjLSpoR15e21HQJAo8Hh1eYscfXfCUHkj+CeHMLAnMIu09+rVq8LPTZs21Y4dvvsypUqLFi0qLWwMU+YMGzaswnnmZzMyxpRBpQYMGHDIbWNiYirctxmpY25j7ispKansZKY8rV69usJIGwAAAKA22OKmhnbl7bMdAUHm3tS9WjHmGF37w3x5cnNsxwECZ09gpo9GR0dX+NmsBVO6KHB8fLxf7sNMvzqYOba5r1LZ2dnOtCsz5ap0+lUpU974Mw8AAADCG3/2r6Hd+ZQ2qL43Y/fq9pE9VNSgke0oQNCVNkdiRsJs2rRJK1asqPTyrl27OuvdlGd+NqNlDi5ejsZMoTIjbcwonw4dOlQ4mQWSS/N8++23hz2GGb1TfoQPAAAAUBlKmxrak59lOwKC1LTIbF0ytLmy23awHSXstXl3kjwvfXnI6Yaflla4nln665Qv5ziXfbxue5WPf93UJc5tnlz8y85A+cUluuSHhar32jfq9P5kfbN5d4Xb/GXhWv122jIFtcyMOr/L4cOH6/jjj9c555zjLE68du1aff755/riiy+cy2+99VanRDG7Q5lixyxq/PTTTzs7QFWXKXrMGjlml6kPP/zQua+ZM2fqkUcecdbIMe68807NmjVL119/vbNQ8fLly/XMM89o165dZevnmAWVza5R5jy2EQcAAEBlKG1qaDfTo1ALmyLyNbZ3rDb26Ws7SlibdcYQbb3ghLLT1yf71jMZ19Y3WqLUk0vW65fJMVXz0brtmr4jU80SYiuc//zyjZqze5+mnX6MrunSQhf+sNAphYy1WTl64edNeqh/RwW1fXus3K3Z0nvgwIG64IILnF2bzELDpaNZ+vXrp/fee8/Z7clsBX7PPfc4u0+ZxY5r4uWXX3ZKG1MGde7cWWeddZZT0rRq1aqs2DGLHi9YsMBZnNjsFvXJJ58oKso3K9mURWaEj8nZsGFDZ9FiAAAA4GDsHlUDJd4SjfjfH1Xs5S+jqL1H96Ro6OQZ8vB+su7m6cs0ccNOrRx3XNkaJvN379Ovvpqr2WcOUdO3f9BHJ/XRWW0aH/E4m/fnafCn0/XlyQN02ldzdHP31rq5RxvnsuunLlW9mCg9OrCTcouKlfDqN9px4YlqGB+jk7+YrWu7tNTZRzm+66U3lB5/3XYKAAAAIOgx0qYG9hbsp7CB39yRnqnXRg+RNzbOdpSwVlBcojdWbdWVnVqUFTY5RcXOSJgJQ7upyUEjZg6nxOvVJZMW6Q8926p7mm9R2vJ610/WlO0ZTmHz5aZdapoQqwZx0Xpz1RbFRUYGf2Fj7GN3PQAAAMAfKG1qgKlR8LcX4zN096heKk5rYDtK2Pp4/Q7tLSjS5R2blZ13y/TlGtooVWe2rvrC0Y8tXKsoj0c3dfdNkznYlZ2aq3d6srp9MFUPLVij907srYyCQt0zd5X+OaSL7pq9Uh3e+1FjvpjtjNgJSkWFUjbrfgEAAAC1xZbfNbCvkO2a4X+TorJ1xfGt9Oy8ZCVsWGs7Tth5acUmndKigZol+kY8fbp+h77bukfzzhpS5WPM2ZWpfyxZr7lnDqmwRXR50RERzsid8q74cZFu6tZa83ZnOeXRgrOH6vFF63TT9GX64KQgXfcoe6+UlGw7BQAAABDUKG1qILco33YEhKi1njyN7Zuol1N6q+miBbbjhI31Wbn6ZstufViuIPlu626t3pej1Ne/q3Ddc76br+Map+mH0wYdcpzJ2zK0I7dArd79sey8Yq9Xt8782VnMeN15ww+5zfdbdmtJRrZePLaH/jDzZ53asoESo6M0vm0TPb00iBenLSiwnQAAAAAIepQ2NZBXzIcRBM5+T4nGty/RE/WOUf+fzALFrBUeaC+v3KxGcTE6reUv09Pu6NVOV3VqUeF6PT/6SU8M7qLTWzWs9DiXdGimkc3qVzhvzJdznPOv6Nj8kOvnFRXrhmnL9ObwXoqM8DgFT+lyWYUlJc7PQauQ/04CAAAAtcWaNjWQw0gb1IFbGu7Te6OGyhsdYztKSDMLB7+8YrMu69hcURG//CfRLDzcIz25wslolRintskJZdfr8p8pzvbeRv24mENuEx3hUZP4GHVOTTzkvh+cv0antmiovg3qOT8Pa5ymD9dt18I9Wc4om2GNUhW0KG0AAACAWqO0qYFcRtqgjjydkKGHR/dTcb0021FC1jebd2vD/jxngeCa+DlzvzILiqp9u8V7svTe2m26v1/7svPObdtYp7VsqOMmznSKm38M6aKgRWkDAAAA1JrH6w3m8fd2vLrya7348+e2YyCMdC6J09NzdilucxCvcYLwcv3dUr9htlMAAAAAQY2RNjXAQsSoaz9H5OncAana1bWH7ShA1TDSBgAAAKg1SpsaYHoUbMj0FGlspxItGjLYdhTg6AoLbScAAAAAgh6lTQ0UFPNhBHZ4PdL1jbP0ychh8kZF244DHB4jbQAAAIBao7QBgtBfkzL0t9EDVJLk23UIcB1KGwAAAKDWKG1qwOPx2I4A6JOYTP32xE4qaFKzXY+AgCqitAEAAABqi9KmBqhs4BYLI3M0fnB95TdtYTsKUBFr2gAAAAC1RmlTAx4PTxvc4/jCRMXs2GY7BlBREaUNAAAAUFu0DzXASBu4RbuSWP1uynJ5iotsRwEqio6xnQAAAAAIepQ2NeChtoELxHg9mrAoS5H7MmxHAQ4VG2c7AQAAABD0KG1qgMoGbjBha4KS1q6yHQOoXAylDQAAAFBbUbU+QhiKCNI1bTa+P1O7f1ql3M17FBETpeQuzdTm8mOV0CK97DoL73xf+xZvqnC7Jif3VIcbRh7x2Dkbd2vdK1OUuXiTvMUlSmhZX13u/JXiGvm2pF7z4iTt+HaJIuKi1eayY9XohK5lt901ZYW2f7dU3e85y++POVT9dn+ausycajsGcHgxsbYTAAAAAEGP0qYG4qKCc60GU6g0Pa23kjo2lrfEq/WvTdWSez5Uv39dpsi46LLrNR7TQ60vGlr2c0Tskd8muVv3auHt76nxqO5qdeEQRSbEKGfDbqcYMnbPXK2dk5ar+wNjlbdlr1Y+9ZXS+rZRdEq8ivbna93rU9XjwXMC+MhDy9CiJI37cY7tGMCRMT0KAAAAqDVKmxpIjArODyM97h9b4edON4/WjIufU/aq7Urp8cuW0ZGx0YpJS6zycde/PlVp/duo7RXHl50X3zS17PvcjXuU0rOFkjs2cU5m1E3e9kyntFn38mQ1PaV32YgcHFl9b5T+PHOjPPl5tqMAR0ZpAwAAANQapU0YlTYHK9pf4HyNSq74eHb8sFw7vl/mFDfpg9qp5XmDK4zEKc+M2MmYvVbNxw7Q4ns+1P41OxTbOEUtzx2o+kM6ONdJbNtQ275cpKLsPOVty1RJfpHim6Uqc8lmZa/eofa/GVEHjzY0vLCyRNE7ttqOARwd06MAAACAWqO0qYGEqOD/MGLKljUv/KB6XZspsXWDsvMbDe+s2Eb1FJOepP3rdjrr1ORuzlDX/zu90uMUZuaoOLdQm/4zS60vHuaskZMxZ52WPfJf9XxonDPCJq1fGzU8oavm//4tZ8pUx1vGKCI2Wquf+Vadbh6jrZ8v1NaJ8xVVL85ZO6d8Hvzisd0parh0mu0YQNUw0gYAAACoNUqbMB1ps/rZ75x1Z3o9Nr7C+U1O7lX2fWKbBs5om8V3feCsW1N+ylP58seoP7i9mp/Vz/k+qV0jZS3fqq1fLHRKG6P1hUOcU6kNb09Tau9W8kRGaOO7M9Tv6Uu0Z9ZarXjiS/V98qKAPe5gNT4/VUOmTrcdA6g6do8CAAAAai04t0GyLNhLG1PY7Jm1Rj0fOlexDZKPeN3kzk2dr3lb91Z6eXS9eKd4iW9Vv8L58S3Tlb9zX6W3ydm4Rzu+X67WFw9V5qJNSuneXNEpCWpwbCftX71DRTm+aVvw6VwSpxumLJGnpMR2FKDqYoN/RCIAAABgGyNtaiAhOjhLG6/XqzXPfa/d01ap5yPjFNck5ai3MWvUGIdbmDgiOtLZjSp3054K55spVXEN61WaYdWEb9T2quMVGR/jjNQpKfaVEd6iYt+VKCfKxHoj9NSCvYrIyrQdBageRtoAAAAAtcZImxpICtKRNquf+c5ZZLjzbac6hUlBxn7nVJxf5FxupkBteGe6s5uU2d1p94zVznSlet2bO4sJl5pz3SvaNW1V2c9mEeJdU1Y4iw3nbtmrLRPna8/MNWpyau9DMmz/arGza1T9Qe2dn+t1a6bMhRu1b/lWbf5krhJapisqKTif30B4blOsEtavsR0DqL64eNsJAAAAgPAdabNt2zY99NBD+uyzz7R582Y1atRIffr00c0336yTTjpJbvLKK684ufburXyKT3WlxiQpGG37fKHzddH/vV/h/I6/G63GI7srIipSe+dv0JZP56k4r9CZOlV/aAdn96iDR9EU788v+7nBkA4quv4kbXp/ltY8/73im6er652nO9OeyjMF0cb3ZqrX4+eVnZfcqYman9VfSx/42Jki1emWMQF69MHn1uw0tZ8z1XYMoPoSk6XoGNspAAAAgKDn8Zr5KtW0bt06DRs2TKmpqXrggQfUs2dPFRYW6ssvv9Tzzz+v5cuXVztIQUGBYmIO/SXfHDc6uvLtpm2VNsaoz+9QXjFrryAwhhcl6cGvFshT8Es5BgSNlu2leyfYTgEAAACE5/So66+/Xh6PRzNnztQ555yjTp06qXv37vr973+v6dN9O9xs2LBBZ555ppKSklSvXj2NHz9e27dvLzvGfffd54zMefHFF9W2bVvFxfmmxJjjPvPMMzrjjDOUmJjojOYxPvnkE/Xr18+5Xrt27XT//ferqMg3rccwhcy1116rxo0bO9fp0aOHJk6cqB9++EFXXHGFMjMznWObk7nv2kqPPfICvkBNNfZG677p6yhsELzSG9hOAAAAAITn9Kg9e/boiy++cMoUU6oczIy+KSkpKStsJk2a5JQrN9xwg8477zynRCm1atUqffDBB/rwww8VGRlZdr4pVR599FE9+eSTioqK0uTJk3XppZfqqaee0nHHHafVq1frmmuuca577733Ovd3yimnKCsrS2+88Ybat2+vpUuXOsccOnSoc5x77rlHP//8s3Mbk6u26sfW05ac3bU+DlCexys9/3Ohonb5FoAGglL6L2tgAQAAAKjD0sYULWZGVZcuXQ57nW+//VaLFi3S2rVr1bJlS+e81157zRmNM2vWLA0cOLBsSpQ5v2HDir/gX3jhhc7omFJXXnml7rjjDl122WXOz2akzYMPPqg//vGPTmnzzTffOKN+li1b5oz6Kb1OqZSUFGeETZMmTeQvDeNTpAy/HQ5w/G13itKXT7MdA6id9Ea2EwAAAADhWdpUZQkcU56Ysqa0sDG6devmjMIxl5WWNq1btz6ksDEGDBhQ4ecFCxZo6tSpZVOljOLiYuXl5SknJ0fz589XixYtygqbutAoLrXO7gvh4aK8VA2Y6pteCAQ1RtoAAAAAdkqbjh07OqNWarLY8MEqm15V2fnZ2dnOGjZjx4495Lpm/Zr4+LrfWrZxPKUN/KdHSbyumbxIHm+J7ShA7VHaAAAAAHYWIk5PT9eYMWM0YcIE7d+//5DLzYLAXbt21caNG51TKbPGjLnMjLipLrMAsVmPpkOHDoecIiIi1KtXL23atEkrVqyo9PZmVyozMsefGGkDf0n0Rujvc3cpYn+W7SiAf1DaAAAAAPZ2jzKFjSlBBg0a5CwkvHLlSmfak1koeMiQIRo5cqSzDfhFF12kuXPnOuvNmIWEhw8ffsjUp6owiwibtW/MaJslS5Y49/XOO+/orrvuci43xz3++OOdnay+/vprZy2dzz//3Fkw2WjTpo0zWsestbNr1y5nSlVtNUusX+tjAMazG2IUv2m97RiAf3gipFR2jwIAAACslTZmkV9Txpx44om69dZbne21R40a5ZQiZrtuM33KbNGdlpbmlCmmxDG3effdd2sU0ozsMdt3f/XVV856OMccc4yeeOIJZ02cUqY8MpddcMEFzmges0hx6egas4PUdddd5+xeZdbQefzxx1VbLRMbyiNPrY+D8HZnVprazJtrOwbgP6npUrndAAEAAADUnMdblZWFUalx3z6obblsIYWaGVlUT/d8OVeewgLbUQD/ad9VuvMJ2ykAAACA8B1pA59WSWxri5pp5o3Rn35aTWGD0FOf/y4CAAAA/kJpUwutKW1QA5Fe6blleYras9N2FMD/WrSznQAAAAAIGZQ2tdA6qbHtCAhCT+xMVuqK5bZjAIHRqr3tBAAAAEDIoLSpBaZHobquyEtTn2kzbccAAqclpQ0AAADgL5Q2tcBIG1RHn5IEXfHjArP6t+0oQGCkpPlOAAAAAPyC0qYW0mOTlRKTaDsGgkCyN1J/mb1dnpxs21GAwGnZwXYCAAAAIKRQ2tRSl5SWtiMgCDy/LkpxWzbajgEEVisWIQYAAAD8idKmlrqmtrIdAS53T2aqWiyYZzsGEHgsQgwAAAD4FaVNLXVJZaQNDu+UwnoaOZmFhxEmWIQYAAAA8CtKm1pipA0Op1VJrG7/aaU8RUW2owCBF5cgNWpmOwUAAAAQUiht/LAYceN4dktBRdHy6Jkl+xWZsdt2FKButGgjeTy2UwAAAAAhhdLGD1iMGAd7aluS6q1eYTsGUHdasXMUAAAA4G+UNn7QlXVtUM41OWnqPoN1bBBm2nSynQAAAAAIOZQ2ftAtrbXtCHCJAcWJuvjHefJ4vbajAHWrax/bCQAAAICQQ2njB91T2yg2Itp2DFiW5o3UY7O2yJOXYzsKULeatJTSGthOAQAAAIQcShs/iImMUq/0trZjwLLnV3sUs22z7RhA3evW13YCAAAAICRR2vhJ/wYdbUeARQ9mpKrJ4oW2YwB2UNoAAAAAAUFp4yf9G7AIZ7g6syBFw6ew8DDCVGSk1LmX7RQAAABASKK08ZNOKc2VHB1vOwbqWLuSWN0yZbk8xUW2owD2do2KT7SdAgAAAAhJlDZ+EuGJUN/6HWzHQB2K8Xo0YVGWIvdl2I4C2NOVqVEAAABAoFDa+BHr2oSXCVsTlLR2le0YgF2sZwMAAAAEDKWNHw1s0Nl2BNSRG3PS1GXmLNsxALti46V2XW2nAAAAAEIWpY0ftUxqqNZJjW3HQIANKU7S+ElzbMcA7OvUQ4qKsp0CAAAACFmUNn52fJOetiMggOp7o/TQjI3y5OfZjgLYx3o2AAAAQEBR2vjZcU162I6AAHphZYmid2y1HQNwh75DbCcAAAAAQhqljZ91SWmpRnGptmMgAB7dk6KGSxfbjgG4Q7suUsOmtlMAAAAAIY3Sxs88Ho+OZbRNyBlXkKKhU2bYjgG4x8DhthMAAAAAIY/SJgCYIhVaOpfE6cbJS+UpKbEdBXAHT4Q08HjbKQAAAICQR2kTAH3S26tedILtGPCDWG+EnlqwVxFZmbajAO7aNSq1vu0UAAAAQMijtAmAqIhIRtuEiOc2xSph/RrbMQB3GXSC7QQAAABAWKC0CZAxLQbYjoBauiU7Te3nzLEdA3CXyCip/7G2UwAAAABhgdImgFOkmiak246BGjq+KFln/zjbdgzAfbr1lZLq2U4BAAAAhAVKmwDuInVyc0bbBKNG3mjdN32dPAX5tqMA7sPUKAAAAKDOUNoE0MktBsojj+0YqAaPV3r+5yJF79puOwrgPjGxUt8htlMAAAAAYYPSJoCaJdZXr/S2tmOgGv62O0X1ly+xHQNwp54DpTh2xgMAAADqCqVNgJ3MgsRB46K8VA2YOsN2DMC9hpxkOwEAAAAQVihtAuzEpn0UGxFtOwaOontJgq6Zslgeb4ntKIA7NWgi9RpsOwUAAAAQVihtAiwxOk4jm/e1HQNHkOiN0BPzdikie5/tKIB7nXi6FMH/ZQAAAAB1id/A68A5bY6zHQFH8OyGGMVvXGc7BuBesXHScWNspwAAAADCDqVNHeiY0ly909vZjoFK3JmVpjbz5tqOAbjbkJFSQpLtFAAAAEDYobSpI4y2cZ+RRfV0yo+zbMcA3M3jkUacYTsFAAAAEJYoberI8U17qlFcqu0YOKCZN0Z/mrZansIC21EAd+vaV2rWynYKAAAAICxR2tSRSE+ExrYZZjsGzGvhlZ5blqeo3TttRwHc76QzbScAAAAAwhalTR06vdUxbP/tAk/sTFbqiuW2YwDu16iZ1GuQ7RQAAABA2KK0qUP1YhI1ukV/2zHC2hV5aeozbabtGEDwbPNt1rQBAAAAYAWlTR27qP0IZ6oU6l6vkgRd8eMCebxe21EA94uNl44dbTsFAAAAENZoD+pY88QGGtmsn+0YYSfZG6m/zd4uT0627ShAcDhujBSfaDsFAAAAENYobSy4tONIRYgpB3Xp+XVRituy0XYMIDhEx0gnj7OdAgAAAAh7lDYWtEpqpBOb9bEdI2zck5mqFgvm2Y4BBI/hp0mp9W2nAAAAAMIepY0ll3UcJQ+jbQLulMJ6GjmZhYeBKouJlU5hlA0AAADgBpQ2lrRNbqLjm/S0HSOktfTG6PafVspTVGQ7ChBco2xS0m2nAAAAAEBpY9flnRhtEyjR8ujZJTmKzNhtOwoQXKNsWMsGAAAAcA1KG4s61Guu4U172Y4Rkp7alqh6q1bYjgEEl5FnSSlptlMAAAAAOIDSxrJrOp+qSA8vgz9dk5Om7jNm2Y4BBJfEZOnk8bZTAAAAACiHtsCylkkNdUarIbZjhIwBxYm6+Md58ni9tqMAweXU86WERNspAAAAAJRDaeMCV3QarfjIWNsxgl6KN0qPzdoiT16O7ShAcElvJI043XYKAAAAAAehtHGBtNhkXdzhJNsxgt4LazyK2bbZdgwg+Jx5sRQdYzsFAAAAgINQ2rjEee2Gq3E8C4DW1IMZqWq6aIHtGEDwadVBGjLSdgoAAAAAlaC0cYnYyGhd1+U02zGC0pkFKRo+ZabtGEDwMYugX/JbKYL/KwAAAADciN/UXWRk837qmdbWdoyg0tYbp1umLpenuMh2FCD4nHCq1Laz7RQAAAAADoPSxmVu63muojyRtmMEhRivRxMW7VNkZobtKEDwSUmTzr7CdgoAAAAAR0Bp4zLt6jV11rfB0U3YmqDkNatsxwCC0/hr2OIbAAAAcDlKG5duAd4sob7tGK52Y06ausycZTsGEJy69ZMGn2g7BQAAAICjoLRxodjIGP2+x1jbMVxrSHGSxk+aYzsGEJzM1t4X3Wg7BQAAAIAqoLRxqcGNumpEsz62Y7hOfW+UHpqxUZ78PNtRgOB0ynipcTPbKQAAAABUAaWNi93U7SwlRcXZjuEqz6/yKnrHVtsxgODUuLmvtAEAAAAQFChtXKx+XD39puvptmO4xqN7UtRoySLbMYDgdfGNvulRAAAAAIICpY3LndF6iI5p1FXhblxBioZOmWE7BhC8hoyUuva1nQIAAABANVDaBIE7ep2nlJjw3Zq3c0mcbpy8VJ6SEttRgODUsKl00fW2UwAAAACoJkqbIJkm9Yee4xSOYr0RemrBXkVkZdqOAgSnyCjp6jukuATbSQAAAABUE6VNkBjetJdObjFA4ebZzXFKWL/GdgwgeJ15idSus+0UAAAAAGqA0iaI3Nx9rJrEpylc3JKdpg6zZ9uOAQSvLn2kk8NzlB4AAAAQCihtgkhidJz+r88FipBHoe74omSd/SOFDVBjSSnSVX+QIvjPPAAAABCs+G0+yPSt30EXdThJoayRN1r3TV8nT0G+7ShA8Lr8Zim1vu0UAAAAAGqB0iYI/brzyepXv6NCkccrPf9zkaJ3bbcdBQheJ54u9RliOwUAAACAWqK0CUKRngjd1+9iNYitp1Dz1931VH/5EtsxgODVvI00/mrbKQAAAAD4AaVNkEqLTdYD/S9TlCdSoeKivFQNnDrTdgwgeMXEStfeKUXH2E4CAAAAwA8obYJYz/S2+k3XXykUdC9J0DVTFsvjLbEdBQheF90gNWttOwUAAAAAP6G0CXLj2w3XiKZ9FMwSvRF6Yt4uRWTvsx0FCF5ma+9ho22nAAAAAOBHlDYh4Pbe56l1UiMFq2c3xih+4zrbMYDgZRYdHnuF7RQAAAAA/IzSJgQkRMXqsYFXKSUmUcHm9qw0tZk713YMIHi1bC9dfbsUwX/OAQAAgFDDb/khonliAz084ErFREQpWJxUmKzTfpxlOwYQvFLSpd/eJ8XG2U4CAAAAIAAobUJIr/S2uqP3eQoGzbwxumv6GnkKC2xHAYJ3p6gb75XSG9pOAgAAACBAKG1CzKjm/XVlpzFys0iv9OyyfEXt3mk7ChCcPB7pilultp1tJwEAAAAQQJQ2IeiKTmM0unl/udUTO5OVtmKZ7RhA8DrjYmng8bZTAAAAAAgwSpsQZaZJ9U5vJ7e5PC9VfabNtB0DCF6DT5ROv8h2CgAAAAB1gNImREVHROmRAVeqfXJTuUWvkgRd+eNCebxe21GA4NSxh3T5LbZTAAAAAKgjlDYhLDkmQX8/5jq1SLS/UGmyN1J/m71dnpxs21GA4NSui/S7B6ToGNtJAAAAANQRSpsQlx6brCePuU6N49Os5nh+fZTitmy0mgEIWm06Sjc/JMUl2E4CAAAAoA5R2oQBU9g8Mfg6p8Cx4e7MVLWYP8/KfQNBr2U76ZaHpYRE20kAAAAA1DFKmzDRMqmh/j74WiVHx9fp/Z5SWE+jJrPwMFAjzVpLv39ESrRTuAIAAACwi9ImjLSv10x/HXSN4iNj6+T+WnpjdPtPK+UpKqqT+wNCSpMW0q2PSskptpMAAAAAsITSJsx0S2utvw2+RolRcQG9n2h59OySHEVm7A7o/QAhqVEz6bbHpBS7a1EBAAAAsIvSJgz1TG+rfxzzG6VEB26NjH9sT1K9VSsCdnwgZDVo7CtsUuvbTgIAAADAMkqbMNU5taWeGnJ9QBYnvjo3TT2ms44NUG3pDaVbH/N9BQAAABD2KG3CWLt6TfXPITeoUVyq3445oDhRl/w4Tx6v12/HBMJC4+bSH/4iNWxiOwkAAAAAl/B4vXy6Dndbc/bo5unPaEtO7dafSfFG6cMZuxWzbbPfsgFhoX1X6bf3S0n1bCcBAAAA4CKMtIGaJqTr6SE3qHVS41od54U1HgoboLr6DvXtEkVhAwAAAOAglDZwNIxP1TNDf6ve6e1qdPsH9qaq6aIFfs8FhLQTfyX95i4pJtZ2EgAAAAAuxPQoVFBYUqRHFryjrzfPrfJtzihI0W1fzpKnuCig2YCQ4fFIZ18unXqe7SQAAAAAXIzSBpV66ecv9MrKr456vbbeOL38w1pFZmbUSS4g6EVGSZffLA0ZaTsJAAAAAJejtMFhfb5xlh5f+J6KvMWVXh7j9ejjRflKXrOqzrMBQSkuwTcdqns/20kAAAAABAFKGxzRnF0rddecV5RdmHvIZS9sSVKXmTOt5AKCTkq69LsHpVbtbScBAAAAECQobXBU67O36/9mvawN+3eUnXdDTprO/2qq1VxA0GjfTbr2Tim9oe0kAAAAAIIIpQ2qZH9hnv48/y1N2b5YQ4oT9dhXi+TJz7MdC3C/UWdL5/xaioqynQQAAABAkKG0QZWZt8qbK7/W+NfeVcy2zbbjAO4WnyBd/nup/7G2kwAAAAAIUpQ2qL4lc6UXH5OyMm0nAdypZTvpuj9JjZvbTgIAAAAgiFHaoGYydknPPSytWmo7CeAuw0ZLF90gxcTaTgIAAAAgyFHaoOaKi6UP/y19+YHtJIB9pqS58Hrp2DG2kwAAAAAIEZQ2qL3506RXn2S6FMJXo2bSb+7yTYsCAAAAAD+htIF/mMLmzael2ZNtJwHq1pCTfCNs4hNtJwEAAAAQYiht4F+zf5TenMCoG4S+tAbSJTdJvQbZTgIAAAAgRFHawP+y9kpvPC3NmWI7CeB/Ho903MnSuKsYXQMAAAAgoChtEDizDoy6yWbUDUJEw6bSpb+TuvaxnQQAAABAGKC0QWDt2+tb64ZRNwhmnghpxOnS2Cuk2DjbaQAAAACECUob1I2Zk6S3zKibfbaTANXTpIV0+e+lDt1sJwEAAAAQZihtULejbj56RZryleQtsZ0GOLKICGn0udKZF0vRMbbTAAAAAAhDlDaoexvXSO8+Ly2fbzsJULmufaXzr5Wat7GdBAAAAEAYo7SBPfOmSf95Udq+2XYSwKdxc2nc1VKfY2wnAQAAAABKG1hWVCR996k08S0pJ9t2GoSrhCTpVxdKI86QoqJspwEAAAAAB6UN3MEsUPzpG9Kkz6TiYttpEC6ioqUTT5dOu0BKSradBgAAAAAqoLSBu2zZIL33grR4lu0kCPUtvI8ZIZ11qVS/ke00AAAAAFApShu40/IF0mfvSMvm2U6CUNNzoHTOlVKLtraTAAAAAMARUdrA3dat8JU386dJvFVRm+27+x8nnXyu1Lqj7TQAAAAAUCWUNggOW9ZLn78vzfyeNW9QdTGx0rBR0uhzpIZNbacBAAAAgGqhtEFw2b1d+uI/0pQvpcIC22ngVonJvgWGTzpDSk61nQYAAAAAaoTSBsEpM0P6+iNp0kQpN8d2GriFWVR41FjpuJOl2DjbaQAAAACgVihtENxy9ktTvvCNvDE7TyE8mUWFTx4nDRwuRUbaTgMAAAAAfkFpg9Cxeqk0+Utp1o9Sfq7tNAi0+ERp4PG+NWvad7OdBgAAAAD8jtIGoScvV5r9ozT5C2n1Mttp4E+eCKlrH19R03eob6FhAAAAAAhRlDYIbWbKlClvpn8rZWXaToOaatxcGjJSGjpSSm9oOw0AAAAA1AlKG4SHoiJpwXTpp6+lpfPYeSoYxCVIA46Tho2WOna3nQYAAAAA6hylDcJPfp60dK40f7q0cAYjcNzEbM/dc6DUe7DUYwA7QAEAAAAIa5Q2CG8lJb51b+ZP8522b7adKLx4PFLL9lKvQVKvwVLbTr7zAAAAAACUNkAF2zZK86ZLC6ZJq5dL3hLbiUKPGT3Tte+BomaQlFrfdiIAAAAAcCVKG+BwsvZKKxZLq5b4RuOsXyUVF9lOFXwiI6XmbX3r0pipT517SdExtlMBAAAAgOtR2gBVVZAvrVshrVrqO61ZJmXvs53KfdIaSO26/HJq3ZGtuQEAAACgBihtgJoy/3S2bZJWLz0wGme5tGOzVFyssGHKGFPKlC9pTGkDAAAAAKg1ShvA31uL79rqK3NKT9sPfA3WXarMwsAp6VKjZr5T4+a/fG3ayjf9CQAAAADgd5Q2QF3Zn1WxyDE7Ve3dI+3LkPbtlfJz7WWLT5ASk6X6jQ+UM6aYafpLUcPW2wAAAABQ5yhtALfIz/OVN6bEMQVPTvYvp/3ZUm62VGx2s/L6tio3nH++5ucDX0v/OZdeHmfKmCRfIWNOCUkVv5Z+z2gZAAAAAHAdShsAAAAAAAAXirAdAAAAAAAAAIeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAHAhShsAAAAAAAAXorQBAAAAAABwIUobAAAAAAAAF6K0AQAAAAAAcCFKGwAAAAAAABeitAEAAAAAAJD7/D87VGHtN424SAAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 1200x1000 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sys_instruct = (\n",
    "    \"You are a clinical decision support assistant.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Your task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\\n\"\n",
    "    \"\\n\"\n",
    "    \"There are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\\n\"\n",
    "    \"\\n\"\n",
    "    \"PERC Criteria:\\n\"\n",
    "    \"1. Age < 50 years\\n\"\n",
    "    \"2. Heart rate < 100 bpm\\n\"\n",
    "    \"3. Oxygen saturation ≥ 95%\\n\"\n",
    "    \"4. No hemoptysis\\n\"\n",
    "    \"5. No estrogen use\\n\"\n",
    "    \"6. No prior venous thromboembolism (VTE)\\n\"\n",
    "    \"7. No unilateral leg swelling\\n\"\n",
    "    \"\\n\"\n",
    "    \"After your output return a **single JSON object*.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Format:\\n\"\n",
    "    \"{\\n\"\n",
    "    \"  \\\"Explanation\\\": \\\"<A short explanation of how each criterion was evaluated>\\\",\\n\"\n",
    "    \"  \\\"Criteria\\\": {\\n\"\n",
    "    \"    \\\"Age < 50\\\": true or false,\\n\"\n",
    "    \"    \\\"HR < 100\\\": true or false,\\n\"\n",
    "    \"    \\\"O₂ ≥ 95%\\\": true or false,\\n\"\n",
    "    \"    \\\"No hemoptysis\\\": true or false,\\n\"\n",
    "    \"    \\\"No estrogen use\\\": true or false,\\n\"\n",
    "    \"    \\\"No prior VTE\\\": true or false,\\n\"\n",
    "    \"    \\\"No unilateral leg swelling\\\": true or false\\n\"\n",
    "    \"  },\\n\"\n",
    "    \"  \\\"Answer\\\": <sum of false values>\\n\"\n",
    "    \"}\\n\"\n",
    "    \"\\n\"\n",
    "\n",
    ")\n",
    "invalid_outputs, wrong_outputs, results_df,parsed_json = await run_models_with_output(\n",
    "    sys_instruct = sys_instruct\n",
    "    ,prompt=\"Calculate the PERC score for this patient based on the 7 criteria above. Explain how each criterion applies, then return the result in the specified JSON format.\",\n",
    "    model_ids=model_ids,\n",
    "    include_relevant_entities=True,\n",
    "    full_df=True\n",
    ")\n",
    "plot_df_pie(results_df)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4c0c554d",
   "metadata": {},
   "source": [
    "#### More detailed system instruction (does not include relevant entities in prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "f74ba153",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Evaluating model: Llama-3.3-70B-Instruct ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Llama3-Med42-70B ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Evaluating model: Med42-Qwen2.5-72B-v3-bi ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Summary Table ===\n",
      "                  model_id  wrong  correct  invalid  total  accuracy\n",
      "0   Llama-3.3-70B-Instruct    103       30        0    133     0.226\n",
      "1         Llama3-Med42-70B     95       38        0    133     0.286\n",
      "2  Med42-Qwen2.5-72B-v3-bi    106       27        0    133     0.203\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x1000 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sys_instruct = (\n",
    "    \"You are a clinical decision support assistant.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Your task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\\n\"\n",
    "    \"\\n\"\n",
    "    \"There are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\\n\"\n",
    "    \"\\n\"\n",
    "    \"PERC Criteria:\\n\"\n",
    "    \"1. Age < 50 years\\n\"\n",
    "    \"2. Heart rate < 100 bpm\\n\"\n",
    "    \"3. Oxygen saturation ≥ 95%\\n\"\n",
    "    \"4. No hemoptysis\\n\"\n",
    "    \"5. No estrogen use\\n\"\n",
    "    \"6. No prior venous thromboembolism (VTE)\\n\"\n",
    "    \"7. No unilateral leg swelling\\n\"\n",
    "    \"\\n\"\n",
    "    \"After your output return a **single JSON object*.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Format:\\n\"\n",
    "    \"{\\n\"\n",
    "    \"  \\\"Explanation\\\": \\\"<A short explanation of how each criterion was evaluated>\\\",\\n\"\n",
    "    \"  \\\"Criteria\\\": {\\n\"\n",
    "    \"    \\\"Age < 50\\\": true or false,\\n\"\n",
    "    \"    \\\"HR < 100\\\": true or false,\\n\"\n",
    "    \"    \\\"O₂ ≥ 95%\\\": true or false,\\n\"\n",
    "    \"    \\\"No hemoptysis\\\": true or false,\\n\"\n",
    "    \"    \\\"No estrogen use\\\": true or false,\\n\"\n",
    "    \"    \\\"No prior VTE\\\": true or false,\\n\"\n",
    "    \"    \\\"No unilateral leg swelling\\\": true or false\\n\"\n",
    "    \"  },\\n\"\n",
    "    \"  \\\"Answer\\\": <sum of false values>\\n\"\n",
    "    \"}\\n\"\n",
    "    \"\\n\"\n",
    "\n",
    ")\n",
    "invalid_outputs, wrong_outputs, results_df,parsed_json = await run_models_with_output(\n",
    "    sys_instruct = sys_instruct\n",
    "    ,prompt=\"Calculate the PERC score for this patient based on the 7 criteria above. Explain how each criterion applies, then return the result in the specified JSON format.\",\n",
    "    model_ids=model_ids,\n",
    "    include_relevant_entities=False,\n",
    "    full_df=True\n",
    ")\n",
    "plot_df_pie(results_df)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "70dfbcb0",
   "metadata": {},
   "source": [
    "### Accuracy (Used the data from \"More detailed system instruction (does not include relevant entities in prompt)\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "25f80452",
   "metadata": {},
   "source": [
    "#### Outputs and Ground truth answer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "54e5fa2d",
   "metadata": {},
   "outputs": [],
   "source": [
    "''' A function that computes the truth table for the PERC criteria based on parsed JSON outputs and patient data.\n",
    "It returns a DataFrame with accuracy for each criterion per model.'''\n",
    "def compute_truth_table(parsed_json, patient_df):\n",
    "    rows = []\n",
    "\n",
    "    def to_bool(val):\n",
    "        if isinstance(val, bool):\n",
    "            return val\n",
    "        if isinstance(val, str):\n",
    "            return val.lower() in ['true', 'yes', '1']\n",
    "        return bool(val)\n",
    "\n",
    "    for model_id, outputs in parsed_json.items():\n",
    "        for i, output in enumerate(outputs):\n",
    "            try:\n",
    "                criteria_pred = output[\"parsed_criteria\"][\"Criteria\"]\n",
    "            except (TypeError, KeyError):\n",
    "                continue  # skip bad or invalid outputs\n",
    "\n",
    "            row = patient_df.iloc[i]\n",
    "            entities = row[\"Parsed Entities\"]\n",
    "\n",
    "            age = extract_number(entities.get(\"age\"))\n",
    "            hr = extract_number(entities.get(\"Heart Rate or Pulse\"))\n",
    "            o2 = extract_number(entities.get(\"O₂ saturation percentage\"))\n",
    "\n",
    "            truth = {\n",
    "                \"Age < 50\": age is not None and age < 50,\n",
    "                \"HR < 100\": hr is not None and hr < 100,\n",
    "                \"O₂ ≥ 95%\": o2 is not None and o2 >= 95,\n",
    "                \"No hemoptysis\": not to_bool(entities.get(\"Hemoptysis\", False)),\n",
    "                \"No estrogen use\": not to_bool(entities.get(\"Estrogen use\", False)),\n",
    "                \"No prior VTE\": not to_bool(entities.get(\"Prior VTE\", False)),\n",
    "                \"No unilateral leg swelling\": not to_bool(entities.get(\"Unilateral leg swelling\", False)),\n",
    "            }\n",
    "\n",
    "            for criterion, true_val in truth.items():\n",
    "                pred_val = criteria_pred.get(criterion)\n",
    "                match = (pred_val == true_val)\n",
    "                rows.append({\n",
    "                    \"Model\": model_id,\n",
    "                    \"Criterion\": criterion,\n",
    "                    \"Correct\": match\n",
    "                })\n",
    "\n",
    "    df = pd.DataFrame(rows)\n",
    "\n",
    "    # Group by model and criterion, compute mean accuracy\n",
    "    accuracy_df = (\n",
    "        df.groupby([\"Model\", \"Criterion\"])[\"Correct\"]\n",
    "        .mean()\n",
    "        .reset_index()\n",
    "        .pivot(index=\"Criterion\", columns=\"Model\", values=\"Correct\")\n",
    "        .round(3)\n",
    "    )\n",
    "\n",
    "    return accuracy_df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "10b38cb8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model                       Llama-3.3-70B-Instruct  Llama3-Med42-70B  \\\n",
      "Criterion                                                              \n",
      "Age < 50                                     0.534             0.563   \n",
      "HR < 100                                     0.556             0.563   \n",
      "No estrogen use                              0.947             0.849   \n",
      "No hemoptysis                                0.880             0.889   \n",
      "No prior VTE                                 0.955             0.810   \n",
      "No unilateral leg swelling                   0.917             0.810   \n",
      "O₂ ≥ 95%                                     0.541             0.595   \n",
      "\n",
      "Model                       Med42-Qwen2.5-72B-v3-bi  \n",
      "Criterion                                            \n",
      "Age < 50                                      0.481  \n",
      "HR < 100                                      0.426  \n",
      "No estrogen use                               0.891  \n",
      "No hemoptysis                                 0.868  \n",
      "No prior VTE                                  0.868  \n",
      "No unilateral leg swelling                    0.845  \n",
      "O₂ ≥ 95%                                      0.512  \n"
     ]
    }
   ],
   "source": [
    "accuracy_table = compute_truth_table(parsed_json, perc_df)\n",
    "print(accuracy_table)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "b07bb45d",
   "metadata": {},
   "outputs": [],
   "source": [
    "'''A function that plots confusion matrices for each model and criterion based on parsed JSON outputs and patient data.\n",
    "It creates a grid of subplots with each model's confusion matrix for each criterion.'''\n",
    "def plot_confusion_matrices_by_model(parsed_json, patient_df):\n",
    "    def to_bool(val):\n",
    "        if isinstance(val, bool):\n",
    "            return val\n",
    "        if isinstance(val, str):\n",
    "            return val.lower() in ['true', 'yes', '1']\n",
    "        return bool(val)\n",
    "\n",
    "    data = []\n",
    "\n",
    "    for model_id, outputs in parsed_json.items():\n",
    "        for i, output in enumerate(outputs):\n",
    "            try:\n",
    "                criteria_pred = output[\"parsed_criteria\"][\"Criteria\"]\n",
    "            except (TypeError, KeyError):\n",
    "                continue\n",
    "\n",
    "            row = patient_df.iloc[i]\n",
    "            entities = row[\"Parsed Entities\"]\n",
    "\n",
    "            age = extract_number(entities.get(\"age\"))\n",
    "            hr = extract_number(entities.get(\"Heart Rate or Pulse\"))\n",
    "            o2 = extract_number(entities.get(\"O₂ saturation percentage\"))\n",
    "\n",
    "            truth = {\n",
    "                \"Age < 50\": age is not None and age < 50,\n",
    "                \"HR < 100\": hr is not None and hr < 100,\n",
    "                \"O₂ ≥ 95%\": o2 is not None and o2 >= 95,\n",
    "                \"No hemoptysis\": not to_bool(entities.get(\"Hemoptysis\", False)),\n",
    "                \"No estrogen use\": not to_bool(entities.get(\"Estrogen use\", False)),\n",
    "                \"No prior VTE\": not to_bool(entities.get(\"Prior VTE\", False)),\n",
    "                \"No unilateral leg swelling\": not to_bool(entities.get(\"Unilateral leg swelling\", False)),\n",
    "            }\n",
    "\n",
    "            for criterion, true_val in truth.items():\n",
    "                pred_val = criteria_pred.get(criterion)\n",
    "                if pred_val is None:\n",
    "                    continue\n",
    "                data.append({\n",
    "                    \"Model\": model_id,\n",
    "                    \"Criterion\": criterion,\n",
    "                    \"True\": true_val,\n",
    "                    \"Pred\": pred_val,\n",
    "                })\n",
    "\n",
    "    df = pd.DataFrame(data)\n",
    "\n",
    "    models = df[\"Model\"].unique()\n",
    "    criteria = df[\"Criterion\"].unique()\n",
    "\n",
    "    nrows = len(models)\n",
    "    ncols = len(criteria)\n",
    "    fig, axes = plt.subplots(nrows, ncols, figsize=(4 * ncols, 4 * nrows), squeeze=False)\n",
    "\n",
    "    for i, model in enumerate(models):\n",
    "        for j, criterion in enumerate(criteria):\n",
    "            ax = axes[i][j]\n",
    "            sub = df[(df[\"Model\"] == model) & (df[\"Criterion\"] == criterion)]\n",
    "            cm = pd.crosstab(sub[\"True\"], sub[\"Pred\"])\n",
    "            sns.heatmap(cm, annot=True, fmt=\"d\", cbar=False, cmap=\"Blues\", ax=ax)\n",
    "            ax.set_title(f\"{model} — {criterion}\")\n",
    "            ax.set_xlabel(\"Predicted\")\n",
    "            ax.set_ylabel(\"Actual\")\n",
    "\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "148894b3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2800x1200 with 21 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_confusion_matrices_by_model(parsed_json, perc_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "ccd1e7d4",
   "metadata": {},
   "outputs": [],
   "source": [
    "''' A function that plots the accuracy of PERC criteria by outcome (correct or incorrect) for each model.\n",
    "It creates a heatmap for each outcome type, showing the accuracy of each criterion per model.'''\n",
    "def plot_criteria_accuracy_by_outcome(parsed_json, patient_df):\n",
    "    def to_bool(val):\n",
    "        if isinstance(val, bool):\n",
    "            return val\n",
    "        if isinstance(val, str):\n",
    "            return val.lower() in ['true', 'yes', '1']\n",
    "        return bool(val)\n",
    "\n",
    "    def compute_data(filter_correct: bool):\n",
    "        rows = []\n",
    "        for model_id, outputs in parsed_json.items():\n",
    "            for i, output in enumerate(outputs):\n",
    "                if output.get(\"correct\") != filter_correct:\n",
    "                    continue\n",
    "\n",
    "                try:\n",
    "                    criteria_pred = output[\"parsed_criteria\"][\"Criteria\"]\n",
    "                except (TypeError, KeyError):\n",
    "                    continue\n",
    "\n",
    "                row = patient_df.iloc[i]\n",
    "                entities = row[\"Parsed Entities\"]\n",
    "\n",
    "                age = extract_number(entities.get(\"age\"))\n",
    "                hr = extract_number(entities.get(\"Heart Rate or Pulse\"))\n",
    "                o2 = extract_number(entities.get(\"O₂ saturation percentage\"))\n",
    "\n",
    "                truth = {\n",
    "                    \"Age < 50\": age is not None and age < 50,\n",
    "                    \"HR < 100\": hr is not None and hr < 100,\n",
    "                    \"O₂ ≥ 95%\": o2 is not None and o2 >= 95,\n",
    "                    \"No hemoptysis\": not to_bool(entities.get(\"Hemoptysis\", False)),\n",
    "                    \"No estrogen use\": not to_bool(entities.get(\"Estrogen use\", False)),\n",
    "                    \"No prior VTE\": not to_bool(entities.get(\"Prior VTE\", False)),\n",
    "                    \"No unilateral leg swelling\": not to_bool(entities.get(\"Unilateral leg swelling\", False)),\n",
    "                }\n",
    "\n",
    "                for criterion, true_val in truth.items():\n",
    "                    pred_val = criteria_pred.get(criterion)\n",
    "                    if pred_val is None:\n",
    "                        continue\n",
    "                    match = (pred_val == true_val)\n",
    "                    rows.append({\n",
    "                        \"Model\": model_id,\n",
    "                        \"Criterion\": criterion,\n",
    "                        \"CorrectCriterion\": match\n",
    "                    })\n",
    "\n",
    "        return pd.DataFrame(rows)\n",
    "\n",
    "    # Get data for both correct and incorrect predictions\n",
    "    correct_df = compute_data(filter_correct=True)\n",
    "    incorrect_df = compute_data(filter_correct=False)\n",
    "\n",
    "    fig, axes = plt.subplots(1, 2, figsize=(16, 6), sharey=True)\n",
    "\n",
    "    for df, ax, title in zip(\n",
    "        [correct_df, incorrect_df],\n",
    "        axes,\n",
    "        [\"Given Correct Final Answer\", \"Given Incorrect Final Answer\"]\n",
    "    ):\n",
    "        if df.empty:\n",
    "            ax.set_visible(False)\n",
    "            continue\n",
    "\n",
    "        summary = (\n",
    "            df.groupby([\"Model\", \"Criterion\"])[\"CorrectCriterion\"]\n",
    "            .mean()\n",
    "            .reset_index()\n",
    "            .pivot(index=\"Criterion\", columns=\"Model\", values=\"CorrectCriterion\")\n",
    "            .round(3)\n",
    "        )\n",
    "\n",
    "        sns.heatmap(summary, annot=True, fmt=\".2f\", cmap=\"Blues\", vmin=0, vmax=1, cbar=True, ax=ax)\n",
    "        ax.set_title(f\"Criterion Accuracy — {title}\")\n",
    "        ax.set_xlabel(\"Model\")\n",
    "        ax.set_ylabel(\"PERC Criterion\")\n",
    "\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "b1347248",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x600 with 4 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_criteria_accuracy_by_outcome(parsed_json, perc_df)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3d31f359",
   "metadata": {},
   "source": [
    "#### Criteria and Answer Accuracy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1eb672a0",
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Takes a parsed_json object (output from each model), Takes a patient_df (your DataFrame with patient notes and entities), Extracts and compares predicted vs actual PERC criteria, \n",
    "And produces pie charts showing how often models: Got all criteria right, Got one or more criteria wrong, Separately for correct and incorrect final predictions.'''\n",
    "def plot_criteria_accuracy_pie(parsed_json, patient_df):\n",
    "    def to_bool(val):\n",
    "        if isinstance(val, bool):\n",
    "            return val\n",
    "        if isinstance(val, str):\n",
    "            return val.lower() in ['true', 'yes', '1']\n",
    "        return bool(val)\n",
    "\n",
    "    def get_truth(entities):\n",
    "        age = extract_number(entities.get(\"age\"))\n",
    "        hr = extract_number(entities.get(\"Heart Rate or Pulse\"))\n",
    "        o2 = extract_number(entities.get(\"O₂ saturation percentage\"))\n",
    "        return {\n",
    "            \"Age < 50\": age is not None and age < 50,\n",
    "            \"HR < 100\": hr is not None and hr < 100,\n",
    "            \"O₂ ≥ 95%\": o2 is not None and o2 >= 95,\n",
    "            \"No hemoptysis\": not to_bool(entities.get(\"Hemoptysis\", False)),\n",
    "            \"No estrogen use\": not to_bool(entities.get(\"Estrogen use\", False)),\n",
    "            \"No prior VTE\": not to_bool(entities.get(\"Prior VTE\", False)),\n",
    "            \"No unilateral leg swelling\": not to_bool(entities.get(\"Unilateral leg swelling\", False)),\n",
    "        }\n",
    "\n",
    "    # Store counts separately for correct/incorrect predictions\n",
    "    model_stats = {}\n",
    "\n",
    "    for model_id, outputs in parsed_json.items():\n",
    "        correct_all = 0\n",
    "        correct_some = 0\n",
    "        wrong_all = 0\n",
    "        wrong_some = 0\n",
    "\n",
    "        for i, output in enumerate(outputs):\n",
    "            try:\n",
    "                criteria_pred = output[\"parsed_criteria\"][\"Criteria\"]\n",
    "            except (TypeError, KeyError):\n",
    "                continue\n",
    "\n",
    "            row = patient_df.iloc[i]\n",
    "            entities = row[\"Parsed Entities\"]\n",
    "            truth = get_truth(entities)\n",
    "\n",
    "            match_flags = []\n",
    "            for criterion, true_val in truth.items():\n",
    "                pred_val = criteria_pred.get(criterion)\n",
    "                if pred_val is None:\n",
    "                    continue\n",
    "                match_flags.append(pred_val == true_val)\n",
    "\n",
    "            if not match_flags:\n",
    "                continue  # Skip if we couldn't match anything\n",
    "\n",
    "            if builtins.all(match_flags):\n",
    "                if output.get(\"correct\"):\n",
    "                    correct_all += 1\n",
    "                else:\n",
    "                    wrong_all += 1\n",
    "            else:\n",
    "                if output.get(\"correct\"):\n",
    "                    correct_some += 1\n",
    "                else:\n",
    "                    wrong_some += 1\n",
    "\n",
    "        model_stats[model_id] = {\n",
    "            \"correct\": {\n",
    "                \"All Criteria Correct\": correct_all,\n",
    "                \"One or More Incorrect\": correct_some\n",
    "            },\n",
    "            \"incorrect\": {\n",
    "                \"All Criteria Correct\": wrong_all,\n",
    "                \"One or More Incorrect\": wrong_some\n",
    "            }\n",
    "        }\n",
    "\n",
    "    # Plot 2 pie charts per model\n",
    "    num_models = len(model_stats)\n",
    "    fig, axes = plt.subplots(2, num_models, figsize=(6 * num_models, 12))\n",
    "\n",
    "    if num_models == 1:\n",
    "        axes = axes.reshape(2, 1)\n",
    "\n",
    "    for col, (model_id, counts) in enumerate(model_stats.items()):\n",
    "        for row_idx, key in enumerate([\"correct\", \"incorrect\"]):\n",
    "            subset = counts[key]\n",
    "            total = sum(subset.values())\n",
    "            ax = axes[row_idx][col]\n",
    "\n",
    "            if total == 0:\n",
    "                ax.set_title(f\"{model_id}\\n(No {key} answers)\")\n",
    "                ax.axis(\"off\")\n",
    "                continue\n",
    "\n",
    "            sizes = [subset[\"All Criteria Correct\"], subset[\"One or More Incorrect\"]]\n",
    "            labels = [\"All Criteria Correct\", \"One or More Incorrect\"]\n",
    "            colors = [\"mediumseagreen\", \"tomato\"]\n",
    "\n",
    "            ax.pie(sizes, labels=labels, autopct=\"%1.1f%%\", colors=colors, startangle=140)\n",
    "            ax.set_title(f\"{model_id} - {key.capitalize()}\")\n",
    "\n",
    "    plt.suptitle(\"Criteria Accuracy Breakdown per Model\", fontsize=18)\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "ef60614b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x1200 with 6 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_criteria_accuracy_pie(parsed_json, perc_df)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5eac7a66",
   "metadata": {},
   "outputs": [],
   "source": [
    "def llm(text:str) -> str:\n",
    "    pass\n",
    "\n",
    "def parser(text:str) -> dict:\n",
    "    pass\n",
    "\n",
    "def tool(args: dict) -> int:\n",
    "    pass\n",
    "\n",
    "\n",
    "def agent(input_message):\n",
    "    '''  '''\n",
    "    text_output = llm(input_message)\n",
    "    json_dict = parser(text_output)\n",
    "    perc_score = tool(json_dict)\n",
    "\n",
    "    explanation = llm(f\"{perc_score}\")\n",
    "    return perc_score\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "33638bfd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Wrong Reply 1 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 65 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 75 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 95% on room air, which meets the criterion. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluations above, the only false criterion is the patient's age being greater than 50 years. \n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100, oxygen saturation of 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling. Only the age criterion is false.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 2 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 37 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 85, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. The patient is a female, but her medications do not include any form of estrogen, and there's no indication of estrogen therapy. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. The patient has a history of surgeries and other medical conditions, but VTE is not mentioned. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had right lower leg surgery for a fracture, but there is no current mention of unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given that all criteria are met (true), the PERC score would be 0, as each false criterion adds 1 point to the score.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, estrogen use, prior VTE, and unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 3 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 15 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is mentioned as 80 beats/min initially and 90 beats/min at baseline before the procedure. Both values are less than 100 bpm. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's O2 saturation on room air is 98%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient's age (15 years old) and the context, it is reasonable to assume this criterion is met (true), although it's not explicitly stated.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of any prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The note mentions \"no pedal edema,\" which implies there is no unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given that all criteria are met (true), the PERC score would be 0, as each false criterion adds 1 point to the score, and there are no false criteria in this case.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each PERC criterion was evaluated based on the patient's note. The patient's age, heart rate, oxygen saturation, and the absence of hemoptysis, estrogen use, prior VTE, and unilateral leg swelling all met the criteria for a low PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 4 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 56 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate (PR) is 96 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on 4 L/min oxygen facemask, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it's reasonable to assume he is not using estrogen. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The note mentions \"no lower leg edema,\" which implies there is no unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluations above, the PERC score is calculated by summing the false criteria, which in this case is only the first criterion (Age < 50 years).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, which is the only false criterion. The heart rate is less than 100 bpm, oxygen saturation is greater than or equal to 95%, there's no mention of hemoptysis, no estrogen use is assumed due to the patient being male, no prior VTE is mentioned, and there's no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 5 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for the patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 32 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 90 beats per minute, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% while breathing ambient air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient is breastfeeding, which implies recent childbirth and possible hormonal changes, but there is no explicit mention of estrogen use. However, given the context of recent childbirth and breastfeeding, it might be inferred that she is not on estrogen therapy. For the purpose of this calculation and without explicit information to the contrary, we will consider this criterion as met (true), but it's essential to note this assumption.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score can be calculated as the sum of the false values, which in this case is 0 since all criteria are met.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient meets all PERC criteria: she is under 50, has a heart rate less than 100 bpm, oxygen saturation of 98%, no hemoptysis, no mentioned estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 6 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 35 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's initial heart rate was 126 beats per minute, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's initial oxygen saturation was 97% on 2 liters of oxygen, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of the patient experiencing hemoptysis (coughing up blood). Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. However, the note does mention that she denied ever using alcohol or recreational drugs and was a former smoker, but it specifically asks about estrogen use, which is not mentioned as part of her medical history or current medications. Given the information provided, we can infer this criterion is met (true), but it's based on the absence of information rather than explicit confirmation.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient's medical history includes deep vein thrombosis, which is a type of VTE. Therefore, this criterion is not met (false).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient denied leg pain, and the lower extremity exam revealed no edema or calf pain. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the number of false criteria, which are:\n",
      "\n",
      "- Heart rate < 100 bpm (false)\n",
      "- No prior VTE (false)\n",
      "\n",
      "So, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient meets criteria 1, 3, 4, 5, and 7 but does not meet criteria 2 and 6.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 7 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is a 75-year-old woman, so this criterion is false.\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 86/min, which is less than 100 bpm, so this criterion is true.\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 92.2%, which is less than 95%, so this criterion is false.\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note, so we can infer that this criterion is true. However, it's worth noting that the presence of microscopic hematuria is mentioned, but hemoptysis specifically is not.\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, so we can infer that this criterion is true, but without explicit confirmation.\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note, so we can infer that this criterion is true, but again, without explicit confirmation.\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note, so we can infer that this criterion is true, but once more, without explicit confirmation.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Heart rate < 100 bpm: True\n",
      "- Oxygen saturation ≥ 95%: False\n",
      "- No hemoptysis: True (inferred)\n",
      "- No estrogen use: True (inferred)\n",
      "- No prior VTE: True (inferred)\n",
      "- No unilateral leg swelling: True (inferred)\n",
      "\n",
      "The false criteria are \"Age < 50 years\" and \"Oxygen saturation ≥ 95%\". Therefore, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on the provided note. The patient is over 50, has an oxygen saturation less than 95%, but meets the other criteria either explicitly or by inference due to lack of mention in the note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 8 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 58 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 57 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 93% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: The patient has a cough productive of brown sputum, but there is no explicit mention of hemoptysis (coughing up blood). However, given the context, it might be inferred that the brown sputum could potentially contain blood, but it's not clearly stated as hemoptysis. For the purpose of this calculation and based on the strict interpretation of the provided information, we will consider this criterion as true because hemoptysis is not explicitly mentioned.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. Therefore, based on the information provided, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE. Therefore, based on the information provided, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of the patient having unilateral leg swelling. Therefore, based on the information provided, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- HR < 100: True\n",
      "- O₂ ≥ 95%: False\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: True\n",
      "- No prior VTE: True\n",
      "- No unilateral leg swelling: True\n",
      "\n",
      "The false criteria are \"Age < 50 years\" and \"O₂ ≥ 95%\". Therefore, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. Each false criterion adds 1 point to the score. The patient's age is greater than 50, and her oxygen saturation is less than 95%, making these two criteria false.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 9 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 43 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 103/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation on room air is 93%, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: The patient had one episode of coughing up blood, which means hemoptysis is present. Therefore, this criterion is not met (false).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, given the patient's history of invasive ductal carcinoma and a recent mastectomy, it might be inferred that she is not on estrogen, but without explicit information, this could be considered not met if we strictly interpret the absence of information as insufficient to confirm the criterion. However, in clinical practice, the absence of mention often implies the condition is not present, so this could be considered met (true) based on the information given, but it's a bit ambiguous.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Similar to the estrogen use criterion, without explicit information stating otherwise, it might be inferred that there is no prior VTE, so this could be considered met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has swelling and erythema of the left lower extremity, indicating unilateral leg swelling. Therefore, this criterion is not met (false).\n",
      "\n",
      "Given these evaluations, the PERC score would be the sum of the false values, which are criteria 2, 3, 4, and 7, and potentially 5 if we were to interpret the lack of information about estrogen use as indicative of use, but based on standard interpretation of medical records, we will consider it as not applicable or met due to lack of evidence to the contrary.\n",
      "\n",
      "Therefore, the PERC score, considering the explicit false criteria, would be at least 4. However, since the question about estrogen use is somewhat ambiguous without explicit confirmation, the most conservative interpretation based on provided information would not include it as a false criterion without further clarification.\n",
      "\n",
      "Here is the result in the specified JSON format, considering the explicit information provided:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's note. The patient's age is less than 50, but her heart rate is over 100, oxygen saturation is below 95%, she experienced hemoptysis, and has unilateral leg swelling. The absence of explicit mention of estrogen use and prior VTE suggests these criteria might be considered met, but this interpretation could vary.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 10 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 28 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: Initially, the patient's pulse was 85/min, which is less than 100 bpm. However, later during the episode of chest tightness and shortness of breath, the heart rate increased to 138 bpm. For the purpose of the PERC score, we consider the initial presentation or the context in which the PERC rule is being applied. Since the PERC rule is typically applied at the initial assessment to rule out pulmonary embolism, we'll consider the initial heart rate of 85/min, making this criterion met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: Initially, the patient's finger oxygen saturation degree (FOSD) was 98%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is a male, it's reasonable to assume this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient did develop a deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) during the hospital stay, but at the time of initial presentation, there is no mention of prior VTE. Therefore, considering the context of initial evaluation, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does mention a flocculent echo in the superior cavity of the upper right femoral vein extending into the external iliac vein, indicating DVT in the right lower extremity. This suggests unilateral leg involvement, meaning this criterion is not met (false).\n",
      "\n",
      "Given the evaluation of these criteria:\n",
      "\n",
      "- **Age < 50**: true\n",
      "- **HR < 100**: true\n",
      "- **O₂ ≥ 95%**: true\n",
      "- **No hemoptysis**: true\n",
      "- **No estrogen use**: true\n",
      "- **No prior VTE**: true\n",
      "- **No unilateral leg swelling**: false\n",
      "\n",
      "The PERC score is calculated by summing the false criteria, which in this case is 1 (for \"No unilateral leg swelling\").\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion of the PERC rule was evaluated based on the patient's note. The patient met criteria for age, heart rate, oxygen saturation, no hemoptysis, no estrogen use, and no prior VTE at the time of initial presentation. However, the patient did have unilateral leg swelling due to DVT, which was not present at initial evaluation but developed during the hospital stay. For the purpose of PERC scoring, we consider the initial presentation.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 11 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 65 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 110/min, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation on room air is 85%, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it's reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The note mentions that the extremities are warm and there is no edema, implying no unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false criteria, which are Age < 50 years, Heart rate < 100 bpm, and Oxygen saturation ≥ 95%.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50, heart rate is greater than 100, and oxygen saturation is less than 95%, making these criteria false. The other criteria are either not mentioned or do not apply based on the provided information, thus considered true.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 12 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 46 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 54/min, which is less than 100 bpm. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 100% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, since the patient is a female and there's no explicit mention of estrogen use, and given the context of other medical conditions and treatments discussed, we might infer this criterion as met (true) due to lack of information suggesting otherwise.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not explicitly mention a history of prior VTE, but it does mention significant vascular and cardiac issues, including a distal thrombus and the need for thrombo-embolectomy. However, these are not described as prior VTE events but rather as part of the current acute presentation. Therefore, based on the information given, we consider this criterion as met (true) because there's no explicit mention of a prior VTE.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient presents with right leg numbness and decreased pulsation and sensation, and later develops worsening pain and coolness in the right lower extremity due to 100% occlusion of the right anterior and posterior tibial arteries. This indicates unilateral leg involvement. Therefore, this criterion is not met (false).\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which in this case is 1 (for the criterion \"No unilateral leg swelling\").\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, presence of hemoptysis, estrogen use, history of prior VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 13 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 60 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 120/min, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 93% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient's symptoms. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen, and given that the patient is a man, it is unlikely. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a past medical history of an ST-elevation myocardial infarction but there is no mention of prior VTE. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient's presentation. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is the sum of the false criteria, which are criteria 1, 2, and 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is over 50, heart rate is over 100, and oxygen saturation is below 95%, contributing to a positive PERC score. Other criteria such as no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling do not contribute to the score as they are met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 14 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 56 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate was 130 beats per minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was 91% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: The patient had four episodes of hemoptysis. Therefore, this criterion is false.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it is reasonable to assume this criterion is true, but without explicit information, this assumption might not always hold. However, based on the context provided, we will consider this criterion as true because there's no indication of estrogen use.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: There is no mention of prior VTE in the patient's past medical history. Therefore, we will consider this criterion as true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, we will consider this criterion as true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false criteria, which are:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Heart rate < 100 bpm: False\n",
      "- Oxygen saturation ≥ 95%: False\n",
      "- No hemoptysis: False\n",
      "\n",
      "The sum of the false criteria is 4.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's information. The patient's age, heart rate, oxygen saturation, and presence of hemoptysis led to false evaluations for those criteria. The absence of mentioned estrogen use, prior VTE, and unilateral leg swelling in the note led to true evaluations for those criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 15 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 17 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 125 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's pulse oxygenation saturation is 97% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: The patient denies any coughing or respiratory symptoms that would suggest hemoptysis. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient discontinued oral contraceptive use 6 months ago. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient's past medical history. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has mild nonpitting bilateral edema, which indicates swelling in both legs, not unilateral. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score is calculated by summing the false values. In this case, only the heart rate criterion is false.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age, oxygen saturation, absence of hemoptysis, no current estrogen use, no prior VTE, and bilateral (not unilateral) leg swelling meet the PERC criteria. However, the patient's heart rate exceeds 100 bpm.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 16 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 18 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 89/min, which is less than 100 bpm. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient note does not mention the use of estrogen or any form of hormonal contraception other than the patient being sexually active and using condoms inconsistently. However, the use of condoms does not imply estrogen use. But given the context of sexual activity and the fact that she has regular menstrual periods, it might suggest she is not on hormonal contraception that would contain estrogen. Yet, without explicit information about estrogen use, this could be considered not directly applicable. However, based on the information given (regular menstrual periods, use of condoms), it could be inferred that she is not using estrogen. Therefore, this criterion could be considered met (true), but it's a bit ambiguous without direct information on hormonal contraception use.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. The focus is on abdominal pain and pelvic examination findings. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score would be calculated based on the number of false values, which in this case is 0 since all criteria are met as true based on the provided information.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, potential estrogen use, history of VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 17 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 71 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 116 beats per minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's peripheral oxygen saturation is 97% with a non-rebreathing mask, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it is reasonable to assume estrogen use is not applicable. Therefore, we consider this criterion as true.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: The patient has signs of chronic venous insufficiency, which might suggest a history of venous issues, but there is no explicit mention of a prior VTE. However, the presence of chronic venous insufficiency could imply a risk or history of venous thromboembolism, but without explicit mention, we cannot definitively say this criterion is false based solely on the information given. Therefore, based on the explicit information provided and the need for clear evidence to mark a criterion as false, we will consider this criterion as true, acknowledging this interpretation may vary based on how one weighs the implication of chronic venous insufficiency.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has a wound on his right foot with signs of chronic venous insufficiency, but there is no explicit mention of unilateral leg swelling. Given the focus on the wound and venous insufficiency without specific mention of swelling, we will consider this criterion as true, although this interpretation could vary depending on how one interprets the presence of a wound and venous insufficiency.\n",
      "\n",
      "Based on these evaluations:\n",
      "- The false criteria are: Age < 50 years and Heart rate < 100 bpm.\n",
      "- The true criteria are: Oxygen saturation ≥ 95%, No hemoptysis, No estrogen use, No prior VTE, and No unilateral leg swelling.\n",
      "\n",
      "Therefore, the PERC score is 2, as there are 2 false criteria.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient's age is over 50, and his heart rate is over 100, making these criteria false. The patient's oxygen saturation is 97%, which is ≥ 95%, and there's no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling, making these criteria true.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 18 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 36 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 110 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's SpO2 is 96%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient is a male, and there is no mention of estrogen use. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention leg swelling at all, let alone unilateral leg swelling. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the number of false values, which in this case is 1 (for the heart rate criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, vital signs, medical history, and current symptoms as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 19 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 71 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 67 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 97% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it's reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any history of VTE. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention any unilateral leg swelling. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria, which in this case is only the first criterion (Age < 50 years).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, which makes the first criterion false. All other criteria are true based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 20 ---\n",
      "Expected: 4 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 55 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 110/min, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation on room air is 98%, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is a man, and there is no mention of estrogen use. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The note mentions decreased femoral pulses bilaterally but does not specifically mention unilateral leg swelling. Given the information provided, we will consider this criterion as true because there's no explicit mention of unilateral leg swelling.\n",
      "\n",
      "Now, let's calculate the PERC score. Each false criterion adds 1 point to the score. From the evaluation:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Heart rate < 100 bpm: False\n",
      "- Oxygen saturation ≥ 95%: True\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: True\n",
      "- No prior VTE: True\n",
      "- No unilateral leg swelling: True\n",
      "\n",
      "The PERC score is the sum of the false values, which is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on the provided note. The age and heart rate criteria were not met, while the other criteria were met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 21 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 45 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 96 bpm, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% in room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Therefore, assuming no estrogen use, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given that all criteria are met (true), the PERC score would be 0, as each false criterion adds 1 point to the score.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"All PERC criteria are met for this patient. The patient is under 50 years old, has a heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no mention of estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 22 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 52 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 76 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 97%, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is a male, and there is no mention of estrogen use. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has no prior medical history of VTE. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluations above, the only false criterion is the patient's age being greater than 50 years. \n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50, which is the only criterion not met. All other criteria (heart rate < 100 bpm, oxygen saturation ≥ 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling) are met based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 23 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 55 years old, which means this criterion is not met (false). \n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is mentioned as 104 beats per minute on admission, which means this criterion is not met (false).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 94% while breathing ambient air, which means this criterion is not met (false).\n",
      "4. **No hemoptysis**: There is no mention of the patient experiencing hemoptysis, which means this criterion is met (true).\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen, which means this criterion is met (true).\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE, which means this criterion is met (true).\n",
      "7. **No unilateral leg swelling**: There is no mention of the patient having unilateral leg swelling, which means this criterion is met (true).\n",
      "\n",
      "Given the explanations above, the PERC score can be calculated by summing the number of false criteria, which are 3 in this case (Age < 50 years, Heart rate < 100 bpm, and Oxygen saturation ≥ 95%).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate over 100 bpm, and an oxygen saturation less than 95%, but does not have hemoptysis, estrogen use, prior VTE, or unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 24 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 35 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is mentioned as 80/min initially and 83/min post-operatively, both of which are less than 100 bpm. Thus, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 100% on room air, both initially and post-operatively, which is greater than or equal to 95%. So, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant and was on warfarin, which was switched to labetalol and enoxaparin during pregnancy. There is no mention of estrogen use. Thus, we consider this criterion met (true) based on the information provided.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any prior VTE. It discusses the patient's history of aortic regurgitation, Bentall operation, vitrectomy, and other conditions related to Marfan syndrome, but does not indicate a history of VTE. Therefore, this criterion is considered met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention unilateral leg swelling. Given the detailed description of the patient's medical history and current condition, the absence of this symptom suggests this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, all 7 criteria are met (true), meaning none of the criteria that would add points to the PERC score are present.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"All PERC criteria were evaluated based on the patient note. The patient's age is less than 50, heart rate is less than 100 bpm, oxygen saturation is greater than or equal to 95%, there is no mention of hemoptysis, no estrogen use is indicated, no prior VTE is mentioned, and no unilateral leg swelling is noted.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 25 ---\n",
      "Expected: 4 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 37 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate was 114 beats/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: Initially, the patient's oxygen saturation was 87%, but it increased to 95% and then 98% with oxygen supplementation. However, the criterion specifically mentions the initial condition, and the patient required supplementation to reach the threshold. The initial saturation was below 95%, so this criterion is not met (false) based on the initial presentation without supplementation.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it's reasonable to assume this criterion is met (true), although it's not explicitly stated.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient was diagnosed with deep vein thrombosis during the hospital stay, indicating a current VTE. However, there's no mention of a prior VTE before this incident. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had a purplish discoloration of the right ankle, which could imply some form of swelling or inflammation, and duplex sonography revealed deep vein thrombosis in the left leg. The mention of unilateral leg issues (both in terms of discoloration and thrombosis) suggests that this criterion is not met (false), as there is evidence of leg swelling or issues, even if the specifics of \"swelling\" are not detailed.\n",
      "\n",
      "Given these evaluations:\n",
      "- The patient meets criteria 1, 4, 5, and 6.\n",
      "- The patient does not meet criteria 2, 3, and 7.\n",
      "\n",
      "The PERC score is the sum of the false values, which are 3 in this case.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on the provided note. The patient is under 50, has no hemoptysis, no mentioned estrogen use, and no prior VTE, meeting criteria 1, 4, 5, and 6. The patient's heart rate was over 100, initial oxygen saturation was below 95% without supplementation, and there were unilateral leg issues, not meeting criteria 2, 3, and 7.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 26 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 28 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 89 beats/min, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 94%, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient did not have a history of oral contraceptive use, which implies no current estrogen use related to contraceptives. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which in this case is only 1 (for the oxygen saturation criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, presence of hemoptysis, estrogen use, history of VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 27 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 62 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 90/min, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 95% on room air, which meets the criterion. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, given the patient's age and presentation, and without explicit information on estrogen use, we cannot definitively conclude this criterion as true or false based solely on the provided text. For the purpose of this calculation and following the principle of assuming the least risky condition when information is not explicitly provided, we might lean towards assuming no estrogen use is mentioned, thus potentially considering it as true. However, this is an assumption due to lack of information.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient presents with problems in her legs, including pain and swelling, but the note does not specify if the swelling is unilateral or bilateral. Given the mention of \"her legs\" and the context, it might imply bilateral involvement, but without clear specification, this could be considered ambiguous. However, the inspection of the lower extremities and the context provided suggest leg issues that could involve swelling, but the specifics of unilateral vs. bilateral are not clearly stated. For the purpose of this exercise, without explicit mention of unilateral leg swelling, and considering the patient's symptoms could imply bilateral involvement or at least do not clearly state unilateral swelling, we might consider this criterion as potentially true, though this is an interpretation based on incomplete information.\n",
      "\n",
      "Given these considerations, the PERC score would be calculated based on the clearly false criteria:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- The other criteria are either true or assumed true based on the lack of contradictory information.\n",
      "\n",
      "Therefore, the PERC score, based on the explicit information provided and the assumptions necessary due to incomplete data, would primarily be influenced by the patient's age.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is determined by evaluating each criterion. The patient is older than 50, has a heart rate less than 100 bpm, oxygen saturation of 95%, no mentioned hemoptysis, assumed no estrogen use due to lack of information, no prior VTE mentioned, and ambiguous information regarding unilateral leg swelling but considered in the context of potential bilateral involvement or lack of clear specification.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 28 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 26 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is reported as 113 beats/minute on admission and later as 120 beats/minute during readmission, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is initially reported as 95% and later falls to 86% during episodes of coughing but improves with oxygen supplementation. However, the initial value meets the criterion. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant, which implies estrogen levels are naturally elevated, but there's no mention of exogenous estrogen use. However, pregnancy itself is a condition that affects the PERC criteria due to the increased risk of thromboembolism, but the direct question is about estrogen use, which is not explicitly mentioned as being part of her treatment. Therefore, based strictly on the information given and the context of the question, this criterion could be considered met (true) because there's no explicit mention of estrogen therapy.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient's medical history provided. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false values, which in this case is 1 (for the heart rate criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets 6 out of 7 criteria, with the exception of the heart rate being over 100 bpm.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 29 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 34 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's initial heart rate is 153 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (SpO2) is 96% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: The patient experienced one episode of hemoptysis, which means this criterion is not met (false).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen, and given the patient is male, it's reasonable to assume this criterion is met (true) based on the information provided.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE. The patient does have a history of spontaneous pneumothoraces, but this is not the same as VTE. Therefore, this criterion is met (true) based on the information provided.\n",
      "\n",
      "7. **No unilateral leg swelling**: The physical exam notes that there was no lower extremity edema present. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the number of false criteria, which are:\n",
      "\n",
      "- Heart rate < 100 bpm (false)\n",
      "- No hemoptysis (false)\n",
      "\n",
      "So, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient meets criteria 1, 3, 5, 6, and 7 but does not meet criteria 2 and 4.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 30 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 33 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 114/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: The patient has a history of hemetemesis (vomiting blood), which indicates bleeding in the upper gastrointestinal tract, but there's no specific mention of hemoptysis (coughing up blood). However, given the context, it seems the focus is on gastrointestinal bleeding rather than respiratory. Since hemoptysis specifically refers to coughing up blood and is not directly mentioned, we might consider this criterion met (true) in the context of evaluating for pulmonary embolism, but it's a bit of a nuanced interpretation. For the purpose of this calculation and focusing strictly on the definition of hemoptysis, we will consider it as not directly applicable but lean towards true due to the lack of direct evidence of hemoptysis.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. Given the patient is male and there's no indication of estrogen use, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention a prior VTE, but it does discuss suspected partial thrombosis of the Superior Mesenteric Vein (SMV) near the pancreatic head region. However, this is not explicitly stated as a prior VTE in the traditional sense (like DVT or PE), but rather a complication related to pancreatitis. For the purpose of this evaluation, we will consider this criterion as met (true) because the focus is on prior VTE events typically associated with deep vein thrombosis or pulmonary embolism, not the current suspected thrombosis related to another condition.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations:\n",
      "- The patient meets criteria 1, 3, 4 (with nuance), 5, 6 (with the understanding that the thrombosis mentioned is not a traditional VTE), and 7.\n",
      "- The patient does not meet criterion 2.\n",
      "\n",
      "Thus, the PERC score would be based on the false criteria, which in this case is primarily the heart rate being over 100 bpm.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is under 50, has an oxygen saturation of 99%, no mention of estrogen use, no prior traditional VTE, and no unilateral leg swelling. However, the patient's heart rate is over 100 bpm. Hemoptysis is not directly mentioned, and the suspected thrombosis is related to pancreatitis, not a traditional VTE.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 31 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 25 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 84/min, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (SaO2) is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the context, it can be inferred that this criterion is met (true), as there's no indication of conditions or treatments that would typically involve estrogen use.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any history of VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given that all criteria are met (true), the PERC score would be 0, as each false criterion adds 1 point to the score.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"All PERC criteria are met for this patient. The patient is under 50, has a heart rate less than 100 bpm, oxygen saturation of 98%, no hemoptysis, no mention of estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 32 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 66 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 120/min, which is greater than 100. Therefore, this criterion is false.\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "5. **No estrogen use**: The patient is a man, and there is no mention of estrogen use in his medication list or elsewhere in the note. Therefore, this criterion is true.\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient's past medical history. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the physical exam or elsewhere in the note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which are criteria 1 and 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50, and his heart rate is greater than 100 bpm. All other criteria are met based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 33 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 74 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is 120 beats/minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (SpO2) is 96% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no history of hemoptysis mentioned in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no history of prior VTE mentioned in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no history of leg swelling mentioned in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluations above, the criteria that are false are: Age < 50 years and Heart rate < 100 bpm. Each false criterion adds 1 point to the PERC score. Therefore, the PERC score for this patient is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. For this patient, the criteria for Age < 50 years and Heart rate < 100 bpm were not met, resulting in a score of 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 34 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 57 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 90/min, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient is a man, and there is no mention of estrogen use in his current medications. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a past medical history of VTE. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention any leg swelling. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which in this case is only the first criterion (Age < 50 years).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is determined by evaluating 7 criteria. The patient is older than 50, which is the only false criterion. Other criteria such as heart rate, oxygen saturation, absence of hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling are all true based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 35 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 57 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate was above 125 bpm upon arrival to the ED, and an ECG showed an average ventricular response of 107 bpm. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's pulse oximeter showed 98% oxygenation, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. The note does mention ruling out acute coronary or pulmoembolic syndrome, and the patient had a CHA2DS2-VASC score of zero, suggesting no known history of VTE. Therefore, we can assume this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. The physical examination findings were unremarkable other than irregular heart rhythm on heart auscultation, suggesting no evidence of unilateral leg swelling. Therefore, we can assume this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria, which are criteria 1 and 2.\n",
      "\n",
      "The final answer is: \n",
      "```\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50, and his heart rate was above 100 bpm. All other criteria were met based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 36 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 24 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 98/min, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient uses a progesterone intrauterine device (IUD) for contraception. Since it's progesterone and not estrogen, this might seem like the criterion is met. However, the context of the question typically implies any form of hormone use that could increase the risk of thromboembolism, but strictly speaking, the criterion mentions estrogen. Given the strict interpretation of the criteria as written, this could be considered met (true) because it specifies \"estrogen use,\" but it's essential to note the nuance.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of any prior VTE in the patient's past medical history. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluations above, all criteria are met, meaning none of the criteria are false.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, type of contraceptive used, past medical history regarding VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 37 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 78 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate was 77 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was above 97%, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is taking Tamoxifen, which is an estrogen receptor modulator and can be considered as estrogen use in this context. Therefore, this criterion is false.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Based on these evaluations, the PERC score is calculated by summing the false criteria, which are \"Age < 50 years\" and \"No estrogen use\".\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100, oxygen saturation above 95%, no hemoptysis, is on estrogen use (Tamoxifen), no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 38 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 72 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate (PR) is 92 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (SPO2) is 92% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it is reasonable to assume this criterion is true, although it's not explicitly stated.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note mentions \"No signs of... edema\" during the general physical examination, which implies there is no unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false criteria, which are \"Age < 50 years\" and \"Oxygen saturation ≥ 95%\". \n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on 7 criteria. The patient is older than 50, has an oxygen saturation less than 95%, but meets all other criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 39 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 66 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 124/min, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 86% on 2L of oxygen, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: The patient denied any sputum production, and there is no mention of hemoptysis. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. Given the patient is a male, it's reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of the patient having unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Now, let's calculate the PERC score. Each false criterion adds 1 point to the score. From the evaluation:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Heart rate < 100 bpm: False\n",
      "- Oxygen saturation ≥ 95%: False\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: True\n",
      "- No prior VTE: True\n",
      "- No unilateral leg swelling: True\n",
      "\n",
      "The PERC score is the sum of the false criteria, which is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient's age is over 50, heart rate is over 100, and oxygen saturation is below 95%, making these criteria false. The patient does not have hemoptysis, is not on estrogen, has no prior VTE, and no unilateral leg swelling, making these criteria true.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 40 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 38 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 112 beats per minute, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 92% on room air, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient is intermittently adherent with the oral contraceptive pill, which implies estrogen use. Therefore, this criterion is not met (false).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note mentions no peripheral edema, which implies no unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluations above, the PERC score is calculated by summing the false values, which are criteria 2, 3, and 5.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. Each criterion not met adds 1 point to the score. The patient's age is less than 50, there's no hemoptysis, no prior VTE, and no unilateral leg swelling, meeting criteria 1, 4, 6, and 7. However, the patient's heart rate is over 100, oxygen saturation is below 95%, and there is estrogen use, not meeting criteria 2, 3, and 5.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 41 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 59 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 85/min, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is a man, and there is no mention of estrogen use. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient's history only mentions eczema, with no prior VTE mentioned. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the only false criterion is the patient's age being greater than 50 years. \n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50, but all other criteria are met as the patient has a heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 42 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 70 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: Initially, the patient's heart rate was 93 bpm, which is less than 100. However, during the worsening of his condition, his heart rate ranged between 140 and 150 bpm, which is greater than 100. For the purpose of the PERC score, we consider the initial presentation, so this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's initial oxygen saturation was 94% on room air, which is less than 95%. Later, it improved to 95% on 2 L of oxygen, but for the PERC score, we consider the initial presentation on room air. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it's reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a history of chronic atrial fibrillation and is on anticoagulation with warfarin, and there's a mention of a concern for a non-occlusive thrombus in the left main pulmonary artery, suggesting a possible current VTE (pulmonary embolism) but not explicitly stating a prior VTE. However, the presence of anticoagulation suggests a history of thromboembolic events or a high risk for them, but without explicit mention of prior VTE, we might consider this criterion as true based on the information given.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations:\n",
      "- The false criteria are: Age < 50 years, Oxygen saturation ≥ 95%, and potentially the interpretation of prior VTE could be considered false if assuming the anticoagulation is for a previous VTE event, but based on the explicit information provided, we do not count prior VTE as false.\n",
      "- The true criteria are: Heart rate < 100 bpm, No hemoptysis, No estrogen use, and No unilateral leg swelling.\n",
      "\n",
      "Therefore, the PERC score, based on the explicit false criteria (Age < 50 years and Oxygen saturation ≥ 95%), would be 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient's age is over 50, initial heart rate was less than 100 bpm, initial oxygen saturation was less than 95% on room air, no hemoptysis was mentioned, no estrogen use was noted, no prior VTE was explicitly mentioned, and no unilateral leg swelling was described.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 43 ---\n",
      "Expected: 5 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 9 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 118 beats/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 100%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient's age (9 years old) and gender (male), it is highly unlikely. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of any prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note explicitly states \"no periorbital or lower limb edema,\" which implies there is no unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the only criterion not met is the heart rate being less than 100 bpm. Therefore, the PERC score is 1.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, presence of hemoptysis, estrogen use, history of VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 44 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 40 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate on presentation to the ED for the second time was 122 beats per minute, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation on room air was 97%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true), assuming that the absence of mention implies its absence.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it is reasonable to assume estrogen use is not applicable. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has developed a pulmonary embolism (PE) during the course of the events described, but there is no mention of a prior VTE before the current episode. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The physical examination found no evidence of lower extremity edema. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values. In this case, only one criterion (Heart rate < 100 bpm) is false.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's presentation and history. The patient's age, oxygen saturation, absence of hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling met the criteria. However, the patient's heart rate was above 100 bpm, which did not meet the criterion.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 45 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 50 years old, which means this criterion is not met (false). \n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 131 bpm, which is greater than 100 bpm, so this criterion is not met (false).\n",
      "3. **Oxygen saturation ≥ 95%**: Although the patient's oxygen saturation dropped to 78% at one point, it returned to 100% after intervention and was maintained between 95-99% in the fingers. However, the criterion specifically refers to the overall oxygen saturation, and at the time of evaluation for PERC, it's crucial to consider the patient's condition in a more stable state or as presented initially. Given the context, this might be considered met (true) based on the final stable readings, but it's essential to note the patient did experience significant desaturation.\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note, so we can consider this criterion met (true).\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, so we can consider this criterion met (true).\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note, so we can consider this criterion met (true).\n",
      "7. **No unilateral leg swelling**: The patient had severe edema and swelling of the right hand, not the leg, so we can consider this criterion met (true).\n",
      "\n",
      "Given these evaluations, the criteria that are not met (false) are: Age < 50 years and Heart rate < 100 bpm, and potentially the oxygen saturation criterion could be debated based on the timing of the evaluation. However, based on the final interpretation that oxygen saturation was adequately managed and the focus on other clear criteria:\n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on the provided note. The patient is 50 years old, has a heart rate of 131 bpm, but has no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling. Oxygen saturation, while initially a concern, was managed and not considered a criterion not met in the final assessment.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 46 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 28 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 112/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation on room air is 90%, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true), assuming hemoptysis is not present since it's not mentioned.\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant, which implies she is under the influence of high levels of estrogen. Therefore, this criterion is not met (false).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true), assuming no prior VTE since it's not mentioned.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has bilateral pitting edema, but it is worse on the right side, indicating some degree of unilateral leg swelling. Therefore, this criterion is not met (false).\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the number of false values, which are criteria 2, 3, 5, and 7.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, presence of hemoptysis, estrogen use, history of VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 47 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 31 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 98/min, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant, which implies she is under the influence of estrogen due to her pregnancy. However, the criterion specifically mentions \"estrogen use,\" which typically refers to exogenous estrogen (e.g., birth control pills or hormone replacement therapy). Since the note does not explicitly mention exogenous estrogen use and her pregnancy implies endogenous estrogen, this could be considered not directly applicable. However, given the context of PERC and the emphasis on pregnancy as a risk factor for VTE, it might be reasonable to consider pregnancy-related estrogen increase as relevant. But strictly according to the criteria as written, without explicit mention of exogenous estrogen use, one might argue this criterion is met (true) based solely on the information given.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the explanations above, all criteria are met, meaning none of the criteria are false.\n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"All PERC criteria were evaluated based on the patient note. The patient's age is less than 50, heart rate is less than 100 bpm, oxygen saturation is greater than or equal to 95%, there's no mention of hemoptysis, no explicit mention of exogenous estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 48 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 29 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's initial heart rate was 99 bpm, which is less than 100. However, later it was recorded as 120/min, which exceeds 100 bpm. For the purpose of PERC, we consider the initial presentation, so this criterion is met (true) based on the initial heart rate.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was 99% on ambient air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it's reasonable to assume this criterion is met (true) unless specified otherwise, which it is not.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the explanations above, all criteria are met, meaning none of the criteria are false. The PERC score is calculated by summing the false criteria, which in this case is 0.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"All PERC criteria were met based on the patient's age, initial heart rate, oxygen saturation, absence of hemoptysis, no mention of estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 49 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 84 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 90 beats/min, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Therefore, we will assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we will assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, we will assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "Based on the evaluation of these criteria, the PERC score can be calculated as follows:\n",
      "\n",
      "- The patient meets criteria 2, 3, 4, 5, 6, and 7 (heart rate < 100 bpm, oxygen saturation ≥ 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling), which are all true.\n",
      "- The patient does not meet criterion 1 (age < 50 years), which is false.\n",
      "\n",
      "Since each false criterion adds 1 point to the PERC score, and only criterion 1 is false, the PERC score for this patient is 1.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling. Only the age criterion is not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 50 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 56 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 84 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's SpO2 is 91%, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it is reasonable to assume this criterion is true, although it's not explicitly stated.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient developed a thrombus in the right jugular vein during the ICU stay, but there is no mention of prior VTE. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Based on these evaluations, the PERC score can be calculated by summing the false criteria, which are \"Age < 50 years\" and \"Oxygen saturation ≥ 95%\".\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has an oxygen saturation less than 95%, but meets the other criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 51 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 57 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is exactly 100 bpm. For the purpose of this criterion, we consider values strictly less than 100 bpm as meeting the criterion. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 95% while breathing 100% oxygen. This meets the criterion, so it is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met, and it is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is a male, it is reasonable to assume this criterion is met. Therefore, it is true.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: The patient's mother had pulmonary embolism, but there is no mention of the patient himself having a prior VTE. However, during the hospital stay, a right popliteal vein thrombosis was found, indicating a current VTE. The criterion specifically asks about prior VTE, which is not mentioned. Therefore, based on the information given, we consider this criterion as true because there's no explicit mention of a prior VTE in the patient's history.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had varicose veins on the right groin and was wearing an elastic bandage, and later, a right popliteal vein thrombosis was diagnosed. This suggests there was an issue with one leg, which could imply unilateral leg involvement. However, the presence of varicose veins and the later diagnosis of thrombosis do indicate some form of unilateral leg condition, but the criterion specifically mentions swelling. Since there's no explicit mention of unilateral leg swelling in the note, and considering the context provided, we might interpret this criterion as true because the focus is on swelling, not varicose veins or thrombosis directly. However, given the context, this interpretation might be nuanced, and some could argue it's false due to the implication of unilateral issues. For the purpose of this calculation and based on the strict interpretation of \"swelling,\" we'll consider it as true, acknowledging this could be a point of debate.\n",
      "\n",
      "Given these evaluations:\n",
      "- The false criteria are: Age < 50 years, Heart rate < 100 bpm.\n",
      "- The true criteria are: Oxygen saturation ≥ 95%, No hemoptysis, No estrogen use, No prior VTE, No unilateral leg swelling.\n",
      "\n",
      "The PERC score is the sum of the false criteria, which is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. Each false criterion adds 1 point to the score. The patient is 57 years old (false), has a heart rate of 100 bpm (false), oxygen saturation of 95% (true), no hemoptysis (true), no estrogen use (true), no prior VTE mentioned (true), and no explicit unilateral leg swelling mentioned (true).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 52 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 34 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 110 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (SaO2) is 99%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the context, it can be inferred that this criterion is met (true), but it's based on the absence of information rather than explicit confirmation.\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient's chart demonstrates no other medical problems, which implies that there is no prior VTE. Therefore, this criterion is met (true).\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which in this case is only the heart rate criterion.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, vital signs, medical history, and symptoms as described in the note. The heart rate was the only criterion not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 53 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 62 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 104 beats per minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's O2 saturation is 85%, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, given the context of a 62-year-old woman who has undergone a mastectomy and is being treated for breast cancer, it might be inferred that she is post-menopausal and not on estrogen therapy. Without explicit information, we might lean towards this being true, but it's an assumption. For the sake of calculation and without clear evidence to the contrary, we will consider this criterion as true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient developed pulmonary embolism during the course of her treatment, and Doppler ultrasound of the legs confirmed bilateral deep vein thrombosis. This indicates that she did have a venous thromboembolism. Therefore, this criterion is false.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had bilateral deep vein thrombosis, which suggests leg swelling, but it is bilateral rather than unilateral. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria: \n",
      "- Age < 50 years: False\n",
      "- HR < 100: False\n",
      "- O₂ ≥ 95%: False\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: True (with the assumption that she is not on estrogen therapy)\n",
      "- No prior VTE: False\n",
      "- No unilateral leg swelling: True\n",
      "\n",
      "The sum of the false values is 4.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's information. The patient's age, heart rate, oxygen saturation, and history of VTE led to false evaluations, contributing to the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 54 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 63 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 90 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 94% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Based on these evaluations, the criteria that are false (and thus contribute to the PERC score) are \"Age < 50 years\" and \"Oxygen saturation ≥ 95%\". \n",
      "\n",
      "The explanation for each criterion's evaluation is as follows: The patient's age and oxygen saturation level did not meet the respective criteria due to being over 50 years old and having an oxygen saturation below 95%. All other criteria were met as there was no indication of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling, and the heart rate was below 100 bpm.\n",
      "\n",
      "The result in the specified JSON format is:\n",
      "\n",
      "```\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is based on the evaluation of 7 criteria. The patient did not meet the criteria for age and oxygen saturation, having an age over 50 and an oxygen saturation below 95%. All other criteria were met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 55 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 66 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 83 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 95% on room air, which meets the criterion. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. The patient's medications include bupropion, dutasteride, lisinopril, and tolterodine, none of which are estrogens. Therefore, we can assume this criterion is true.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: There is no mention of a prior VTE in the patient note. Therefore, we can assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. The patient does have ataxia and dysmetria, but there is no specific mention of leg swelling. Therefore, we can assume this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false values. In this case, only the first criterion (Age < 50 years) is false.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, which makes the first criterion false. All other criteria are true based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 56 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 77 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 92 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. However, the patient experienced nonbloody emesis, which is different from hemoptysis. Given the information, we can infer that there was no hemoptysis, making this criterion true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Without explicit information stating the patient is using estrogen, we cannot assume its use. However, given the context and the fact that the patient's medical history and current complaints do not mention estrogen use, and considering the age of the patient (77 years old), it's reasonable to infer that this criterion might be true, but ideally, this should be confirmed. For the purpose of this calculation and based on the information provided, we will consider this criterion as true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a history of deep vein thrombosis, which is a type of venous thromboembolism. Therefore, this criterion is false.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient complained of right lower leg cramping, which could imply some form of discomfort or issue localized to one leg, suggesting unilateral involvement. However, the ultrasound with Doppler of the lower extremities did not show deep vein thrombosis, and there's no explicit mention of swelling. Given the information about leg cramping, it might suggest some form of unilateral leg issue, but without clear evidence of swelling, this could be considered a grey area. For the purpose of this exercise and based on the explicit mention of \"cramping\" without clear reference to swelling, we might lean towards considering this criterion as true, but it's a point that could be debated.\n",
      "\n",
      "Given these evaluations:\n",
      "- The false criteria are: Age < 50 years and No prior VTE.\n",
      "- The true criteria are: Heart rate < 100 bpm, Oxygen saturation ≥ 95%, No hemoptysis, No estrogen use, and No unilateral leg swelling (with the understanding that the last one is based on an interpretation of available data).\n",
      "\n",
      "The PERC score is the sum of the false criteria, which in this case is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's note. The patient's age is over 50, heart rate is under 100, oxygen saturation is over 95%, no hemoptysis was mentioned, estrogen use was not mentioned, there is a history of prior VTE, and while there was leg cramping, unilateral leg swelling was not clearly indicated.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 57 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 40 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is reported as 90 beats/minute in the emergency department, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 96% in room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of the patient experiencing hemoptysis (coughing up blood). Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient note does not mention the patient using estrogen. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient complains of weakness in all four extremities, but there is no specific mention of unilateral leg swelling. Given the context, it seems this criterion is also met (true), as the focus is on generalized weakness rather than localized swelling.\n",
      "\n",
      "Given that all criteria are met (true), the PERC score would be 0, as each false criterion adds 1 point to the score, and there are no false criteria in this case.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, estrogen use, prior VTE, and unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 58 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 67 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 90/min, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient is a man, and there is no mention of estrogen use. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a past medical history of hypertension and peripheral vascular disease, but there is no mention of a prior VTE. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has bilateral lower extremity pitting edema, which means both legs are affected. However, the criterion specifically mentions \"unilateral leg swelling,\" implying that if the swelling is bilateral, this criterion is met. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which in this case is only the first criterion (Age < 50 years).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is determined by evaluating 7 criteria. The patient is older than 50, which is the only false criterion among the ones listed, contributing 1 point to the PERC score. Other criteria such as heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling are all met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 59 ---\n",
      "Expected: 5 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 52 years old, which means this criterion is not met (false). \n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is initially 95 bpm and later 90 bpm, both of which are less than 100 bpm, so this criterion is met (true).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's O2Sat is 96%, which meets this criterion (true).\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note, so we assume this criterion is met (true).\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is a man, it's reasonable to assume this criterion is met (true).\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note, so we assume this criterion is met (true).\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note, so we assume this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the only criterion not met is the patient's age being less than 50 years.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is over 50, but all other criteria are met based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 60 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 29 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse was 97 BPM at the time of examination, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was 98%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of the patient experiencing hemoptysis (coughing up blood). Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient's health history is unremarkable except for ulcerative colitis and primary sclerosing cholangitis, with no mention of prior VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of the patient experiencing unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given that all criteria are met (true), the PERC score would be 0, as each false criterion adds 1 point to the score.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient meets all PERC criteria: age is less than 50, heart rate is less than 100 bpm, oxygen saturation is greater than or equal to 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 61 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 21 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's initial heart rate was 121 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's initial pulse oximetry (SpO2) was 100% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. The patient was previously treated with prednisone and later with dexamethasone, but these are corticosteroids, not estrogens. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score is calculated by summing the number of false values, which in this case is 1 (for the heart rate criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets 6 of the criteria (age < 50, oxygen saturation ≥ 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling) but does not meet the criterion for heart rate < 100 bpm.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 62 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 22 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 90/min, which is less than 100 bpm. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of the patient coughing up blood (hemoptysis) in the note. However, the presence of a bloody vaginal discharge is noted, which is distinct from hemoptysis. Therefore, this criterion is met (true) because hemoptysis specifically refers to coughing up blood, not vaginal bleeding.\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant and has been trying to get pregnant, but there is no specific mention of her using estrogen. However, pregnancy itself involves significant changes in hormone levels, including estrogen. The criterion specifically asks about \"estrogen use,\" which typically refers to exogenous (external) estrogen, such as birth control pills or hormone replacement therapy. Since the note does not mention the patient taking any medications, including estrogen, and given the context that \"estrogen use\" typically implies exogenous sources, this criterion could be considered met (true) based on the information provided. However, it's a bit nuanced because the patient's condition (pregnancy) does involve endogenous estrogen increases. For the purpose of this calculation and based on the strict interpretation of \"estrogen use\" as exogenous, we will consider this criterion as met.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention in the patient note of a past medical history of venous thromboembolism (VTE), which includes conditions like deep vein thrombosis (DVT) or pulmonary embolism (PE). Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention any leg swelling, unilateral or otherwise. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluations above, all criteria are met, meaning none of the criteria are false. The PERC score is calculated by summing the false criteria, which in this case is 0.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, estrogen use, prior VTE, and unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 63 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 25 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is 142/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's pulse oximetry saturation is 86% to 88% on 100% inspired oxygen, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: Although the patient has a hemothorax and significant bleeding, hemoptysis (coughing up blood) is not explicitly mentioned in the note. However, given the context of a hemothorax and the presence of blood, it might be inferred that there could be some form of bleeding in the respiratory tract, but strictly based on the information provided, hemoptysis is not directly stated. For the purpose of this evaluation, we will consider this criterion as not directly applicable or not met due to the presence of a hemothorax indicating significant intrathoracic bleeding (false).\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant, which implies estrogen levels are elevated due to the pregnancy itself. However, the criterion specifically mentions \"estrogen use,\" which typically refers to exogenous estrogen (e.g., birth control pills or hormone replacement therapy). Since the note does not mention exogenous estrogen use and focuses on the pregnancy, we might consider this criterion met (true) in the context of exogenous estrogen use, but it's a bit nuanced.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient's past medical history. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The note does not mention unilateral leg swelling. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score would be the sum of the false values, which are criteria 2, 3, 4, and potentially nuanced but considered false for simplicity in criterion 5 due to the pregnancy context, but strictly speaking, only 2, 3, and 4 are clearly false based on the provided information.\n",
      "\n",
      "**Explanation**: Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, presence of hemoptysis, estrogen use, history of VTE, and presence of unilateral leg swelling as described in the patient note.\n",
      "\n",
      "**Criteria**:\n",
      "- \"Age < 50\": true\n",
      "- \"HR < 100\": false\n",
      "- \"O₂ ≥ 95%\": false\n",
      "- \"No hemoptysis\": false (considering the context of significant intrathoracic bleeding)\n",
      "- \"No estrogen use\": true (in the context of exogenous estrogen use)\n",
      "- \"No prior VTE\": true\n",
      "- \"No unilateral leg swelling\": true\n",
      "\n",
      "**Answer**: The sum of the false values is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, presence of hemoptysis, estrogen use, history of VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 64 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 57 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 78 beats per minute, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% at room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient has undergone hysterectomy, and there is no mention of estrogen use. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has erythematous tender nodules on bilateral lower extremities, which suggests involvement of both legs rather than unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluations above, the PERC score is calculated by summing the false values, which in this case is only 1 (for the age criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, which is the only false criterion. The heart rate, oxygen saturation, absence of hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling all meet the criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 65 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 73 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 92 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient has a history of breast cancer and was treated with tamoxifen and letrozole, which are hormonal therapies, but there is no current mention of estrogen use. However, given her history of hormonal treatment for breast cancer, it might be implied that she has had estrogen-related therapy in the past. The note does not specify current estrogen use, but given the context, it seems she is not currently on estrogen therapy. Therefore, this criterion could be considered true based on the information provided, but it's a bit ambiguous. For the purpose of this calculation, we will consider it true as there's no explicit mention of current estrogen use.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention unilateral leg swelling. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated as follows:\n",
      "\n",
      "- False criteria: Age < 50 years.\n",
      "- True criteria: Heart rate < 100 bpm, Oxygen saturation ≥ 95%, No hemoptysis, No estrogen use, No prior VTE, No unilateral leg swelling.\n",
      "\n",
      "The PERC score is the sum of the false criteria, which in this case is 1 (for Age < 50 years).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no mention of hemoptysis, no current estrogen use mentioned, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 66 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 44 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate was 88 beats/minute, which is less than 100 bpm. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation level was 92% on room air, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the context, it seems unlikely that estrogen use would be relevant or present without mention, especially since the patient's presentation and diagnosis do not directly relate to conditions typically treated with estrogen. Therefore, we will assume this criterion is met (true) based on the lack of information suggesting estrogen use.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note mentions \"no evidence of... pitting edema\" but does not specifically address unilateral leg swelling. However, given the comprehensive nature of the physical examination described, it is reasonable to infer that significant unilateral leg swelling would have been noted if present. Therefore, we will assume this criterion is met (true) based on the lack of information suggesting its presence.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false values, which in this case is only criterion 3 (Oxygen saturation ≥ 95%).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient note. The patient's age, heart rate, lack of hemoptysis, no mentioned estrogen use, no prior VTE, and no unilateral leg swelling met the criteria. However, the patient's oxygen saturation was less than 95%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 67 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 21 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 95 bpm, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient has a normal saturation value at rest in ambient air with an SPO2 of 95%, which meets or exceeds 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a 21-year-old girl and there's no specific mention of estrogen use, we cannot definitively say this criterion is not met based on the provided information. However, without explicit evidence of estrogen use, we might lean towards assuming this criterion could be met (true) by default, but it's essential to note this assumption is based on the lack of information rather than explicit confirmation.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of any prior VTE in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, all criteria are considered met (true), meaning none of the criteria are false. The PERC score is calculated by summing the false criteria, which in this case would be 0 since all criteria are true.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, and the absence of specific conditions or symptoms as described in the patient note. All criteria were found to be met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 68 ---\n",
      "Expected: 4 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 69 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate was 114/min upon arrival and later 109/min, both of which are greater than 100 bpm. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was 96% on 3 L of oxygen via nasal cannula. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can consider this criterion as true, assuming hemoptysis was not present.\n",
      "\n",
      "5. **No estrogen use**: The patient is taking raloxifene, which is a selective estrogen receptor modulator (SERM) and can be considered as estrogen use for the purposes of this criterion. Therefore, this criterion is false.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient note. Therefore, we can consider this criterion as true, assuming no prior VTE was present.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had bilateral pitting lower extremity edema, which means she did not have unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Now, let's calculate the PERC score based on the false criteria:\n",
      "- Age < 50 years: False (1 point)\n",
      "- Heart rate < 100 bpm: False (1 point)\n",
      "- No estrogen use: False (1 point)\n",
      "\n",
      "The total PERC score is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. Each false criterion adds 1 point to the score. The patient's age is greater than 50, heart rate is greater than 100 bpm, and she is taking estrogen (raloxifene), contributing to a score of 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 69 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 63 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 92/min, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation on room air is 93%, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient note does not mention the patient taking any medications, including estrogen. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no history of serious illness mentioned, which implies no prior VTE. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention any unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false criteria, which are \"Age < 50 years\" and \"Oxygen saturation ≥ 95%\". Thus, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50 and oxygen saturation is less than 95%, contributing to a PERC score of 2. Other criteria were met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 70 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 40 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate at presentation was 87 beats/min, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation on room air was initially 80%, but it improved to 96% with 6 liters of nasal cannula. However, the criterion specifically mentions oxygen saturation without specifying the need for supplemental oxygen. Given the context, the initial saturation on room air is what's critical for this assessment, which was below 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can infer that this criterion is met (true), as there's no indication of its presence.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it's reasonable to assume this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient did develop a peroneal deep-vein thrombosis post-ECMO, but there is no mention of prior VTE before the current illness. Therefore, this criterion is met (true) based on the information provided about the patient's history before the current hospitalization.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no complaint of leg swelling mentioned in the initial assessment. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false values, which in this case is only 1 (for the oxygen saturation criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets 6 out of 7 criteria: age is less than 50, heart rate is less than 100, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling. The patient does not meet the criterion for oxygen saturation ≥ 95% on room air.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 71 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 79 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is mentioned as irregular with a rate of 78 beats per minute initially, and later it's noted that the patient has atrial fibrillation with a rate of 130 bpm. Given the heart rate of 130 bpm, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient is saturating 100% on room air, which meets this criterion. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: The patient denied hemoptysis, which means this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient's home medications or elsewhere in the note. However, since the patient is a female and there's no explicit mention of estrogen use, we cannot definitively say this criterion is met based solely on the absence of information. But given the context and the fact that estrogen use is not mentioned among her medications or medical history, we might lean towards considering this criterion as true, but it's essential to note this assumption is based on the lack of information rather than explicit confirmation.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a history of lower extremity venous insufficiency, which could be related to or increase the risk of VTE, but there is no explicit mention of a prior VTE. Therefore, based on the information provided, we consider this criterion as true, although the patient's history suggests a potential risk.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has grade 2+ bilateral lower limb edema, which means the swelling is not unilateral. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations:\n",
      "- The false criteria are: Age < 50 years, Heart rate < 100 bpm.\n",
      "- The true criteria are: Oxygen saturation ≥ 95%, No hemoptysis, No estrogen use (assumed due to lack of mention), No prior VTE (based on the information given), No unilateral leg swelling.\n",
      "\n",
      "The PERC score is the sum of the false criteria, which in this case is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient's age is over 50, and the heart rate exceeds 100 bpm at some point, contributing to the score. Other criteria such as oxygen saturation, no hemoptysis, assumed no estrogen use, no prior VTE, and no unilateral leg swelling do not contribute to the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 72 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 75 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 68 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's peripheral saturation is 80%, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it is unlikely. Therefore, we can assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any prior VTE, but it does mention the diagnosis of pulmonary embolism during the current hospitalization. However, for the purpose of the PERC rule, we consider prior VTE, which is not mentioned. Therefore, we can assume this criterion is true based on the information provided.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note mentions that neither jugular venous distention nor peripheral edema was observed, which implies there was no unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria, which are \"Age < 50 years\" and \"Oxygen saturation ≥ 95%\". \n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100, oxygen saturation less than 95%, no hemoptysis, no estrogen use, no prior VTE mentioned, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 73 ---\n",
      "Expected: 6 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 53 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse was 76 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's O2 saturation was 100% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it is unlikely. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of any prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient does have an injury to one foot (the left foot), which resulted in edema (swelling) to the medial aspect of the left foot. This indicates unilateral leg swelling. Therefore, this criterion is false.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false criteria, which are \"Age < 50 years\" and \"No unilateral leg swelling\".\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on the provided note. The patient is over 50, has a heart rate less than 100, oxygen saturation of 100%, no hemoptysis, no estrogen use, no prior VTE, but does have unilateral leg swelling due to the injury.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 74 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 70 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's initial pulse rate was 110/minute, which is greater than 100 bpm. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's initial oxygen saturation was 97% in room air, which meets this criterion. However, it's important to note that oxygen saturation levels fluctuated throughout the patient's care, including periods where saturation was below 95%. For the purpose of the PERC score, we consider the initial presentation. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is a 70-year-old female, and there is no mention of estrogen use. Given her age and the context, it's reasonable to assume she is postmenopausal, but without explicit information about hormone replacement therapy (HRT), we must consider the information provided. Since there's no mention of estrogen use, we will consider this criterion as true, but it's worth noting that this assumption might not always be accurate without explicit information.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Heart rate < 100 bpm: False\n",
      "- Oxygen saturation ≥ 95%: True\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: True\n",
      "- No prior VTE: True\n",
      "- No unilateral leg swelling: True\n",
      "\n",
      "The patient has 2 false criteria (Age < 50 years and Heart rate < 100 bpm), so the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate greater than 100 bpm, but meets the other criteria based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 75 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 53 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate was 90 beats/minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's SpO2 was 98% and later 94% during the procedure, both of which are greater than or equal to 95% at the time of evaluation relevant to PERC criteria. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it's reasonable to infer this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluations above, the only false criterion is the patient's age being greater than 50 years. \n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, which is the only criterion not met. Other criteria such as heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling are all met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 76 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 49 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 101/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's blood saturation on room air is 89%, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient had a prophylactic ovariectomy 2 weeks ago, which would significantly reduce her estrogen levels. However, the criterion specifically mentions \"estrogen use,\" and there's no indication that she is currently using estrogen supplements or medications. Therefore, we can consider this criterion as met (true) based on the information given, assuming \"use\" refers to external or supplemental estrogen.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The note specifically mentions \"There is no leg edema,\" which implies there is no unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which are criteria 2, 3. \n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on the provided note. Each criterion was evaluated as either true (met) or false (not met), with false criteria contributing 1 point each to the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 77 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 29 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is over 110 beats/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's pulse oximetry is 93% on a fraction of inspired oxygen of 49%, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: The patient denied hemoptysis. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male and there's no indication of estrogen therapy, we can infer this criterion is met (true), although it's not explicitly stated.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient had no history of thrombosis. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The note does not explicitly mention unilateral leg swelling, but it does mention the exploration of femoral, popliteal, and calf muscular venous thrombosis in the right extremity using color Doppler scans. This implies there might be some concern or finding related to the venous system in one leg, but it does not directly state the presence of unilateral leg swelling. However, given the context and the fact that specific tests were done to check for thrombosis in one extremity, it could be inferred that there might be some issue, but since it's not explicitly stated as swelling, and considering the absence of clear information about swelling, we might lean towards considering this criterion as not directly applicable or not clearly failed based on the information given. However, for the purpose of PERC score calculation and given the lack of explicit denial of unilateral leg swelling in the context of examining for venous thrombosis, one might cautiously consider this as not met (false) if assuming any concern for DVT could imply swelling, but this is a bit of an inference. For strict interpretation based on provided details without assuming, it's challenging to definitively mark this as false without explicit mention of swelling.\n",
      "\n",
      "Given these considerations and focusing strictly on the explicit information provided:\n",
      "\n",
      "- The patient clearly does not meet criteria 2 (HR < 100) and 3 (O₂ ≥ 95%).\n",
      "- The status of criterion 7 (No unilateral leg swelling) is not clearly stated as failed based on the information provided, but if we are to follow a cautious approach considering the context of venous thrombosis examination, one might consider it as not met. However, for clarity and sticking to explicit information, let's consider the directly failed criteria.\n",
      "\n",
      "Thus, based on explicit failures:\n",
      "- The patient fails criteria 2 and 3 directly.\n",
      "\n",
      "However, considering the need for a clear explanation and the format requested, and acknowledging the potential inference regarding criterion 7 but not marking it as failed due to lack of explicit information on swelling:\n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient is under 50, denies hemoptysis, has no prior VTE, and no mention of estrogen use. The patient's heart rate is over 100, and oxygen saturation is less than 95%. The presence of unilateral leg swelling is not explicitly stated, but there's an examination for venous thrombosis.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 78 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 22 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 92 beats per minute, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true), as there is no indication that the patient has hemoptysis.\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant, and there is no mention of estrogen use. However, pregnancy itself involves high levels of estrogen. But in the context of the PERC rule, \"estrogen use\" typically refers to exogenous estrogen (e.g., birth control pills or hormone replacement therapy), which is not indicated here. Therefore, considering the common interpretation in this medical context, this criterion could be considered met (true) because there's no mention of exogenous estrogen use.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient's history. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the explanations above, all criteria are met, meaning none of the criteria are false. The PERC score is calculated by summing the false criteria, which in this case is 0.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, estrogen use, prior VTE, and unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 79 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 38 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 122 beats per minute, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is initially 88% and increases to 94% on 2 liters of nasal oxygen, but it does not reach 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient is later placed on oral estradiol for hormone replacement therapy, but at the time of presentation, there is no mention of estrogen use. However, given the context, it seems the patient was not on estrogen at the time of evaluation, but this could be considered not directly relevant as the decision for PERC scoring is typically based on the clinical presentation and history at the time of evaluation. For the purpose of this calculation and based on the information given, we will consider this criterion as met (true) because there's no indication she was on estrogen at the time of the medical evaluation in question.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the number of false criteria, which are criteria 2, 3, and potentially considering the nuances around criterion 5, but based on our interpretation, we proceed with the information directly provided and relevant to the time of medical evaluation.\n",
      "\n",
      "The final answer is: \n",
      "```\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient meets criteria 1, 4, 5, 6, and 7 but does not meet criteria 2 and 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 80 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 48 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 92 bpm, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 95% on room air, which meets or exceeds 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient's medications include insulin and tacrolimus, with no mention of estrogen or any estrogen-containing medications. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient's past medical history. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note does not mention unilateral leg swelling. Given the focus on respiratory symptoms and the absence of any mention of leg swelling, we assume this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, the patient meets all 7 criteria, meaning none of the criteria are false. Therefore, the PERC score, which is the sum of the false criteria, is 0.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient meets all PERC criteria: age is less than 50, heart rate is less than 100 bpm, oxygen saturation is 95% or greater, there's no mention of hemoptysis, no estrogen use is noted, no prior VTE is mentioned, and there's no unilateral leg swelling reported.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 81 ---\n",
      "Expected: 3 | Predicted: 5\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 65 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: Upon arrival to the emergency department, the patient's heart rate was 155 beats per minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was 70% in ambient air upon arrival, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can consider this criterion as true.\n",
      "\n",
      "5. **No estrogen use**: The patient has a history of hormone therapy (Letrozole/Tamoxifen) but also underwent bilateral hystero-salpingo-ovoforectomy (removal of ovaries, which produce estrogen) three years before the current presentation. However, given the history of estrogen use (even if not current), this criterion could be considered false, but it's more nuanced due to the surgical removal of estrogen-producing organs. For the purpose of this calculation and given the direct question, we might lean towards considering estrogen use as not currently applicable due to the surgery, but the history of use could still influence the decision. However, the PERC rule is about current risk factors, and the patient has undergone surgery that would significantly reduce estrogen levels. Thus, this could be considered true in the context of current estrogen use influencing thromboembolic risk, but it's a complex consideration.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient had acute extensive thrombus formation in the superficial femoral vein of the right leg, which is a VTE. Therefore, this criterion is false.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient developed right lower extremity swelling, which is unilateral leg swelling. Therefore, this criterion is false.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated as the sum of the false criteria:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- HR < 100: False\n",
      "- O₂ ≥ 95%: False\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: Considering the nuances, we might lean towards True due to the removal of ovaries, but acknowledging the complexity.\n",
      "- No prior VTE: False\n",
      "- No unilateral leg swelling: False\n",
      "\n",
      "If we consider \"No estrogen use\" as True due to the removal of the ovaries and focusing on current risk factors:\n",
      "The false criteria are 5 (Age, HR, O₂, prior VTE, unilateral leg swelling).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's information. The patient's age, heart rate, oxygen saturation, history of VTE, and unilateral leg swelling led to false evaluations for these criteria. Hemoptysis was not mentioned, and considering the patient's surgical history, estrogen use was considered in a nuanced manner but leaned towards not being a current factor.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 5\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 82 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 64 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 94 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient is saturating at 86% on 4-5 L nasal cannula, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is a male, it is unlikely. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has 1+ bilateral lower extremity edema, which means there is swelling, but it is bilateral, not unilateral. Therefore, this criterion is true.\n",
      "\n",
      "Now, let's calculate the PERC score. Each false criterion adds 1 point to the score. From the evaluation above, the false criteria are:\n",
      "\n",
      "- Age < 50 years\n",
      "- Oxygen saturation ≥ 95%\n",
      "\n",
      "So, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient's age is greater than 50, and oxygen saturation is less than 95%, making these criteria false. All other criteria are true based on the information provided in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 83 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 47 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 98 beats/minute, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's O2 saturation is 97% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Hemoptysis refers to coughing up blood, and the patient's symptoms include melena (black, tarry stools), which indicates gastrointestinal bleeding, not hemoptysis. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man and there's no indication of estrogen therapy, we can infer this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "Given that all criteria are met (true), the PERC score would be 0, as each false criterion adds 1 point to the score, and there are no false criteria in this case.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, estrogen use, prior VTE, and unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 84 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 48 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is mentioned as 110/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient note does not directly mention the oxygen saturation level. However, it discusses severe pulmonary arterial hypertension, biventricular dysfunction, and later mentions issues with hypoxia due to low cardiac output, suggesting potential issues with oxygen saturation. Without a specific oxygen saturation value, we cannot directly apply this criterion based on the provided information. However, given the context of significant cardiac and respiratory issues, it might be inferred that the patient could have had saturation issues, but we will have to consider this as not directly evaluable from the information given. For the purpose of PERC calculation, we will consider this criterion as not met (false) due to the lack of explicit information confirming saturation ≥ 95%.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can consider this criterion as met (true), assuming hemoptysis was not present since it was not mentioned.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, estrogen use is unlikely. Therefore, we can consider this criterion as met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any prior VTE. Therefore, we can consider this criterion as met (true), assuming no prior VTE since it was not mentioned.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note mentions bilateral pedal edema, indicating swelling in both legs, not unilateral. Therefore, this criterion is met (true).\n",
      "\n",
      "Based on the evaluation:\n",
      "- The patient does not meet criteria 2 (Heart rate < 100 bpm) and potentially criterion 3 (Oxygen saturation ≥ 95%) due to the lack of direct information, but we've considered it as not met for calculation purposes.\n",
      "- All other criteria are met.\n",
      "\n",
      "Therefore, the PERC score would be the sum of the false values, which are 2 (for criteria 2 and 3, considering the interpretation for calculation purposes).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on the provided note. The patient is under 50, has no mentioned hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling, meeting criteria 1, 4, 5, 6, and 7. The patient's heart rate is over 100 bpm, not meeting criterion 2. Oxygen saturation is not directly mentioned but considered not met for calculation purposes due to the patient's significant respiratory and cardiac issues.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 85 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 85 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 80 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% while breathing ambient air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: The patient has a history of hemoptysis, which means this criterion is false.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is male and there's no indication of estrogen therapy, we can consider this criterion as true based on the information provided.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, based on the information provided, we consider this criterion as true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, based on the information provided, we consider this criterion as true.\n",
      "\n",
      "Given these evaluations, the criteria that are false (and thus contribute to the PERC score) are: Age < 50 years and No hemoptysis.\n",
      "\n",
      "The PERC score is the sum of the false criteria, which in this case is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a history of hemoptysis, but meets the other criteria based on the information provided in the note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 86 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 52 years old, which means this criterion is not met (false). \n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is 107 beats per minute, which is greater than 100 bpm, so this criterion is not met (false).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 93%, which is less than 95%, so this criterion is not met (false).\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note, which implies this criterion is met (true) since hemoptysis is not indicated.\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, which implies this criterion is met (true) since estrogen use is not indicated.\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a history of CLL and underwent autologous stem cell transplantation, but there is no mention of prior VTE, which implies this criterion is met (true) since prior VTE is not indicated.\n",
      "7. **No unilateral leg swelling**: The patient note does not mention unilateral leg swelling, which implies this criterion is met (true) since unilateral leg swelling is not indicated.\n",
      "\n",
      "Given the evaluations above, the criteria that are not met (false) are: Age < 50 years, Heart rate < 100 bpm, and Oxygen saturation ≥ 95%. Each false criterion adds 1 point to the PERC score. Therefore, the PERC score for this patient is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. For this patient, the criteria not met are Age < 50 years (patient is 52), Heart rate < 100 bpm (patient's heart rate is 107), and Oxygen saturation ≥ 95% (patient's oxygen saturation is 93%). The other criteria are met as there is no indication of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 87 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 52 years old, which means this criterion is not met (false). \n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 97 bpm, which means this criterion is met (true).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's SpO2 is 99% on room air, which means this criterion is met (true).\n",
      "4. **No hemoptysis**: The patient denies any cough or other symptoms that might suggest hemoptysis, and there's no mention of it in the exam findings, which means this criterion is met (true).\n",
      "5. **No estrogen use**: The patient is a male and there's no mention of him taking any medications, including estrogen, which means this criterion is met (true).\n",
      "6. **No prior venous thromboembolism (VTE)**: There's no mention of the patient having a history of VTE, which means this criterion is met (true).\n",
      "7. **No unilateral leg swelling**: There's no mention of leg swelling in the patient note, which means this criterion is met (true).\n",
      "\n",
      "Given the evaluations above, the only criterion not met is the patient's age being less than 50 years.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, symptoms, medication use, medical history, and physical examination findings.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 88 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 63 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient was tachycardic at 120 beats per minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient was hypoxic with oxygen saturation at 88% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can consider this criterion as true, assuming hemoptysis was not present.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it's reasonable to assume estrogen use is not applicable. Therefore, we can consider this criterion as true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient developed multiple upper and lower extremity deep vein thromboses (DVTs) during the hospital stay, but there is no mention of prior VTE. Therefore, considering the context of the question which asks for prior VTE, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had arterial catheter-associated thrombosis in the mid left radial artery leading to gangrene of left 1st and 2nd digits, but there is no specific mention of unilateral leg swelling. However, given the development of DVTs, it might be inferred that leg swelling could have been present, but it's not explicitly stated for the criteria evaluation at the time of assessment. Without explicit mention, and considering the focus on leg swelling as a specific symptom, we might lean towards considering this criterion as true based on the information given, but it's a bit ambiguous. For the purpose of this calculation and based on the explicit details provided, we will consider it as true, acknowledging this might not fully capture the clinical complexity.\n",
      "\n",
      "Given these evaluations:\n",
      "- The false criteria are: Age < 50, Heart rate < 100, Oxygen saturation ≥ 95%.\n",
      "- The true criteria are: No hemoptysis, No estrogen use, No prior VTE, and considering the provided details, No unilateral leg swelling.\n",
      "\n",
      "The PERC score is the sum of the false criteria, which in this case is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. For this patient, Age < 50, Heart rate < 100, and Oxygen saturation ≥ 95% were false, contributing to the PERC score. No hemoptysis, No estrogen use, No prior VTE, and No unilateral leg swelling were considered true based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 89 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 69 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is mentioned as 60 beats/min when recumbent, which is less than 100 bpm. However, it increases to 120 beats/min when upright. Since the criterion is about the heart rate being less than 100 bpm, and it is mentioned that the heart rate remained normal with recumbency, we consider the heart rate of 60 beats/min for this evaluation. Thus, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: Initially, the patient's oxygen saturation was 94% and desaturated to 80% when upright. However, post-intervention, the patient maintained oxygen saturations of 95% without supplemental oxygen. For the purpose of evaluating the PERC score, we consider the patient's condition before any intervention, so this criterion is false based on the initial oxygen saturation of 94%.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The physical examination revealed no peripheral edema, which implies no unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Based on the evaluation, the false criteria are:\n",
      "- Age < 50 years\n",
      "- Oxygen saturation ≥ 95%\n",
      "\n",
      "The sum of false values is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient is older than 50, had an initial oxygen saturation less than 95%, but met the other criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 90 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 88 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 87 beats/min, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 96%, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Therefore, assuming no estrogen use, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, assuming no prior VTE, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has bilateral buttock pain and numbness in both lower extremities, but there is no specific mention of unilateral leg swelling. However, given the context, it seems the patient's symptoms are bilateral rather than unilateral. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluations above, the only false criterion is the patient's age being greater than 50. \n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, which is the only criterion not met. Other criteria such as heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling are all met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 91 ---\n",
      "Expected: 4 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 26 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 120 beats/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 85% at room air and increases to 90% with 100% oxygen, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Therefore, assuming no estrogen use, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has embolization to the pulmonary arteries due to tumor fragments, but there is no mention of a prior VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: Ultrasonography of the bilateral lower limb Doppler was unremarkable, suggesting no unilateral leg swelling due to deep vein thrombosis. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluations above, the PERC score is calculated by summing the false values, which are criteria 2, 3.\n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets criteria 1, 4, 5, 6, and 7 but does not meet criteria 2 and 3 due to a heart rate greater than 100 bpm and oxygen saturation less than 95%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 92 ---\n",
      "Expected: 4 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 56 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 120 per minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's peripheral oxygen saturations dropped to 85% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient taking any estrogen or being on any regular medications that could imply estrogen use. Therefore, we assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient had surgery for a traumatic fracture of his right leg three weeks ago, which could increase the risk of VTE, and the CT scan revealed thrombi in the pulmonary arteries, indicating a current VTE. However, there is no explicit mention of a prior VTE before this event. Given the context, it seems this criterion might be considered true based on the information provided, but it's a bit ambiguous due to the recent surgery and development of thrombi. For the purpose of this calculation, we will consider it as true because there's no clear indication of a prior VTE before the current hospital admission.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had surgery for a traumatic fracture of his right leg, which could potentially lead to swelling. However, there is no specific mention of unilateral leg swelling in the context of the criteria for VTE or during the hospital stay. Therefore, we assume this criterion is true, although this assumption might be considered somewhat tentative without explicit information on leg swelling.\n",
      "\n",
      "Given these evaluations, the PERC score would be calculated based on the false criteria:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Heart rate < 100 bpm: False\n",
      "- Oxygen saturation ≥ 95%: False\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: True\n",
      "- No prior VTE: True\n",
      "- No unilateral leg swelling: True\n",
      "\n",
      "The sum of the false values is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, presence of hemoptysis, estrogen use, history of prior VTE, and presence of unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 93 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 57 years old, which means this criterion is not met (false). \n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 95 beats per minute, which means this criterion is met (true).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 96%, which means this criterion is met (true).\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note, which implies this criterion is met (true) since it is not indicated as a symptom.\n",
      "5. **No estrogen use**: The patient is a male, and there is no mention of estrogen use, which means this criterion is met (true).\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note, which implies this criterion is met (true) since it is not indicated in his past medical history.\n",
      "7. **No unilateral leg swelling**: The patient has trace pitting edema noted to the ankle bilaterally, which means this criterion is not met (false) because it indicates some form of leg swelling, although it's bilateral.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false values, which are criteria 1 and 7.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no prior VTE, and bilateral leg swelling which does not strictly meet the 'no unilateral leg swelling' criterion due to the presence of any leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 94 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 44 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 88 bpm, which is less than 100. Therefore, this criterion is met (true).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (SpO2) is 99%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis (coughing up blood) in the patient note. Therefore, this criterion is met (true).\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and the patient is male, making estrogen use unlikely. Therefore, this criterion is met (true).\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient's past medical history is significant only for hypertension, with no mention of prior VTE. Therefore, this criterion is met (true).\n",
      "7. **No unilateral leg swelling**: The physical examination does not reveal any abnormal findings, including no mention of unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given that all criteria are met (true), the PERC score is 0, as each false criterion would add 1 point to the score.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, vital signs, medical history, and physical examination findings as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 95 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 32 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 126 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 95% on room air, which meets the criterion. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient was not taking oral contraceptives, which implies no estrogen use relevant to the context. Therefore, this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient had undergone surgery and presented with symptoms of pulmonary embolism but had no prior VTE mentioned before this incident. Therefore, at the time of evaluation for PERC, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There was no limb swelling noted. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score is calculated by summing the false values, which in this case is only 1 (for the heart rate criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets 6 out of 7 criteria: age is less than 50, oxygen saturation is 95% or greater, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling. The only criterion not met is a heart rate of less than 100 bpm, as the patient's heart rate was 126 bpm.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 96 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 20 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is 140/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 90% at room air, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true), assuming hemoptysis was not present but not explicitly stated.\n",
      "\n",
      "5. **No estrogen use**: The patient is pregnant (seven months amenorrhea), which implies she is under the influence of estrogen due to her pregnancy. However, the criterion specifically mentions \"estrogen use,\" which typically refers to exogenous estrogen (e.g., birth control pills or hormone replacement therapy). Since the note does not explicitly mention exogenous estrogen use and her condition (pregnancy) is a natural state of increased estrogen, we might interpret this criterion as met (true) in the context of exogenous estrogen use. However, given the context, it's a bit ambiguous, but for the purpose of this calculation and following the strict interpretation of \"estrogen use\" as exogenous, we'll consider it true.\n",
      "\n",
      "6. **No prior VTE**: There is no mention of prior venous thromboembolism (VTE) in the patient note. Therefore, this criterion is met (true), assuming no prior VTE was present but not explicitly stated.\n",
      "\n",
      "7. **No unilateral leg swelling**: The note does not mention unilateral leg swelling. Therefore, this criterion is met (true), assuming no unilateral leg swelling was present but not explicitly stated.\n",
      "\n",
      "Given these evaluations, the PERC score would be the sum of the false values, which are criteria 2 and 3.\n",
      "\n",
      "**Explanation**: The patient's PERC score is calculated based on the absence of certain risk factors for pulmonary embolism. The patient is young, has no mentioned history of hemoptysis, prior VTE, or unilateral leg swelling, and there's no explicit mention of exogenous estrogen use. However, the patient's heart rate is elevated, and oxygen saturation is below 95%, contributing to a positive PERC score.\n",
      "\n",
      "**JSON Result**:\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is based on an elevated heart rate and low oxygen saturation, with other criteria not contributing to the score due to either being met or not explicitly mentioned in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 97 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 39 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 101 beats per minute, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it is reasonable to assume this criterion is met (true).\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: There is no mention of a prior VTE in the patient note. Therefore, this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. The patient had diffuse arthralgia but no specific mention of leg swelling. Therefore, this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score can be calculated by summing the number of false values. In this case, only one criterion (heart rate < 100 bpm) is false.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets 6 out of 7 criteria, with the only false criterion being a heart rate of 101 bpm, which is greater than 100.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 98 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 40 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 100 beats/min, which is not less than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation in room air is 78%, and even with 5 L/min of oxygen via nasal prong, it only increases to 92%, which is not ≥ 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient's last childbirth was 15 years prior to presentation and there's no indication of her being on any form of estrogen therapy, we can infer this criterion is likely met (true), but it's based on the absence of information rather than explicit confirmation.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has bilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the number of false criteria, which are:\n",
      "\n",
      "- Heart rate < 100 bpm (false)\n",
      "- Oxygen saturation ≥ 95% (false)\n",
      "\n",
      "So, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient meets criteria 1, 4, 5, 6, and 7 but does not meet criteria 2 and 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 99 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 65 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 52 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's pulsoximetry reading is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is a male, and there is no mention of estrogen use. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: The patient has a history of cardiomyopathy and atrial flutter, and the current diagnosis includes renal artery thrombosis, which is an embolic event. Although it doesn't explicitly state a prior VTE, the presence of a current thromboembolic event suggests a potential for prior events or a predisposition. However, based strictly on the information given, there's no explicit mention of a prior VTE, so this could be considered true in the context of the PERC criteria as described, but it's a bit nuanced.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the criteria that are false are:\n",
      "- Age < 50 years\n",
      "\n",
      "The rest of the criteria are true based on the information provided.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no explicit prior VTE mentioned, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 100 ---\n",
      "Expected: 5 | Predicted: 0\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 29 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 97/min, which is less than 100. Therefore, this criterion is met (true).\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "4. **No hemoptysis**: There is no mention of the patient experiencing hemoptysis (coughing up blood). Therefore, this criterion is met (true).\n",
      "5. **No estrogen use**: The patient is a postpartum woman and there's no mention of her using estrogen. However, given her recent pregnancy and the context, it might be implied that she has been under the influence of natural estrogen increases during pregnancy, but the criterion specifically refers to \"estrogen use,\" which typically implies exogenous estrogen (like birth control pills or hormone replacement therapy). Since there's no explicit mention of exogenous estrogen use, and considering the context of the question, we might interpret this as not applicable directly due to lack of information, but in the strictest sense of \"use\" (as in taking estrogen), this could be considered met (true) based on the information given.\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE. Therefore, this criterion is met (true).\n",
      "7. **No unilateral leg swelling**: There is no mention of the patient experiencing unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given the information provided and the interpretation of each criterion, all criteria are met (true), meaning none of the criteria are false, which would add points to the PERC score.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, absence of hemoptysis, estrogen use, prior VTE, and unilateral leg swelling as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 101 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 73 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 72 beats/min, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 94% in room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient note does not mention the patient taking any medications, including estrogen. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a history of lower limb venous insufficiency, but there is no explicit mention of a prior VTE. However, the patient was later diagnosed with a new bilateral pulmonary embolism (PE), which is a type of VTE. Since the question asks for \"prior\" VTE and the note initially discusses conditions before the diagnosis of the new PE, we might interpret this as the patient not having a known prior VTE at the time of initial evaluation. However, given the context and the fact that the patient developed a PE, it's reasonable to consider the patient's risk factors and the eventual diagnosis. For the purpose of this calculation and based on the information given at the start of the patient's history, we will consider this criterion as true, acknowledging this interpretation might vary.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had a pneumatic compression device on both legs to prevent deep vein thrombosis, and there's mention of lower limb venous insufficiency but not specifically of unilateral leg swelling. Therefore, we assume this criterion is true, as there is no explicit evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score would be the sum of the false criteria, which are:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Oxygen saturation ≥ 95%: False\n",
      "\n",
      "The other criteria are considered true based on the information provided or the lack thereof.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. Each false criterion adds 1 point to the score. The patient's age is over 50, and oxygen saturation is less than 95%, making these criteria false.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 102 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 43 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 79 bpm, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's SPO2 is 96%, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: The patient has a history of cough with hemoptoic sputum, indicating the presence of hemoptysis. Therefore, this criterion is not met (false).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a man, it is reasonable to assume this criterion is met (true), although the note does not explicitly state it.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient note. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score is calculated by summing the false values, which in this case is only 1 (for the criterion \"No hemoptysis\").\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's information. The patient met criteria 1, 2, 3, 5, 6, and 7 but did not meet criterion 4 due to the presence of hemoptysis.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 103 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 46 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 124 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's arterial oxygen saturation is 97.5% under nasal oxygen, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, the patient is receiving hormone therapy, which could potentially include estrogen. Without explicit information stating the patient is not using estrogen, and considering the context of hormone therapy, this assumption might lean towards the criterion not being met. However, given the lack of clear information, the most conservative approach based on the provided details would be to assume this criterion is not directly addressed, but for the purpose of this calculation and without clear evidence of estrogen use, we might consider it as not met due to the mention of hormone therapy, which introduces uncertainty.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has bruising and swelling in the left thigh due to the femur fracture. This indicates unilateral leg swelling, meaning this criterion is not met (false).\n",
      "\n",
      "Given these evaluations:\n",
      "- The patient meets criteria 1, 3, 4, and 6.\n",
      "- The patient does not meet criteria 2, 5 (with the assumption based on hormone therapy), and 7.\n",
      "\n",
      "Therefore, the PERC score would be the sum of the false values, which are 3 (for criteria 2, 5, and 7).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient is under 50, has an oxygen saturation of 97.5%, no mention of hemoptysis, and no prior VTE, meeting criteria 1, 3, 4, and 6. The patient's heart rate is over 100 bpm, has unilateral leg swelling, and the mention of hormone therapy introduces uncertainty regarding estrogen use, thus not meeting criteria 2, 5 (with assumptions), and 7.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Wrong Reply 104 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 58 years old, which is above the age of 50. Her heart rate is 57 bpm, which is less than 100 bpm. Her oxygen saturation is 93%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 105 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 15 years old, which is less than 50 years. Heart rate is 90 bpm, which is less than 100 bpm. Oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, all criteria are met, and the PERC score is 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 106 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 32 years old, which is less than 50 years. The heart rate is 90 bpm, which is less than 100 bpm. The oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient note. Therefore, all criteria are met, and the PERC score is 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 107 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 37 years old, which is less than 50 years. Her heart rate is 85 bpm, which is less than 100 bpm. Her oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, all criteria are met, resulting in a PERC score of 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 108 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 65 years old, which is above the age of 50. His heart rate is 75 bpm, which is less than 100 bpm. His oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, the PERC score is 1, indicating that the patient does not meet the criteria for pulmonary embolism rule-out.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 109 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 66 years old, which is greater than 50 years. The heart rate is 120 bpm, which is greater than 100 bpm. The oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient note. Therefore, the patient meets criteria 3, 4, 5, 6, and 7, but not criteria 1 and 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 110 ---\n",
      "Expected: 0 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 43 years old, which is less than 50 years. The heart rate is 103 bpm, which is greater than 100 bpm. The oxygen saturation is 93%, which is less than 95%. The patient has hemoptysis, as she coughed up blood. She has a history of estrogen use due to her recent mastectomy. She has no prior VTE. She has unilateral leg swelling in the left lower extremity. The patient meets 4 out of 7 criteria for the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 111 ---\n",
      "Expected: 0 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 28 years old, which is less than 50 years. The heart rate is 138 bpm, which is greater than 100 bpm. The oxygen saturation is 86%, which is less than 95%. There is no mention of hemoptysis. There is no mention of estrogen use. The patient has a history of venous thromboembolism (VTE) as evidenced by the deep vein thrombosis (DVT) in the right lower extremity. There is no mention of unilateral leg swelling. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 112 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 75 years old, which is above 50, so criterion 1 is false. The heart rate is 86 bpm, which is below 100, so criterion 2 is true. The oxygen saturation is 92.2%, which is below 95%, so criterion 3 is false. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age and oxygen saturation are the only false criteria, so the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 113 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 59 years old, which is above the age threshold. His heart rate is 85 bpm, which is below the threshold. His oxygen saturation is 98%, which is above the threshold. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, all criteria except age are met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 114 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 65 years old, which is greater than 50 years. His heart rate is 88 bpm, which is less than 100 bpm. His oxygen saturation is 99%, which is greater than or equal to 95%. He has unilateral leg swelling, which is a criterion for pulmonary embolism. He has no history of estrogen use or prior VTE. He denies hemoptysis. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 115 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 56 years old, which is above the age of 50. Heart rate is 130 bpm, which is above 100 bpm. Oxygen saturation is 91%, which is below 95%. The patient has hemoptysis, estrogen use is not mentioned, no prior VTE is mentioned, and no unilateral leg swelling is mentioned. Therefore, the PERC score is 4.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 116 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 28 years old, which is less than 50 years. The heart rate is 89 bpm, which is less than 100 bpm. The oxygen saturation is 94%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 117 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 18 years old, which is less than 50 years. Her heart rate is 89 bpm, which is less than 100 bpm. Her oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, all criteria are met except for the age criterion, which is not applicable in this case. The PERC score is 0, indicating a low risk of pulmonary embolism.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 118 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 36 years old, which is less than 50 years. The heart rate is 110 bpm, which is greater than 100 bpm. The oxygen saturation is 96%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, or prior VTE. The patient does not have unilateral leg swelling. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 119 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 73 years old, which is above the age of 50. The heart rate is 67 bpm, which is less than 100 bpm. Oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, or prior VTE. However, the patient has bilateral pedal edema, which indicates unilateral leg swelling is not met. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 120 ---\n",
      "Expected: 4 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 75 years old, which is above the age of 50. The heart rate is 105 bpm, which is above 100 bpm. The oxygen saturation is 98%, which is above 95%. There is no mention of hemoptysis. The patient is on long-term steroids, which is a form of estrogen use. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient has chest pain, which is a symptom of pulmonary embolism, but it is not explicitly mentioned as unilateral leg swelling. Therefore, the criterion is considered not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 121 ---\n",
      "Expected: 4 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 17 years old, which is less than 50 years. The heart rate is 125 bpm, which is greater than 100 bpm. The oxygen saturation is 97%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient has a history of estrogen use, as she was on oral contraceptives. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient has a history of intermittent oligomenorrhea and amenorrhea, but no mention of hemoptysis or unilateral leg swelling. The patient's heart rate is elevated, and she has a history of estrogen use, which are the two criteria not met. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 122 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 69 years old, which is above the age of 50. The heart rate is 105 bpm, which is above 100 bpm. The oxygen saturation is 92%, which is below 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, these criteria are considered not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 123 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 26 years old, which meets the age criterion. The heart rate is 112 bpm, which does not meet the heart rate criterion. The oxygen saturation is 94%, which does not meet the oxygen saturation criterion. There is no mention of hemoptysis, so this criterion is met. There is no mention of estrogen use, so this criterion is met. There is no mention of prior VTE, so this criterion is met. There is no mention of unilateral leg swelling, so this criterion is met. The patient's age is less than 50 years, which meets the age criterion. The patient's heart rate is greater than 100 bpm, which does not meet the heart rate criterion. The patient's oxygen saturation is less than 95%, which does not meet the oxygen saturation criterion. The patient has no hemoptysis, which meets the hemoptysis criterion. The patient has no estrogen use, which meets the estrogen use criterion. The patient has no prior VTE, which meets the prior VTE criterion. The patient has no unilateral leg swelling, which meets the unilateral leg swelling criterion.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 124 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 35 years old, which is less than 50 years. Her heart rate is 83/min, which is less than 100 bpm. Her oxygen saturation is 100%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, all criteria are met, and the PERC score is 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 125 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 71 years old, which is above the age of 50. The heart rate is 109 bpm, which is above 100 bpm. Oxygen saturation is 100%, which is above 95%. There is no mention of hemoptysis. There is no mention of estrogen use. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient has difficulty walking and weakness in both lower extremities, which could be indicative of bilateral leg swelling, but it is not explicitly stated as unilateral leg swelling. Therefore, the criterion is considered not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 126 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 45 years old, which is less than 50 years. The heart rate is 96 bpm, which is greater than 100 bpm. The oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, these criteria are considered not met. The patient's age and oxygen saturation meet the criteria, while the heart rate does not meet the criteria. The other criteria are not mentioned in the patient's history, so they are considered not met by default.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 127 ---\n",
      "Expected: 4 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 62 years old, which is greater than 50 years. Her heart rate is 90 bpm, which is less than 100 bpm. Her oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis. There is no mention of estrogen use. She has a history of myocardial infarction, which is a risk factor for VTE. She has unilateral leg swelling as noted in the figure. She has a history of falling recently, which may be a risk factor for VTE. The patient's age and unilateral leg swelling contribute to the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 128 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 65 years old, which is greater than 50 years. The heart rate is 110 bpm, which is greater than 100 bpm. The oxygen saturation is 85%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. Therefore, the patient meets 4 out of 7 criteria for the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 129 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 33 years old, which is less than 50 years, so criterion 1 is met. The heart rate is 114 bpm, which is greater than 100 bpm, so criterion 2 is not met. The oxygen saturation is 99%, which is greater than or equal to 95%, so criterion 3 is met. The patient has hemoptysis, so criterion 4 is not met. The patient has no history of estrogen use, so criterion 5 is met. The patient has a history of venous thromboembolism (VTE), so criterion 6 is not met. The patient has no unilateral leg swelling, so criterion 7 is met. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 130 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 34 years old, which is less than 50 years. The heart rate is 153 bpm, which is greater than 100 bpm. The oxygen saturation is 96%, which is greater than or equal to 95%. The patient has hemoptysis, which is a criterion not met. The patient does not use estrogen. The patient has no prior VTE. The patient does not have unilateral leg swelling. The patient meets 4 out of 7 criteria, resulting in a PERC score of 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 131 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 26 years old, which is less than 50 years. The heart rate is 120 bpm, which is greater than 100 bpm. The oxygen saturation is 99% with 5 L of oxygen, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient is pregnant, which implies estrogen use. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient is currently receiving thromboprophylaxis, which implies a risk of VTE. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 132 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 62 years old, so criterion 1 is not met. The heart rate is 92 bpm, so criterion 2 is met. Oxygen saturation is 99%, so criterion 3 is met. There is no mention of hemoptysis, so criterion 4 is met. There is no mention of estrogen use, so criterion 5 is met. There is no mention of prior VTE, so criterion 6 is met. There is no mention of unilateral leg swelling, so criterion 7 is met. The patient's age is the only criterion not met, so the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 133 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 74 years old, which is above 50, so criterion 1 is false. The heart rate is 120 bpm, which is above 100, so criterion 2 is false. The oxygen saturation is 96%, which is above 95%, so criterion 3 is true. There is no hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no prior VTE, so criterion 6 is true. There is no unilateral leg swelling, so criterion 7 is true. The patient has a total of 2 false criteria, so the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 134 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 57 years old, so criterion 1 is false. The heart rate is 90 bpm, so criterion 2 is true. The oxygen saturation is 98%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age is the only criterion that is not met, so the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 135 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 57 years old, which is above 50, so criterion 1 is false. Heart rate is above 100 bpm, so criterion 2 is false. Oxygen saturation is 98%, which is above 95%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 136 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 66 years old, which is above the age of 50. The heart rate is 124 bpm, which is above 100 bpm. The oxygen saturation is 86%, which is below 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, the patient meets 4 out of the 7 criteria for the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 137 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 72 years old, which is greater than 50 years. The heart rate is 92 bpm, which is less than 100 bpm. The oxygen saturation is 92%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient note. Therefore, these criteria are considered not met. The patient's age and oxygen saturation are the only criteria that are not met, resulting in a PERC score of 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 138 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 78 years old, which is above 50 years. Heart rate is 77 bpm, which is less than 100 bpm. Oxygen saturation is above 97%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient is on Tamoxifen, which is an estrogen. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient's age and estrogen use contribute to the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 139 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 21 years old, which meets the age criterion. The heart rate is 180 bpm, which does not meet the heart rate criterion. The oxygen saturation is 91%, which does not meet the oxygen saturation criterion. The patient has hemoptysis, which does not meet the hemoptysis criterion. There is no mention of estrogen use, so this criterion is met. The patient has a history of chronic graft-versus-host disease, which does not meet the prior VTE criterion. There is no mention of unilateral leg swelling, so this criterion is met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 140 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 85 years old, which is greater than 50 years. Heart rate is 96 bpm, which is greater than 100 bpm. Oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient is on dabigatran, which is an anticoagulant, so estrogen use is not applicable. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient has a history of atrial fibrillation and recent pacemaker insertion, which may indicate a higher risk for VTE, but no specific history of VTE is mentioned.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 141 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 56 years old, which is above 50, so criterion 1 is false. Heart rate is 96 bpm, which is below 100 bpm, so criterion 2 is true. Oxygen saturation is 98%, which is above 95%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 142 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 55 years old, so criterion 1 is false. The heart rate is 110 bpm, so criterion 2 is false. The oxygen saturation is 98%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age and heart rate are above the threshold, but the other criteria are met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 143 ---\n",
      "Expected: 5 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 9-year-old male with a heart rate of 118 bpm and oxygen saturation of 100%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. The patient's age is less than 50 years, and there is no mention of estrogen use or prior VTE. The patient does not meet the criteria for heart rate < 100 bpm and oxygen saturation ≥ 95%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 144 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 50 years old, so criterion 1 is false. Heart rate is 131 bpm, so criterion 2 is false. Oxygen saturation is 95-99%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age and heart rate are the only false criteria, so the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 145 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 29 years old, which is less than 50 years. The heart rate is 99 bpm, which is less than 100 bpm. Oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. Therefore, all criteria are met, and the PERC score is 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 146 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 57 years old, which is above the age of 50. His heart rate is 100 bpm, which is not less than 100 bpm. His oxygen saturation is 95% while breathing 100% oxygen, which meets the criterion. He has no history of hemoptysis. He has a history of varicose veins and was wearing an elastic bandage, indicating possible estrogen use. He has a family history of pulmonary embolism. He has unilateral leg swelling due to right popliteal vein thrombosis. He has no history of prior VTE, but he has a current diagnosis of pulmonary embolism and right popliteal vein thrombosis, which indicates a history of VTE. Therefore, the criterion is not met. He has unilateral leg swelling due to right popliteal vein thrombosis, which does not meet the criterion.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 147 ---\n",
      "Expected: 4 | Predicted: 5\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 62 years old, which is above 50 years. Her heart rate is 104 bpm, which is above 100 bpm. Her oxygen saturation is 85%, which is below 95%. She has hemoptysis, estrogen use, and prior VTE. She does not have unilateral leg swelling. Therefore, the PERC score is 5.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 5\n",
      "}\n",
      "\n",
      "--- Wrong Reply 148 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 42 years old, which is less than 50 years. The heart rate is 132 bpm, which is greater than 100 bpm. Oxygen saturation is 100%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient used a contraceptive vaginal ring, which is a form of estrogen use. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient's age is less than 50 years, but the other criteria are not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 149 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 34 years old, which is less than 50 years. Her heart rate is 110 bpm, which is greater than 100 bpm. Her oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's note. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 150 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 63 years old, which is above the age of 50. Heart rate is 90 bpm, which is less than 100 bpm. Oxygen saturation is 94%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, these criteria are considered not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 151 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 77 years old, which is above the age of 50. The heart rate is 92 bpm, which is below 100 bpm. The oxygen saturation is 99%, which is above 95%. The patient has a history of deep vein thrombosis, which is a prior VTE. The patient is experiencing right lower leg cramping, which could be indicative of unilateral leg swelling. The patient does not have hemoptysis or estrogen use mentioned in the note. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 152 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 66 years old, which is above the age of 50. His heart rate is 83 bpm, which is less than 100 bpm. His oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, these criteria are considered not met. The patient's age is the only criterion that is not met, resulting in a score of 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 153 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 40 years old, which is less than 50 years. The heart rate is 90 bpm, which is less than 100 bpm. Oxygen saturation is 96%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. Therefore, all criteria are met, resulting in a PERC score of 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 154 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 67 years old, which is greater than 50 years. His heart rate is 90 bpm, which is less than 100 bpm. His oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, or prior VTE. However, he has bilateral lower extremity pitting edema, which indicates unilateral leg swelling is not applicable. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 155 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 25 years old, which meets the age criterion. The heart rate is 142 bpm, which does not meet the heart rate criterion. The oxygen saturation is 86-88%, which does not meet the oxygen saturation criterion. There is no mention of hemoptysis, so this criterion is met. The patient is pregnant, which means she is likely using estrogen, so this criterion is not met. There is no mention of prior VTE, so this criterion is met. There is no mention of unilateral leg swelling, so this criterion is met. The patient is a female, which does not meet the gender criterion. The patient has a history of gestational thrombocytopenia, which does not meet the prior VTE criterion.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 156 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 73 years old, which is above the age of 50. Her heart rate is 92 bpm, which is below 100 bpm. Her oxygen saturation is 98%, which is above 95%. She has a history of estrogen use due to tamoxifen treatment for breast cancer. She has no hemoptysis, no prior VTE, and no unilateral leg swelling. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 157 ---\n",
      "Expected: 5 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 21 years old, which meets the age criterion. The heart rate is 121 bpm, which does not meet the heart rate criterion. The oxygen saturation is 100%, which meets the oxygen saturation criterion. There is no mention of hemoptysis, so this criterion is met. There is no mention of estrogen use, so this criterion is met. There is no mention of prior VTE, so this criterion is met. There is no mention of unilateral leg swelling, so this criterion is met. The patient's heart rate is the only criterion not met, resulting in a score of 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 158 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 44 years old, which is less than 50 years. Her heart rate is 88 bpm, which is less than 100 bpm. Her oxygen saturation is 92%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 159 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 21 years old, which is less than 50 years. The heart rate is 95 bpm, which is less than 100 bpm. The oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, all criteria are met, and the PERC score is 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 160 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 40 years old, which is less than 50 years. His heart rate is 87 bpm, which is less than 100 bpm. His oxygen saturation is 96% on 6 liters of nasal cannula, which is greater than or equal to 95%. There is no mention of hemoptysis. There is no mention of estrogen use. He has a history of peroneal deep-vein thrombosis, which is a prior VTE. There is no mention of unilateral leg swelling. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 161 ---\n",
      "Expected: 4 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 57 years old, which is above the age of 50. The heart rate is 78 bpm, which is less than 100 bpm. The oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient has a history of hysterectomy, which implies no estrogen use. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient has erythematous tender nodules on bilateral lower extremities, which indicates leg swelling, but it is not unilateral. Therefore, the criterion is not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 162 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 63 years old, which is greater than 50 years. Her heart rate is 92 bpm, which is less than 100 bpm. Her oxygen saturation is 93%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 163 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 64 years old, which is above 50, so criterion 1 is false. His heart rate is 72 bpm, which is less than 100 bpm, so criterion 2 is true. His oxygen saturation is 100%, which is greater than or equal to 95%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. The patient has a history of pulmonary embolism, so criterion 6 is false. There is no mention of estrogen use, so criterion 5 is true. The patient has bilateral mild pitting oedema, so criterion 7 is false. The patient has a history of pulmonary embolism, so criterion 6 is false. The patient's PERC score is 3, indicating a low risk of pulmonary embolism.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 164 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 53 years old, which is above the age threshold. Heart rate is 76 bpm, which is below the threshold. Oxygen saturation is 100%, which is above the threshold. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. Therefore, the patient meets all criteria except for age.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 165 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 55 years old, which is above the age of 50. His heart rate is 119 bpm, which is above 100 bpm. His oxygen saturation is 93%, which is below 95%. He has a history of pulmonary emboli and deep vein thrombosis, indicating prior VTE. He does not have hemoptysis or estrogen use. He does not have unilateral leg swelling. Therefore, the PERC score is 4.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 166 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 22 years old, which is less than 50 years. Her heart rate is 92 bpm, which is less than 100 bpm. Her oxygen saturation is 99%, which is greater than or equal to 95%. She has no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling. Therefore, all criteria are met, resulting in a PERC score of 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 167 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 42 years old, which is less than 50 years. The heart rate is 110-120 bpm, which is greater than 100 bpm. Oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 168 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 65 years old, which is above the age threshold. Heart rate is 155 bpm, which is above the threshold. Oxygen saturation is 70%, which is below the threshold. There is no mention of hemoptysis. The patient has a history of estrogen use (Letrozole/Tamoxifen). The patient has a history of VTE (acute extensive thrombus formation in the superficial femoral vein). There is no mention of unilateral leg swelling. The patient has a history of bilateral leg swelling (right lower extremity swelling).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 169 ---\n",
      "Expected: 6 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 49 years old, so the age criterion is met. The heart rate is 101 bpm, which is above 100 bpm, so this criterion is not met. The oxygen saturation is 89%, which is below 95%, so this criterion is not met. There is no mention of hemoptysis, so this criterion is met. The patient had a prophylactic ovariectomy, which implies estrogen use, so this criterion is not met. There is no mention of prior VTE, so this criterion is met. There is no leg edema, so this criterion is met. The patient has a history of opioid abuse, but this is not relevant to the PERC score. The patient has a history of type 2 diabetes mellitus and stage 1 hypertension, but this is not relevant to the PERC score. The patient smokes 1 pack of cigarettes per day, but this is not relevant to the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 170 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 38 years old, which is less than 50 years. The heart rate is 122 bpm, which is greater than 100 bpm. Oxygen saturation is 88% initially and increased to 94% on 2 liters of nasal oxygen, which is less than 95%. There is no mention of hemoptysis. The patient is on oral estradiol for hormone replacement therapy, which is a form of estrogen use. There is no mention of prior VTE. There is no mention of unilateral leg swelling. Therefore, the PERC score is 4.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 171 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 48 years old, which is less than 50 years. His heart rate is 92 bpm, which is less than 100 bpm. His oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, all criteria are met except for the age criterion, which is false. The PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 172 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 48 years old, which is less than 50 years. The heart rate is 110 bpm, which is greater than 100 bpm. Oxygen saturation is not mentioned in the note. Hemoptysis is not mentioned in the note. Estrogen use is not mentioned in the note. The patient has a history of VTE. Unilateral leg swelling is not mentioned in the note, but bilateral pedal edema is present. Therefore, the PERC score is 4.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": null,\n",
      "    \"No hemoptysis\": null,\n",
      "    \"No estrogen use\": null,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 173 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 64 years old, which is above the age of 50. The heart rate is 94 bpm, which is below 100 bpm. The oxygen saturation is 86%, which is below 95%. There is no mention of hemoptysis. The patient is on anticoagulation for atrial fibrillation, which implies estrogen use. There is a history of VTE. There is bilateral lower extremity edema, not unilateral. The patient does not meet the criteria for age, oxygen saturation, estrogen use, and prior VTE. The patient meets the criteria for heart rate, hemoptysis, and unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 174 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 47 years old, which is less than 50 years. His heart rate is 98 bpm, which is greater than 100 bpm. His oxygen saturation is 97%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, these criteria are considered not met. The patient's age is less than 50 years, so this criterion is met. The patient's heart rate is greater than 100 bpm, so this criterion is not met. The patient's oxygen saturation is less than 95%, so this criterion is not met. The patient has no hemoptysis, estrogen use, prior VTE, or unilateral leg swelling, so these criteria are met. The patient's PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 175 ---\n",
      "Expected: 4 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 81 years old, which is above the age threshold. Her heart rate is 115 bpm, which is above the threshold. Her oxygen saturation is 95%, which meets the threshold. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, these criteria are considered not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 176 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 12 years old, which is less than 50 years. Her heart rate is 96 bpm, which is less than 100 bpm. Her oxygen saturation is 96%, which is greater than or equal to 95%. There is no mention of hemoptysis. There is no mention of estrogen use. There is no mention of prior VTE. There is bilateral leg swelling, not unilateral. The patient has a history of recent travel and hiking, which may be a risk factor for VTE, but it is not explicitly mentioned in the note. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 177 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 69 years old, which is above 50, so criterion 1 is false. The heart rate is 60 bpm in recumbency and 120 bpm in upright position, so criterion 2 is true. Oxygen saturation is 94% in recumbency and 80% in upright position, so criterion 3 is false. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age and oxygen saturation in upright position contribute to the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 178 ---\n",
      "Expected: 2 | Predicted: 5\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 38 years old, which is less than 50 years. The heart rate is 112 bpm, which is greater than 100 bpm. The oxygen saturation is 92%, which is less than 95%. There is no mention of hemoptysis. The patient is using oral contraceptive pills, which is a form of estrogen. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient has a history of endometriosis, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of dyspneic episodes during menstruation, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of PAF, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of right heart enlargement, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of mild pHTN, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of elevated pulmonary vascular resistance, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a significant hemodynamic left-to-right shunt, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a large-sized, right pleural effusion, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a hemorrhagic exudative effusion, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a recurrent catamenial pleural effusion, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a PAPVC, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac CT angiogram, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac MRI, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a left heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a right heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a significant hemodynamic left-to-right shunt, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a Qp:Qs ratio of 3:1, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of mild pHTN, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of elevated pulmonary vascular resistance, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac CT angiogram, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac MRI, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a left heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a right heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a significant hemodynamic left-to-right shunt, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a Qp:Qs ratio of 3:1, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of mild pHTN, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of elevated pulmonary vascular resistance, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac CT angiogram, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac MRI, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a left heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a right heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a significant hemodynamic left-to-right shunt, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a Qp:Qs ratio of 3:1, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of mild pHTN, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of elevated pulmonary vascular resistance, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac CT angiogram, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac MRI, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a left heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a right heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a significant hemodynamic left-to-right shunt, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a Qp:Qs ratio of 3:1, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of mild pHTN, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of elevated pulmonary vascular resistance, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac CT angiogram, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a cardiac MRI, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a left heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a right heart catheterization, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a significant hemodynamic left-to-right shunt, which may be related to the recurrent catamenial pleural effusions, but it is not a direct indication of VTE. The patient has a history of a Qp:Qs ratio of 3:1, which may be related to the recurrent catamenial pleural effusions\n",
      "\n",
      "--- Wrong Reply 179 ---\n",
      "Expected: 0 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 56 years old, which is above 50, so criterion 1 is false. The heart rate is 120 bpm, which is above 100, so criterion 2 is false. The oxygen saturation is 85%, which is below 95%, so criterion 3 is false. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. The patient had a recent surgery, which increases the risk of VTE, so criterion 6 is false. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age, heart rate, and oxygen saturation are all above the threshold, and he had a recent surgery, which increases the risk of VTE. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 180 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 43 years old, which is less than 50 years. The heart rate is 210-230 bpm, which is greater than 100 bpm. The oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 181 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 26 years old, which is less than 50 years. The heart rate is 120 bpm, which is greater than 100 bpm. The oxygen saturation is 85% at room air and 90% with 100% oxygen, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 182 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 57 years old, so criterion 1 is false. Heart rate is 95 bpm, so criterion 2 is false. Oxygen saturation is 96%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. The patient has a history of atrial fibrillation and is on warfarin, so criterion 6 is false. There is trace pitting edema noted bilaterally, so criterion 7 is false. The patient's PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 183 ---\n",
      "Expected: 0 | Predicted: 5\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 56 years old, which is above 50, so criterion 1 is false. The heart rate is 84 bpm, which is less than 100 bpm, so criterion 2 is true. The oxygen saturation is 91%, which is less than 95%, so criterion 3 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has no mention of estrogen use, so criterion 5 is true. The patient has no mention of unilateral leg swelling, so criterion 7 is true. The patient has no mention of hemoptysis, so criterion 4 is true. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in the right jugular vein, which indicates prior VTE, so criterion 6 is false. The patient has a thrombus in\n",
      "\n",
      "--- Wrong Reply 184 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 32 years old, which is less than 50 years. The heart rate is 126 bpm, which is greater than 100 bpm. The oxygen saturation is 95%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient is not taking oral contraceptives, so there is no estrogen use. There is no prior VTE mentioned. There is no unilateral leg swelling noted. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 185 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 59 years old, which is above the age of 50. The heart rate is 93 bpm, which is below 100 bpm. Oxygen saturation is 99%, which is above 95%. There is no mention of hemoptysis. The patient is not using estrogen. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient's PERC score is 1, indicating a low risk of pulmonary embolism.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 186 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 20 years old, which meets the age criterion. The heart rate is 140 bpm, which does not meet the heart rate criterion. The oxygen saturation is 90%, which does not meet the oxygen saturation criterion. There is no mention of hemoptysis, so this criterion is met. There is no mention of estrogen use, so this criterion is met. There is no mention of prior VTE, so this criterion is met. There is no mention of unilateral leg swelling, so this criterion is met. The patient is a primigravida, which may indicate potential estrogen use, but it is not explicitly stated, so this criterion is met. The patient's symptoms developed after receiving an iron infusion, which may be related to an allergic reaction rather than a pulmonary embolism, but this is not explicitly stated, so this criterion is met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 187 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 44 years old, which is less than 50 years. His heart rate is 88 bpm, which is less than 100 bpm. His oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history or physical examination. Therefore, all criteria are met, resulting in a PERC score of 0.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 188 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 39 years old, which is less than 50 years. The heart rate is 101 bpm, which is greater than 100 bpm. The oxygen saturation is 99%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history or physical examination. Therefore, these criteria are considered not met. The patient's age is less than 50 years, so this criterion is met. The heart rate is greater than 100 bpm, so this criterion is not met. The oxygen saturation is greater than or equal to 95%, so this criterion is met. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling, so these criteria are considered not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 189 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 40 years old, which is less than 50, so criterion 1 is met. The heart rate is 100 bpm, which is not less than 100 bpm, so criterion 2 is not met. The oxygen saturation is 78% in room air, which is less than 95%, so criterion 3 is not met. There is no mention of hemoptysis, so criterion 4 is met. There is no mention of estrogen use, so criterion 5 is met. There is no mention of prior VTE, so criterion 6 is met. There is bilateral leg swelling, so criterion 7 is not met. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 190 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 29 years old, which is less than 50 years. The heart rate is 97 bpm, which is less than 100 bpm. The oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, all criteria are met except for the heart rate criterion, which is not met. The PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 191 ---\n",
      "Expected: 1 | Predicted: None\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 27 years old, which is less than 50 years. The heart rate is between 75-90 bpm, which is less than 100 bpm. The oxygen saturation is 97%, which is greater than or equal to 95%. The patient denies hemoptysis. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies prior VTE. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has a history of endometriosis and has undergone endometrial cyst removal and paracentesis, which indicates estrogen use. The patient denies unilateral leg swelling. The patient has\n",
      "\n",
      "--- Wrong Reply 192 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 29 years old, which meets the age criterion. The heart rate is 100 bpm, which does not meet the heart rate criterion. The oxygen saturation is 95%, which meets the oxygen saturation criterion. There is no mention of hemoptysis, so this criterion is met. There is no mention of estrogen use, so this criterion is met. The patient has a history of a right tibia-fibula fracture with intra-medullary nailing, but no prior VTE, so this criterion is met. There is no mention of unilateral leg swelling, so this criterion is met. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 193 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 69 years old, which is above the age of 50. The heart rate is 114/min, which is above 100 bpm. Oxygen saturation is 96%, which is above 95%. There is no mention of hemoptysis. The patient is using estrogen (raloxifene). There is no mention of prior VTE. The patient has bilateral pitting lower extremity edema, which is not unilateral leg swelling. Therefore, the PERC score is 4.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 194 ---\n",
      "Expected: 5 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 43 years old, which is less than 50 years. The heart rate is 79 bpm, which is less than 100 bpm. The oxygen saturation is 96%, which is greater than or equal to 95%. The patient has hemoptysis, so this criterion is not met. The patient has a history of HIV/AIDS and is not on estrogen therapy, so this criterion is met. The patient has no history of prior VTE. The patient has no unilateral leg swelling. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 195 ---\n",
      "Expected: 1 | Predicted: None\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 70 years old, which is above 50 years. The heart rate is 110 bpm, which is above 100 bpm. The oxygen saturation is 97% initially, which is above 95%. There is no mention of hemoptysis. There is no mention of estrogen use. There is no prior VTE. There is no unilateral leg swelling mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenocarcinoma, which may increase the risk of VTE, but no prior VTE is mentioned. The patient has a history of recent surgery and a diagnosis of endometrial adenoc\n",
      "\n",
      "--- Wrong Reply 196 ---\n",
      "Expected: 1 | Predicted: None\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 29 years old, which is less than 50 years. The heart rate is over 110 bpm, which is greater than 100 bpm. The oxygen saturation is 93%, which is less than 95%. The patient denies hemoptysis. There is no mention of estrogen use. The patient has no history of prior VTE. There is no mention of unilateral leg swelling. The patient has a history of smoking and poor blood glucose control, but these are not part of the PERC criteria. The patient has a high D-dimer value, which is not part of the PERC criteria but is a risk factor for PE. The patient has a history of N2O addiction and peripheral neuropathy, which are not part of the PERC criteria. The patient has a history of anxiety, which is not part of the PERC criteria. The patient has a history of abnormal liver biochemistry and hyperlipidemia, which are not part of the PERC criteria. The patient has a history of high Vit B12 levels, which is not part of the PERC criteria. The patient has a history of normal folate levels, which is not part of the PERC criteria. The patient has a history of normal protein S, protein C, anti-thrombin III antibody, anti-cardiolipin antibody, lupus anticoagulant, and other autoantibodies, which are not part of the PERC criteria. The patient has a history of normal clotting profile, which is not part of the PERC criteria. The patient has a history of thrombophilia screening, which is not part of the PERC criteria. The patient has a history of high BNP and CTnI levels, which are not part of the PERC criteria. The patient has a history of sinus tachycardia, which is not part of the PERC criteria. The patient has a history of right ventricular enlargement, which is not part of the PERC criteria. The patient has a history of pulmonary artery occlusion, which is not part of the PERC criteria. The patient has a history of increased right heart load, which is not part of the PERC criteria. The patient has a history of femoral, popliteal, and calf muscular venous thrombosis, which is not part of the PERC criteria. The patient has a history of pulmonary artery trunk, lobar artery, and arterial branches occlusion, which is not part of the PERC criteria. The patient has a history of right extremity venous thrombosis, which is not part of the PERC criteria. The patient has a history of arterial blood gas levels, which are not part of the PERC criteria. The patient has a history of ECG changes, which are not part of the PERC criteria. The patient has a history of ultrasonic cardiogram, which is not part of the PERC criteria. The patient has a history of CTPA, which is not part of the PERC criteria. The patient has a history of right ventricular compression, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of SIQIIITIII, which is not part of the PERC criteria. The patient has a history of S wave in the aVL lead, which is not part of the PERC criteria. The patient has a history of Q wave and T wave in the III lead, which is not part of the PERC criteria. The patient has a history of sinus tachycardia, which is not part of the PERC criteria. The patient has a history of right ventricular enlargement, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of pulmonary artery trunk, lobar artery, and arterial branches occlusion, which is not part of the PERC criteria. The patient has a history of increased right heart load, which is not part of the PERC criteria. The patient has a history of femoral, popliteal, and calf muscular venous thrombosis, which is not part of the PERC criteria. The patient has a history of right extremity venous thrombosis, which is not part of the PERC criteria. The patient has a history of arterial blood gas levels, which are not part of the PERC criteria. The patient has a history of ECG changes, which are not part of the PERC criteria. The patient has a history of ultrasonic cardiogram, which is not part of the PERC criteria. The patient has a history of CTPA, which is not part of the PERC criteria. The patient has a history of right ventricular compression, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of SIQIIITIII, which is not part of the PERC criteria. The patient has a history of S wave in the aVL lead, which is not part of the PERC criteria. The patient has a history of Q wave and T wave in the III lead, which is not part of the PERC criteria. The patient has a history of sinus tachycardia, which is not part of the PERC criteria. The patient has a history of right ventricular enlargement, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of pulmonary artery trunk, lobar artery, and arterial branches occlusion, which is not part of the PERC criteria. The patient has a history of increased right heart load, which is not part of the PERC criteria. The patient has a history of femoral, popliteal, and calf muscular venous thrombosis, which is not part of the PERC criteria. The patient has a history of right extremity venous thrombosis, which is not part of the PERC criteria. The patient has a history of arterial blood gas levels, which are not part of the PERC criteria. The patient has a history of ECG changes, which are not part of the PERC criteria. The patient has a history of ultrasonic cardiogram, which is not part of the PERC criteria. The patient has a history of CTPA, which is not part of the PERC criteria. The patient has a history of right ventricular compression, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of SIQIIITIII, which is not part of the PERC criteria. The patient has a history of S wave in the aVL lead, which is not part of the PERC criteria. The patient has a history of Q wave and T wave in the III lead, which is not part of the PERC criteria. The patient has a history of sinus tachycardia, which is not part of the PERC criteria. The patient has a history of right ventricular enlargement, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of pulmonary artery trunk, lobar artery, and arterial branches occlusion, which is not part of the PERC criteria. The patient has a history of increased right heart load, which is not part of the PERC criteria. The patient has a history of femoral, popliteal, and calf muscular venous thrombosis, which is not part of the PERC criteria. The patient has a history of right extremity venous thrombosis, which is not part of the PERC criteria. The patient has a history of arterial blood gas levels, which are not part of the PERC criteria. The patient has a history of ECG changes, which are not part of the PERC criteria. The patient has a history of ultrasonic cardiogram, which is not part of the PERC criteria. The patient has a history of CTPA, which is not part of the PERC criteria. The patient has a history of right ventricular compression, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of SIQIIITIII, which is not part of the PERC criteria. The patient has a history of S wave in the aVL lead, which is not part of the PERC criteria. The patient has a history of Q wave and T wave in the III lead, which is not part of the PERC criteria. The patient has a history of sinus tachycardia, which is not part of the PERC criteria. The patient has a history of right ventricular enlargement, which is not part of the PERC criteria. The patient has a history of left ventricular compression, which is not part of the PERC criteria. The patient has a history of pulmonary artery trunk, lobar artery, and arterial branches occlusion, which is not part of the PERC criteria. The patient has a history of increased right heart load, which is not part of the PERC criteria. The patient has a history of femoral, popliteal, and calf muscular venous thrombosis, which is not part of the PERC criteria. The patient has a history of right extrem\n",
      "\n",
      "--- Wrong Reply 197 ---\n",
      "Expected: 4 | Predicted: None\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 85 years old, which is above 50 years. The heart rate is 80 bpm, which is less than 100 bpm. The oxygen saturation is 99%, which is greater than or equal to 95%. The patient has hemoptysis, which is a criterion not met. The patient has no history of estrogen use, which is a criterion met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met. The patient has a history of hemoptysis, which is a criterion not met. The patient has no prior VTE, which is a criterion met. The patient has no unilateral leg swelling, which is a criterion met\n",
      "\n",
      "--- Wrong Reply 198 ---\n",
      "Expected: 2 | Predicted: 5\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 73 years old, which is above 50, so criterion 1 is false. The heart rate is 72 bpm, which is less than 100 bpm, so criterion 2 is true. The oxygen saturation is 94%, which is less than 95%, so criterion 3 is false. There is no mention of hemoptysis, so criterion 4 is true. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. There is no mention of estrogen use, so criterion 5 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of lower limb venous insufficiency, which is a prior VTE, so criterion 6 is false. The patient has a history of\n",
      "\n",
      "--- Wrong Reply 199 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 28-year-old man with a history of recurrent cough, yellow-phlegm, and fever for more than 10 months. He was diagnosed with pulmonary tuberculosis and pulmonary infection. He was admitted with symptoms of chest tightness, chest pain, and shortness of breath after increased activity. The patient's physical examination and test results were evaluated against the PERC criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 200 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 35-year-old female with a history of coronary artery disease, uncontrolled diabetes mellitus type 2, obesity, deep vein thrombosis, dyslipidemia, gastroesophageal reflux, headaches, and hypertension. She presented with chest pain and dyspnea, and her symptoms worsened with inhalation. The patient has a history of smoking but is currently a former smoker. She uses caffeine daily and denies alcohol or recreational drug use. The patient's medical history and symptoms do not meet the criteria for a low PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 201 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 15-year-old female with a history of osteogenesis imperfecta (OI) type I, recurrent fractures, and previous surgeries under general anesthesia. The patient has a short stature, blue sclera, fragile bones, progressive hearing loss, and kyphoscoliosis. The patient's blood pressure is 130/80 mmHg, heart rate is 80 beats/min, and oxygen saturation is 98% on room air. The patient has a mildly restrictive lung disease and a Mallampatti Class III airway. The patient underwent spinal anesthesia for the surgery, and the operation lasted for 1 hour and 45 minutes with no significant variation in vitals and an uneventful recovery.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 202 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 43-year-old woman with severe central chest pain, mild shortness of breath, and one episode of coughing up blood. She has a history of invasive ductal carcinoma and a recent left modified radical mastectomy. The patient's vital signs show a heart rate of 103/min, oxygen saturation of 93%, and no abnormalities in the cardiac examination. The left lower extremity is swollen and erythematous. The chest x-ray shows no abnormalities. The patient's arterial blood gas analysis shows a pH of 7.49, PCO2 of 29 mm Hg, PO2 of 69 mm Hg, and HCO3- of 22 mEq/L. The patient's laboratory studies show a normal complete blood count, creatinine of 1.0 mg/dL, and a creatinine clearance of 81 mL/min.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 203 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 63-year-old Caucasian male, which means he does not meet the first criterion (Age < 50). His heart rate was 120 bpm, which is higher than 100 bpm, so he does not meet the second criterion (HR < 100). The patient was hypoxic with oxygen saturation at 88% on room air, which is lower than 95%, so he does not meet the third criterion (O₂ ≥ 95%). The patient did not have hemoptysis, so he meets the fourth criterion (No hemoptysis). There is no mention of estrogen use, so we assume he meets the fifth criterion (No estrogen use). The patient did not have a prior history of venous thromboembolism (VTE), so he meets the sixth criterion (No prior VTE). The patient did not have unilateral leg swelling, so he meets the seventh criterion (No unilateral leg swelling).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 204 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 46-year-old female with a history of unspecified arthritis who presented with substernal chest pain and right leg numbness. The following criteria were evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 205 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 59-year-old Hispanic male with a history of headache and fever. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 59 years old, so this criterion is not met (false).\n",
      "2. HR < 100: The patient's heart rate is 75 beats/minute, which is less than 100 bpm, so this criterion is met (true).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 95% on ambient air, so this criterion is met (true).\n",
      "4. No hemoptysis: The patient denies any hemoptysis, so this criterion is met (true).\n",
      "5. No estrogen use: The patient denies estrogen use, so this criterion is met (true).\n",
      "6. No prior VTE: The patient has no history of venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: The patient has no unilateral leg swelling, so this criterion is met (true).\n",
      "\n",
      "The PERC score for this patient is 1, as only the \"Age < 50\" criterion is not met.\n",
      "\n",
      "--- Wrong Reply 206 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 32-year-old female who tested positive for SARS-CoV-2 nucleic acid. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 32 years old, which is less than 50, so this criterion is true.\n",
      "2. HR < 100: The patient's pulse is 90 beats per minute, which is less than 100, so this criterion is true.\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 98% while breathing ambient air, which is greater than or equal to 95%, so this criterion is true.\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's symptoms, so this criterion is true.\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is true.\n",
      "6. No prior VTE: There is no mention of prior venous thromboembolism in the patient's history, so this criterion is true.\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's symptoms, so this criterion is true.\n",
      "\n",
      "Since all 7 criteria are true, the PERC score is 0.\n",
      "\n",
      "--- Wrong Reply 207 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 65-year-old man with bilateral flank pain, weight loss, and a history of prostate cancer. The PERC score is calculated based on the following criteria:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 65 years old, so this criterion is not met (false).\n",
      "2. HR < 100: The patient's heart rate is 75 bpm, which is less than 100 bpm, so this criterion is met (true).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 95% on room air, so this criterion is met (true).\n",
      "4. No hemoptysis: The patient did not report any hemoptysis, so this criterion is met (true).\n",
      "5. No estrogen use: The patient has no history of estrogen use, so this criterion is met (true).\n",
      "6. No prior VTE: The patient has no history of venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: The patient did not report any unilateral leg swelling, so this criterion is met (true).\n",
      "\n",
      "The PERC score is calculated by adding up the false values. In this case, there is only one false value (Age < 50), so the PERC score is 1.\n",
      "\n",
      "--- Wrong Reply 208 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 55-year-old man with severe, migrating anterior chest pain, shortness of breath, and sweating at rest. He has a history of hypertension, hypercholesterolemia, and type 2 diabetes mellitus. He is a heavy smoker. His vital signs show tachycardia, tachypnea, and normal oxygen saturation. A diastolic murmur is heard over the right sternal border, and femoral pulses are decreased bilaterally. The ECG shows sinus tachycardia and left ventricular hypertrophy. Based on these findings, the PERC score is calculated as follows:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 209 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 37-year-old female with a history of migraine and hypertension, presenting with chest pressure and dyspnea on exertion. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 37 years old, so this criterion is met (true).\n",
      "2. HR < 100: The patient's pulse is 85 bpm, so this criterion is met (true).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 98%, so this criterion is met (true).\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's history or physical exam, so this criterion is met (true).\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's medication list, so this criterion is met (true).\n",
      "6. No prior VTE: There is no mention of prior VTE in the patient's history, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's physical exam, so this criterion is met (true).\n",
      "\n",
      "Since all 7 criteria are met, the PERC score is 0.\n",
      "\n",
      "--- Wrong Reply 210 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 65-year-old man who underwent a Whipple procedure for pancreatic cancer. He has shortness of breath, fever, tachycardia, tachypnea, and hypotension. His oxygen saturation is 85% on room air, and he has diffuse bilateral crackles on lung auscultation. The patient's age is greater than 50 years, heart rate is greater than 100 bpm, oxygen saturation is less than 95%, and he has hemoptysis (diffuse bilateral crackles). He is not on estrogen, has no prior VTE, and no unilateral leg swelling. The patient's PERC score is calculated based on these criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 211 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 56-year-old man with pleuritic chest pain, hemoptysis, and a history of siphoning gasoline. His vital signs show tachypnea, tachycardia, and hypoxia. The chest radiograph and CT scan reveal right middle and lower lobe infiltrates and a right infrahilar mass. The patient was intubated and required mechanical ventilation. Sputum and blood cultures were negative. A thoracentesis was performed, and pleural fluid analysis was exudative with a negative gram stain and culture. Bronchoscopy showed friable mucosa and purulent fluid in the right middle and lower lobes. The patient underwent thoracotomy with right middle lobe resection, and surgical pathology confirmed necrotizing lipoid pneumonia with abscess formation. The patient also suffered an acute cerebellar stroke during his hospitalization.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 212 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 60-year-old man with shortness of breath, cough, and fever. He recently returned from international travel and has a past medical history of an ST-elevation myocardial infarction. His vital signs show a temperature of 102°F, blood pressure of 187/108 mmHg, pulse of 120/min, respirations of 17/min, and oxygen saturation of 93% on room air. A chest radiograph reveals bilateral pleural effusions, and pleurocentesis shows a protein ratio of 0.8, lactate dehydrogenase ratio of 0.75, glucose of 25 mg/dL, and lymphocytic leukocytosis of the pleural fluid.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 213 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 73-year-old female with a history of hypertension, diabetes mellitus, and recent immunosuppressive therapy for myasthenic crisis. She presented with a paroxysmal dry cough and was found to have a pulmonary cryptococcal infection. Here's how each criterion applies to her case:\n",
      "\n",
      "1. Age < 50 years: False (the patient is 73 years old)\n",
      "2. Heart rate < 100 bpm: True (heart rate is 80 beats/min)\n",
      "3. Oxygen saturation ≥ 95%: True (oxygen saturation is 99%)\n",
      "4. No hemoptysis: True (no mention of hemoptysis in the patient's history)\n",
      "5. No estrogen use: True (no mention of estrogen use in the patient's history)\n",
      "6. No prior venous thromboembolism (VTE): True (no mention of prior VTE in the patient's history)\n",
      "7. No unilateral leg swelling: True (no mention of unilateral leg swelling in the patient's history)\n",
      "\n",
      "The patient meets 6 out of 7 criteria, which means only 1 criterion is false (age < 50 years). Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 214 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 75-year-old female with a history of chronic kidney disease, polymyalgia rheumatica, asthma, and chronic back pain. She presented with dyspnoea and was diagnosed with pneumonia and S. aureus bacteraemia. The patient was treated with intravenous piperacillin-tazobactam and later switched to flucloxacillin. She developed nausea and worsening renal function associated with HAGMA, which was attributed to AKI. The patient was investigated for AKI and HAGMA, and it was suspected to be caused by the concurrent use of flucloxacillin and paracetamol. The patient was changed to cefazolin and transferred to a tertiary facility for further investigations and suspected pulmonary embolism following reports of chest pain.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 215 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 26-year-old male with a history of severe mycoplasma pneumonia. We will evaluate each criterion based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 216 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 36-year-old male with a gunshot wound to the abdomen who underwent an emergent exploratory laparotomy. He now presents with increased generalized abdominal pain, fever, tachycardia, and physical exam findings suggestive of peritonitis. A CT scan reveals a 4 cm abscess in the left lower quadrant. The PERC score is calculated as follows:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 217 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 71-year-old African American male who presented with elevated liver enzymes after starting atorvastatin and pioglitazone. We will evaluate each PERC criterion based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 218 ---\n",
      "Expected: 2 | Predicted: 7\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 65-year-old man who recently underwent a total hip replacement. He has a history of hypertension and diabetes, and is on aspirin, lisinopril, metformin, and atorvastatin. He presents with pain and swelling in his right leg, which is erythematous and tender to palpation. His vital signs are stable, with a temperature of 99°F, blood pressure of 135/82 mmHg, pulse of 88/minute, and oxygen saturation of 99% O2. He denies chest pain or shortness of breath. A CBC shows a leukocyte count of 6500/mm^3, hemoglobin of 13.0 g/dL, and platelet count of 150,000/mm^3. He is started on anti-coagulation therapy. Seven days later, he returns with crushing substernal chest pain and a new lesion on his right leg. A CBC shows a leukocyte count of 8500/mm^3, hemoglobin of 13.5 g/dL, platelet count of 58,000/mm^3, INR of 2.5, aPTT of 34 seconds, fibrinogen level of 200 mg/dL, and troponin T of 0.2 ng/mL. An ECG shows ST-segment elevation in leads II, III, and aVF. The patient meets the following PERC criteria: age ≥ 50 years, heart rate ≥ 100 bpm, oxygen saturation < 95%, hemoptysis, estrogen use, prior VTE, and unilateral leg swelling. He does not meet the criteria for age < 50 years, heart rate < 100 bpm, oxygen saturation ≥ 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 7\n",
      "}\n",
      "\n",
      "--- Wrong Reply 219 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 27-year-old African American female with a history of stage IV endometriosis, presenting with exertional dyspnea, unintentional weight loss, night sweats, paroxysmal nocturnal dyspnea, and orthopnea. The patient has a history of endometrial cyst removal and paracentesis. The patient's vital signs and laboratory results are provided, along with imaging studies showing a massive right pleural effusion and endometrioma in the pelvis. The patient underwent thoracocentesis, chest tube placement, and video-assisted thoracoscopic surgery (VATS) with diaphragm and pleural biopsy, which revealed chronic inflammation and no malignancy. The patient was discharged on Leuprolide Depot and norethindrone hormonal therapy.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 220 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 55-year-old African American male with a history of hypertension, diabetes, and hyperlipidemia. He was admitted for fever and difficulty breathing, with a diagnosis of possible community-acquired coronavirus. His vital signs and lab results were evaluated against the PERC criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 221 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 71-year-old male with chest pain, difficulty breathing, back pain, and weakness of both lower extremities. The following criteria were evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 222 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 56-year-old man with a history of diabetes mellitus and hypertension. He presented with severe acute central chest pain and was diagnosed with acute ST-segment elevation extensive anterior wall myocardial infarction. The patient was given Streptokinase and later transferred to a tertiary care hospital for further management. The patient underwent CABG with simultaneous repair of VSD and was discharged in stable condition. The PERC score is calculated based on the 7 criteria provided.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 223 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 28-year-old woman who presented with acute onset of substernal chest pain radiating to the left arm and interscapular region. She has no coronary risk factors, no family history of heart disease, and no history of oral contraceptive use. She does not smoke or use alcohol or drugs. The patient's physical examination, chest X-ray, and initial laboratory analyses were within normal limits. However, electrocardiography demonstrated ST-segment elevation and reciprocal ST segment depression, and cardiac catheterization revealed spontaneous dissection of the left anterior descending artery with 80% stenosis. The patient underwent percutaneous transluminal coronary angioplasty with bare-metal stent placement and was discharged with good hemodynamic balance. Follow-up echocardiography revealed normal left ventricular function.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 224 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 69-year-old male with a history of anterior myocardial infarction, pericardial effusion, and cardiac tamponade. Here's how each criterion applies to this patient: 1. Age < 50 years: False (patient is 69 years old). 2. Heart rate < 100 bpm: False (pulse rate is 105 bpm). 3. Oxygen saturation ≥ 95%: True (O2 saturation is 92%, but this criterion is not met). 4. No hemoptysis: True (no mention of hemoptysis in the note). 5. No estrogen use: True (no mention of estrogen use in the note). 6. No prior venous thromboembolism (VTE): True (no mention of prior VTE in the note). 7. No unilateral leg swelling: True (no mention of unilateral leg swelling in the note).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 225 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 62-year-old woman with a history of obesity, hypertension, hyperlipidemia, myocardial infarction, and a 52 pack-year smoking history. She presents with leg pain, swelling, and fatigue. The patient's vital signs are: temperature 99.5°F, blood pressure 177/108 mmHg, pulse 90/min, respirations 17/min, and oxygen saturation 95% on room air. The cardiopulmonary exam reveals mild expiratory wheezes and a murmur along the right sternal border. Inspection of the lower extremities shows unilateral leg swelling (Figure A).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 226 ---\n",
      "Expected: 4 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 45-year-old woman with a history of chronic anemia and abdominal pain. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 45 years old, so this criterion is met (true).\n",
      "2. Heart rate < 100: The patient's heart rate is 96 bpm, so this criterion is met (true).\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation is 98% in room air, so this criterion is met (true).\n",
      "4. No hemoptysis: The patient has no history of hemoptysis, so this criterion is met (true).\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is met (true).\n",
      "6. No prior VTE: The patient has no history of venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history, so this criterion is met (true).\n",
      "\n",
      "Since all 7 criteria are met, the PERC score is 0.\n",
      "\n",
      "--- Wrong Reply 227 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 59-year-old man who presented with sudden-onset vertigo, nausea, and vomiting. His symptoms resolved upon arrival at the emergency department. He has a history of eczema but is otherwise healthy. The physical exam revealed a normal gait, physiologic nystagmus, and an unremarkable cranial nerve exam. The patient's symptoms were exacerbated when his head was turned to the left and he was laid back on the stretcher, but improved after 2 minutes in this position. Based on the provided information, the PERC criteria are evaluated as follows:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 228 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 26-year-old woman who presented with symptoms of COVID-19 and was diagnosed with SARS-CoV-2. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 229 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 33-year-old Caucasian male with a history of intermittent hematemesis, lightheadedness, and dizziness. He has a past medical history of diabetes mellitus type 1, gallstone pancreatitis, and spinal stenosis. He is on multiple medications, including insulin, omeprazole, and tramadol. The patient is a non-smoker, non-alcoholic, and denies illicit drug use. His physical examination shows pallor, tachycardia, and hypotension. Initial investigations reveal severe anemia, elevated blood urea nitrogen, and normal liver enzymes. Upper GI endoscopy and CT scan suggest a large submucosal bulge in the duodenum, gastric outlet obstruction, and a pancreatic pseudocyst. Mesenteric arteriogram shows superior mesenteric vein obstruction and multiple venous varicosities. The patient underwent end-to-side mesocaval anastomosis and was discharged without complications.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 230 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 52-year-old male with chest pain and pressure after a motor vehicle collision. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 52 years old, so this criterion is not met (false).\n",
      "2. HR < 100: The patient's heart rate is 76 bpm, which is less than 100 bpm, so this criterion is met (true).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 97%, which is greater than or equal to 95%, so this criterion is met (true).\n",
      "4. No hemoptysis: The patient has no history of hemoptysis, so this criterion is met (true).\n",
      "5. No estrogen use: The patient is male and has no history of estrogen use, so this criterion is met (true).\n",
      "6. No prior VTE: The patient has no history of venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: The patient has no unilateral leg swelling, so this criterion is met (true).\n",
      "\n",
      "The PERC score for this patient is 1, as only the \"Age < 50\" criterion is not met.\n",
      "\n",
      "--- Wrong Reply 231 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 37-year-old male with dyspnea, fever, chills, and respiratory difficulty. He has a purplish discoloration of the right ankle, but no local heat or tenderness. Initial blood pressure was 163/91 mmHg, pulse rate was 114 beats/min, respiratory rate was 24 breaths/min, and body temperature was 38℃. Oxygen saturation was initially detected as 87%, and increased to 95% upon oxygen supplement via nasal cannula at 5 L/min. The patient has peripheral eosinophilia and thrombocytopenia, with a white blood cell count of 22,580/µL (50% neutrophils, 31% eosinophils, 10% lymphocytes), Hb levels at 13.7 g/dL, and a platelet count of 26,000/µL. D-dimer levels were markedly elevated at 26.69 µg/mL. The patient was diagnosed with ARDS and underwent intubation and mechanical ventilation. Bronchoalveolar lavage revealed marked eosinophilia (93.5% eosinophils). Duplex sonography revealed deep vein thrombosis in the left popliteal, soleal, and peroneal veins. A diagnosis of IHES was reached based on the presence of peripheral and tissue eosinophilia, along with the exclusion of other causes of eosinophilia. High-dose corticosteroid therapy was initiated, and the patient showed clinical and radiological improvements. Pulmonary thromboembolism (PTE) was detected in the bilateral lobar and segmental branches of the pulmonary arteries, and anticoagulant therapy was started.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 232 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 34-year-old male with a history of methamphetamine use, presenting with palpitations, shortness of breath, and hemoptysis. The patient's symptoms and medical history are evaluated against the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 233 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 17-year-old female with a history of weight loss, fatigue, and intermittent oligomenorrhea. The following criteria were evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 234 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 35-year-old woman with Marfan syndrome, which is a genetic disorder that affects the body's connective tissue. She has a history of aortic regurgitation, aortic aneurysm, and dural ectasia. The patient is currently pregnant at 37 weeks gestational age and is scheduled for an elective cesarean section under epidural anesthesia. The PERC score is calculated based on the following criteria:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "Explanation of each criterion:\n",
      "1. Age < 50: The patient is 35 years old, which is less than 50, so this criterion is true.\n",
      "2. Heart rate < 100 bpm: The patient's heart rate is 80/min, which is less than 100 bpm, so this criterion is true.\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation is 100% on room air, which is greater than or equal to 95%, so this criterion is true.\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's history or current symptoms, so this criterion is true.\n",
      "5. No estrogen use: The patient is not taking estrogen, as her medications include verapamil, atenolol, warfarin, labetalol, and enoxaparin, but no estrogen, so this criterion is true.\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's history, so this criterion is true.\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history or current symptoms, so this criterion is true.\n",
      "\n",
      "Since all criteria are true, the PERC score is 0.\n",
      "\n",
      "--- Wrong Reply 235 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 74-year-old male smoker with a history of chronic bronchitis predominant chronic obstructive pulmonary disease (COPD). He presented with progressively increasing shortness of breath, cough, white, mucoid expectoration, and retrosternal and right sided parasternal, oppressive chest pain for last 2 months. The patient was admitted with a suspicion of acute myocardial infarction (AMI).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 236 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 57-year-old man with epigastric pain, obesity, hypertension, alcohol abuse, diabetes, and constipation. He is clinically intoxicated and has a history of alcohol abuse. The patient's age is greater than 50 years, heart rate is 90/min, oxygen saturation is 98% on room air, and there is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 237 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 72-year-old male with intractable hiccups for the last 5 days. He has a history of hypertension, which is well controlled on Amlodipine. The patient is not a known case of diabetes mellitus, bronchial asthma, tuberculosis, epilepsy, ischemic heart disease, or chronic kidney disease. On examination, the patient was febrile, with a BP of 140/90 mmHg, PR of 92 bpm, SPO2 of 92% on room air, and a temperature of 100° F. There were bilateral crepitations on lung examination, but no other significant findings.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 238 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 57-year-old Caucasian male who presented with atrial fibrillation and an allergic reaction to amiodarone. Here's how each criterion applies to him:\n",
      "\n",
      "1. Age < 50 years: False (patient is 57 years old)\n",
      "2. Heart rate < 100 bpm: False (patient's heart rate was above 125 bpm)\n",
      "3. Oxygen saturation ≥ 95%: True (patient's oxygen saturation was 98%)\n",
      "4. No hemoptysis: True (no mention of hemoptysis in the patient's history or presentation)\n",
      "5. No estrogen use: True (no mention of estrogen use in the patient's history or presentation)\n",
      "6. No prior venous thromboembolism (VTE): True (no mention of prior VTE in the patient's history or presentation)\n",
      "7. No unilateral leg swelling: True (no mention of unilateral leg swelling in the patient's history or presentation)\n",
      "\n",
      "The patient meets 4 of the 7 criteria, so the PERC score is 3 (sum of false values).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 239 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 69-year-old Caucasian male who was admitted to the emergency department with symptoms of bacterial meningitis. Here's how each criterion applies to the patient's case:\n",
      "\n",
      "1. Age < 50 years: The patient is 69 years old, so this criterion is false.\n",
      "2. Heart rate < 100 bpm: The patient's heart rate was 111 bpm, so this criterion is false.\n",
      "3. Oxygen saturation ≥ 95%: The patient's peripheral oxygen saturation was 87%, so this criterion is false.\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's case, so this criterion is true.\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's case, so this criterion is true.\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's case, so this criterion is true.\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's case, so this criterion is true.\n",
      "\n",
      "Since 4 criteria are true, the PERC score is 3 (7 - 4 = 3).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 240 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 66-year-old Caucasian man with no significant past medical history who presented with flu-like symptoms, progressively worsening shortness of breath, difficulty in breathing (NYHA class III) and dry cough over the past 2 weeks prior to presentation. He denied any fever, chills, sputum production, orthopnea or paroxysmal nocturnal dyspnea, anorexia, weight loss, recent or past exposure to tuberculosis, sick contacts, pets, recent travel or past exposure to cigarette smoke (active or passive), asbestos, silica, coal dust or chemicals. He maintained an active lifestyle walking 5 miles three times a week without overt dyspnea. He had no prior history of connective tissue disease or HIV and denied any history of skin rash or joint pains. Past surgical, social and family histories were non-contributory. He also had no history of prior use of any long term medications. He had presented to the hospital 4 days prior to present admission and a provisional diagnosis of community acquired pneumonia was made based on chest radiograph findings and he was discharged home on 2L of oxygen and Levofloxacin, but came back to the hospital due to lack of obvious improvement.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 241 ---\n",
      "Expected: 0 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 38-year-old female with a history of endometriosis, intermittently adherent with the oral contraceptive pill, who presented with acute dyspnea. The following criteria were evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 242 ---\n",
      "Expected: 5 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 78-year-old female with a history of breast cancer and moderate COPD who presented with syncope. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 78 years old, so this criterion is not met (false).\n",
      "2. Heart rate < 100 bpm: The patient's heart rate was 77 bpm, so this criterion is met (true).\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation was above 97%, so this criterion is met (true).\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's history, so this criterion is met (true).\n",
      "5. No estrogen use: The patient is on Tamoxifen, which is an estrogen receptor modulator, so this criterion is not met (false).\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's history, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history, so this criterion is met (true).\n",
      "\n",
      "The PERC score for this patient is 1, as only one criterion (Age < 50) is not met.\n",
      "\n",
      "--- Wrong Reply 243 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 70-year-old man with a history of stage IV clear cell RCC, chronic atrial fibrillation, coronary artery disease, and ischemic cardiomyopathy. He was recently started on pazopanib for metastatic RCC. The patient presented with dyspnea and palpitations on exertion, and a CT angiogram showed a non-occlusive thrombus in the left main pulmonary artery, raising concerns for pulmonary embolism. The PERC score is calculated based on the following criteria:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 244 ---\n",
      "Expected: 3 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 21-year-old male with a history of T-cell acute lymphoblastic lymphoma, acute myelogenous leukemia, and chronic graft-versus-host disease. He has a history of multiple infections, including MRSA bacteremia and pneumonia. The PERC score is calculated based on the following criteria:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "Explanation of each criterion:\n",
      "1. Age < 50: The patient is 21 years old, so this criterion is met (true).\n",
      "2. HR < 100: The patient's heart rate is 180 beats per minute, which is higher than 100, so this criterion is not met (false).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 91% on room air, which is lower than 95%, so this criterion is not met (false).\n",
      "4. No hemoptysis: The patient presented with blood-tinged phlegm, which indicates hemoptysis, so this criterion is not met (false).\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is met (true).\n",
      "6. No prior VTE: The patient has a history of acute myelogenous leukemia, but no mention of prior venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history, so this criterion is met (true).\n",
      "\n",
      "The PERC score is calculated by adding the number of false criteria, which in this case is 4.\n",
      "\n",
      "--- Wrong Reply 245 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 69-year-old woman with a history of chest pain and shortness of breath. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 246 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 29-year-old male with a history of ulcerative colitis and primary sclerosing cholangitis. He was diagnosed with COVID-19 and experienced symptoms such as fatigue, weakness, loss of appetite, dry cough, body aches, muscle pain, loss of taste and smell, sore throat, and fever. He used kratom to relieve his symptoms and reported significant improvement in physical symptoms and mood. The patient did not experience any side effects from using kratom and was able to discontinue its use without any withdrawal symptoms. The sample of kratom provided by the patient was analyzed and found to contain mitragynine and 7-hydroxymitragynine, with no evidence of adulteration with opioids or benzodiazepines.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 247 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 45-year-old female, which meets the first criterion (Age < 50). Her heart rate is 116 bpm, which does not meet the second criterion (HR < 100). Her oxygen saturation is 98% on room air, which meets the third criterion (O₂ ≥ 95%). There is no mention of hemoptysis, so the fourth criterion (No hemoptysis) is met. The patient is not on any medications, including estrogen, so the fifth criterion (No estrogen use) is met. There is no mention of prior VTE, so the sixth criterion (No prior VTE) is met. There is no mention of unilateral leg swelling, so the seventh criterion (No unilateral leg swelling) is met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 248 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 40-year-old man who presented with fever, cough, and a positive SARS-CoV-2 test. He was discharged to self-quarantine and his symptoms resolved. However, two months later, he developed dyspnea, syncope, and was found to have a significantly elevated D-dimer and a history of SARS-CoV-2 infection. A CT angiogram revealed acute bilateral PE. The patient's vital signs and labwork were evaluated against the PERC criteria as follows:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 249 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 9-year-old male with a history of pallor, lethargy, shortness of breath, headache, and yellowish discoloration of the sclera. He had an upper respiratory tract infection 2 weeks prior to hospital admission, followed by diarrhea, epigastric pain, vomiting, and decreased urine output. The patient's heart rate is 118 beats/min, respiratory rate is 20/min, blood pressure is 119/61 mmHg, and oxygen saturation is 100%. The patient is pale with yellowish sclera but no other significant signs. The patient has a positive immune profile for SLE (i.e., ANA and dsDNA).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 250 ---\n",
      "Expected: 1 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 28-year-old woman at 34 weeks' gestation with dyspnea, dry cough, and chest pain. Her pulse is 112/min, respirations are 24/min, and blood pressure is 108/78 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 90%. Examination shows jugular venous distention and bilateral pitting edema below the knees that is worse on the right side. There is dullness to percussion over the right lung base.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 251 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 50-year-old man who was bitten by a diamondback rattlesnake. Here's how each criterion applies to him: 1. Age < 50: The patient is 50 years old, so this criterion is false. 2. Heart rate < 100 bpm: The patient's heart rate was 131 bpm, so this criterion is false. 3. Oxygen saturation ≥ 95%: The patient's oxygen saturation was 78% initially, but it returned to 100% after securing the airway, so this criterion is true. 4. No hemoptysis: There is no mention of hemoptysis in the patient's history, so this criterion is true. 5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is true. 6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's history, so this criterion is true. 7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history, so this criterion is true.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 252 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 57-year-old man who presented with chest pain, nausea, fatigue, and difficult breathing. He has a history of varicose veins, elevated cholesterol levels, and a family history of pulmonary embolism. The patient was hypotensive, tachycardic, and had a low oxygen saturation. The ECG showed ST segment elevations and negative T waves. The patient was diagnosed with pulmonary embolism and right to left intra-atrial communication. The patient received unfractionated heparin and was later switched to warfarin.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 253 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 34-year-old woman who has been assaulted and has multiple stab wounds to her abdomen. She has a Grade V splenic laceration and has undergone an emergent splenectomy. The following criteria are evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 254 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 63-year-old male with a history of COPD, coronary artery disease, and aortic valve replacement. He presented with dyspnea at rest and productive cough. The following criteria were evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 255 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 29-year-old man with a history of crampy abdominal pain, diarrhea, and bloody stools. He has no fever, nausea, or vomiting. He smokes cigarettes and uses 'Mr. Nice Guy,' a synthetic cannabinoid. He has no relevant personal or familial medical history. The patient's vital signs are stable, with a heart rate of 99 bpm and oxygen saturation of 99% on ambient air. Initial blood work shows leukocytosis with neutrophilia, but other laboratory values are within normal limits. The patient's abdominal CT scan is unremarkable. The patient continues to use 'Mr. Nice Guy' during hospitalization and experiences intermittent episodes of abdominal pain and diarrhea. On the fifth day of hospitalization, the patient develops severe abdominal pain, shock, and cardiac arrest. Postmortem CT scan reveals extensive pneumatosis intestinalis and free air in the peritoneal cavity, consistent with acute intestinal perforation and nonobstructive mesenteric infarction (NOMI).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 256 ---\n",
      "Expected: 0 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 62-year-old woman who underwent a right mastectomy with axillary node dissection for a poorly differentiated ductal carcinoma, followed by a left nephrectomy for renal cell carcinoma. She developed progressive shortness-of-breath, dry cough, and mild fever after receiving her first cycle of CMF chemotherapy. She was intubated and mechanically ventilated due to respiratory deterioration. A spiral CT of the chest showed a non-occlusive saddle pulmonary embolism with multiple bilateral pulmonary emboli. She was treated with thrombolytics and heparin, and an open lung biopsy confirmed BOOP. She was treated with steroids and discharged on long-term anticoagulation and steroids.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 257 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 77-year-old African American female with a history of hypertension, diabetes, and deep vein thrombosis. She presented with shortness of breath, left-sided abdominal pain, left-sided pleuritic chest pain, and right lower leg cramping. The initial vitals showed a heart rate of 92 bpm, respiratory rate of 18 breaths per minute, and oxygen saturation of 99% on room air. The patient was diagnosed with submassive PE and treated with UAT. The following criteria were evaluated based on the patient's presentation and medical history.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 258 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 56-year-old man with a history of persistent dry cough, fever, and progressive shortness of breath. He was hypoxemic with a SpO2 of 91% and a respiratory rate of 35 breaths per minute. His heart rate was 84 bpm, and he had a fever of 38.1°C. The chest radiograph showed bilateral basal consolidations, and the suspicion of Covid-19 was confirmed by RT-PCR analysis. The patient was admitted to the ICU due to severe hypoxemic respiratory failure and developed a high fever and increased inflammatory parameters on the 5th day of ICU admission. A CT-scan revealed extensive subcutaneous emphysema, pneumomediastinum, and a thrombus in the right jugular vein. The patient was ventilated for 19 days and received therapeutic doses of unfractionated heparin for the venous thrombus. Chest CT obtained at 19th and 25th day of ICU admission showed complete resorption of mediastinal air and venous thrombus. The patient was discharged to the ward after 32 days of ICU stay in stable hemodynamic and respiratory condition.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 259 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 42-year-old female with severe abdominal pain and sepsis. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 42 years old, so this criterion is met (true).\n",
      "2. Heart rate < 100 bpm: The patient's heart rate is 132 beats/min, so this criterion is not met (false).\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation is 100% on room air, so this criterion is met (true).\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's history, so this criterion is met (true).\n",
      "5. No estrogen use: The patient used a contraceptive vaginal ring and Provera, which are forms of estrogen, so this criterion is not met (false).\n",
      "6. No prior VTE: There is no mention of prior VTE in the patient's history, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history, so this criterion is met (true).\n",
      "\n",
      "The PERC score is the sum of false values, which is 2 in this case.\n",
      "\n",
      "--- Wrong Reply 260 ---\n",
      "Expected: 5 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 67-year-old man with a history of STEMI, hypertension, and peripheral vascular disease. He has not filled his prescriptions and missed a follow-up appointment. His vital signs show a blood pressure of 167/118 mmHg, pulse of 90/min, and oxygen saturation of 99% on room air. Physical exam reveals jugular venous distention and bilateral lower extremity pitting edema. Echocardiography shows an ejection fraction of 55%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 261 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 52-year-old man who presented with abdominal pain, tiredness, fever, and nausea. The patient's initial vital signs showed a pulse rate of 95 bpm and blood pressure of 80/120 mmHg. The patient's oxygen saturation was 96%. The patient's medical history and laboratory findings do not indicate any estrogen use, prior VTE, or unilateral leg swelling. The patient's age is over 50 years, heart rate is above 100 bpm, and oxygen saturation is below 95%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 262 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 21-year-old woman who presented with chest pain, shortness of breath, and near syncope. She has a history of diffuse erythematous rash following minocycline use, which was treated with prednisone. Initial vitals showed hypotension, tachycardia, and normal oxygen saturation. The patient had episodes of syncope and PEA arrest, and was intubated for airway protection. CT chest angiography was unremarkable, but echocardiogram showed reduced heart function and severely reduced ejection fraction. The patient was treated with vasopressors, antibiotics, and dexamethasone for suspected DRESS-induced myocarditis. She was placed on VA-ECMO and eventually discharged after 62 days in the hospital with improved ejection fraction.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 263 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 66-year-old man with a history of hypertension and hyperlipidemia who presented with altered mental status, dysarthria, and discoordination of extremities. The patient's wife reported that he ingested two glasses of wine and took a nap before the onset of symptoms. The patient's home medications include bupropion, dutasteride, lisinopril, and tolterodine. The patient's vital signs were stable, and his oxygen saturation was 95% on room air. The patient's mental status and ataxia worsened during his ED stay. A head CT angiogram was negative for hemorrhage or other abnormality. Laboratory values were within normal limits. Blood alcohol level was 57 mg/dL. ECG showed normal sinus rhythm. Naloxone was trialed without improvement. The patient was evaluated by the neurology consultant team and determined to have a National Institute of Health Stroke Scale of 11. Tissue plasminogen activator was administered for thrombolysis. The patient was intubated for airway protection and admitted to the ICU. The patient developed status epilepticus and received multiple doses of benzodiazepine and phenytoin. Subsequent EEG did not demonstrate ongoing seizure activity. MRI of the brain did not show evidence of acute stroke. Comprehensive urine drug screen was positive for clozapine and clozapine metabolites. The patient was extubated on hospital day three and discharged with a normal neurologic exam and no further seizure activity on hospital day five.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 264 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 25-year-old female at 36 weeks gestation with progressive dyspnea and right-sided pleuritic chest pain. She has a history of gestational thrombocytopenia but no history of epistaxis or family history of Osler-Weber-Rendu syndrome. The patient is hypotensive, hypoxic, and on ventilator support. Chest X-ray shows right-sided pleural effusion causing complete hemithorax opacification. The patient underwent emergent cesarean delivery and was admitted to the ICU with ventilator support. Initial labs show normal platelets, normal coagulation panel, and low hemoglobin. A chest tube was placed, revealing a hemothorax, and CT-chest with IV contrast showed a likely 1 cm area of active contrast extravasation along with compressive atelectasis of the right lower lobe. Pulmonary angiography confirmed an AVM with feeding branch of a basilar right pulmonary artery supplying aneurysmal AVM and dilated draining vein. Embolisation of the culprit vessel was performed. Repeat chest X-ray showed continued opacification of the right lung, and thoracoscopic evacuation was performed.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 265 ---\n",
      "Expected: 4 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 21-year-old girl with a history of progressive dyspnoea and chest pain, transferred due to heart failure. The patient has a continuous machinery murmur, cardiomegaly, and a dilated right subclavian artery with an arteriovenous fistula to the SVC. The patient underwent transcatheter occlusion for the fistula and had significant improvement in symptoms at the 3-month follow-up.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 266 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 73-year-old female who was involved in a motor vehicle collision. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 73 years old, so this criterion is not met.\n",
      "2. Heart rate < 100 bpm: The patient's heart rate is 92 bpm, so this criterion is met.\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation is 98% on room air, so this criterion is met.\n",
      "4. No hemoptysis: The patient did not report any hemoptysis, so this criterion is met.\n",
      "5. No estrogen use: The patient is not taking any estrogen, so this criterion is met.\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's history, so this criterion is met.\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history or physical exam, so this criterion is met.\n",
      "\n",
      "The PERC score for this patient is 1, as only the age criterion is not met.\n",
      "\n",
      "--- Wrong Reply 267 ---\n",
      "Expected: 4 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 22-year-old woman who is 10 weeks pregnant and experiencing abdominal pain, contractions, and a bloody vaginal discharge. She has a past medical history of constipation, anxiety, and substance abuse. The patient is not currently taking any medications. Her vital signs are within normal limits, and the physical exam is notable for a bloody vaginal discharge and an open cervix. The patient is having a spontaneous abortion and becomes angry and aggressive upon hearing the news. She has new lacerations over her wrists and has broken some medical equipment in the room.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "Explanation of each criterion:\n",
      "1. Age < 50 years: The patient is 22 years old, which is less than 50, so this criterion is true.\n",
      "2. Heart rate < 100 bpm: The patient's pulse is 90/min, which is less than 100 bpm, so this criterion is true.\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation is 98% on room air, which is greater than or equal to 95%, so this criterion is true.\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's history or physical exam, so this criterion is true.\n",
      "5. No estrogen use: The patient is not currently taking any medications, including estrogen, so this criterion is true.\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's history, so this criterion is true.\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history or physical exam, so this criterion is true.\n",
      "\n",
      "Since all criteria are true, the PERC score is 0.\n",
      "\n",
      "--- Wrong Reply 268 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 70-year-old female who underwent central line placement for parenteral nutrition. The following criteria were evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 269 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 44-year-old Hispanic woman with a history of generalized weakness, weight loss, and dyspnea. She has a history of hypertension but has been noncompliant with her medication for three years. The patient denies alcohol or illicit drug use and is a lifelong non-smoker. On admission, her vital signs showed a respiratory rate of 24 breaths/minute, oxygen saturation of 92% on room air, and a pulse rate of 88 beats/minute. Physical examination revealed mucosal pallor, generalized wasting, and non-tender, rubbery axillary and inguinal lymphadenopathy. Laboratory investigations showed anemia, leukopenia, elevated blood urea nitrogen, and elevated serum creatinine. Chest radiography revealed bilateral pleural effusions. Serological workup revealed high anti-nuclear antibody, anti-double-stranded DNA antibody, and anti-Smith antibody titers, with low complement 3 levels. Renal biopsy showed diffuse global proliferative and membranous glomerulonephritis consistent with lupus nephritis. The patient was diagnosed with SLE complicated by a generalized lupus flare and treated with hydroxychloroquine, intravenous methylprednisolone, prednisone, and mycophenolate mofetil. The patient's renal function improved, and she was discharged after 19 days to follow up in the Rheumatology and Nephrology clinics.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 270 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 64-year-old male with a history of bioprosthetic aortic valve replacement and coronary artery bypass graft surgery, hypertension, type-2 diabetes mellitus, hypercholesterolemia, nephrotic syndrome, and pulmonary embolism. He presented with fatigue, shortness of breath, and peripheral edema. The patient's heart rate is 72 bpm, oxygen saturation is 100% on air, and he has a history of pulmonary embolism. He is on warfarin, which is an anticoagulant. The patient has a history of aortic valve dehiscence and a complex aortic root pseudoaneurysm with LVOT to RA fistulation, which could be related to his symptoms. The patient's age is greater than 50 years, heart rate is less than 100 bpm, oxygen saturation is greater than or equal to 95%, he has a history of pulmonary embolism, and he is on anticoagulant therapy. The patient does not have hemoptysis, estrogen use, prior venous thromboembolism, or unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 271 ---\n",
      "Expected: 6 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 55-year-old male with a history of type II diabetes mellitus, hypertension, obstructive sleep apnea, and depression. He presented with pleuritic chest pain, shortness of breath, and a syncopal episode. The following criteria were evaluated based on the provided information:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 272 ---\n",
      "Expected: 0 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 49-year-old woman with progressive dyspnea and cough. She has a history of type 2 diabetes mellitus, stage 1 hypertension, opioid abuse, and smoking. Her vital signs show a heart rate of 101/min, respiratory rate of 31/min, and blood saturation of 89% on room air. On examination, she is dyspneic, acrocyanotic, and has bilateral rales over the lower lobes. The cardiac examination reveals S2 accentuation and S3 presence. There is no leg edema. Neurological examination is within normal limits.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 273 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 29-year-old man with sudden-onset chest pain, no hemoptysis, dyspnea, or syncope. He has a history of N2O addiction, peripheral neuropathy, poor blood glucose control, and anxiety. He is overweight, with a BMI of 31.12 kg/m2, and has a heart rate over 110 beats/min, respiratory rate over 30 breaths/min, and pulse oximetry of 93% on 49% FiO2. The physical examination shows diminished breath sounds on both sides and accentuated pulmonic second sounds. Laboratory data indicates high leukocyte count, increased hemoglobin level, abnormal liver biochemistry, hyperlipidemia, HHcy, high Vit B12, and normal folate. Clotting profile is normal except for elevated D-dimer. ECG shows sinus tachycardia with typical changes on SIQIIITIII. Ultrasonic cardiogram demonstrates right ventricular enlargement with left ventricular compression. CTPA reveals occlusion of the pulmonary artery trunk, lobar artery, and arterial branches on both sides and signs of increased right heart load.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 274 ---\n",
      "Expected: 1 | Predicted: 5\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 65-year-old female with a history of metastatic breast cancer and brain involvement. She presented with dyspnea, tachypnea, tachycardia, and hypotension. The following criteria were evaluated based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 5\n",
      "}\n",
      "\n",
      "--- Wrong Reply 275 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 22-year-old female at 36 weeks gestation with a history of left flank pain and nausea. She has no fever, chills, dysuria, hematuria, urinary frequency, or urgency. The patient has a history of migraine headaches and anxiety/depression, but no history of chronic hypertension, gestational hypertension, episodic hypertension, flushing, diarrhea, malignancy, endocrine dysfunction, coagulation disorder, family or personal history of a bleeding disorder, or blunt trauma to the abdomen. She has a past surgical history of right laparoscopic oophorectomy for a large simple cyst. The patient was diagnosed with preeclampsia with severe features and underwent a cesarean delivery.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 276 ---\n",
      "Expected: 4 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 24-year-old man with progressive shortness of breath, low-grade fever, bilateral chest pain, and nonproductive cough for three days. He has no history of wheezing, sputum production, hemoptysis, night sweats, weight loss, or anorexia. He recently started working as an automobile mechanic and had accidentally aspirated a small volume of diesel several times in the last two weeks. He is a nonsmoker and has no past medical history of note. On examination, he had a decreased excursion of the chest wall, diminished breath sounds bilaterally, diffuse bilateral basal crepitations, and a dull stony percussion note bilaterally. The patient had leukocytosis with a total WBC count of 13900/mm3, and differential leukocyte count consisted of 90% neutrophils and 10% lymphocytes. Hemoglobin, hematocrit, and platelet count were normal. Renal function test, liver function test, coagulation assay, and serology tests were regular. Arterial blood gas analysis was within the reference range. Chest X-ray showed pneumonic consolidation over the bilateral lung field with bilateral pleural effusion and pneumothorax. Contrast-enhanced computed tomography of thorax revealed right-sided pneumothorax, bilateral pleural effusion, bilateral patchy consolidated lung parenchyma, and bilateral chest tube in situ. The diagnosis of hydrocarbon pneumonitis was made. The patient was kept under intravenous piperacillin/tazobactam, nebulization was done six hourly, and high flow oxygen was administered. The patient was discharged after two weeks when there was significant radiological regression of consolidations, improvements in pulmonary symptoms, and maintenance of oxygen saturation above 90% in room air. The patient was advised to follow-up regularly and is doing well at the time of writing.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 277 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 38-year-old woman with severe abdominal pain, nausea, and vomiting. She has a history of hypertension, fibroid uterus, and cholecystectomy. The patient's vital signs show a heart rate of 122 bpm, blood pressure of 48/37, and oxygen saturation of 88% (increased to 94% on 2 liters of nasal oxygen). The patient has a palpable abdominal mass and diffuse rebound tenderness. Biochemical testing shows elevated white blood cell count, neutrophilia, elevated creatinine, low hemoglobin, low potassium, and elevated myoglobin. The patient's renal function deteriorates, and she undergoes continuous renal replacement therapy and exploratory laparotomy. The patient's postoperative period is complicated by atrial fibrillation and anemia, but she shows biochemical and clinical improvement over the next 48 hours. The patient is discharged on postoperative day 8 with stable serum creatinine and myoglobin levels.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 278 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 63-year-old Caucasian male with a history of supraventricular tachycardia and recurrent deep vein thrombosis. He presented with pleuritic chest pain and was found to have a right lower lobe pulmonary embolus. He was restarted on Rivaroxaban® and discharged. He presented again 5 days later with left arm weakness and was found to have multiple areas of punctuate infarctions of both cerebral and cerebellar hemispheres, more confluent within the right frontal lobe on MRI of the brain. He has been compliant with his Rivaroxaban® since the previous hospital discharge 5 days prior. The patient was admitted and subsequently started on unfractionated heparin. On admission, his vital signs were blood pressure 138/93, heart rate 65 beats per minute, respiratory rate 16, and oxygen saturation 97% on room air. Cardiopulmonary examination revealed regular rate and rhythm, without murmurs, rubs, or gallops and clear lungs on auscultation. Neurologic examination revealed intact cranial nerves, preserved strength in all extremities with an exception of mild dysmetria in the left upper extremity and an NIH score of 1. Electrocardiogram revealed normal sinus rhythm, non-specific ST changes, and a premature ventricular contraction. Transthoracic echocardiogram was notable for normal left ventricular function with mild tricuspid regurgitation and stage 1 diastolic dysfunction. Transesophageal echocardiogram was negative for intracardiac thrombus. The echocardiography with agitated saline contrast revealed microbubbles of moderate opacity entering the left atrium from the left lower pulmonary vein indicative of a grade 2 intra-pulmonary arteriovenous shunt. There was no atrial septal defect or patent foramen ovale. Unfractionated heparin was continued, and the patient was transferred to a tertiary care center for embolization of the shunt. There, he developed recurrent cerebral infarctions while anticoagulation was temporarily held. Computed tomography of the abdomen and pelvis was done for persistent abdominal pain, and noted an omental mass, and subsequent exploratory laparotomy revealed an adenocarcinoma within the omentum with nodular peritoneal implants. The patient was placed on weight-based Enoxaparin® and discharged home with scheduled outpatient chemotherapy. Embolotherapy of the intrapulmonary shunt was deferred given this new diagnosis of malignancy.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 279 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 48-year-old diabetic male with a history of breathlessness, bilateral pedal edema, and oliguria. He has a diagnosis of basal VSR and a recent MI. The patient's heart rate is 110/min, and he has elevated cardiac markers and severe pulmonary arterial hypertension. He underwent surgical closure of the VSR and coronary artery bypass grafting. Postoperatively, he experienced complications including severe RV dysfunction and low cardiac output, requiring IABP support and inotropes. The patient was discharged on the 18th postoperative day with moderate biventricular dysfunction and moderate MR.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 280 ---\n",
      "Expected: 3 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 48-year-old male with a history of diabetes mellitus and aplastic anemia, presenting with fever, chest pain, and dyspnea. His vital signs show a temperature of 38.8°C, pulse 92 bpm, respiratory rate 24 per minute, BP 115/64 mm Hg, and oxygen saturation of 95% on room air. He has right-sided chest dullness and crackles. His lab results indicate severe neutropenia, anemia, and thrombocytopenia. A chest x-ray and CT scan revealed a large mass in the right upper lobe, which was diagnosed as pulmonary mucormycosis via transthoracic core biopsy. The patient's condition deteriorated, requiring ICU admission and mechanical ventilation, and he died 12 days after admission.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "--- Wrong Reply 281 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 68-year-old man with increasing breathlessness, no chest pain, sputum production, or haemoptysis. He has a history of type 2 diabetes, hypertension, and a 40-pack-year smoking history. He recently returned from holiday in Spain and was prescribed amoxicillin for a presumed chest infection. His examination revealed sinus tachycardia at 100 beats/min, a respiratory rate of 26 breaths/min, and an oxygen saturation of 96% on air. The patient has a large left hilar mass, left upper lobe collapse, and associated pleural effusion. He also has a separate mass in the right lung, which might represent a synchronous primary. The patient experienced massive haemoptysis and was treated with tranexamic acid and LMWH. He was diagnosed with pulmonary embolism and received urgent palliative radiotherapy. The patient's condition improved, and he was discharged home on long-term full-dose LMWH. He presented 3 weeks later with progressive respiratory failure and was palliated according to his wishes.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 282 ---\n",
      "Expected: 2 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 42-year-old African American female who presented with non-resolving productive cough and dyspnea. She has no significant past medical history, no history of medication use, no history of surgery, or recent prolonged immobilization. The patient's vitals showed tachycardia with a heart rate of 110-120 beats/min, and her oxygen saturation was 95% on room air. The patient was anxious on presentation. The physical exam was unremarkable except for bilateral rales. The patient tested positive for HIV with a CD4 count of 46 cells/micro litre and an HIV viral load of 810231 copies/ml. The CT angiogram chest showed diffuse ground glass lung opacities with hilar lymphadenopathy. The patient was treated for suspected Pneumocystis carinii pneumonia (PCP) and later confirmed by bronchoscopy specimen. The patient was re-admitted with worsening dyspnea and cough, and her treatment was switched to broad-spectrum antibiotics due to possible superadded bacterial infection. The patient developed severe epigastric pain, pruritic macular rashes, and pancreatitis. The patient's clinical condition worsened, and she developed a low-grade fever, hypotension, and multi-organ involvement. The patient was switched to Acyclovir for disseminated varicella, and her condition improved gradually. The patient was started on anti-retroviral drugs and prophylactic Dapsone for PCP. The patient recovered well and was followed up regularly in the clinic with no further recurrence in six months of follow-up.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 283 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 47-year-old man who presented with melena, abdominal pain, and syncope. He has no prior history of gastrointestinal bleeding and no history of alcohol consumption or liver disease. He was taking esomeprazole and had recently taken ibuprofen for back pain. His vital signs showed hypotension and tachycardia, but his oxygen saturation was normal. He had a significant drop in hemoglobin during hospitalization. The patient underwent esophagogastroduodenoscopy, which revealed a small gastric ulcer and severe chronic gastritis with Helicobacter pylori infection. The gastric balloons were removed during the procedure.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 284 ---\n",
      "Expected: 1 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is an 85-year-old male with a history of hemoptysis and a mass in the right lower lobe. Here's how each criterion is evaluated for the PERC score calculation:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 285 ---\n",
      "Expected: 2 | Predicted: 4\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 56-year-old man who was admitted for abdominal pain and had a recent surgery for a traumatic fracture of his right leg. He suddenly became short of breath and unwell with severe hypoxemia, hypotension, and tachycardia. A CT scan revealed filling defects in the pulmonary artery and a free-floating thrombus in the right atrium. The patient was intubated, ventilated, and received thrombolysis but eventually passed away. Here's how each criterion applies to this patient:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Wrong Reply 286 ---\n",
      "Expected: 0 | Predicted: 5\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is an 81-year-old woman with a history of Graves' disease and malignant mesothelioma, currently undergoing nivolumab treatment. She presents with worsening abdominal pain and general fatigue. We will evaluate each PERC criterion based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 5\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 81 years old, so this criterion is not met (false).\n",
      "2. HR < 100: The patient's pulse rate is 115 beats per minute, so this criterion is not met (false).\n",
      "3. O₂ ≥ 95%: The patient's SpO2 is 95% on ambient air, so this criterion is met (true).\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's history or current symptoms, so this criterion is met (true).\n",
      "5. No estrogen use: The patient has a history of Graves' disease and is on levothyroxine and thiamazole, but there is no mention of estrogen use, so this criterion is met (true).\n",
      "6. No prior VTE: There is no mention of prior venous thromboembolism in the patient's history, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history or current symptoms, so this criterion is met (true).\n",
      "\n",
      "The PERC score for this patient is 5, as there are 5 false criteria.\n",
      "\n",
      "--- Wrong Reply 287 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 64-year-old African American man with a history of worsening dyspnea, cough, and lower extremity edema. He has a history of nonadherence to medications and dietary restrictions. His past medical history includes morbid obesity, paroxysmal atrial fibrillation, coronary artery disease, hypertension, ventricular septal defect, and a previous motor vehicle collision. The patient's vital signs upon arrival to the emergency department were blood pressure 106/77, heart rate 94, and respirations 23. He was saturating at 86% on 4-5 L nasal cannula and was started on BiPAP. Physical exam showed bibasilar crackles, a grade II/VI holosystolic murmur, mildly elevated jugular venous pressure, and 1+ bilateral lower extremity edema. Admission labs were unremarkable. Chest X-ray showed interstitial pulmonary vascular congestion, and EKG was sinus tachycardia with first-degree AV block. The patient was admitted for acute decompensated heart failure. Transthoracic echocardiogram and computed tomography pulmonary angiogram were ordered. TTE showed normal biventricular systolic function, grade 2 diastolic dysfunction, and a small VSD. CTPA showed no evidence of pulmonary embolism but a calcified lesion concerning for a giant LAD coronary artery aneurysm. Heart catheterization revealed elevated right-sided and left-sided pressures, elevated cardiac output, and no evidence of LAD aneurysm. Follow-up imaging confirmed a pseudoaneurysm arising from the mid-apical free wall of the RV and a mid-apical VSD. The patient has a history of alcohol abuse and a cirrhotic liver. The patient was seen by cardiothoracic surgery for further evaluation.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 288 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is an 88-year-old woman with a history of congestive heart failure and cerebral infarction. She presented with low back and bilateral buttock pain, numbness in both lower extremities, and a gait disorder. The patient has a history of lumbar nerve root and epidural blocks. MRI revealed multiple old compression fractures, vertebroplasty, and spinal canal stenosis. During a fluoroscopy-guided epidural steroid injection, a dural puncture occurred, leading to a severe headache and suspected pneumocephalus. Brain CT confirmed the presence of air in various locations. The patient was admitted, treated, and discharged with complete resolution of symptoms two weeks later.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 289 ---\n",
      "Expected: 3 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 26-year-old female who presented with sudden onset of dyspnea and left precordial pain. The following criteria were evaluated based on the provided information:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 290 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 75-year-old woman, which means she does not meet the first criterion (Age < 50). Her heart rate is 124 beats/minute, which is higher than 100 bpm, so she does not meet the second criterion (HR < 100). Her oxygen saturation is 90% with oxygen mask 6 L/min, which is lower than 95%, so she does not meet the third criterion (O₂ ≥ 95%). The patient has no history of hemoptysis, so she meets the fourth criterion (No hemoptysis). The patient is being treated with prednisolone, which is a steroid, but there is no mention of estrogen use, so we assume she meets the fifth criterion (No estrogen use). The patient has a history of polymyalgia rheumatica, which is not a prior VTE, so she meets the sixth criterion (No prior VTE). The patient has no unilateral leg swelling, so she meets the seventh criterion (No unilateral leg swelling).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 291 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 57-year-old white man with a history of severe, bi-frontal headaches, weight loss, and other symptoms. The PERC score is calculated based on the following criteria:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 292 ---\n",
      "Expected: 4 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 69-year-old man who underwent liver transplantation and developed profound positional hypoxia. We will evaluate each PERC criterion based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 69 years old, so this criterion is not met (false).\n",
      "2. HR < 100: The patient's heart rate is 60 beats/min in the supine position, which is less than 100 bpm, so this criterion is met (true).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 94% in the supine position and desaturates to 80% in the upright position, so this criterion is not met (false).\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's history, so this criterion is met (true).\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is met (true).\n",
      "6. No prior VTE: There is no mention of prior VTE in the patient's history, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history, so this criterion is met (true).\n",
      "\n",
      "The PERC score is the sum of false values, which is 2 in this case.\n",
      "\n",
      "--- Wrong Reply 293 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 32-year-old female who presented with acute dyspnea, chest pain, tachycardia, and feeling light-headed 19 days postoperatively after a left knee ACL reconstruction and partial lateral meniscectomy. She was not taking oral contraceptives. The following criteria were evaluated based on the provided information:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 294 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 59-year-old female with abdominal pain, dysuria, and left-sided flank pain. She has a history of insulin-dependent diabetes mellitus, hypertension, and prior cerebrovascular accident. The patient's vital signs and lab results are provided in the note. We will evaluate each PERC criterion based on the information given.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 295 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 20-year-old primigravida with severe iron deficiency anemia who presented with giddiness and difficulty in breathing after receiving an infusion of iron sucrose. The patient's age is less than 50 years, heart rate is greater than 100 bpm, oxygen saturation is less than 95%, and she has no history of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. The patient's symptoms and physical examination findings are consistent with an acute allergic reaction to the iron infusion, which led to cardiac arrest and death within 24 hours.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 296 ---\n",
      "Expected: 0 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 43-year-old man who presented with sudden-onset palpitations and near syncope after strenuous heavy lifting. His blood pressure was 90/70 mmHg, oxygen level was 99%, heart rate was 210-230 bpm, and body temperature was 36.6°C. He has no history of cardiac disease, syncope, or pre-syncope, and no family history of sudden cardiac death or cardiomyopathy. He denied recent flu-like symptoms, smoking, illicit drug use, or excessive alcohol consumption. Physical examination was unremarkable. Initial ECG showed an irregularly irregular, broad QRS complex tachycardia. DC cardioversion restored sinus rhythm with manifest ventricular pre-excitation and clear 'delta' waves, confirming WPW syndrome. Echocardiography ruled out abnormalities associated with WPW, and cardiac ischemia was excluded. The patient was put on enoxaparin and propafenone, and his clinical course remained uneventful. EPS was performed, and a left anterolateral AP with antegrade only conduction properties was ablated. The patient was scheduled for routine cardiologic follow-up and advised to abstain from intense physical activity for at least 1-month post-discharge. CHA2DS2-VASc Score was calculated zero, so 1 month of rivaroxaban 20 mg daily was deemed sufficient post-ablation. Family members were also screened for pre-excitation. The patient remained symptom free without pre-excitation on surface ECG on his latest follow-up visit 3 months after the procedure.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 297 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 44-year-old male with a history of hypertension, recently started on hydrochlorothiazide. He presents with fatigue, muscle weakness, cramps, and increased urination. His vital signs are within normal limits, and physical examination does not reveal any abnormal findings. His serum potassium level is low at 2.1 mEq/L. We will evaluate each PERC criterion based on the provided information.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "Explanation of each criterion:\n",
      "1. Age < 50 years: The patient is 44 years old, so this criterion is true.\n",
      "2. Heart rate < 100 bpm: The patient's heart rate is 88 bpm, so this criterion is true.\n",
      "3. Oxygen saturation ≥ 95%: The patient's SpO2 is 99%, so this criterion is true.\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's symptoms, so this criterion is true.\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is true.\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's history, so this criterion is true.\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's symptoms, so this criterion is true.\n",
      "\n",
      "Since all criteria are true, the PERC score is 0.\n",
      "\n",
      "--- Wrong Reply 298 ---\n",
      "Expected: 3 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 39-year-old male with a medical history of diabetes mellitus who presented with jaundice, fever, nausea, headache, dry cough, and diffuse arthralgia. The initial evaluation showed a temperature of 100°F, heart rate of 101 bpm, and oxygen saturation of 99% on room air. The physical examination revealed severe jaundice, icteric sclera, and diffuse arthralgia with tenderness. The laboratory analysis showed elevated total bilirubin and creatinine, but normal platelet count, hemoglobin, and hematocrit. The patient's LDL, HDL, serum cholesterol, and serum triglyceride were within normal ranges. Abdominal ultrasound and CT scan were normal, except for diffuse pulmonary and hilar infiltrates in both lung bases. The patient was started on intravenous ampicillin-sulbactam and doxycycline. The total bilirubin remained high during the hospital stay, but the patient's fever and joint pain resolved. The repeat ultrasound showed possible fatty/fibrotic change in the liver. The patient tested positive for Lyme disease and was discharged with outpatient follow-up. The bilirubin was 9.0 mg/dL on the day of discharge.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 299 ---\n",
      "Expected: 2 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 40-year-old woman with sickle cell disease (SCD) who presented with dry cough, difficulty in breathing, and bilateral leg swelling. The PERC score is calculated based on the following criteria:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 40 years old, so this criterion is met (true).\n",
      "2. HR < 100: The patient's heart rate is 100 beats/min, so this criterion is not met (false).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation in room air is 78%, which is below 95%, so this criterion is not met (false).\n",
      "4. No hemoptysis: The patient does not have hemoptysis, so this criterion is met (true).\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is met (true).\n",
      "6. No prior VTE: The patient has no history of prior venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: The patient has bilateral leg swelling, not unilateral, so this criterion is not met (false).\n",
      "\n",
      "The PERC score is the sum of the false values, which is 3 in this case.\n",
      "\n",
      "--- Wrong Reply 300 ---\n",
      "Expected: 5 | Predicted: 2\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 73-year-old woman with a history of lower limb venous insufficiency, obesity, dyslipidemia, and impaired fasting glucose. She was admitted with compressive chest pain and diagnosed with a proximal ascending aorta dissection. She tested positive for COVID-19 infection. The patient's vital signs upon arrival at the ICU were: oral temperature of 36.8°C, heart rate of 72 beats/min, respiratory rate of 24 breaths/min, blood pressure of 106/55 mmHg, and oxygen saturation of 94% in room air. Laboratory tests showed no leucocytosis, D-dimer blood levels of 7,353 ng/ml, and CRP blood levels of 129 mg/l. A third CT angiogram showed no change in the aortic dissection but a new bilateral PE was demonstrated. The patient underwent aortic dissection repair and thrombectomy.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Wrong Reply 301 ---\n",
      "Expected: 1 | Predicted: 3\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 46-year-old woman who experienced a femur fracture and was later diagnosed with Fat Embolism Syndrome (FES). Here's how each criterion applies to her case:\n",
      "\n",
      "1. Age < 50 years: True, the patient is 46 years old.\n",
      "2. Heart rate < 100 bpm: False, the patient's heart rate is 124 bpm.\n",
      "3. Oxygen saturation ≥ 95%: False, the patient's PO2 is 64 mm Hg, which indicates hypoxemia.\n",
      "4. No hemoptysis: True, there is no mention of hemoptysis in the patient's history.\n",
      "5. No estrogen use: True, there is no mention of estrogen use in the patient's history.\n",
      "6. No prior venous thromboembolism (VTE): True, there is no mention of prior VTE in the patient's history.\n",
      "7. No unilateral leg swelling: False, the patient's left thigh presented bruising and swelling.\n",
      "\n",
      "The patient meets 4 of the 7 criteria, which means the PERC score is 3 (sum of false values).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Wrong Reply 302 ---\n",
      "Expected: 1 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 29-year-old woman who has just given birth to twins. She is experiencing vaginal pain, chills, and a light red voluminous discharge. Her past medical history includes diabetes, which was managed with insulin during pregnancy. Her vital signs are within normal limits, with a temperature of 99.5°F (37.5°C), blood pressure of 107/68 mmHg, pulse of 97/min, respirations of 16/min, and oxygen saturation of 98% on room air. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n",
      "\n",
      "Explanation of each criterion:\n",
      "1. Age < 50 years: The patient is 29 years old, so this criterion is met (true).\n",
      "2. Heart rate < 100 bpm: The patient's pulse is 97/min, so this criterion is met (true).\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation is 98% on room air, so this criterion is met (true).\n",
      "4. No hemoptysis: There is no mention of hemoptysis in the patient's symptoms, so this criterion is met (true).\n",
      "5. No estrogen use: The patient's past medical history does not mention estrogen use, so this criterion is met (true).\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's past medical history, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's symptoms, so this criterion is met (true).\n",
      "\n",
      "Since all 7 criteria are met (true), the PERC score is 0.\n",
      "\n",
      "--- Wrong Reply 303 ---\n",
      "Expected: 4 | Predicted: 1\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 43-year-old Brazilian man with a history of HIV/AIDS, illicit drug abuse, and generalized anxiety disorder. He presented with a cough with hemoptoic sputum for more than 1 month, evolving to mild respiratory distress in the last 7 days. He did not show signs of fever and other symptoms. On physical examination, his weight was 55 kg, heart rate was 79 bpm, respiratory rate was 18 rpm, and SPO2 was 96%. No lymphadenopathy was observed. Blood cell count presented low hemoglobin (9.9 g/dL) and hematocrit levels (29.7%), and normal platelet and white cell count ranges. Lactate dehydrogenase and C-reactive protein levels were 312 U/L, above reference limits (140–271 U/L), and 52.3 mg/dL, respectively. The D-dimer level (0.6 mcg/mL) exceeded the normal range. Troponin, AST, ALT, and ferritin levels were in normal range. Chest CT revealed bilateral glass-ground opacities occupying approximately 25% of both lungs. Respiratory secretion was collected with a nasopharyngeal swab and tested positive for SARS-CoV-2. Mycobacterium tuberculosis DNA was detected using PCR (GeneXpert MTB/RIF assay) without RIF resistance. Treatment was initiated with azithromycin (500 mg/day), HCQ (400 mg/day) for 5 days, and ceftriaxone (2 g/day). He was treated with isoniazid, ethambutol, pyrazinamide, and RIF. Antiretroviral therapy was not started to avoid complications with anti-TB treatment. The patient was clinically stable and discharged to home after 1 week. Currently, the patient is under follow-up and remains asymptomatic without developing relapses.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Wrong Reply 304 ---\n",
      "Expected: 2 | Predicted: 0\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 29-year-old male with a penetrating stab wound to the anterior left second intercostal space. The patient presented with grade 3 haemorrhagic shock and was resuscitated. A left-sided intercostal drain was inserted for a large haemothorax. The patient's vital signs after resuscitation were: heart rate 100; respiratory rate 14; saturating at 95% on room air; blood pressure 101/64. No angina was reported, and no features of cardiac failure, central cyanosis, bruits, or murmurs were elicited. No ST or other rhythm abnormalities were noted on electrocardiogram. The patient had a history of chronic septic hardware in the right lower limb. A preliminary diagnosis of local septic hardware led to screening for methicillin-resistant Staphylococcus aureus, and antibiotic prophylaxis with broad-spectrum coverage. Focused Assessment with Sonography for Trauma scan demonstrated a 1 cm pericardial effusion. Computed tomographical findings demonstrated a right ventricular outflow tract (RVOT) injury at the level of the pulmonary valve and an associated suspected thrombus. A small aortic root injury with a small pseudo-aneurysm and intimal flap was also observed. The injury tract extended to the medial superior vena cava (SVC) and a high index of suspicion for an SVC injury was entertained. Transthoracic cardiac ECHO findings did not demonstrate valvulopathies, clear flow reversal or shunting, regional wall motion abnormalities, tamponade, or features of infective endocarditis. The patient had a preserved left ventricular ejection fraction. A large dense lesion was noted immediately beneath the pulmonary valve which demonstrated beat to beat movement and was noted to be highly suggestive of a clot. Pertinent laboratory findings showed that the patient had normal renal and liver function with a normocytic normochromic anaemia (haemoglobin = 10.9) and no coagulation abnormalities (normal prothrombin and partial thromboplastin time). The patient underwent successful surgical repair of the RVOT, aortic wall, and SVC injuries. The patient made a complete recovery with no residual thrombus or intracardiac shunt at early follow-up. There was no cardiac, respiratory, or neurological sequelae at 30-day follow-up.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 0\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "#Troubleshooting: wrong/invalud outputs\n",
    "for i, entry in enumerate(wrong_outputs):\n",
    "    print(f\"\\n--- Wrong Reply {i+1} ---\")\n",
    "    print(f\"Expected: {entry['expected']} | Predicted: {entry['predicted']}\")\n",
    "    print(f\"Reply:\\n{entry['reply']}\")\n",
    "\n",
    "# Extract invalid replies with metadata\n",
    "for i, entry in enumerate(invalid_outputs):\n",
    "    print(f\"\\n--- Invalid Reply {i+1} ---\")\n",
    "    print(f\"Expected: {entry['expected']} | Predicted: {entry['predicted']}\")\n",
    "    print(f\"Reply:\\n{entry['reply']}\")\n",
    "\n",
    "invalid_replies = [entry['reply'] for entry in invalid_outputs if 'reply' in entry]\n",
    "for i, reply in enumerate(invalid_replies):\n",
    "    print(f\"\\n--- Invalid Reply {i+1} ---\\n{reply}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "aaa2c4e3",
   "metadata": {},
   "outputs": [],
   "source": [
    "def print_correct_with_wrong_criteria(parsed_json, patient_df):\n",
    "    def to_bool(val):\n",
    "        if isinstance(val, bool):\n",
    "            return val\n",
    "        if isinstance(val, str):\n",
    "            return val.lower() in ['true', 'yes', '1']\n",
    "        return bool(val)\n",
    "\n",
    "    def get_truth(entities):\n",
    "        age = extract_number(entities.get(\"age\"))\n",
    "        hr = extract_number(entities.get(\"Heart Rate or Pulse\"))\n",
    "        o2 = extract_number(entities.get(\"O₂ saturation percentage\"))\n",
    "        return {\n",
    "            \"Age < 50\": age is not None and age < 50,\n",
    "            \"HR < 100\": hr is not None and hr < 100,\n",
    "            \"O₂ ≥ 95%\": o2 is not None and o2 >= 95,\n",
    "            \"No hemoptysis\": not to_bool(entities.get(\"Hemoptysis\", False)),\n",
    "            \"No estrogen use\": not to_bool(entities.get(\"Estrogen use\", False)),\n",
    "            \"No prior VTE\": not to_bool(entities.get(\"Prior VTE\", False)),\n",
    "            \"No unilateral leg swelling\": not to_bool(entities.get(\"Unilateral leg swelling\", False)),\n",
    "        }\n",
    "\n",
    "    count = 0\n",
    "\n",
    "    for model_id, outputs in parsed_json.items():\n",
    "        for i, output in enumerate(outputs):\n",
    "            if not output.get(\"correct\"):\n",
    "                continue  # Only focus on correct predictions\n",
    "\n",
    "            try:\n",
    "                criteria_pred = output[\"parsed_criteria\"][\"Criteria\"]\n",
    "            except (TypeError, KeyError):\n",
    "                continue\n",
    "\n",
    "            row = patient_df.iloc[i]\n",
    "            entities = row[\"Parsed Entities\"]\n",
    "            truth = get_truth(entities)\n",
    "\n",
    "            wrong_criteria = []\n",
    "            for criterion, true_val in truth.items():\n",
    "                pred_val = criteria_pred.get(criterion)\n",
    "                if pred_val is None:\n",
    "                    continue\n",
    "                if pred_val != true_val:\n",
    "                    wrong_criteria.append(criterion)\n",
    "\n",
    "            if wrong_criteria:\n",
    "                count += 1\n",
    "                print(f\"\\n--- Correct Answer with Wrong Criteria {count} ---\")\n",
    "                print(f\"Model: {model_id}\")\n",
    "                print(f\"Wrong Criteria: {wrong_criteria}\")\n",
    "                print(f\"Expected (Ground Truth): {output.get('ground_truth')} | Predicted: {output.get('predicted')}\")\n",
    "                print(f\"\\nParsed Entities:\\n{entities}\")\n",
    "                print(f\"\\nPatient Note:\\n{row.get('Patient Note', 'N/A')}\")\n",
    "                print(f\"\\nReply:\\n{output.get('raw_reply', 'N/A')}\")\n",
    "\n",
    "    if count == 0:\n",
    "        print(\"✅ No correct predictions with incorrect criteria.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "c83a85bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Correct Answer with Wrong Criteria 1 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [28, 'years'], 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [89.0, 'beats per minute'], 'Hemoptysis': False, 'O₂ saturation percentage': [94.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 28-year-old woman gave birth to a healthy male infant following a normal, uneventful vaginal delivery (gravida 10, para 8). The patient was admitted to the emergency department six days postpartum with the acute onset, two hours prior, of substernal chest pain radiating to the left arm and interscapular region. The patient had no coronary risk factors such as hypertension, diabetes, or dyslipidemia, had no family history of heart disease, and did not have a history of oral contraceptive use. She did not smoke and did not use alcohol or drugs.\n",
      "On physical examination, her blood pressure was 110/65 mmHg and her heart rate 89 beats/min, temperature of 37.2°C, and oxygen saturation of 94%. Auscultation of heart and lung fields was normal. Physical examination revealed no signs of heart failure. Chest X-ray was normal. Electrocardiography demonstrated the presence of ST-segment elevation in leads I, aVL (both 1 mm) and V1–V5 (all 3 mm), along with reciprocal ST segment depression in leads II, III, and aVF (all 2 mm). The initial laboratory analyses were within normal limits.\n",
      "Subsequent cardiac catheterization revealed spontaneous dissection of the left anterior descending artery (LAD) (). There was a 80% stenosis of the true lumen of the mid-LAD caused by external compression by the hematoma in the false lumen. The right coronary artery (RCA) and left circumflex artery (LCX) were angiographically normal. The patient underwent percutaneous transluminal coronary angioplasty with bare-metal stent (3.0 × 18 mm) placed in the LAD (). We continued with low-molecular-weight heparin, clopidogrel, ramipril, metoprolol, and aspirin. The patient was discharged with good hemodynamic balance on the fourth day after admittance. One month after the control examination, the patient had no chest pain at all. Follow-up echocardiography revealed normal left ventricular function.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 73 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 80 beats/min, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99%, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, given the context, it can be inferred that the patient is a postmenopausal woman (given her age and the absence of any mention of estrogen therapy or pregnancy), but without explicit information about current estrogen use, this could be considered not directly applicable. However, for the purpose of this calculation and based on the information provided, we will consider this criterion as true because there's no indication of estrogen use.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false criteria. In this case, only the first criterion (Age < 50 years) is false.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no mentioned estrogen use, no prior VTE, and no unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 2 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['No unilateral leg swelling']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [56, 'years'], 'Heart Rate or Pulse': [96.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 56-year-old man presented to a peripheral hospital with a history of severe acute central chest pain accompanied by sweating. He has been suffering from diabetes mellitus for 3 years for which he was taking oral hypoglycemic agent (glibenclamide 5 mg, BID). However, he was not on regular follow-up. He was hypertensive for 3 years and for which he was on regular medication.\n",
      "He was diagnosed with acute ST-segment elevation extensive anterior wall myocardial infarction and was given Streptokinase due to unavailability of reteplase/alteplase. Although the chest pain improved, his post lysis ECG showed poor resolution. However, next morning the ECG showed transient inferior leads ST elevation with fast atrial fibrillation (AF). He was given a bolus intravenous amiodarone (300 mg). While he was on amiodarone infusion, he became hypotensive and dobutamine was started at low dose (5 mcg/kg/min). Eventually, his case was discussed and it was decided he needed a tertiary care hospital. He was shifted with 12 hours for further management.\n",
      "On arrival, his radial arterial blood pressure was 106/70 mmHg, mean arterial BP was 59 mmHg. He was maintained on low dose dobutamine. The PR was 96 b.p.m, in sinus rhythm. His urine output was 75 ml / hour. On physical examination, he had bilateral fine crepitation and a pan systolic murmur at the left lower sternal area, radiating to the right precordium. Further examination showed the jugular venous pulse was mildly raised but no lower leg edema and warm touch. Oxygen saturation was 98% on 4 L/min oxygen facemask.\n",
      "Electrocardiography [] revealed sinus rhythm with persistent ST-segment elevation in the anterior (V1-V6) with established Q-waves in anterior leads. Chest X-ray [] showed bilateral mild pulmonary congestion.\n",
      "Transthoracic echocardiography revealed multiple (2–3 mm) apical muscular ventricular septal defects (VSD) with the largest VSD measuring 1 cm [], and a left to right shunt []. Left ventricular (LV) systolic function was mildly impaired with an ejection fraction of 45%. The left ventricular apex was akinetic. There was Grade-I diastolic dysfunction with normal right side dimension and functions. There was no significant valvular regurgitation or stenosis, but there was moderate pericardial effusion measuring 1.6 cm posteriorly and 1.1 cm anteriorly []. There was no sign of cardiac tamponade. The results of the biochemical Labs were unremarkable except for mild renal impairment (creatinine 105 mmol/L, eGFR-65) and raised Troponin T (364 pg/ml). Lactate level was 2.1mmol/L.\n",
      "Coronary angiography (CAG) revealed the left anterior descending artery had tight lesions in the proximal (95%) and mid segment (85%) with diffusely diseased distal LAD []. Right coronary had proximal 30% stenosis; the right posterior descending artery had ostial (90%) lesion []. There was non-significant lesion at distal left circumflex artery. LV Angiography showed Apical VSR with LV to RV flow [Figure and ].\n",
      "His Society for Cardiovascular Angiography and Intervention (SCAI) cardiogenic shock (CS) stage was determined to be Stage B. At this time cardiac surgeons were consulted, who advised to continue medical treatment with an intention to heal infarct area spontaneously and they would consider either for coronary artery bypass graft (CABG) plus VSD repair versus Percutaneous Coronary Intervention (PCI) plus device closure.\n",
      "The patient was initially treated medically with intravenous diuretics, inotropes, and with oral aspirin and statin. Gradually, all inotropes were tapered off and he was clinically asymptomatic with stable hemodynamics without support of intra-aortic balloon pump (IABP). Later, low dose of lisinopril and carvedilol was added as vasodilators to reduce afterload.\n",
      "Eventually, at the eighteenth day of admission, the patient underwent CABG (one venous graft to r-PDA) with simultaneous repair of VSD with Gortex patch with infarct exclusion technique. The LAD artery could not be grafted due to poor visualization hence dit was decided for PCI later if needed.\n",
      "Postoperatively, the patient remained stable and was extubated the next day. Follow-up echocardiography revealed no residual intra-cardiac shunt. He was discharged on the 7th post-operative day in stable condition. Due to expatriate issue, a follow-up was arranged over telephone at 2 weeks. After two months, he was asymptomatic, hemodynamically stable and could perform routine daily activities. Later a clinic follow- up was arranged with echocardiography.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 65 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 88/minute, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% O2, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of the patient experiencing hemoptysis (coughing up blood). Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is a man, and there is no mention of him using estrogen. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: Although the patient recently underwent a total hip replacement, which increases the risk of VTE, and has been experiencing leg swelling and pain, there is no explicit mention of a prior VTE. However, given the context of recent surgery and current symptoms, it might be inferred that the patient could be at risk or have had a VTE, but based strictly on the information provided without direct reference to a prior VTE diagnosis, we might consider this criterion as true for the purpose of this calculation. However, the presence of unilateral leg swelling and the patient's recent history suggest that this criterion could be considered false if we interpret the recent symptoms as indicative of a current or recent VTE event. Given the direct information, we will consider it true for this calculation, but it's a complex scenario.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has swelling and pain in his right leg, which indicates unilateral leg swelling. Therefore, this criterion is false.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated as the sum of the false criteria, which are:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- No unilateral leg swelling: False\n",
      "\n",
      "The other criteria are true. \n",
      "\n",
      "Therefore, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100 bpm, oxygen saturation greater than or equal to 95%, no hemoptysis, no estrogen use, no explicitly mentioned prior VTE (though recent surgery and symptoms could suggest risk), and unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 3 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [110.0, 'beats per minute'], 'O₂ saturation percentage': [96.0, '%'], 'Recent surgery or trauma': True, 'age': [36, 'years'], 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 36-year-old male suffered a gun-shot wound to the abdomen that required an emergent exploratory laparotomy to repair and resect damaged portions of the bowel. Four days later, the patient reports increased generalized abdominal pain. His vital signs are as follows: T 38.5, HR 110, BP 110/60, RR 18, SpO2 96%. Physical exam reveals extreme tenderness to palpation of the abdomen as well as rebound tenderness, worse in the bilateral lower quadrants. The abdomen is mildly distended with guarding and decreased bowel sounds. The surgical and bullet-entrance wounds appear intact without any evidence of leakage/drainage, erythema, or warmth. Initial lab-work shows an elevated white blood cell count of 17.1 x 10^9 cells/L. A CT scan of the abdomen shows a 4 cm abscess in the left lower quadrant.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 75 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate was initially 95 bpm and later 105 bpm. Since the heart rate is not consistently less than 100 bpm, and at one point exceeds 100 bpm, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was 96% on presentation and 98% later on. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the extensive list of medications, if estrogen were being used, it would likely be mentioned. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of a prior VTE in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which are criteria 1 and 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50, and the heart rate exceeds 100 bpm at one point. Oxygen saturation is consistently ≥ 95%, there's no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 4 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [56, 'years'], 'Heart Rate or Pulse': [84.0, 'beats per minute'], 'O₂ saturation percentage': [91.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': True}\n",
      "\n",
      "Patient Note:\n",
      "A 56-year-old man was admitted to our institution with an 11-day history of persistent dry cough, fever, and progressive shortness of breath. On arrival at the hospital, he was hypoxemic, with a SpO2 of 91% and a respiratory rate of 35 breaths per minute requiring ambient oxygen therapy with a flow of 15 L/min via a non-rebreather mask. Hemodynamically, he showed a stable profile with a blood pressure of 120/80 mmHg and a heart rate of 84 bpm. His body temperature was 38.1°C. Laboratory tests revealed an elevated C-reactive protein concentration of 37 mg/L (reference: <5 mg/L), a leukocyte count of 7.7 × 109/L (reference: 4–10 × 109/L) and D-dimer of 0.41 mg/L (reference: <0.50 mg/L). The chest radiograph demonstrated bilateral basal consolidations. The suspicion of Covid-19 was confirmed by real-time reverse transcription polymerase chain reaction (RT-PCR) analysis of nasopharyngeal swab samples.\n",
      "The patient was primarily admitted to a designated Covid-19 ward for further observation and oxygen therapy. Due to severe hypoxemic respiratory failure within 24 h after admission, he was immediately transferred to the intensive care unit (ICU) where he was intubated. On the 5th day of ICU admission (T0), the patient developed a high fever accompanied with an increase in inflammatory parameters (). Hemodynamic parameters did not indicate an unstable course (). Microcirculatory monitoring was carried out sublingually using Cytocam-IDF imaging (CytoCam, Braedius Medical, Huizen, The Netherlands). Image analysis which was performed offline using MicroTools, showed an increase in microcirculatory density (total vessel density and perfused vessel density) and perfusion parameters (proportion of perfused vessels and microvascular mean flow index) as well as in red blood cell (RBC) velocity (). Subsequent CT-scan demonstrated extensive subcutaneous emphysema and pneumomediastinum as well as a thrombus in the right jugular vein extending to the superior vena cava and into the right brachial vein (). A tracheal defect was ruled out by bronchoscopy. There was no pneumothorax or evidence of esophageal rupture.\n",
      "The patient was ventilated for 19 days and a temporary tracheostomy was performed for a gradual wean from the ventilator. Unfractionated heparin was given in therapeutic doses for his venous thrombus. Chest CT obtained at 19th (T1) and 25th day of ICU admission (T2) showed complete resorption of mediastinal air and venous thrombus (). Concurrent microcirculatory images revealed a recovery of microcirculatory alterations ( and ). Thereupon on the 30th day of ICU admission, the tracheostomy was removed and the patient was discharged to the ward after 32 days of ICU stay in stable hemodynamic and respiratory condition.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 69 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is 105 bpm, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 92%, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can consider this criterion as true, assuming hemoptysis was not present.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it's reasonable to assume estrogen use is not applicable. Therefore, we can consider this criterion as true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we can consider this criterion as true, assuming no prior VTE was known or documented.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, we can consider this criterion as true, assuming no such symptom was observed or reported.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false values, which are criteria 1, 2, and 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's age is greater than 50, heart rate is greater than 100 bpm, and oxygen saturation is less than 95%. These criteria are false. The other criteria (no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling) are considered true based on the absence of information suggesting otherwise in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 5 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [45, 'years'], 'Heart Rate or Pulse': [130.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hormone use': False, 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 45-year-old African female nursing assistant presented to the emergency department with four days of diarrhea, nausea, and vomiting. She endorsed recent contact with COVID-19-positive patients. She denied cough, shortness of breath, chest pain, and fever. She was a non-smoker and was not on any medications. Vital signs showed a blood pressure of 113/85 mm Hg, heart rate of 116 beats per minute (bpm), respiration of 18 breaths per minute, a temperature of 96.0 degrees Fahrenheit, and oxygen saturation of 98% on room air. Her examination was remarkable for an overweight, diaphoretic female in distress with abdominal tenderness and cold and clammy extremities.\n",
      "An electrocardiogram (EKG) showed sinus tachycardia and diffuse ST-segment elevation in I, II, augmented Vector Left (aVL), and V3-V6 (Figure ).\n",
      "Laboratory testing was remarkable for a white blood cell count of 3.8 103/uL (reference range: 4.0 - 11.0 103/uL), platelets 144 103/uL, (reference range 150 - 400 103/uL), international normalized ratio (INR) 1.26 (reference range 0.8 - 1.1), lactic acid 2.97 mmol/L (reference range: 0.5 - 2.00 mmol/L), ferritin 562 ng/mL (reference range: 13 - 150 ng/mL), C-reactive protein (CRP) 24.1 mg/L, (reference range: 0 - 5 mg/L); serum aspartate aminotransferase (AST) 141 U/L (reference range: 10 - 34 U/L), lactate dehydrogenase (LDH) 464 U/L (reference range: 135 - 235 U/L), creatine kinase (CK) 693 U/L (reference range: 26 - 192 U/L), N-terminal pro-B-type natriuretic peptide (NT-proBNP) 4,585 pg/mL (reference range: 0 - 450 pg/mL), and troponin T 0.43 ng/mL (reference: 0 - 0.02). The chest x-ray showed patchy infiltrates bilaterally (Figure ). SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) was positive.\n",
      "The patient initially received 2 liters of normal saline, hydroxychloroquine 400 mg, aspirin 325 mg, and atorvastatin 80 mg for presumptive COVID-19-associated myocarditis. She improved symptomatically and remained hemodynamically stable. Two hours later, she became lethargic with a heart rate of 130 bpm. Pulses were unmeasurable. She received another liter bolus of normal saline and was immediately transferred to the intensive care unit. A bedside echocardiogram showed a left ventricular ejection fraction of approximately 10% with global hypokinesis and no pericardial effusion.\n",
      "Ultimately, the patient developed cardiogenic shock. She was intubated and started initially on norepinephrine and subsequently required additional pressor support with phenylephrine and dopamine. She received intravenous immunoglobulin and methylprednisolone. She subsequently became asystolic. She received four doses of intravenous (IV) epinephrine and 1 ampule of IV bicarbonate. The patient expired after 15 minutes of resuscitation.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 62 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 92/min, which is less than 100 bpm. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 99% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, given the patient's age and the context, it's reasonable to assume this could be relevant, but without explicit information, we cannot definitively say this criterion is met or not. For the purpose of this calculation and following the principle of assuming the least risky condition when information is not provided, we will consider this criterion as true, acknowledging this assumption may not always be correct.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any prior VTE. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The physical exam reveals stable gait and strength 5/5 in the upper and lower extremities, with an obese abdomen and abdominal distension, but it does not specifically mention unilateral leg swelling. Given the absence of this information, and similar to the reasoning for other criteria not explicitly mentioned, we will assume this criterion is true.\n",
      "\n",
      "Given these evaluations:\n",
      "- The false criteria are only \"Age < 50 years.\"\n",
      "- The true criteria are \"Heart rate < 100 bpm,\" \"Oxygen saturation ≥ 95%,\" \"No hemoptysis,\" \"No estrogen use,\" \"No prior VTE,\" and \"No unilateral leg swelling.\"\n",
      "\n",
      "The PERC score is the sum of the false criteria, which in this case is 1.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's note. The patient's age is over 50, heart rate is less than 100 bpm, oxygen saturation is over 95%, there's no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling, leading to a score based on the absence of these conditions except for age.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 6 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['HR < 100', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [72, 'years'], 'Heart Rate or Pulse': [92.0, 'beats per minute'], 'O₂ saturation percentage': [92.0, '%'], 'Hormone use': False, 'Unilateral Leg Swelling': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A case study was done after obtaining ethical clearance from the institutional ethics committee and after obtaining informed written and oral consent from the patient.\n",
      "A 72-year-old male patient presented to Bapuji teaching hospital attached to JJM medical college, Davangere on July 24, 2020 with hiccups in the last 5 days. There was no history of fever, cough, breathlessness, loose stools, burning micturition, chest pain or headache.\n",
      "The patient was apparently normal 5 days back after which he developed intractable hiccups, insidious in onset, which failed to subside with home remedies. The patient got prolonged episodes every 3 hours which caused discomfort. Hiccups did not affect sleep or appetite. The patient is a known case of hypertension well controlled on 5 mg Amlodipine OD. The patient is not a known case of diabetes mellitus, bronchial asthma, tuberculosis, epilepsy, ischemic heart disease, or chronic kidney disease.\n",
      "On general physical examination (GPE):\n",
      "The patient was febrile at the time of examination\n",
      "BP: 140/90 mmHg\n",
      "PR: 92 bpm\n",
      "SPO2: 92% @ room air\n",
      "Temperature: 100° F\n",
      "No signs of pallor icterus clubbing cyanosis lymphadenopathy or edema.\n",
      "Head to toe examination appears to be normal.\n",
      "On systemic examination:\n",
      "RS: B/L crepitations +\n",
      "B/L air entry equal\n",
      "CVS: S1S2 heard, no murmurs\n",
      "P/A: soft, non-tender, no organomegaly\n",
      "CNS: clinically normal\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 71 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate on arrival to the ED was 109 beats/min, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient had 100% pulse oximetry on room air, which meets this criterion. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can consider this criterion as true, assuming hemoptysis was not present but not explicitly mentioned.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is male, it's reasonable to assume estrogen use is not applicable. Therefore, we can consider this criterion as true.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: There is no mention of prior VTE in the patient note. Therefore, we can consider this criterion as true, assuming no prior VTE was present but not explicitly mentioned.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had weakness of both lower extremities and later developed acute ischemia of the right lower extremity, but there's no specific mention of unilateral leg swelling. However, given the context of his symptoms and the development of ischemia in one leg, it might be inferred that there could be some form of unilateral involvement. Yet, based strictly on the information given and the absence of explicit mention of swelling, we might lean towards considering this criterion as true, but it's a bit ambiguous. For the purpose of this calculation and given the lack of clear evidence to the contrary, we'll consider it as true.\n",
      "\n",
      "Given these evaluations:\n",
      "- The patient meets criteria 3, 4, 5, 6, and 7 (considering the assumptions made for criteria not explicitly mentioned).\n",
      "- The patient does not meet criteria 1 and 2.\n",
      "\n",
      "Therefore, the PERC score would be the sum of the false criteria, which are 2 out of the 7 criteria.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate greater than 100, but meets the other criteria based on the information provided in the note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 7 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [74, 'years'], 'Heart Rate or Pulse': [120.0, 'beats per minute'], 'Hemoptysis': False, 'O₂ saturation percentage': [96.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 74-year-old normotensive, nondiabetic, male smoker (30-pack years) presented with progressively increasing shortness of breath, cough, white, mucoid expectoration, and retrosternal and right sided parasternal, oppressive chest pain for last 2 months. Chest pain and shortness of breath were increased in severity on exertion and were associated with palpitation, but there is no history of sweating, orthopnoea, paroxysmal nocturnal dyspnoea, unconsciousness, and convulsion. There was no radiation of chest pain. Chest pain was suddenly increased for last five days and the patient was admitted in the emergency department with a suspicion of acute myocardial infarction (AMI). There was no history of fever, hemoptysis, leg swelling, and facial puffiness. History of significant weight loss and anorexia were present. There was no history of household contact with the patient of sputum smear positive tuberculosis. The patient received formoterol + tiotropium metered dose inhaler (2 puffs once daily with spacer) and oral doxofylline (400 mg twice daily) for last five years, as he suffered from chronic bronchitis predominant chronic obstructive pulmonary disease (COPD) which resulted in persistent breathlessness, cough, and expectoration.\n",
      "General survey revealed anemia and clubbing, but there was no cyanosis, edema, and engorged neck vein. There were multiple cervical and supraclavicular enlarged lymph nodes on left side, which were hard in consistency, discrete, nontender, and fixed to underlying structure, but not fixed to overlying skin, and there was no discharging sinus. His temperature was 37°C, respiratory rate 24 breaths/minute, pulse rate 120 beats/minute, regular blood pressure 94/64 mmHg, oxygen saturation in capillary blood (SpO2) 96% @ room air, and FiO2 0.21.\n",
      "Examination of respiratory system revealed no abnormality, except vesicular breath sound with prolonged expiration on both sides, bilateral crackles, mainly over the bases of the lungs, and occasional wheezes. Examination of other system was normal. Complete hemogram showed anemia with hemoglobin concentration of 7.1 g/dL. Blood biochemistry was normal. Electrocardiogram (ECG) showed atypical ST segment elevation and T wave inversion in lateral chest leads (Lead V4, Lead V5, and Lead V6). Initial rapid troponin-t-test was inconclusive, but repeat one after 12 hours of first test was negative. Sputum for acid fast bacilli and Gram stain was negative, and pyogenic culture of sputum showed no growth. Chest X-ray posteroanterior (PA view) showed cardiothoracic ratio was more than 0.5; that is, size of the cardiac silhouette was increased, but lung parenchyma was normal. Contrast enhanced computed tomography (CECT) of thorax showed a large, nonhomogenous mass lesion in right lower lobe which invaded the left atrium and was compressing the adjacent ventricular walls (). There was also mediastinal and hilar lymphadenopathy. CT-guided fine needle aspiration cytology (FNAC) showed discrete clusters of malignant epithelial cells which showed nuclear pleomorphism, hyperchromasia, high nucleocytoplasmic ratio, pale cytoplasm, and ill-defined cell boundary—suggestive of non-small-cell carcinoma, possibly squamous cell variety (). FNAC of left sided supraclavicular lymph nodes showed metastatic squamous cell carcinoma. Sputum for malignant cell was negative and fibre optic bronchoscopy did not show any abnormality. Echocardiogram showed a large echogenic mass of 15 × 12 mm, attached to the roof of the left atrium adjacent to right pulmonary venous openings, encroaching to interatrial septum, an extension of the tumour from adjacent lung parenchyma. Ejection fraction was 66%. Ultrasound of abdomen and CECT scan of brain were normal. Hence the diagnosis was a non-small-cell carcinoma of lower lobe of right lung with invasion of the left atrium and compression of adjacent ventricular wall (T4 disease) with contralateral supraclavicular metastatic lymphadenopathy (N3 disease). First cycle chemotherapy regimen comprising intravenous cisplatin (100 mg on day 1) and etoposide (100 mg on days 1, 2, and 3) was given, but unfortunately he died just after completion of first cycle.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 16 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 140 beats/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 94% on room air, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: The patient denied hemoptysis. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. However, given her age and the context, it's reasonable to infer that she is not using estrogen, especially since she denied sexual activity and there's no mention of hormonal treatments other than what's related to her psoriasis treatment, which does not include estrogen. Therefore, this criterion is met (true), but with the understanding that the note does not explicitly address estrogen use.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient does not have peripheral oedema, and there's no specific mention of unilateral leg swelling. Given the absence of this symptom in the description, it's reasonable to infer that this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false values, which are criteria 2 (Heart rate < 100 bpm) and 3 (Oxygen saturation ≥ 95%). \n",
      "\n",
      "The final answer is: \n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on the provided criteria. The patient meets criteria 1, 4, 5, 6, and 7 but does not meet criteria 2 and 3 due to a heart rate over 100 bpm and oxygen saturation below 95%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 8 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['No hemoptysis']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [28, 'years'], 'Heart Rate or Pulse': [138.0, 'beats per minute'], 'O₂ saturation percentage': [86.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': True, 'Hormone use': False, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 28-year-old man was admitted in our hospital on Jul 13, 2018 because of recurrent cough and yellow-phlegm accompanied by fever for more than 10 months. The symptoms were repeated after routine symptomatic treatment. A chest computed tomography (CT) scan taken in January 2018 had showed that his right lung was spotted by small piece of shadow, accompanied by a cavity. The patient refused to initiate antitubercular therapy. The symptoms were improved after self-administration of cephalosporin as anti-infection treatment for 1 week. In May, the cough and sputum were aggravated, accompanied by fever in the afternoon, with body temperature around 38 °C. In the beginning of July, chest CT showed that the patchy shadow was scattered in two lungs with multiple cavities. The large consolidation in the right upper lung was significantly progressed compared with half a year ago. Considering combination of pulmonary tuberculosis and pulmonary infection, he was hospitalized.\n",
      "At admission, physical examination revealed the following: weight 53 kg; BMI 16.7, body temperature 38.7 °C, pulse 85/min, blood pressure 118/72 mmHg, finger oxygen saturation degree (FOSD) 98%. The lungs had lower breath sounds, with no obvious dry or wet rale. The auxiliary examination showed that the following test items were normal, including blood routine, biochemistry, coagulation, erythrocyte sedimentation rate, arterial blood gas analysis and echocardiography. D-dimer was 13.17 mg/L. Electrocardiogram showed sinus tachycardia. The details of chest CT was shown in Fig. . Acid-fast bacilli staining test for sputum sample was positive (4+/3+), which confirmed the diagnosis of pulmonary tuberculosis.\n",
      "Routine anti-tuberculosis regimen was initiated, including isoniazid (300 mg/day), rifampin (450 mg/day), pyrazinamide (1500 mg/day) and ethambutol (750 mg/day). After 3 days of treatment, the body temperature dropped down to the normal, and the cough was relieved. Respiratory symptoms were also improved after 15 days of treatment. At that time, the patient suddenly felt chest tightness, chest pain, and shortness of breath after increased activity (three times more than the usual). Physical examination revealed: heart beats 138/m, blood pressure 88/58 mmHg, FOSD 86%. Even after 6 L high-flow oxygen intake, FOSD was maintained at 90%. Arterial blood gas analysis without oxygen inhalation indicated: pH 7.44, PO2 48 mmHg, PCO2 33 mmHg, SPO2 86%, Oxygenation Index 228.57 mmHg, D-dimer 14.03 mg/L. Electrocardiogram showed atrial tachycardia, non-specific ST elevation. Taking together, all the data highly suggested PTE. Emergency computer tomography pulmonary angiography (CTPA) inspection showed signs of filling defects in the trunk and branches of the left pulmonary artery and the right lower pulmonary artery (Fig. ).\n",
      "According to the CTPA result, the patient was diagnosed as a large-scale PTE, and the risk stratification was medium-high. The patient was prescribed with low-molecular-weight heparin (LMWH) (0.1 mL/10 kg) for anticoagulation. Then, under pulmonary angiography, a combined thrombolytic therapy including mechanical thrombolysis, aspiration, and topical urokinase (300,000 U) was applied to the left pulmonary artery. Fortunately, as shown in Fig. , the filling defect of left pulmonary artery disappeared. After the interventional therapy, the patient received intravenous pumping of 20,000 U urokinase every 1 h for 24 h. The symptoms of chest tightness, chest pain and shortness of breath were significantly improved, while the blood oxygen saturation and blood pressure returned to normal, and the vital signs were stable. Neither hemoptysis nor gastrointestinal bleeding occurred during the period of thrombolysis. The deep vein B-ultrasound of double lower limbs was performed and found a flocculent echo in the superior cavity of the upper right femoral vein, and extended into the external iliac vein. Then protein C, protein S activity, coagulation factor V leiden mutation, prothrombin 20210A, lupus anticoagulant, homocysteine, were determined and no abnormality was found. Anti-tuberculosis and warfarin anticoagulant therapy were continued, and international normalized ratio (INR) value was monitored and adjusted between 2 and 3. The patient was discharged with self-administration of oral anti-TB drugs and anticoagulant drug. At follow-up after 20 days of discharge, B-ultrasound showed that the deep vein thrombosis (DVT) of right lower extremity of the patient disappeared. At follow-up of 4 months, the patient was re-examined with chest enhanced CT in the outpatient department of our hospital and no obvious emboli was found.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 21 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is reported as 180 beats per minute, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 91% on room air, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: The patient presents with \"acute onset of copious blood-tinged phlegm,\" indicating hemoptysis. Therefore, this criterion is not met (false).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it is reasonable to assume this criterion is met (true), although it's not explicitly stated.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, based on the information provided, this criterion is met (true).\n",
      "\n",
      "Given the evaluations above, the PERC score is calculated by summing the false values: 3 criteria are not met (Heart rate < 100 bpm, Oxygen saturation ≥ 95%, and No hemoptysis), so the PERC score is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient meets criteria 1 (Age < 50), 5 (No estrogen use), 6 (No prior VTE), and 7 (No unilateral leg swelling) but does not meet criteria 2 (Heart rate < 100 bpm), 3 (Oxygen saturation ≥ 95%), and 4 (No hemoptysis) based on the provided patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 9 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [24, 'years'], 'Heart Rate or Pulse': [98.0, 'beats per minute'], 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False, 'O₂ saturation percentage': [99.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': True, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 24-year-old woman presents to the emergency department for chest pain and shortness of breath. She was at home making breakfast when her symptoms began. She describes the pain as sharp and located in her chest. She thought she was having a heart attack and began to feel short of breath shortly after. The patient is a college student and recently joined the soccer team. She has no significant past medical history except for a progesterone intrauterine device which she uses for contraception, and a cyst in her breast detected on ultrasound. Last week she returned on a trans-Atlantic flight from Russia. Her temperature is 98.4°F (36.9°C), blood pressure is 137/69 mmHg, pulse is 98/min, respirations are 18/min, and oxygen saturation is 99% on room air. Physical exam reveals an anxious young woman. Cardiac and pulmonary exam are within normal limits. Deep inspiration and palpation of the chest wall elicits pain. Neurologic exam reveals a stable gait and cranial nerves II-XII are grossly intact.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 45 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's initial heart rate was 116 bpm, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation was 98% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: The patient denied cough, shortness of breath, chest pain, and fever, but there is no specific mention of hemoptysis. However, given the context, it seems reasonable to assume that if hemoptysis were present, it would have been noted. Therefore, we will consider this criterion as met (true), but it's worth noting that the information is not explicitly provided.\n",
      "\n",
      "5. **No estrogen use**: The patient note does not mention the patient being on any medications, including estrogen. Given that she is a nursing assistant and the context provided, it seems reasonable to assume that if she were on estrogen, it would have been mentioned, especially since she is not on any other medications. Therefore, we will consider this criterion as met (true), but again, the information is not explicitly provided.\n",
      "\n",
      "6. **No prior VTE**: There is no mention of prior venous thromboembolism (VTE) in the patient note. Therefore, based on the information provided, we will consider this criterion as met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note mentions that the patient had cold and clammy extremities but does not specifically mention unilateral leg swelling. Given the absence of this detail, and considering the focus on other symptoms, we will assume this criterion is met (true), though, like other criteria, it's not explicitly stated.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated as follows:\n",
      "\n",
      "- The patient meets criteria 1, 3, 4, 5, 6, and 7 (assuming no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling based on the information provided).\n",
      "- The patient does not meet criterion 2 (heart rate < 100 bpm).\n",
      "\n",
      "Therefore, the patient has 1 false criterion out of the 7, which corresponds to a PERC score of 1.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on the provided patient note. The patient is under 50, has an oxygen saturation of 98%, and there's no explicit mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling, so these criteria are considered met. The heart rate was above 100 bpm, so this criterion is not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 10 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'No estrogen use']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [55, 'years'], 'Heart Rate or Pulse': [100.0, 'beats per minute'], 'O₂ saturation percentage': [96.0, '%'], 'Hemoptysis': False, 'Recent surgery or trauma': False, 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 55-year-old African American male with past medical history of hypertension, diabetes, and hyperlipidemia was admitted for fever and difficulty breathing for several days. His associated symptoms were chest tightness without any pain. A diagnosis of possible community-acquired coronavirus was made. His vital signs were a temperature of 101.8 °F, heart rate of 100 beats/min, blood pressure of 163/101 mmHg, respiratory rate of 16 breaths/min, and pulse oximetry of 96% on room air. Physical examination was remarkable for decreased breath sounds without any rales or rhonchi. The patient was placed on nasal cannula. Tests for influenza and respiratory syncytial virus by PCR were negative. Initial chest X-ray (CXR) revealed right upper lobe and bilateral lower lobe infiltrates (Figure ), without hilar fullness, congestion, or Kerley lines. Complete blood count and complete metabolic panel were remarkable for sodium of 133 mmol/L, blood glucose of 230 mg/dL, and a creatinine of 1.51 mg/dL. Troponin was elevated at 0.307 ng/ml and it slowly trended down afterwards. He was transferred to our facility on hospital day 2. The initial workup at our facility was unremarkable with a creatinine of 1.2 mg/dL and negative troponin level. Hemoglobin A1c was 8.7%. His inflammatory markers were markedly elevated, with a C-reactive protein (CRP) of 34.86 mg/dL and a D-dimer of 462. A CXR showed bilateral infiltrate (Figure ). He was placed on airborne and contact precautions. He was started on oral hydroxychloroquine and intravenous ceftriaxone with the eventual addition of doxycycline for a suspected superimposed bacterial pneumonia. His home medication of Losartan was held during hospitalization. Repeated nasal COVID PCR swabs on hospital day 2 and 3 were negative. Blood and urine cultures were negative as well. Electrocardiogram revealed left bundle branch block. Echocardiogram suggested by cardiologist revealed a reduced ejection fraction of 35%. The patient was placed on 4-5 liters of oxygen via nasal cannula throughout the hospital course and his symptoms were well controlled. Subsequently, he was able to wean off the supplemental oxygen. His CRP and D-dimer trended down. He was discharged with instructions on self-isolation.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 42 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse is 132 beats/min, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 100% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: The patient used a contraceptive vaginal ring for three months prior to presentation, which indicates estrogen use. Therefore, this criterion is not met (false).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, we assume this criterion is met (true), as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the number of false values, which are criteria 2 (Heart rate < 100 bpm) and 5 (No estrogen use).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient meets criteria 1, 3, 4, 6, and 7 but does not meet criteria 2 and 5.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 11 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'No estrogen use']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [65, 'years'], 'Heart Rate or Pulse': [52.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Recent surgery or trauma': False, 'Hormone use': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 65-year-old male presented with an abrupt onset of sharp, burning, constant right lower abdominal pain after previously been feeling well. There was no history of trauma, fever, vomiting, diarrhea, chest pain, shortness of breath, syncope, dysuria, hematuria or melena. His past medical history included hypertension, atrial flutter and cardiomyopathy, and he had an implantable cardioverter/defibrillator (ICD). There was no prior history of abdominal aortic aneurysm in the patient or in his family. His past surgical history included an inguinal hernia repair. His medications included aspirin, valsartan, metoprolol and atorvastatin. He did not smoke, use alcohol or illicit drugs.\n",
      "Physical exam showed vitals signs as follows: body temperature of 36.3°C, blood pressure of 140/82 mmHg, heart rate of 52 beats per minute, respiratory rate of 18 breaths per minute and pulsoximetry of 98% on room air. He was alert, but appeared in mild distress due to pain. His abdominal exam revealed tenderness to palpation in the right lower quadrant, with no rebound, guarding, distention or organomegaly. The remainder of the exam was normal.\n",
      "The initial emergency department evaluation included an electrocardiogram that showed atrial flutter with a 4:1 block. Laboratory assessment revealed trace hematuria, no leukocytosis, creatinine of 1.3 mg/dL (normal range, 0.7–1.4 mg/dL), mildly elevated lipase to 85 U/L (normal range, 12–70 U/L), mild hyperglycemia and mildly elevated aspartate aminotransferase to 46 U/L (normal range, 7–40 U/L). The lactate and coagulation profiles were within normal limits. Lactate dehydrogenase was not ordered at presentation, but obtained 2 days after admission, and was elevated at 1,479 U/L (normal range, 100–220 U/L). Lactate dehydrogenase is present in the renal tissue and elevates in serum after kidney insult, and it is unknown whether this level correlates to the severity of the infarct.\n",
      "Given the nature of the pain and the hematuria seen on urinalysis and the history of cardiomyopathy with atrial flutter, both nephrolithiasis and mesenteric ischemia were strongly considered as causes for this acute pain. Therefore, both non-contrast- and contrast-enhanced helical computed tomography (CT) images [Figures and ] were obtained, which showed extensive infarction involving the upper pole of the right kidney with multiple patchy infarcts into the lower pole, a patent right renal artery, but no visualization of the interparenchymal arterial branches within the mid and upper poles of the right kidney, suggesting arterial thromboembolic disease. There was poor opacification of the right renal vein, and, therefore, renal vein thrombus could not be ruled out. A 2-mm left renal calculus was also identified.\n",
      "The urology and vascular surgery services were consulted, and both recommended conservative treatment with anticoagulation. In addition to normal saline and dilaudid for pain control, a heparin bolus of 80 mg/kg was given and an infusion at 18 mg/kg/h was initiated, with the patient being admitted to the general medicine service.\n",
      "It was concluded his renal artery thrombosis was most likely embolic and a 2-D echocardiogram was ordered, which showed no intramural thrombus. He was discharged 5 days later, on coumadin. His creatinine, which was 1.3 mg/dL on admission, rose to 1.8 mg/dL and fell to 1.7 mg/dL by discharge. One month later, the creatinine levels had declined to 1.6 mg/dL.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 27 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate range is 75-90 beats per minute, which is less than 100 bpm. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 97% on room air, which is greater than or equal to 95%. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of the patient experiencing hemoptysis (coughing up blood). Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: The patient is actually being discharged with norethindrone hormonal therapy, which is a form of estrogen therapy. Therefore, this criterion is not met (false).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of the patient having a prior VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient denied lower extremity swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which in this case is only 1 (for the \"No estrogen use\" criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, heart rate, oxygen saturation, symptoms, medical history, and current treatments as described in the patient note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 12 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [22, 'years'], 'Heart Rate or Pulse': [92.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 22-year-old female G2P0010 at 36 weeks gestation presented to an outside hospital with a 24-hour history of left flank pain and nausea. The pain was sharp, stabbing, constant, and radiated to the left mid-abdomen. She denied fever, chills, dysuria, hematuria, urinary frequency, or urgency. She underwent a CT scan that was concerning for adrenal hemorrhage [Figures and ]. She was noted to have blood pressure in the non-severe range. Later she developed severe range blood pressure and was found to have normal preeclampsia labs and negative urine spot. She was treated with antihypertensive medications including IV hydralazine 10 mg × 1, 20 mg × 2. She underwent an MRI that confirmed left adrenal hemorrhage []. Subsequently, she was transferred to our hospital.\n",
      "Upon transfer, the patient's vital signs were as follows: blood pressure 168/110 mmHg, heart rate 92 beats per minute, oxygen saturation 99% on room air, and respiratory rate 18 per minute. The abdomen was gravid, soft and non-tender to palpation. Her laboratory values were notable for a white blood cell count of 19,000/uL, hematocrit (Hct) of 30.8% and spot protein/creatinine ratio of 0.3 g/day. All other laboratory values including liver function and coagulation tests were within normal limits.\n",
      "A review of her history revealed an uneventful pregnancy without prior history of chronic hypertension, gestational hypertension, episodic hypertension, flushing, diarrhea, malignancy, endocrine dysfunction, coagulation disorder, family or personal history of a bleeding disorder, or blunt trauma to the abdomen. Her past medical history was notable only for migraine headaches and anxiety/depression not requiring pharmacological therapy. Her past surgical history included right laparoscopic oophorectomy for a large simple cyst.\n",
      "A plan was made for conservative management of her adrenal hemorrhage and blood pressure control. Based on severe-range blood pressure on intravenous antihypertensive therapy, a diagnosis of preeclampsia with severe features was made. The patient was offered an external cephalic version for fetal breech presentation, but she declined. A decision was made to proceed with cesarean delivery. A combined spinal-epidural anesthetic was provided without complication. The patient tolerated the surgery well and was discharged home 5 days later.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 59 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 75 beats/minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 95% on ambient air, which meets the criterion. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: The patient denied respiratory symptoms, and there is no mention of hemoptysis. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. Given that the patient is a male, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: There is no mention of the patient having a prior VTE. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: The examination was otherwise unremarkable, with no mention of unilateral leg swelling. Therefore, this criterion is true.\n",
      "\n",
      "Given the evaluation of these criteria, the PERC score can be calculated by summing the false values, which in this case is only the first criterion (Age < 50 years).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has a heart rate less than 100, oxygen saturation of 95%, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling. Only the age criterion is false.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 13 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['No prior VTE']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [53, 'years'], 'Heart Rate or Pulse': [90.0, 'beats/minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 53-year-old man (height, 170 cm; weight, 89 kg) was admitted to the hospital because of a 1-year history of shortness of breath after exercise. The patient was a smoker, had a history of hypertension, and was taking captopril and nimodipine. Breathing was reduced in the left lung. However, neither rhonchus nor moist rales were heard during auscultation. Chest computed tomography revealed a GEB, and the left lung was compressed by about 95% with a right mediastinal shift (). An electrocardiogram showed normal findings, and echocardiography revealed that the heart was located in the right thoracic cavity. The left ventricular diastolic function was decreased, and the left ventricular ejection fraction was 64%. Laboratory tests showed no obvious abnormalities. Arterial blood gas analysis showed the following: pH: 7.43, PaCO2: 41 mmHg, PaO2: 94 mmHg, lactate: 1.4 mmol/L, potassium: 3.6 mmol/L, sodium: 138 mmol/L, calcium: 1.10 mmol/L, FiO2: 21%, and SpO2: 98%.\n",
      "On the day of surgery, the patient’s electrocardiogram, blood pressure, SpO2, and bispectral index were monitored upon entry into the operating room. A radial artery catheter and right internal jugular venous catheter were placed. The patient’s arterial blood pressure was 175/109 mmHg, heart rate was 90 beats/minute, and SpO2 was 94%. Before anesthesia, 40 µg of dexmedetomidine was infused within 10 minutes. The thoracic surgeon then created a small incision at the intersection of the sixth intercostal space and the left mid-axillary line to puncture the lung bulla and insert an indwelling catheter (14 Ga, 16 cm in length; Arrow International/Teleflex, Wayne, PA, USA) into the GEB to drain it for 15 minutes. The patient was preoxygenated with 100% oxygen at 6 L/minute for 5 minutes. Anesthesia was administered using 100 mg of propofol, 30 µg of sufentanil, and 50 mg of rocuronium. A 37-Fr right double-lumen endotracheal tube was inserted with the help of a visual laryngoscope, and single-lung ventilation was performed after proper alignment had been confirmed by fiberoptic bronchoscopy. The tidal volume was set at 5 to 6 mL/kg, the respiratory rate was 15 to 17 breaths/minute, the positive end-expiratory pressure was set at 5 cmH2O, and the inhalation:expiration ratio was 1:2. Propofol, remifentanil, and sevoflurane were used to maintain anesthesia. The intraoperative bispectral index was maintained at 40 to 50. After resecting the GEB (), one-lung ventilation was switched to two-lung ventilation and the lungs slowly expanded with a low tidal volume until complete lung re-expansion was observed. During the 3-hour surgery, the patient experienced 50 mL of blood loss, was administered 1300 mL of lactated Ringer’s solution, and excreted 500 mL of urine. After the operation, the double-lumen endotracheal tube was replaced with a single-lumen endotracheal tube and the patient was sent to the intensive care unit for monitoring and further treatment. Two hours after entering the intensive care unit, the patient was fully awake and the tracheal tube was smoothly removed. The following day, the patient was transferred to the thoracic surgery ward, where he recovered; he was discharged 12 days later. Postoperative chest computed tomography showed that the lungs were well inflated with no abnormalities ().\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 64 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 72 bpm, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 100% on air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: The patient is a male, and there is no mention of estrogen use. Therefore, this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a history of pulmonary embolism, which is a type of VTE. Therefore, this criterion is false.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has bilateral mild pitting oedema, which means he has swelling in both legs, not just one. Therefore, this criterion is true.\n",
      "\n",
      "Now, let's count the number of false criteria to determine the PERC score. The false criteria are \"Age < 50 years\" and \"No prior VTE\". Therefore, the PERC score is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient's age is greater than 50, and he has a history of pulmonary embolism. All other criteria are met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 14 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'O₂ ≥ 95%', 'No prior VTE']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [24, 'years'], 'Heart Rate or Pulse': [110.0, 'beats per minute'], 'O₂ saturation percentage': [87.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Hormone use': False, 'Unilateral Leg Swelling': False, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 24-year-old man, a newly appointed automobile mechanic, presented to the emergency room of Tribhuvan University Teaching Hospital with a chief complaint of progressive shortness of breath, low-grade fever, bilateral chest pain, and nonproductive cough for three days. The shortness of breath was exertional, and the patient did not complain of any orthopnea, paroxysmal nocturnal dyspnea, or pedal edema. The low-grade fever occurred three days before dyspnea, had a Tmax of 99.8°F, was on and off, and was not associated with chills or rigors. There was no history of wheezing, sputum production, hemoptysis, night sweats, weight loss, or anorexia. He denies any rash, joint pain, numbness, or weakness in the extremities. On detailed inquiry, he revealed that he recently started working as an automobile mechanic and had to aspirate diesel from fuel tanks often. As he was new to this job, he had accidentally aspirated a small volume of diesel several times in the last two weeks. He was a nonsmoker and had never consumed alcohol in his lifetime. The patient had no past medical history of note, no history of allergies, and had not taken any drugs or medications recently.\n",
      "On examination, he was ill-looking with a temperature of 98°F, a sphygmomanometric blood pressure of 140/90mmHg, a heart rate of 110 beats/minute, and a respiratory rate of 28/minute saturating poorly in ambient air (peripheral SpO2 87%, as measured by pulse oximetry). He had no pallor, icterus, lymphadenopathy, cyanosis, clubbing, edema, and dehydration. There was a decreased excursion of the chest wall on chest examination, diminished breath sounds bilaterally along with diffuse bilateral basal crepitations, and a dull stony percussion note bilaterally. The examination of other systems did not reveal any abnormalities. The patient had leukocytosis with a total WBC count of 13900/mm3, and differential leukocyte count consisted of 90% neutrophils and 10% lymphocytes. Hemoglobin, hematocrit, and platelet count were normal. Renal function test, liver function test, coagulation assay, and serology tests were regular. Arterial blood gas analysis was within the reference range.\n",
      "Chest X-ray (CXR) done at admission (Figure ) showed pneumonic consolidation over the bilateral lung field with bilateral pleural effusion and pneumothorax. Chest tubes were inserted bilaterally under ultrasound guidance to alleviate pleural effusion and pneumothorax. On the second day of chest tube insertion, CXR (Figure ) was done again, revealing the left lung's expansion, persistent right-sided pneumothorax, and bilateral surgical emphysema. Contrast-enhanced computed tomography of thorax revealed right-sided pneumothorax, bilateral pleural effusion, bilateral patchy consolidated lung parenchyma, and bilateral chest tube in situ.\n",
      "Owing to radiological findings, clinical features, and siphonage history, the diagnosis of hydrocarbon pneumonitis was made. Since Nepal is a tuberculosis endemic region, pulmonary tuberculous was also considered as alternative diagnosis. However, sputum examination did not reveal the acid-fast organism; neither did the GeneXpert PCR test. The patient was kept under intravenous piperacillin/tazobactam, nebulization was done six hourly, and high flow oxygen was administered. The patient developed no complications during his hospital stay. The patient was discharged after two weeks when there was significant radiological regression of consolidations (Figure ), improvements in pulmonary symptoms, and maintenance of oxygen saturation above 90% in room air. The patient was advised to follow-up regularly and is doing well at the time of writing.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 63 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 65 beats per minute, which is less than 100. Therefore, this criterion is true.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is 97% on room air, which is greater than or equal to 95%. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has a history of recurrent deep vein thrombosis and a recent pulmonary embolus, indicating prior VTE. Therefore, this criterion is false.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false criteria, which are \"Age < 50 years\" and \"No prior VTE\".\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is older than 50, has no heart rate issues, normal oxygen saturation, no hemoptysis, no estrogen use, a history of VTE, and no mention of unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 15 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [29, 'years'], 'Heart Rate or Pulse': [100.0, 'beats per minute'], 'O₂ saturation percentage': [95.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Unilateral Leg Swelling': False, 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 29-year-old male presented to the Emergency Department with a penetrating stab wound to the anterior left second intercostal space, 2 cm medial to the mid-clavicular line. Previous medical history consisted of a right tibia-fibula fracture with intra-medullary nailing 7 years prior.\n",
      "The patient presented haemodynamically unstable, in grade 3 haemorrhagic shock and after resuscitation, improved as a transient fluid responder. A left-sided intercostal drain was inserted for a large haemothorax. Vital signs after resuscitation: heart rate 100; respiratory rate 14; saturating at 95% on room air; blood pressure 101/64. Post-resuscitation, no angina was reported. On examination: no features of cardiac failure, central cyanosis, bruits, or murmurs were elicited. No ST or other rhythm abnormalities were noted on electrocardiogram (). Pertinent findings were that of chronic septic hardware of the right lower limb which on further enquiry, had not been formally assessed by an orthopaedic service. Microbiological workup of the local septic limb was deferred until after haemodynamic stabilization.\n",
      "A preliminary diagnosis of local septic hardware led to screening for methicillin-resistant Staphylococcus aureus, and antibiotic prophylaxis with broad-spectrum coverage.\n",
      "Focused Assessment with Sonography for Trauma scan demonstrated a 1 cm pericardial effusion. A contrasted computed tomographical scan of the chest and cardiac TTE was ordered.\n",
      "Computed tomographical findings () demonstrated a right ventricular outflow tract (RVOT) injury at the level of the pulmonary valve and an associated suspected thrombus. A small aortic root injury with a small pseudo-aneurysm and intimal flap was also observed. The injury tract extended to the medial superior vena cava (SVC) and a high index of suspicion for an SVC injury was entertained.\n",
      "Transthoracic cardiac ECHO () findings did not demonstrate valvulopathies, clear flow reversal or shunting, regional wall motion abnormalities, tamponade, or features of infective endocarditis. The patient had a preserved left ventricular ejection fraction. A large dense lesion was noted immediately beneath the pulmonary valve which demonstrated beat to beat movement and was noted to be highly suggestive of a clot.\n",
      "Pertinent laboratory findings showed that the patient had normal renal and liver function with a normocytic normochromic anaemia (haemoglobin = 10.9) and no coagulation abnormalities (normal prothrombin and partial thromboplastin time).\n",
      "The patient was intubated under general anaesthesia with a single lumen endotracheal tube (). Femoral cardiopulmonary bypass was initiated via the left groin. A median sternotomy was performed and no active bleeding was seen.\n",
      "The aorta was then clamped and the heart arrested with cold blood cardioplegia administered into the aortic root. Cardioplegia was given every 20 min throughout the procedure.\n",
      "A large clot was found within a defect in the medial wall of the RVOT, abutting the ascending aorta, and was subsequently removed. The RVOT was repaired with continuous 3/0 prolene sutures.\n",
      "The aorta was opened via a transverse ‘J’ incision (). There was a 0.5 cm laceration in the aortic wall, ∼1 mm left of the right coronary ostium which was repaired primarily. The plane between the main pulmonary artery (PA) and ascending aorta was dissected and opened. The right coronary artery was not injured. The contralateral side of the ascending aorta (right side) also had a defect through it and there was a small point injury to the base of the SVC which were both primarily repaired.\n",
      "Pre-operative radiological findings had a good correlation with the intra-operative findings and no other intra-operative injuries were noted.\n",
      "The patient was weaned off of cardiopulmonary bypass and closure of the femoral cannulation site, and sternum was performed successfully. The patient remained intubated and was transported to intensive care unit.\n",
      "A complete recovery was made with no residual thrombus or intracardiac shunt at early follow-up. There was no cardiac, respiratory, or neurological sequelae at 30-day follow-up.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 24 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 110 beats/minute, which is greater than 100. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's peripheral SpO2 is 87%, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: The patient does not have hemoptysis, as stated in the note. Therefore, this criterion is met (true).\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen. Given the patient is a male, it's reasonable to assume this criterion is met (true), although the note does not explicitly address estrogen use in men.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient has no past medical history of note, which implies no prior VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient does not have pedal edema or any mention of unilateral leg swelling. Therefore, this criterion is met (true).\n",
      "\n",
      "Given these evaluations, the PERC score is calculated by summing the false values, which are criteria 2 and 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets criteria 1, 4, 5, 6, and 7 but does not meet criteria 2 and 3 due to a heart rate over 100 bpm and oxygen saturation below 95%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 16 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [59, 'years'], 'Heart Rate or Pulse': [93.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Recent surgery or trauma': False, 'Hormone use': False, 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 59-year-old female presented to the ED with a chief complaint of abdominal pain. Her abdominal pain began three hours before presentation and had awoken her from sleep. This abdominal pain was described as “achy,” 5/10, intermittent, and located in the left lower quadrant without radiation. She denied nausea or vomiting and had no diarrhea or blood in her stools. Review of systems revealed that the patient had symptoms of dysuria for one day and left-sided flank pain along with her abdominal pain. She denied fevers or chills. She stated that, despite taking her prescribed insulin injections, her blood sugars have been persistently elevated above 400 with her personal glucometer. Her past medical history was significant for insulin-dependent diabetes mellitus (DM), hypertension, and prior cerebrovascular accident. She denied ever having any surgeries. She used regular insulin, Lantus (insulin glargine), and Ibuprofen. Her family history was noncontributory, and she denied alcohol, tobacco, or illicit drug use.\n",
      "Physical exam revealed a temperature of 36.5° C, respiratory rate of 18 breaths per minute, heart rate of 93 beats per minute, blood pressure of 166/81 mm Hg, oxygen saturation of 99% on room air, and capillary blood glucose of 447 mg/dL. She was awake, alert, and interacting appropriately. Her pupils were equally round and reactive to light. The cardiac exam was normal and lungs were clear with breath sounds bilaterally. The abdomen was soft with minimal tenderness to palpation in the left periumbilical and left lower quadrant. There was no guarding or rebound. Extremities were warm and well-perfused. The neurological exam revealed no deficit.\n",
      "The metabolic panel revealed sodium of 132 mEq/L (normal 135–145), BUN of 45 mg/dL (normal 8–22), Creatinine of 2.0 mg/dL (normal 0.5–1.3), glucose of 473 mg/dL, and an anion gap of 8.0. A CBC revealed a white blood cell count of 12.0 K/MM3 (normal 4.5–11.0) and a manual differential with 10.10 K/MM3 Neutrophils (normal 0.80–7.70). The hepatic panel was remarkable for an alkaline phosphatase of 189 U/L (normal 35–115). The urine was visibly clear and non-turbid. Urinalysis was leukocyte esterase and nitrate negative, but revealed large occult blood, glucosuria, protein of 300 mg/DL, and 3–6 WBC/HPF (normal 0–3).\n",
      "While laboratory studies were pending, the patient received one liter IV normal saline, four mg of morphine sulfate IV for pain, and 10 units of regular insulin. Despite fluid administration and analgesia, the patient continued to have worsening 6/10 abdominal pain. Given the patient’s presentation of undifferentiated abdominal pain without clear etiology and her immunocompromised state, a non-contrast computed tomography (CT) scan of the abdomen was ordered. The CT scan revealed significant air in the bladder wall and lumen consistent with EC, severe left hydroureter and hydronephrosis without evidence of stones, and significant left perinephric stranding without gas in the renal parenchyma ().\n",
      "A gram of Ceftriaxone and 500 mg of Gentamycin were started empirically along with a repeat fluid bolus and placement of a Foley catheter. While awaiting consultation and admission to the Urology service, the patient complained of increased abdominal pain and was increasingly tender in the left lower quadrant and suprapubic region. Her heart rate was persistently tachycardic (in the 130s), and she developed a fever to 39.4°C. In light of developing urosepsis and the potential for rapid progression to Emphysematous pyelonephritis, Interventional Radiology (IR) was consulted and placed a left nephrostomy tube to relieve the functional obstruction of the urinary tract just eight hours after the patient presented to the ED. After nephrostomy tube placement by IR, the patient was admitted to the ICU for close monitoring. The urine culture grew out Klebsiella pneumoniae and the patient was continued on IV antibiotics. Three days after admission, the nephrostomy tube was removed as the patient was able to void without use of a foley catheter and was able to control her pain. She was subsequently discharged and given a prescription for Levofloxacin 500 mg every day for fourteen days.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 42 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is mentioned as 110-120 beats/min, which is greater than 100 bpm. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (sPO2) is 95% on room air, which meets this criterion (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is met (true), as there's no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the context, it seems unlikely, and without explicit mention, we consider this criterion met (true) based on the information provided.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any prior VTE. Therefore, this criterion is considered met (true) based on the information available.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Thus, we consider this criterion met (true) as there's no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations:\n",
      "- The patient meets criteria 1, 3, 4, 5, 6, and 7 (true).\n",
      "- The patient does not meet criterion 2 (false).\n",
      "\n",
      "The PERC score is calculated by summing the number of false criteria, which in this case is 1 (for the heart rate criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient is under 50, has an oxygen saturation of 95%, no hemoptysis, no mentioned estrogen use, no prior VTE, and no unilateral leg swelling. However, the patient's heart rate is over 100 bpm.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 17 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['HR < 100', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 4 | Predicted: 4\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [73, 'years'], 'Previously Documented Pulmonary Embolism': True, 'Heart Rate or Pulse': [72.0, 'beats per minute'], 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': False, 'O₂ saturation percentage': [94.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': True}\n",
      "\n",
      "Patient Note:\n",
      "A 73-year-old woman with a history of lower limb venous insufficiency, obesity, dyslipidaemia and impaired fasting glucose, who was not taking any medications, was admitted to another hospital due to compressive chest pain. Chest CT angiography demonstrated a proximal ascending aorta dissection. The patient was transferred to our tertiary medical centre and admitted to the cardiac surgery department. Since she came from an endemic area, she was tested for COVID-19 infection by RT-PCR testing of a nasopharyngeal swab, which came back positive. The cardiac surgeons postponed surgery, asked the patient to avoid mobilization, and kept her blood pressure low by administering intravenous labetalol. Physical examination upon arrival at the intensive care unit was notable for an oral temperature of 36.8°C, heart rate of 72 beats/min, respiratory rate of 24 breaths/min, blood pressure of 106/55 mmHg, and oxygen saturation of 94% in room air. Laboratory tests showed no leucocytosis, D-dimer blood levels of 7,353 ng/ml, and CRP blood levels of 129 mg/l. Another chest CT angiogram showed no change in the aortic dissection. The patient was not treated with thromboprophylaxis because of the high risk of aortic rupture and bleeding, but a pneumatic compression device on both legs was used in order to prevent deep vein thrombosis.\n",
      "Over the next days the patient was asymptomatic, oxygen saturation was normal most of the time, CRP blood levels decreased to 67 mg/l, and four RT-PCR tests for COVID-19 infection on nasopharyngeal swabs came back negative. However, there was a discrepancy between these signs and laboratory findings and the steady increase in D-dimer blood levels that reached 3,1041 ng/ml (). A third CT angiogram showed no change in the aortic dissection, but a new bilateral PE was demonstrated (). Thereafter, the patient underwent aortic dissection repair and thrombectomy.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 55 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's initial heart rate was 119/min, and it remained elevated throughout the hospital stay, often above 100 bpm. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's initial oxygen saturation was 93% on room air, which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is true.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. Given the patient is a male, it is reasonable to assume this criterion is true.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient was found to have a right popliteal deep vein thrombosis (DVT) during the hospital stay, indicating a current VTE. However, there is no explicit mention of a prior VTE. Since the presence of a current VTE does not necessarily imply prior VTE, and there's no information provided about previous episodes, we might consider this criterion as true based on the information given. However, the development of pulmonary emboli and DVT suggests a propensity for VTE, but without explicit prior history, we will consider it true for the purpose of this calculation.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient had a right popliteal DVT, which could be associated with unilateral leg swelling, although the note does not explicitly mention swelling. Given the presence of DVT, it is plausible to consider that unilateral leg swelling could be present, even though not explicitly stated. However, without clear evidence, we might lean towards considering this criterion as false due to the presence of DVT, which often correlates with swelling.\n",
      "\n",
      "Given these considerations, the explanation for each criterion and the calculation of the PERC score are as follows:\n",
      "\n",
      "- **Age < 50**: False\n",
      "- **HR < 100**: False\n",
      "- **O₂ ≥ 95%**: False\n",
      "- **No hemoptysis**: True\n",
      "- **No estrogen use**: True\n",
      "- **No prior VTE**: True (based on lack of explicit prior history)\n",
      "- **No unilateral leg swelling**: False (considering the DVT and potential for associated swelling)\n",
      "\n",
      "The PERC score is the sum of the false criteria, which are 4 in this case.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score was calculated based on the provided note. The patient was older than 50, had an elevated heart rate, oxygen saturation below 95%, no mention of hemoptysis or estrogen use, no explicit prior VTE, but had a DVT which might imply potential for unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 18 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%', 'No hemoptysis']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [40, 'years'], 'Heart Rate or Pulse': [100.0, 'beats per minute'], 'O₂ saturation percentage': [78.0, '%'], 'Unilateral Leg Swelling': True, 'Recent surgery or trauma': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "Mrs. A.O., a 40-year-old known SCD patient with hemoglobin SS genotype was referred to the pulmonary division on account of dry cough of 3 weeks, difficulty in breathing of 2 weeks, and bilateral leg swelling of 4 days. There was low-grade fever, no weight loss, and no contact with chronic cough index. Difficulty in breathing initially occurred on exertion but later occurred even at rest. There was orthopnea but no paroxysmal nocturnal dyspnea. There was bilateral leg swelling, which worsened progressively. No swelling in other parts of the body. No reduction in her urine volume. She was not a diagnosed asthmatic, hypertensive, or diabetic and she was not previously treated for tuberculosis or any other chronic lung diseases. She was only admitted for childbirth in her adulthood years. She had a single episode of blood transfusion when she was 6 years old. Afterwards, she has been crisis free for more than 20 years. She neither smokes cigarettes nor consumes alcoholic drinks. No history of exposure to cigarette smoke from others. She is married in a monogamous family with two girls and one boy. Her last childbirth was 15 years prior to presentation. She works as a secretary in the registration office of a state polytechnic. No history of exposure to occupational dust or fumes. No history of chronic drug use and no history of allergy.\n",
      "On general examination, she was a middle aged looking woman, conscious, dyspneic with central cyanosis, afebrile (Temperature=36.5), not pale, anicteric, not dehydrated, grade 3 digital clubbing, bilateral pitting pedal edema up to the lower third of the leg, weight=84 kg, height=1.65 m, and BMI=30.9 kg/m2. Oxygen saturation in room air was 78% and this increased to 92% on 5 L/min of oxygen via nasal prong.\n",
      "Respiratory examination revealed that she was in respiratory distress as evidenced by respiratory rate of 42/ min, flaring of alae nasi, and use of accessory muscles of respiration, and the trachea was central with symmetrical chest movement. Percussion note was resonant with coarse crepitations over the entire right lung and posterior lower zone of the left lung.\n",
      "Cardiovascular examination: pulse=100 beats/min, regular with premature beats, full volume; arterial wall was not thickened. No locomotor brachialis. BP was 105/60 mmHg. JVP was raised to the angle of the jaw. She had a right parasternal heave and apex beat was in the 5th left intercostal just lateral to the mid-clavicular line. Heart sounds were S1, S2, S3 gallop rhythm with loud pulmonary component of second heart sound.\n",
      "Abdomen – full, moves with respiration, liver was 4 cm below the costal margin, mildly tender, smooth surface, and span of 16 cm. Spleen and kidneys were not enlarged. No demonstrable ascites.\n",
      "Other systems were within normal limits.\n",
      "Her packed cell volume was 32% with a white blood cell count of 13.5 ×109/L (neutrophil=52%, lymphocyte=38%, other=9%) and erythrocyte sedimentation rate of 3 mm/h. Sputum examination for acid and alcohol fast bacilli was negative in three samples; sputum culture did not yield any growth. Chest X-ray showed widespread reticulonodular opacities involving the whole of the right lung field and left upper zone with an area of hyperluscency in the left mid and lower zones. Electrocardiography revealed sinus tachycardia of 120 beats/min, P pulmonale, and right ventricular hypertrophy with ventricular extrasystole. Echocardiography demonstrated tricuspid regurgitation with pulmonary hypertension. Spirometry showed severe restrictive pattern {FVC=1.13 L (36% of predicted); FEV1=0.84 L (35% of predicted) FEV1/FVC ratio=74.5% (92% of predicted)}. Chest CT demonstrated diffuse ground glass opacity with thickening of interlobar septa in the entire right lung field as well as left apex and part of the left lower region. There were multiple bullae with reduced attenuation (suggestive of compensatory emphysema of the remaining lung tissue) in the left lung field, sparing the apex. The pulmonary trunk was prominent and there was cardiomegaly [Figures –].\n",
      "She was admitted and managed initially in the intensive care unit with intranasal oxygen, cardiopulmonary monitoring, tablet levofloxacin 500 mg daily, intravenous frusemide 60 mg 8 hourly, tablet spironolactone 25 mg twice daily, and tablet aspirin 75 mg daily.\n",
      "The heart failure gradually improved but she continued to desaturate in room air. She was advised on domiciliary oxygen, which she initially rejected but later purchased a cylinder of oxygen (did not purchase oxygen concentrator because of poor power supply) and pulse oximeter. She was discharged home, on 1–3 L/min of domiciliary oxygen (to be titrated with the pulse oximeter readings), aspirin, and oral diuretics, after 1 month of hospitalization. She was re-admitted 1 week later with productive cough and features of right heart failure. She was managed with oxygen, diuretics, antibiotics, and aspirin. She improved and was discharged after 3 weeks. She has remained relatively stable at subsequent clinic visits. Her clinic oxygen saturation was 91-94% (off oxygen) during clinic visits.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 68 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is initially mentioned as 100 beats per minute, and later it increases to 120 beats per minute. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation is initially 96% on air, which meets this criterion. However, it's important to note that later in the note, his oxygen saturation improves to 93% on air after treatment, but at the time of initial evaluation for PERC, it was 96%, making this criterion true.\n",
      "\n",
      "4. **No hemoptysis**: The patient experiences significant hemoptysis, coughing up approximately 600 mL of fresh blood. Therefore, this criterion is false.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of the patient using estrogen, but given the patient is a male, estrogen use is unlikely. However, without explicit confirmation, this could be considered not directly applicable, but based on the context provided, we can infer this criterion as true because there's no indication of estrogen use.\n",
      "\n",
      "6. **No prior VTE (Venous Thromboembolism)**: The patient develops a pulmonary embolus during his hospital stay, but there is no mention of a prior VTE. Therefore, this criterion is true.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, we can consider this criterion as true, given the absence of information suggesting otherwise.\n",
      "\n",
      "Given these evaluations:\n",
      "- The false criteria are: Age < 50 years, Heart rate < 100 bpm, No hemoptysis.\n",
      "- The true criteria are: Oxygen saturation ≥ 95%, No estrogen use, No prior VTE, No unilateral leg swelling.\n",
      "\n",
      "The PERC score is the sum of the false criteria, which in this case is 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. Each false criterion adds 1 point to the score. The patient's age is over 50, heart rate is over 100 bpm, and he experienced hemoptysis, contributing to his PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 19 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [52, 'years'], 'Heart Rate or Pulse': [90.0, 'beats per minute'], 'O₂ saturation percentage': [96.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "The patient was a 52-year-old man who referred to the Poursina Hospital in Rasht while complaining of abdominal pain from the day before hospitalization. The patient reported a history of tiredness, fever, and nausea. In the examinations performed, there was a brief tenderness in the patient’s epigastrium. The patient’s initial pressure was 80.120 with a pulse rate of 95. The patient’s fever was not detected upon arrival. For the patient, an upright abdominal radiograph, abdominal and pelvic ultrasounds, and blood tests including CBC,BUN,Cr,PT,PTT,INR,LFT,Amylase,Lipase,LDH were requested.\n",
      "The patient’s upright abdominal radiograph was normal. Perihepatic and perisplenic fluid and gallstones were seen on the patient’s ultrasound. On laboratory findings, White Blood Cells (WBC) = 4000 /μL with 30% lymphocytes were reported. Hemoglobin (Hb) = 11 g/dL and Platelets (PLT) = 245,000 /μL were found. Other findings were normal. No pathological lesion was observed on the patient’s lung CT scan (Fig. ). A small amount of perihepatic and perisplenic fluid was observed on the patient’s CT scan (Fig. ).\n",
      "The patient was monitored and about 12 h after hospitalization, ill appearance, respiratory (respiratory distress) symptoms, and high fever were reported for the patient. The patient’s O2Sat was 96%. Due to the exacerbation of the patient’s respiratory symptoms, the CT scan of the lungs was requested again for the patient and the tests were repeated for suspicion of coronavirus.\n",
      "The second CT scan was performed about 18 h after the initial examination. Patchy ground-glass lesions along with bilateral pleural effusion were seen on the CT scan of the patient’s lungs (Fig. ). A bilateral chest tube was inserted for the patient according to the volume of the fluid, and according to the patient’s CT scan and respiratory symptoms, he was transferred to the specialized COVID-19 unit. In the new blood tests, Hb = 9.5 g/dL, WBC = 4800/μL, and PLT = 195,000 /μL were observed. An extensive fluid collection around the spleen was observed on the CT scan performed for the patient (Fig. ). The examination of the patient’s abdomen changed significantly about 20 h after the initial examination and became generalized rebound tenderness. However, the patient’s blood pressure was still 70.110 and the pulse rate was 90. According to the examination, the patient was immediately transferred to the operating room and underwent laparotomy. During the operation, contrary to our expectations, a lot of blood (about 1000 cc) was observed in the patient’s abdomen. After blood suctioning, the left upper quadrant was bleeding and the rupture of the spleen could also be observed. Therefore, a splenectomy was performed (Fig. ).\n",
      "In the examinations performed for the patient, the patient’s PCR confirmed COVID-19. The patient was admitted to the ICU after surgery, and within 3 days after surgery, the patient was extubated. The patient’s chest tubes were removed within 1 week after the surgery according to the radiographs performed. After a concomitant treatment for COVID-19 and during a two-week hospital stay, the patient was discharged in good general condition.\n",
      "During the examinations performed and the history taken several times from the patient and the patient’s companion, no history of the trauma was given and the changes in the patient’s CT scan and the patient’s examinations occurred very quickly.\n",
      "The LE cell, ANA, and HIV as well as the Monospot, RF and Wright agglutination test were negative. The peripheral blood smear and the Widal agglutination test were negative for malaria and VCA Antibody IgM and IgG were negative for Epstein - Barr virus (EBV).\n",
      "In the macroscopic study of splenic pathology, a spleen tissue with dimensions of 11× 8 × 5 cm and a weight of 350 g and a laceration with a size of 2 × 2 cm were observed and in the microscopic study, a focally hemorrhagic area was reported.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 20 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate is 99 bpm, which is less than 100. Therefore, this criterion is met (true).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's oxygen saturation (SpO2) is 85% on room air, which is less than 95%. Therefore, this criterion is not met (false).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true), assuming hemoptysis was not present but not explicitly mentioned.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is male, it's reasonable to assume this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, this criterion is met (true), assuming no prior VTE was present but not explicitly mentioned.\n",
      "\n",
      "7. **No unilateral leg swelling**: There is no mention of unilateral leg swelling in the patient note. Therefore, this criterion is met (true), assuming no unilateral leg swelling was present but not explicitly mentioned.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the number of false criteria, which in this case is 1 (for the oxygen saturation criterion).\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets 6 criteria (age < 50, heart rate < 100, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling) but does not meet the criterion for oxygen saturation ≥ 95%.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 20 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [63, 'years'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': True, 'Heart Rate or Pulse': [65.0, 'beats per minute'], 'O₂ saturation percentage': [97.0, '%'], 'Previously documented Deep Vein Thrombosis': True}\n",
      "\n",
      "Patient Note:\n",
      "A 63-year-old Caucasian male with a past history of supraventricular tachycardia and recurrent deep vein thrombosis, who had been non-compliant with his daily Rivaroxaban® 20 mg, presented with pleuritic chest pain and was found to have a right lower lobe pulmonary embolus. The patient was subsequently restarted on Rivaroxaban® and discharged. He presented again 5 days later with left arm weakness and was found to have multiple areas of punctuate infarctions of both cerebral and cerebellar hemispheres, more confluent within the right frontal lobe on magnetic resonance imaging (MRI) of the brain ( and ). He has been compliant with his Rivaroxaban® since the previous hospital discharge 5 days prior. The patient was admitted and subsequently started on unfractionated heparin. On admission, his vital signs were blood pressure 138/93, heart rate 65 beats per minute, respiratory rate 16, and oxygen saturation 97% on room air. Cardiopulmonary examination revealed regular rate and rhythm, without murmurs, rubs, or gallops and clear lungs on auscultation. Neurologic examination revealed intact cranial nerves, preserved strength in all extremities with an exception of mild dysmetria in the left upper extremity and an NIH score of 1. Electrocardiogram revealed normal sinus rhythm, non-specific ST changes, and a premature ventricular contraction. Transthoracic echocardiogram was notable for normal left ventricular function with mild tricuspid regurgitation and stage 1 diastolic dysfunction. Transesophageal echocardiogram was negative for intracardiac thrombus. The echocardiography with agitated saline contrast revealed microbubbles of moderate opacity entering the left atrium from the left lower pulmonary vein indicative of a grade 2 intra-pulmonary arteriovenous shunt (). There was no atrial septal defect or patent foramen ovale. Unfractionated heparin was continued, and the patient was transferred to a tertiary care center for embolization of the shunt. There, he developed recurrent cerebral infarctions while anticoagulation was temporarily held. Computed tomography of the abdomen and pelvis was done for persistent abdominal pain, and noted an omental mass, and subsequent exploratory laparotomy revealed an adenocarcinoma within the omentum with nodular peritoneal implants. The patient was placed on weight-based Enoxaparin® and discharged home with scheduled outpatient chemotherapy. Embolotherapy of the intrapulmonary shunt was deferred given this new diagnosis of malignancy.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 81 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is 115 beats per minute, which is greater than 100. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's SpO2 is 95% on ambient air, which meets this criterion. Therefore, this criterion is true.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, the patient is an 81-year-old woman, and given her age and the context, it's reasonable to assume she is postmenopausal, but without explicit information about estrogen use, this assumption might not directly apply to the criterion. Since there's no explicit mention of estrogen use, and considering the context might not directly imply its use or non-use, the safest assumption based on the information given would lean towards not having evidence of estrogen use, thus potentially considering it as true. However, this interpretation requires caution due to the lack of explicit information.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "7. **No unilateral leg swelling**: The physical examination is otherwise normal, with specific mention of abdominal tenderness but no mention of leg swelling. Therefore, we assume this criterion is true, as there is no evidence to suggest otherwise.\n",
      "\n",
      "Given these evaluations, the PERC score can be calculated by summing the false criteria:\n",
      "\n",
      "- Age < 50 years: False\n",
      "- Heart rate < 100 bpm: False\n",
      "- Oxygen saturation ≥ 95%: True\n",
      "- No hemoptysis: True\n",
      "- No estrogen use: True (with the assumption that there's no evidence to suggest otherwise)\n",
      "- No prior VTE: True\n",
      "- No unilateral leg swelling: True\n",
      "\n",
      "The sum of the false criteria is 2.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"Each criterion was evaluated based on the patient's age, vital signs, medical history, and physical examination findings as described in the note. The patient's age and heart rate led to false evaluations for the first two criteria. Other criteria were evaluated as true based on the absence of specific conditions or symptoms in the note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 21 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['Age < 50']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [49, 'years'], 'Heart Rate or Pulse': [101.0, 'beats per minute'], 'O₂ saturation percentage': [89.0, '%'], 'Unilateral Leg Swelling': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 49-year-old woman is brought to the emergency department with progressive dyspnea and cough which she developed approx. 8 hours ago. 2 weeks ago she had a prophylactic ovariectomy because of a family history of ovarian cancer. She is known to have type 2 diabetes mellitus and stage 1 hypertension, but she does not take her antihypertensives because she is not concerned about her blood pressure. Also, she has a history of opioid abuse. She takes metformin 1000 mg and aspirin 81 mg. She has been smoking 1 pack of cigarettes per day for 22 years. Her vital signs are as follows: blood pressure 155/80 mm Hg, heart rate 101/min, respiratory rate 31/min, and temperature 37.9℃ (100.2℉). Blood saturation on room air is 89%. On examination, the patient is dyspneic and acrocyanotic. Lung auscultation reveals bilateral rales over the lower lobes. A cardiac examination is significant for S2 accentuation best heard in the second intercostal space at the left sternal border and S3 presence. There is no leg edema. Neurological examination is within normal limits.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 75 years old, which is greater than 50. Therefore, this criterion is false.\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's pulse rate is 124 beats/minute, which is greater than 100 bpm. Therefore, this criterion is false.\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient's peripheral oxygen saturation is 90% (with an oxygen mask 6 L/min), which is less than 95%. Therefore, this criterion is false.\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, we can consider this criterion as true, assuming hemoptysis was not present.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note. However, given the patient's age (75 years old) and the context, it's reasonable to assume estrogen use is unlikely, but without explicit information, this could be considered uncertain. For the purpose of this calculation and without explicit information to the contrary, we might lean towards considering this criterion as true, but it's essential to note this assumption.\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: There is no mention of prior VTE in the patient note. Therefore, we can consider this criterion as true, assuming no prior VTE was known or documented.\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient has reticular dermatosis on both of her lower legs, which suggests some form of skin involvement but does not explicitly indicate unilateral leg swelling. However, without clear evidence of unilateral leg swelling, we might consider this criterion as true, but similar to the estrogen use, this involves some assumption.\n",
      "\n",
      "Given these evaluations, the criteria that are clearly false are:\n",
      "- Age < 50 years\n",
      "- Heart rate < 100 bpm\n",
      "- Oxygen saturation ≥ 95%\n",
      "\n",
      "The others are considered true based on the information provided or the lack thereof, with the understanding that assumptions are made for criteria 5 and 7 due to the absence of explicit information.\n",
      "\n",
      "Therefore, the PERC score, based on the clearly false criteria, would be 3.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The PERC score is calculated based on 7 criteria. The patient's age is over 50, heart rate is over 100 bpm, and oxygen saturation is less than 95%, making these criteria false. The other criteria are considered true based on the information provided or the lack thereof, with assumptions made for estrogen use and unilateral leg swelling due to the absence of explicit details.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 22 ---\n",
      "Model: Llama-3.3-70B-Instruct\n",
      "Wrong Criteria: ['HR < 100', 'No hemoptysis']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [29, 'years'], 'Heart Rate or Pulse': [97.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': True, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "The subject of this report is a 29 year old male, US citizen of Palestinian descent, who works full-time as a biomedical research technician. His health history is unremarkable, except for the fact that at age 16 he was diagnosed with ulcerative colitis and primary sclerosing cholangitis. Since then, he has been treated successfully with mesalamine (1.2 g, 2 times per day), azathioprine (50 mg, 3 times per day), and ursidiol (300 mg, 2 times per day). The subject has been able to live an active lifestyle and participate in a variety of sports including running, weightlifting, basketball, and baseball. The subject denies any history of smoking or use of alcohol, opioids, or illicit drugs. On April 22, 2020, the subject's father, who lives in the same house as the subject, and works for a major shipping company, was diagnosed with COVID-19. This was about 2 months after the first case of COVID had been confirmed in his state of residence, which was one of the early active zones of COVID-19 transmission in the US. On April 25, the patient began to experience general malaise and fatigue. Over the next 24 h, the symptoms worsened to include severe fatigue and weakness, loss of appetite, tiredness, slight dry cough, body aches, muscle pain, loss of taste and smell, sore throat and fever. The patient was then seen by his general practice physician. Vital signs at the time of examination were BP 110/72, pulse 97 BPM, respiration 14 per minute, oxygen saturation 98%, and body temperature 101.7°F. The patient was given a naso-pharyngeal swab, real-time RT-PCR test [COBAS (R) SARS-COV-@ test, Labcorp Laboratories, South Bend, IN] that confirmed a diagnosis of COVID-19. In compliance with standard medical practice standards, the patient was ordered to self-isolate and to start a 5-day course of azithromycin (250 mg, daily), and to also take 1 g of paracetamol (acetaminophen) every 6 h for treatment of pain and fever. Despite good adherence to the recommended treatment, the symptoms other than fever, did not improve, and he also started to feel depressed, demotivated, and spend long periods in bed. During this period, the patient experienced ongoing generalized myalgia and musculoskeletal pain. He described the pain as persistent and relatively severe (rated 7 on a scale of 1–10). Because of this discomfort, after 4 days the patient decided to consume kratom to relieve his symptoms. According to the patient, he had first used kratom 14 months earlier before his COVID-19 infection. He used kratom sporadically (no more than 4–5 times in total) as a cognitive enhancer and not to self-treat pain.\n",
      "The patient decided to take 2.5 gms (or grams) of green kratom (as ground leaf powder suspended in water). The product was purchased at a local shop in April 2020 sold under the name “Green Bali.” After 30 min, he noticed a significant improvement in the intensity of the physical symptoms (mainly pain and fatigue), and within 60 min he felt a sensation of mild euphoria and well-being that lasted for about 5 h. After 6 h following consumption the effects of kratom wore off, and the patient administered another dose. He used kratom three times a day continuously for 3 days (for a total of 9 doses of 2.75 g each) with significant benefit.\n",
      "When asked to score from 0 to 100% the improvement that kratom had on COVID-19 symptoms: fatigue and weakness (80% improvement), tiredness (70% improvement), body aches (80% improvement), muscle pain (90% improvement, “much better than paracetamol/acetaminophen”). The kratom did not seem to have an impact on: fever, cough, or sore throat. The patient also stated: “I didn't have anxiety or any psychological symptoms. For me, kratom mainly gave improvement in physical reaction.” “It also elevated my mood and made me feel less miserable, to the point where I was able to get out of bed, shower, look at work emails without feeling completely exhausted and drained”; “Kratom helped me more than antibiotic”; “I slept better, I essentially fell asleep immediately. Without kratom, sleep was not nice, with kratom less wake ups, about 6 h.” Over the next 2 weeks the patient's symptoms gradually subsided and on May 13 he had a televisit with his physician and a follow-up swab test that was negative for COVID-19. The subject was able to end his quarantine and return to work in early June. In a follow-up interview with us, the patient reported that he did not experience any side effects from using kratom, except for a very bad taste when swallowing it. The patient was also able to discontinue kratom use immediately without any evidence of physical or psychological withdrawal symptoms. The patient also informed us that he still had some of the kratom product that he had taken and he agreed to provide us with a sample for chemical analysis.\n",
      "An established quantitative liquid chromatography mass spectrometry method was conducted () and found that the sample obtained from the patient is kratom due to the presence of mitragynine (102 mg/g kratom powder) and 7-hydroxymitragynine (0.8 mg/g kratom powder). The extracted kratom sample was analyzed for the presence of 13 opioids and 8 benzodiazepines by comparing the chromatograms to those of the reference mixtures Pain Management Multi-component Opiate Mixture-13 solution and Benzodiazepine Multi-component Mixture-8 solution. These data suggest the sample was not fortified with 7-hydroxymitragynine and there was also no evidence of adulteration with opioids or common benzodiazepines in the sample.\n",
      "\n",
      "Reply:\n",
      "To calculate the PERC score for this patient, we need to evaluate each of the 7 criteria based on the information provided in the patient note.\n",
      "\n",
      "1. **Age < 50 years**: The patient is 29 years old, which is less than 50. Therefore, this criterion is met (true).\n",
      "\n",
      "2. **Heart rate < 100 bpm**: The patient's heart rate after resuscitation is 100 bpm, which does not meet the criterion of being less than 100 bpm. Therefore, this criterion is not met (false).\n",
      "\n",
      "3. **Oxygen saturation ≥ 95%**: The patient is saturating at 95% on room air, which meets the criterion. Therefore, this criterion is met (true).\n",
      "\n",
      "4. **No hemoptysis**: There is no mention of hemoptysis in the patient note. Therefore, this criterion is met (true), assuming hemoptysis was not present but not explicitly stated.\n",
      "\n",
      "5. **No estrogen use**: There is no mention of estrogen use in the patient note, and given the patient is a male, it is reasonable to assume this criterion is met (true).\n",
      "\n",
      "6. **No prior venous thromboembolism (VTE)**: The patient note does not mention any prior VTE. Therefore, this criterion is met (true).\n",
      "\n",
      "7. **No unilateral leg swelling**: The patient note mentions a right tibia-fibula fracture with intra-medullary nailing 7 years prior and chronic septic hardware of the right lower limb, which could imply some form of leg issue but does not explicitly state unilateral leg swelling at the time of presentation. However, given the context, it might be inferred that there could be some involvement, but since it's not explicitly stated as swelling and considering the patient's complex presentation is more focused on the thoracic injury, we will cautiously assume this criterion is met (true) based on the lack of explicit mention of unilateral leg swelling as a current symptom.\n",
      "\n",
      "Given these evaluations, the PERC score would be calculated based on the false criteria, which in this case is only the heart rate criterion.\n",
      "\n",
      "Here is the result in the specified JSON format:\n",
      "\n",
      "```json\n",
      "{\n",
      "  \"Explanation\": \"The patient's PERC score is calculated based on 7 criteria. The patient meets 6 criteria (age, oxygen saturation, no hemoptysis, no estrogen use, no prior VTE, and no unilateral leg swelling) but does not meet the criterion for heart rate less than 100 bpm.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "```\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 23 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [62, 'years'], 'Heart Rate or Pulse': [92.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Hemoptysis': False, 'Unilateral Leg Swelling': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 62-year-old woman presents to the emergency department after an episode of light-headedness. She was using the bathroom when she felt light-headed and fell to the floor. Her daughter found her and brought her into the emergency department right away. The patient has a past medical history of obesity and diabetes mellitus. She came to the emergency department 1 week ago for a similar complaint. The patient states that she has otherwise felt well with the exception of fatigue, constipation, an odd sensation in her chest, and a decreased appetite and desire to drink recently causing her to lose 10 pounds. Her temperature is 98.0°F (36.7°C), blood pressure is 122/88 mmHg, pulse is 92/min, respirations are 14/min, and oxygen saturation is 99% on room air. Physical exam reveals a cardiopulmonary exam within normal limits and stable gait. The patient has an obese abdomen with abdominal distension. Strength is 5/5 in the upper and lower extremities.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 46 years old, which is less than 50 years. The heart rate is 54/min, which is less than 100 bpm. Oxygen saturation is 100%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient has a history of unspecified arthritis, but no mention of estrogen use. There is no prior VTE mentioned. However, the patient has unilateral leg swelling as evidenced by the right leg numbness and decreased sensation. The patient's symptoms and findings are more indicative of cardiac issues and rheumatoid arthritis rather than pulmonary embolism.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 24 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [56, 'years'], 'Heart Rate or Pulse': [96.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 56-year-old man presented to a peripheral hospital with a history of severe acute central chest pain accompanied by sweating. He has been suffering from diabetes mellitus for 3 years for which he was taking oral hypoglycemic agent (glibenclamide 5 mg, BID). However, he was not on regular follow-up. He was hypertensive for 3 years and for which he was on regular medication.\n",
      "He was diagnosed with acute ST-segment elevation extensive anterior wall myocardial infarction and was given Streptokinase due to unavailability of reteplase/alteplase. Although the chest pain improved, his post lysis ECG showed poor resolution. However, next morning the ECG showed transient inferior leads ST elevation with fast atrial fibrillation (AF). He was given a bolus intravenous amiodarone (300 mg). While he was on amiodarone infusion, he became hypotensive and dobutamine was started at low dose (5 mcg/kg/min). Eventually, his case was discussed and it was decided he needed a tertiary care hospital. He was shifted with 12 hours for further management.\n",
      "On arrival, his radial arterial blood pressure was 106/70 mmHg, mean arterial BP was 59 mmHg. He was maintained on low dose dobutamine. The PR was 96 b.p.m, in sinus rhythm. His urine output was 75 ml / hour. On physical examination, he had bilateral fine crepitation and a pan systolic murmur at the left lower sternal area, radiating to the right precordium. Further examination showed the jugular venous pulse was mildly raised but no lower leg edema and warm touch. Oxygen saturation was 98% on 4 L/min oxygen facemask.\n",
      "Electrocardiography [] revealed sinus rhythm with persistent ST-segment elevation in the anterior (V1-V6) with established Q-waves in anterior leads. Chest X-ray [] showed bilateral mild pulmonary congestion.\n",
      "Transthoracic echocardiography revealed multiple (2–3 mm) apical muscular ventricular septal defects (VSD) with the largest VSD measuring 1 cm [], and a left to right shunt []. Left ventricular (LV) systolic function was mildly impaired with an ejection fraction of 45%. The left ventricular apex was akinetic. There was Grade-I diastolic dysfunction with normal right side dimension and functions. There was no significant valvular regurgitation or stenosis, but there was moderate pericardial effusion measuring 1.6 cm posteriorly and 1.1 cm anteriorly []. There was no sign of cardiac tamponade. The results of the biochemical Labs were unremarkable except for mild renal impairment (creatinine 105 mmol/L, eGFR-65) and raised Troponin T (364 pg/ml). Lactate level was 2.1mmol/L.\n",
      "Coronary angiography (CAG) revealed the left anterior descending artery had tight lesions in the proximal (95%) and mid segment (85%) with diffusely diseased distal LAD []. Right coronary had proximal 30% stenosis; the right posterior descending artery had ostial (90%) lesion []. There was non-significant lesion at distal left circumflex artery. LV Angiography showed Apical VSR with LV to RV flow [Figure and ].\n",
      "His Society for Cardiovascular Angiography and Intervention (SCAI) cardiogenic shock (CS) stage was determined to be Stage B. At this time cardiac surgeons were consulted, who advised to continue medical treatment with an intention to heal infarct area spontaneously and they would consider either for coronary artery bypass graft (CABG) plus VSD repair versus Percutaneous Coronary Intervention (PCI) plus device closure.\n",
      "The patient was initially treated medically with intravenous diuretics, inotropes, and with oral aspirin and statin. Gradually, all inotropes were tapered off and he was clinically asymptomatic with stable hemodynamics without support of intra-aortic balloon pump (IABP). Later, low dose of lisinopril and carvedilol was added as vasodilators to reduce afterload.\n",
      "Eventually, at the eighteenth day of admission, the patient underwent CABG (one venous graft to r-PDA) with simultaneous repair of VSD with Gortex patch with infarct exclusion technique. The LAD artery could not be grafted due to poor visualization hence dit was decided for PCI later if needed.\n",
      "Postoperatively, the patient remained stable and was extubated the next day. Follow-up echocardiography revealed no residual intra-cardiac shunt. He was discharged on the 7th post-operative day in stable condition. Due to expatriate issue, a follow-up was arranged over telephone at 2 weeks. After two months, he was asymptomatic, hemodynamically stable and could perform routine daily activities. Later a clinic follow- up was arranged with echocardiography.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 71 years old, which is above the age of 50. His heart rate is 116 bpm, which is above 100 bpm. His oxygen saturation is 97%, which is above 95%. There is no mention of hemoptysis. There is no mention of estrogen use. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient has signs of chronic venous insufficiency, which may be related to VTE, but it is not explicitly stated. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 25 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [70, 'years'], 'Heart Rate or Pulse': [93.0, 'beats per minute'], 'O₂ saturation percentage': [94.0, '%'], 'Previously documented Deep Vein Thrombosis': False, 'Hemoptysis': False, 'Recent surgery or trauma': False, 'Hormone use': False, 'Previously Documented Pulmonary Embolism': True}\n",
      "\n",
      "Patient Note:\n",
      "A 70-year-old man presented with dyspnoea and palpitations on exertion to the emergency department (ED). His medical history was significant for stage IV clear cell RCC, chronic atrial fibrillation on anticoagulation with warfarin, coronary artery disease status post the placement of two stents with an ischaemic cardiomyopathy and a LVEF of 40%–45%. He was recently started on pazopanib for systemic treatment of metastatic RCC. Pazopanib was started at 75% of the recommended dose. At the initiation of therapy, the patient had a creatinine of 1.2 mg/dL and was able to walk 90 min a day without any complaints.\n",
      "Within the first week of starting pazopanib, the patient developed dyspnoea on exertion that progressed rapidly to dyspnoea on minimal exertion. He was no longer able to conduct his daily walks. On the 10th day after starting pazopanib, he was unable to shave himself due to dyspnoea, which prompted his ED presentation. In the ED, his blood pressure (BP) was 122/70 mm Hg, heart rate (HR) was 93 beats per minute (bpm), respiratory rate (RR) was 22 breaths/min, and oxygen saturation was 94% on room air. On physical examination, auscultation of the heart was significant for an irregular rhythm with no additional heart sounds or signs of volume overload. His lungs were clear to auscultation, and the remainder of the examination was unremarkable.\n",
      "Initial labs were significant for a creatinine of 1.4 mg/mL and a supratherapeutic international normalised ratio of 4.0. Blood counts, electrolytes and liver function tests were within normal limits. His B-natriuretic peptide (BNP) was 2685 pg/mL. His troponin results were negative. An ECG showed atrial fibrillation without significant changes compared with previous tracings. A CT angiogram (CTA) of the chest in the ED showed heterogeneous opacification of the left main pulmonary artery with concern for a non-occlusive thrombus.\n",
      "The patient was admitted to the hospital and empirically started on anticoagulation with enoxaparin for presumed pulmonary embolism (PE). On the second day, he presented with worsening shortness of breath and compromised mental status. On physical examination, he was dyspnoeic and tachypnoeic with RR of 40 breaths/min and oxygen saturation of 95% on 2 L of oxygen by nasal cannula. His HR ranged between 140 and 150 bpm and his BP was 96/53 mm Hg. He was in respiratory distress, unable to speak in full sentences but alert and following commands.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 60 years old, so criterion 1 is false. The heart rate is 120 bpm, so criterion 2 is false. The oxygen saturation is 93%, so criterion 3 is false. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient has a past medical history of an ST-elevation myocardial infarction, but this is not relevant to the PERC score. The patient has recently returned from international travel, which may increase the risk of VTE, but this is not a criterion for the PERC score. The patient has a fever and bilateral pleural effusions, which may be indicative of an infection or other condition, but this is not relevant to the PERC score. The pleural fluid analysis is not relevant to the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 26 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['O₂ ≥ 95%', 'No prior VTE']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [65, 'years'], 'Heart Rate or Pulse': [88.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Recent surgery or trauma': True, 'Unilateral Leg Swelling': True, 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 65-year-old man arrives to the emergency department (ED) complaining of pain and swelling in his right leg. The patient reports he recently underwent a total hip replacement. His past medical history is significant for hypertension and diabetes. His current medications include aspirin, lisinopril, metformin, and atorvastatin. On arrival, his temperature is 99°F (37.2°C), blood pressure is 135/82 mmHg, pulse is 88/minute, and oxygen saturation is 99% O2. He denies chest pain or shortness of breath. On physical exam, his right leg appears moderately erythematous, swollen, and is tender to palpation. Other physical exam findings are negative.\n",
      "\n",
      "A complete blood count (CBC) was performed with the following findings:\n",
      "\n",
      "Hemoglobin: 13.0 g/dL\n",
      "Leukocyte count: 6500/mm^3\n",
      "Platelet count: 150,000/mm^3\n",
      "\n",
      "The appropriate anti-coagulation therapy is started. Seven days later the patient arrives back to the ED complaining of crushing substernal chest pain. An electrocardiogram is performed and is shown in Figure A.\n",
      "\n",
      "A CBC was performed with the following findings:\n",
      "\n",
      "Hemoglobin: 13.5 g/dL\n",
      "Leukocyte count: 8500/mm^3\n",
      "Platelet count: 58,000/mm^3\n",
      "INR: 2.5\n",
      "aPTT: 34 seconds\n",
      "Fibrinogen level: 200 mg/dL\n",
      "Troponin T: 0.2 ng/mL\n",
      "\n",
      "On physical exam, the right leg is again swollen and tender to palpation. However, a new lesion has also formed, as shown in Figure B.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 70 years old, which is above the age of 50. His heart rate is 93 bpm, which is below 100 bpm. His oxygen saturation is 94% on room air, which is below 95%. He has no history of hemoptysis mentioned. He is on anticoagulation with warfarin, indicating a history of VTE. There is no mention of estrogen use. There is no mention of unilateral leg swelling. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 27 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['O₂ ≥ 95%', 'No prior VTE', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [38, 'years'], 'Heart Rate or Pulse': [112.0, 'beats per minute'], 'O₂ saturation percentage': [92.0, '%'], 'Hormone use': True, 'Unilateral Leg Swelling': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 38-year-old Caribbean-Black (Afro-Trinidadian) female with a medical history of endometriosis, intermittently adherent with the oral contraceptive pill, initially presented to the adult emergency department with acute dyspnea during the preceding 2 days. Her vital signs reflected systolic blood pressures of 142 mm Hg, heart rate of 112 beats per minute, and respiratory rate of 20 breaths per minute with an oxygen saturation of 92% on room air. Her physical examination revealed a mildly elevated jugular venous pulse (10 cm of water), right chest stony dullness, no peripheral edema, and active menses.\n",
      "A 12-lead electrocardiogram revealed sinus tachycardia with an incomplete right bundle branch block, right ventricular hypertrophy, and subtle secondary ST-T segment changes (see ). A portable chest radiograph revealed a large-sized, right pleural effusion with mild perihilar congestion (see ). Pertinent diagnostic laboratory investigations included a D-dimer 208 ng/dL (normal ≤500 ng/mL), pro–brain natriuretic peptide (pro-BNP) 323 pg/mL (normal ≤300 pg/mL), cardiac troponin I (cTnI) 0.08 ng/mL (normal = 0.0-0.15 ng/mL). The patient’s arterial blood gas was consistent with mild hypoxia on 24% fractional inspiration of oxygen (FiO2) with an alveolar-arterial gradient (A-a gradient) of 14 mm Hg.\n",
      "The patient was subsequently admitted for an inpatient hospitalization, and computed tomography (CT)-guided therapeutic thoracentesis was performed with a resultant hemorrhagic exudative effusion. Despite this intervention, the pleural effusion recurred within 48 hours, and cardiothoracic surgery was consulted for a video-assisted thoracoscopic surgery (VATS) pleural biopsy, which later affirmed the presence of endometrial tissue on clinicopathological examination. The tentative diagnosis at this juncture was recurrent catamenial pleural effusions. On further interview, the patient acknowledged that she often experienced dyspneic episodes during menstruation.\n",
      "During the ensuing hospitalization, she continued to experience persistent shortness of breath with an episode of paroxysmal atrial fibrillation (PAF). A 2-dimensional transthoracic echocardiogram (TTE) revealed preserved left ventricular function with moderate right heart enlargement, septal flattening, and mild pHTN with estimated right ventricular systolic pressures of approximately 45 mm Hg. A 2-dimensional and 3-dimensional transesophageal echocardiogram (2D/3D-TEE) also revealed an intact interatrial septum with agitated saline “bubble” study. The PVs were incompletely visualized and hence the rationale for further advanced imaging (see ). A cardiac CT angiogram (CCTA) affirmed the presence of the suspected PAPVC of the left inferior PV to the left brachiocephalic (innominate) vein with angiographically normal coronary arteries (see ). The patient also underwent cardiac magnetic resonance imaging (CMRI), which demonstrated the same aberrant connection with the remaining pulmonary venous vasculature appearing dilated in addition to the RA, right ventricle, and main pulmonary artery (see and , respectively). Left heart catheterization established angiographically normal coronary arteries with right heart catheterization revealing a significant hemodynamic left-to-right shunt with Qp:Qs ratio of 3:1, mild pHTN, and elevated pulmonary vascular resistance (see for a summary of the pertinent cardiovascular investigations).\n",
      "Cardiothoracic surgery was reconsulted regarding the surgical repair of the PAPVC. In the interim, the patient was instituted on an optimal cardiovascular regimen that included apixaban for her PAF, angiotensin receptor blocker with a neprilysin inhibitor (ARNI), β-blocker (BB), mineralocorticoid receptor antagonist (MRA) for her heart failure and nitrates, tadalafil, and calcium channel blockade (CCB) for her pHTN. The rest of her hospital course was uneventful, and she was discharged home with scheduled corrective surgery in 2 months (due to our limited resource setting pending consultation from an international specialist CHD cardiothoracic surgeon).\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 37 years old, which is less than 50 years. The heart rate is 114 bpm, which is greater than 100 bpm. Oxygen saturation is initially 87% but increased to 95% with oxygen supplementation. There is no mention of hemoptysis. The patient is not using estrogen. There is a history of deep vein thrombosis, which is a prior VTE. There is unilateral leg swelling in the right ankle. The patient meets 3 out of 7 criteria, resulting in a PERC score of 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 28 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'Hormone use': True, 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [98.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'age': [31, 'years'], 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 31-year-old, G1P0 woman at 35 weeks of gestation comes to the emergency room for a severe headache. She reports that she was washing the dishes 2 hours ago when a dull headache came on and progressively worsened. She also reports 2 episodes of intermittent blurred vision over the past hour that has since cleared. Nothing similar has ever happened before. She denies any precipitating events, trauma, mental status changes, abdominal pain, lightheadedness, fever, ulcers, or urinary changes. Her temperature is 98.9°F (37.1°C), blood pressure is 160/110 mmHg, pulse is 98/min, respirations are 12/min, and oxygen saturation is 98%. A physical examination demonstrates a rash on her face that she attributes to a recent change in cosmetics. A urine test demonstrates the presence of protein.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 52 years old, which is above the age threshold of 50. His heart rate is 76 bpm, which is below the threshold of 100 bpm. His oxygen saturation is 97%, which is above the threshold of 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, these criteria are considered not met. The patient's age and the absence of the other criteria contribute to the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 29 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'No hemoptysis']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [21, 'years'], 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [180.0, 'beats per minute'], 'Hemoptysis': True, 'O₂ saturation percentage': [91.0, '%'], 'Hormone use': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "This study presents a case of a 21-year-old male patient with T-cell acute lymphoblastic lymphoma status post induction chemotherapy with lineage switch to acute myelogenous leukemia. He received high-dose chemotherapy with cyclophosphamide, total body irradiation (TBI), and later received a matched unrelated donor blood stem cell transplantation. His post-transplant course was complicated by biopsy proven chronic graft-versus-host disease in the gastrointestinal tract requiring daily steroid use. He also developed Cytomegalovirus (CMV) pneumonitis, BK virus-induced hemorrhagic cystitis, Candida glabrata fungemia, and Streptococcus viridans bacteremia-all of which were appropriately treated and resolved.\n",
      "Eleven months after his stem cell transplant, he presented with acute onset of copious blood-tinged phlegm, shortness of breath and left pleuritic chest pain. Upon initial evaluation, the patient was afebrile, respiratory rate was 30 breaths per minute, pulse 180 beats per minute, blood pressure 90/67 mmHg, and oxygen saturation 91% on room air. Broad-spectrum antibiotics including intravenous vancomycin and antifungals were started. The patient later was hypotensive with blood pressure of 70/46 despite aggressive intravenous hydration. Due to septic shock, intravenous norepinephrine drip was started in the intensive care unit. Laboratory studies were significant for pancytopenia with white blood cell count of 2.79 x 103 cells/µL. Intravenous steroids were started given septic shock and patient’s known history of chronic steroid use due to chronic GVHD. Electrolytes and renal function were unremarkable. Arterial blood gas was significant for PaO2 of 64 mmHg. Blood cultures grew methicillin-resistant Staphyloccocus aureus (MRSA). A chest CT scan as seen in Figure showed left lower lobe consolidation in the setting of multiple bilateral cavitary nodules.\n",
      "The infectious disease service was consulted. Blood cultures grew methicillin resistant Staphyloccocus aureus. Given the patient had not been hospitalized recently, it was determined that he had community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) bacteremia. Bronchoscopy was done and was remarkable for the presence of purulent secretions in the tracheobronchial tree. Respiratory culture from bronchoscopy also grew methicillin resistant Staphylococcus aureus. The rest of the infectious workup from the bronchoscopy was unremarkable. A transthoracic echocardiogram was ordered to evaluate for the possibility of endocarditis. The echocardiogram showed a left ventricular ejection fraction of 50%, mild global hypokinesis, and no evidence of vegetation suggestive of endocarditis. After a few days of treatment, the patient had significant clinical improvement and blood cultures were negative. He was discharged with a two week course of intravenous vancomycin which he completed.\n",
      "Two months later, the patient was admitted to the hospital for fevers, productive cough with green sputum, and shortness of breath. He was found to have recurrent MRSA bacteremia and recurrent MRSA pneumonia. The CT chest findings as seen in Figure showed multiple bilateral cavitary nodules consistent with a necrotizing process.\n",
      "Initially, intravenous vancomycin was started, however this was later switched to intravenous linezolid. This was done because the patient had recurrent MRSA bacteremia despite prior intravenous vancomycin therapy. Blood cultures were negative after two days of treatment. Transthoracic echocardiogram showed an improved left ventricular ejection fraction of 60-70% and no vegetations were identified. After clinical improvement, the patient was discharged on oral linezolid for six weeks per infectious disease team recommendations. After completing this course he was placed on prophylaxis with oral doxycycline to prevent further CA-MRSA infections.\n",
      "Six months later, he had a repeat CT of the chest as seen in Figure . This CT showed the presence of permanent pneumatoceles from the focal loss of lung parenchyma.\n",
      "Our patient was readmitted on several occasions mainly due to bouts of community-acquired viral pneumonia (adenovirus, parainfluenza, and influenza) along with a secondary Pseudomonas aeruginosa pneumonia. He did not have recurrent CA-MRSA pneumonia. His chest CT scan as seen in Figure from 2.5 years after the original MRSA infection demonstrated bronchiectasis and persistent pneumatoceles from his original infection with CA-MRSA.\n",
      "His initial recurrent community-acquired pneumonias with secondary MRSA and his recent recurrent episodes of pseudomonas infection suggest the patient was likely chronically colonized.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 55 years old, which is above the age threshold of 50 years. The heart rate is 104 bpm, which is above the threshold of 100 bpm. The oxygen saturation is 94%, which is below the threshold of 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 30 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [74, 'years'], 'Heart Rate or Pulse': [120.0, 'beats per minute'], 'Hemoptysis': False, 'O₂ saturation percentage': [96.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 74-year-old normotensive, nondiabetic, male smoker (30-pack years) presented with progressively increasing shortness of breath, cough, white, mucoid expectoration, and retrosternal and right sided parasternal, oppressive chest pain for last 2 months. Chest pain and shortness of breath were increased in severity on exertion and were associated with palpitation, but there is no history of sweating, orthopnoea, paroxysmal nocturnal dyspnoea, unconsciousness, and convulsion. There was no radiation of chest pain. Chest pain was suddenly increased for last five days and the patient was admitted in the emergency department with a suspicion of acute myocardial infarction (AMI). There was no history of fever, hemoptysis, leg swelling, and facial puffiness. History of significant weight loss and anorexia were present. There was no history of household contact with the patient of sputum smear positive tuberculosis. The patient received formoterol + tiotropium metered dose inhaler (2 puffs once daily with spacer) and oral doxofylline (400 mg twice daily) for last five years, as he suffered from chronic bronchitis predominant chronic obstructive pulmonary disease (COPD) which resulted in persistent breathlessness, cough, and expectoration.\n",
      "General survey revealed anemia and clubbing, but there was no cyanosis, edema, and engorged neck vein. There were multiple cervical and supraclavicular enlarged lymph nodes on left side, which were hard in consistency, discrete, nontender, and fixed to underlying structure, but not fixed to overlying skin, and there was no discharging sinus. His temperature was 37°C, respiratory rate 24 breaths/minute, pulse rate 120 beats/minute, regular blood pressure 94/64 mmHg, oxygen saturation in capillary blood (SpO2) 96% @ room air, and FiO2 0.21.\n",
      "Examination of respiratory system revealed no abnormality, except vesicular breath sound with prolonged expiration on both sides, bilateral crackles, mainly over the bases of the lungs, and occasional wheezes. Examination of other system was normal. Complete hemogram showed anemia with hemoglobin concentration of 7.1 g/dL. Blood biochemistry was normal. Electrocardiogram (ECG) showed atypical ST segment elevation and T wave inversion in lateral chest leads (Lead V4, Lead V5, and Lead V6). Initial rapid troponin-t-test was inconclusive, but repeat one after 12 hours of first test was negative. Sputum for acid fast bacilli and Gram stain was negative, and pyogenic culture of sputum showed no growth. Chest X-ray posteroanterior (PA view) showed cardiothoracic ratio was more than 0.5; that is, size of the cardiac silhouette was increased, but lung parenchyma was normal. Contrast enhanced computed tomography (CECT) of thorax showed a large, nonhomogenous mass lesion in right lower lobe which invaded the left atrium and was compressing the adjacent ventricular walls (). There was also mediastinal and hilar lymphadenopathy. CT-guided fine needle aspiration cytology (FNAC) showed discrete clusters of malignant epithelial cells which showed nuclear pleomorphism, hyperchromasia, high nucleocytoplasmic ratio, pale cytoplasm, and ill-defined cell boundary—suggestive of non-small-cell carcinoma, possibly squamous cell variety (). FNAC of left sided supraclavicular lymph nodes showed metastatic squamous cell carcinoma. Sputum for malignant cell was negative and fibre optic bronchoscopy did not show any abnormality. Echocardiogram showed a large echogenic mass of 15 × 12 mm, attached to the roof of the left atrium adjacent to right pulmonary venous openings, encroaching to interatrial septum, an extension of the tumour from adjacent lung parenchyma. Ejection fraction was 66%. Ultrasound of abdomen and CECT scan of brain were normal. Hence the diagnosis was a non-small-cell carcinoma of lower lobe of right lung with invasion of the left atrium and compression of adjacent ventricular wall (T4 disease) with contralateral supraclavicular metastatic lymphadenopathy (N3 disease). First cycle chemotherapy regimen comprising intravenous cisplatin (100 mg on day 1) and etoposide (100 mg on days 1, 2, and 3) was given, but unfortunately he died just after completion of first cycle.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 16 years old, so age < 50 is true. Heart rate is 140 bpm, so HR < 100 is false. Oxygen saturation is 94%, so O₂ ≥ 95% is false. Hemoptysis is denied, so No hemoptysis is true. Estrogen use is not mentioned, so No estrogen use is true. No prior VTE is not mentioned, so No prior VTE is true. Unilateral leg swelling is not mentioned, so No unilateral leg swelling is true. The patient's PERC score is 2, indicating a low risk of pulmonary embolism.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 31 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'No hemoptysis', 'No prior VTE']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [73, 'years'], 'Heart Rate or Pulse': [80.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Hemoptysis': True, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 73-year-old female patient, who was hospitalized since 3 months, presented with complaints of paroxysmal dry cough since 2 weeks. The patient was admitted initially due to progressive dyspnea. Respiratory distress occurred 2 days later and she was transferred to the intensive care unit (ICU) after intubation for mechanical ventilation. Her past medical history included hypertension and diabetes mellitus for approximately 20 years; both of which were in a stable condition with regular medication. Six months before admission, she underwent a median sternotomy and thymectomy for thymoma. She denied having a recent travel history aboard but reported contact with a large pigeon population as there was a large dovecot near her residence. A series of examinations were performed for the unexplained respiratory failure, and myasthenic crisis was diagnosed based on high levels of acetylcholine receptor antibodies (> 4 nmol/L) and neurophysiological study findings. Consequently, she received several courses of plasma exchange followed by a high dose of prednisolone (30 mg daily) and azathioprine (25 mg daily) to treat the myasthenic crisis. Her respiratory condition improved after the therapy. She was transferred to the general ward after successfully weaning off mechanical ventilation. Oral prednisolone and azathioprine therapy was continued. After receiving prednisolone and azathioprine therapy for nearly 3 months, she developed dry cough. Physical examination revealed that respiratory rate was 15 breaths/min, blood pressure was 140/88 mmHg, heart rate was 80 beats/min, and body temperature was in the normal range. The remainder of the examination including cardiovascular, respiratory, and other organ systems was unremarkable. Laboratory evaluation included a peripheral white blood cell count of 8870/µL; hemoglobin, 10.8 g/dL; and platelet count of 299,000/µL. Her serum alanine aminotransferase level was 9 U/L; aspartate aminotransferase level was 19 U/L; blood urea nitrogen level was 13 mg/dL; creatinine level was 0.3 mg/dL; level of procalcitonin was 0.1 ng/Ml, and level of C-reactive protein was 1.78 mg/dL. Arterial blood gas analysis (with the patient breathing ambient air) revealed pH 7.47, PaCO2 56.9 mmHg, PaO2 66.7 mmHg, and oxygen saturation 99%.\n",
      "A thoracic CT scan was performed. On comparing it with the previous thoracic CT scan performed on admission (Fig. a), a newly developed 2-cm consolidative nodule was observed on the upper lobe of the left lung (Fig. b). Serum aspergillus galactomannan antigen testing, fungus stain and fungus culture of sputum, polymerase chain reaction (PCR) of sputum for mycobacterium tuberculosis were all negative. The CT-guided biopsy was performed, and its pathology revealed chronic granulomatous inflammation with multinucleated giant cells engulfing thick-wall micro-organisms (Fig. a). These organisms were 4–6 microns in diameter, stains bright red with Periodic Acid Schiff (Fig. b) and black in Gomori Methenamine-Silver (Fig. c), consistent with those of cryptococcus. A subsequent serum titer of cryptococcal antigen was 1:8 using Remel Cryptococcus Antigen Test Kit (Remel, Lenexa, KS, USA). Because there were no neurologic symptoms and signs indicated cryptococcus meningoencephalitis, lumbar puncture was not performed. Immune status of the patient was then assessed. Except for recent immunosuppressive therapy for the myasthenic crisis, the patient revealed no evidence of malignancy or vasculitis, and human immunodeficiency virus testing was negative. To determine the possibility of cross transmission from infected patients, we reviewed the incidence of cryptococcal infection cases in the ICU and the general ward for up to 1 month before the patient was diagnosed, but no new cryptococcal infection cases were reported. Intravenous fluconazole, 400 mg daily, was administered for pulmonary cryptococcal infection for 14 days. Respiratory symptoms nearly resolved after treatment and the patient was discharged for outpatient follow-up with continuation of oral fluconazole 400 mg daily. The chest CT scan, 3 months after discharge, revealed complete clearance of the lesion (Fig. c) and the relevant inflammatory biomarkers were in the normal range. No recurrence of the Cryptococcal infection has occurred to date.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 35 years old, which is less than 50 years. The heart rate is 126 bpm, which is greater than 100 bpm. The oxygen saturation is 97% on 2 liters of oxygen, which is greater than or equal to 95%. The patient denies hemoptysis. The patient has a history of deep vein thrombosis, which is a prior venous thromboembolism. The patient denies unilateral leg swelling. The patient does not use estrogen. The patient has a history of coronary artery disease, uncontrolled diabetes mellitus type 2, obesity, dyslipidemia, gastroesophageal reflux, and hypertension. The patient is a former smoker and uses electronic nicotine delivery systems (ENDS) daily. The patient was treated with aspirin, hydromorphone, ondansetron, diphenhydramine, 2L per minute oxygen via nasal cannula, and 1L of normal saline bolus followed by 100 ml/hr continuous infusion. The patient was placed in the clinical decision unit and an extensive investigation was undertaken. Acute coronary syndrome, pulmonary emboli, and pneumonia led the differential diagnoses. The patient received a repeat dose of hydromorphone due to sustained pain. The patient had a normal complete blood count, procalcitonin, creatine kinase, and troponin. A measured glucose of 667 mg/dL with pseudohyponatremia 128mmol/L, chloride of 96 mmol/L, and her D-Dimer was noted to be slightly elevated. A computed tomography (CT) angiogram of the chest was ordered to rule out pulmonary emboli. The CT was reported with nodular infiltrates centered in the lower lung zones with some confluence at the lung bases not previously seen on chest radiograph. Mediastinal adenopathy not previously seen on CT from two years prior and a nodular thickening of the hila were also noted. In addition, there was a 1.5 × 1.5 cm collection of hypodense fluid and loss of distinction in the cortex of the right kidney suggestive of trauma. The patient was transferred to the intensive care unit (ICU) and upon arrival she was noted to have extensive rales, with notable work of breathing that caused truncated speech. The patient tolerated the BIPAP well, but became increasingly dyspneic despite pressure support from the BIPAP. Her increased work of breathing and impending respiratory failure urged endotracheal intubation and mechanical ventilation. A bronchoscopy was performed that demonstrated erythema of the tracheal tissues extending to the carina that appeared cobblestoned and/or leathery. The main bronchi had a yellow, vesicular appearance with interspersed erythema and increased friability of the tissue. The right mainstem bronchus and remaining airways had a rust-colored appearance along with erythema extending into the visible lower airways. The pattern was postulated to be inhalational injury by pulmonary medicine. The patient was treated empirically for bacterial pneumonia with meropenem levofloxacin and vancomycin. The right lower lobe bronchial alveolar lavage culture resulted in heavy growth of methicillin-resistant Staphylococcus aureas (MRSA) 48 hours after admission. Her urine culture was positive for Escherichia coli. The patient continued to decline over the next 48 hours. She was transferred to a tertiary care center for possible ECMO, burn expertise, and continued intensive care. Upon arrival to the tertiary care center, she was persistently hypoxemic and failed a trial of mechanical ventilation with inhaled epoprostenol. Repeat bronchoscopy was performed showing persistent vesicular injury pattern. She underwent emergent placement of veno-venous ECMO. She was stabilized and subsequent examinations showed a left hemiparesis. The neurologic insult was diffuse on magnetic resonance imaging and read as hypoxic, toxic and or metabolic insult. She improved on ECMO, eventually receiving a tracheostomy, which was decannulated 14 days later. She was returned to the long-term rehabilitation unit at the initial treatment center. There she progressed well, where she was ambulating with an assist device and made significant progress toward an independent return to home.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 32 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'No estrogen use']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [71, 'years'], 'Heart Rate or Pulse': [67.0, 'beats per minute'], 'O₂ saturation percentage': [97.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Unilateral Leg Swelling': False, 'Hemoptysis': False, 'Hormone use': False, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 71-year-old African American male presented for routine follow-up with his primary care physician 3 months after initiating atorvastatin 80 mg and pioglitazone 15 mg daily. His lipid panel revealed a total cholesterol of 152 mg/dL, triglycerides of 83 mg/dL, high-density lipoprotein cholesterol of 59 mg/dL, and a calculated low-density lipoprotein cholesterol (LDL-c) of 76 mg/dL. LFTs were notable for an aspartate aminotransferase (AST) of 1093 U/L (upper limit of normal [ULN] 41 U/L), an alanine transaminase (ALT) of 1385 U/L (ULN 58 U/L), and an alkaline phosphatase (ALP) of 265 U/L (ULN 129 U/L; R Factor 11.6; ). Total bilirubin was elevated to 1.5 mg/dL (ULN 1.2 mg/dL). The patient denied myalgias, pruritus, or abdominal pain. He was admitted for further management.\n",
      "The patient denied known hypotensive episodes or recent use of alcohol, herbal supplements, antibiotics, or acetaminophen. Gamma glutamyl-transferase was elevated to 551 U/L (ULN 50 U/L). Serum acetaminophen and ethanol were undetectable. Hepatitis A virus IgM/IgG, hepatitis B virus core IgM/IgG, hepatitis C virus (HCV), and human immunodeficiency virus-1 (HIV-1) antibodies were negative, as were hepatitis B surface antigen (HBsAg) and HIV-1 and HCV RNA. Anti-neutrophil cytoplasmic, anti-mitochondrial, and liver-kidney microsome antibodies were not detected. Serum IgG, copper, and ceruloplasmin levels were normal. Remaining workup was unrevealing except for a borderline-positive smooth muscle antibody titer of 1:20 (normal <1:20) and a ferritin of 1469 ng/mL (ULN 336 ng/mL). Serum albumin (3.4 g/dL) and prothrombin time international normalized ratio (1.01) were within normal limits. Liver ultrasound revealed “mildly increased echogenicity, coarsened echotexture, and attenuation of sound beam” suggestive of “hepatic steatosis and/or diffuse hepatocellular disease.” The right lobe measured 14.1 cm. A prior abdominal computerized tomography scan with contrast at age 60 years revealed only a punctate calcification, likely a granuloma, within the right lobe.\n",
      "On admission, his temperature was 36.8 °C, heart rate was 67 beats per minute, blood pressure was 123/63 mm Hg, respiratory rate was 16 breaths per minute, and oxygen saturation was 97% on room air. Physical examination revealed no scleral icterus, a soft and nontender abdomen without palpable masses or organomegaly, and normal mental status. Atorvastatin and pioglitazone were discontinued on admission with rapid improvement in LFTs (see ). Liver biopsy was therefore not performed. The patient remained asymptomatic and was discharged on hospital day 4 with normalization of LFTs within 1 month. Simvastatin 20 mg daily and pioglitazone 15 mg daily were started 3 and 10 months after discharge, respectively. Contrast-enhanced computed tomography (CT) scan of the abdomen at 3 months again showed a likely granuloma but no steatosis. Serum LFTs have since remained within normal limits.\n",
      "Before starting atorvastatin, the patient had been taking simvastatin 40 mg daily for 11 years for an elevated LDL-c of 137 mg/dL and a 10-year ASCVD risk of 18.9%. Other pertinent medical history included type 2 diabetes mellitus, hypertension, and stage 2 chronic kidney disease. He had no history of ASCVD. His baseline serum LFTs were within normal limits. No change in LFTs or other side effects were noted while on simvastatin. His LDL-c reached a nadir of 74 mg/dL at age 70 years.\n",
      "Three months prior to this presentation, the patient’s LDL-c was elevated to 93 mg/dL, at which point simvastatin was stopped and atorvastatin 80 mg daily was started. A goal LDL-c below 70 mg/dL was targeted for secondary prevention out of concern for prior ischemic stroke resulting in bilateral superior altitudinal hemianopsia noted on visual field testing 6 months prior. Pioglitazone 15 mg daily was started simultaneously with atorvastatin for an elevated hemoglobin A1c of 8.1%. He was continued on his other medications, including gabapentin 300 mg 3 times daily for diabetic neuropathy, glipizide 20 mg twice daily, lisinopril 5 mg daily, metformin 1000 mg twice daily, omeprazole 20 mg twice daily, paroxetine 20 mg daily, and trazodone 100 mg as needed. Subsequent review of medication history revealed that he had not refilled his simvastatin for almost 6 weeks before starting on atorvastatin.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 24 years old, which is less than 50 years. Her heart rate is 98 bpm, which is less than 100 bpm. Her oxygen saturation is 99%, which is greater than or equal to 95%. She has no hemoptysis mentioned in the note. She uses a progesterone intrauterine device for contraception, which is a form of estrogen use. She has no prior VTE history mentioned. She has no unilateral leg swelling mentioned. She recently returned from a trans-Atlantic flight, which increases her risk for VTE, but it is not a prior VTE history. She has no significant past medical history except for a breast cyst, which is not relevant to the PERC criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 33 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [15, 'years'], 'Heart Rate or Pulse': [90.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': True, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Hemoptysis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 15-year-old female presented in preanesthetic checkup clinic for rush nail removal of femur. She was a known case of OI type I and history of recurrent fractures for which she had been operated three times uneventfully under general anesthesia. There was no history of OI in the family.\n",
      "On general examination, she was short statured with a height of 103 cm, weighing 49 kg, blue sclera, fragile bones, progressive hearing loss, kyphoscoliosis. Her blood pressure was 130/80 mmHg, and heart rate was 80 beats/min. There was no pallor, icterus, cyanosis, clubbing, lymphadenopathy, or pedal edema. Respiratory system revealed barrel-shaped chest with bilateral equal air entry, and cardiovascular system revealed normal heart sounds. Electrocardiogram (ECG), liver function test, renal function test, and coagulation profile were normal. Chest X-ray was normal except mediastinal widening; X-ray of the spine revealed dorsolumbar kyphoscoliosis to the left. Pulmonary function test was suggestive of mildly restrictive disease. Airway assessment showed acceptable flexion and extension at neck with adequate mouth opening and normal dentition, Mallampatti Class III. The patient was accepted for surgery as American Society of Anesthesiologists Grade III; in view odontoaxial dislocation and normal coagulation profile, we decided to proceed with a spinal anesthetic technique. Thorough operating room preparation was completed including difficult airway equipment, and measures made ready to deal with hyperthermias if any.\n",
      "The patient was positioned very carefully on the operation table, and pressure points were padded adequately. An 18-gauge intravenous (i.v.) cannula was inserted on the dorsum of the right hand. Monitors including ECG, sphygmomanometer, and SpO2 were placed on the patient.\n",
      "Her baseline blood pressure was 128/80 mmHg, heart rate was 90 beats/min, and O2 saturation on room air was 98%. An i.v. preload of 500 ml Ringer's lactate was administered. Despite the kyphoscoliosis, no difficulty was experienced in finding the subarachnoid space, and spinal anesthesia was given in the sitting position in the space L3–L4 space with 25-gauge Quincke needle with 2.5 ml of bupivacaine heavy 0.5%. The motor block was up to T 10 level. The operation lasted for 1 h and 45 min. There was no significant variation in the vitals, and the recovery was uneventful.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 45 years old, which is less than 50 years. The heart rate is 116 bpm, which is greater than 100 bpm. The oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 34 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [60, 'years'], 'Heart Rate or Pulse': [120.0, 'beats per minute'], 'O₂ saturation percentage': [93.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Hemoptysis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 60-year-old man presents to the emergency department with shortness of breath, cough, and fever. He states that his symptoms started a few days ago and have been progressively worsening. The patient recently returned from international travel. He works from home and manages a chicken coop as a hobby. He has a past medical history of an ST-elevation myocardial infarction and recently has had multiple sick contacts. His temperature is 102°F (38.9°C), blood pressure is 187/108 mmHg, pulse is 120/min, respirations are 17/min, and oxygen saturation is 93% on room air. A radiograph of the chest reveals bilateral pleural effusions. Pleurocentesis demonstrates the findings below:\n",
      "\n",
      "Protein ratio (pleural/serum): 0.8\n",
      "Lactate dehydrogenase ratio (pleural/serum): 0.75\n",
      "Glucose: 25 mg/dL\n",
      "\n",
      "Further analysis reveals a lymphocytic leukocytosis of the pleural fluid.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 28 years old, which is less than 50 years. Her heart rate is 112 bpm, which is greater than 100 bpm. Her oxygen saturation is 90%, which is less than 95%. She has no history of hemoptysis, estrogen use, or prior VTE. She does have unilateral leg swelling on the right side. Therefore, the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 35 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [57, 'years'], 'Heart Rate or Pulse': [90.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 57-year-old man presents to the emergency department with epigastric pain. The patient states that he was at home watching television when his symptoms began. Otherwise, the patient has no complaints. The patient has a past medical history of obesity, hypertension, alcohol abuse, diabetes, and constipation. His current medications include insulin, metformin, lisinopril, and sodium docusate. His temperature is 99.5°F (37.5°C), blood pressure is 160/95 mmHg, pulse is 90/min, respirations are 14/min, and oxygen saturation is 98% on room air. Laboratory values and an abdominal ultrasound are ordered and are currently pending. An abdominal radiograph is ordered as seen in Figure A. On physical exam, the patient is clinically intoxicated. Cardiopulmonary exam is within normal limits. The patient is started on IV fluids and given morphine.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 40 years old, which is less than 50, so criterion 1 is met. The heart rate is 122 bpm, which is greater than 100 bpm, so criterion 2 is not met. The oxygen saturation is 97%, which is greater than or equal to 95%, so criterion 3 is met. There is no mention of hemoptysis, so criterion 4 is met. There is no mention of estrogen use, so criterion 5 is met. There is no mention of prior VTE, so criterion 6 is met. There is no mention of unilateral leg swelling, so criterion 7 is met. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 36 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['No estrogen use', 'No prior VTE']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [46, 'years'], 'Heart Rate or Pulse': [54.0, 'beats per minute'], 'O₂ saturation percentage': [100.0, '%'], 'Unilateral Leg Swelling': True, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 46 years old female with a history of unspecified arthritis presented to the emergency department with complaints of substernal chest pain and right leg numbness of one-hour duration. The chest pain was radiating to the left shoulder and was associated with diaphoresis and dyspnea. On examination, vitals revealed a blood pressure of 92/69 mmHg, heart rate of 54/min, oxygen saturation of 100% on room air, and afebrile at 98.3°F. There was a soft systolic murmur in the right upper sternal border. Pulsation on dorsalis pedis and posterior tibial artery and sensation on right lower extremity was decreased. Electrocardiogram (EKG) revealed complete heart block with junctional escape rhythm and ST elevation in anterior precordial leads with ST depression in leads I and aVL (Figure ). Pertinent labs revealed initial troponin-I of 0.05 ng/ml. The remaining blood work, including complete blood count and the basic metabolic panel, was unremarkable.\n",
      "In the emergency department, the patient received immediate dual antiplatelet therapy, and cutaneous pacer pads were applied. Due to the focal exam findings, a computerized tomography angiogram (CTA) was performed rapidly with quick review ruling out dissection. CTA however revealed a small transverse, linear defect in the proximal aorta (Figure ). This defect was noted to propagate towards the root of the aortic valve on its anterior leaflet suggesting possible vegetation on the aortic valve. Given the ST changes and ongoing chest pain, the patient was taken immediately for cardiac catheterization which revealed a distal thrombus in the posterior left ventricular branch of the right coronary artery which was not amenable for intervention (Figures , ). During cardiac catheterization, right lower extremity pain and coolness suddenly worsened. Angiogram of the right lower extremity showed 100% occlusion of the right anterior and posterior tibial arteries (Figure ). The patient then went for emergent thrombo-embolectomy of the right tibio-peroneal trunk, with a marked resolution of symptoms. Transesophageal echocardiography was performed later confirming the vegetation in the aortic valve measuring about 6.5x4.0 mm (Figure ). Three sets of blood cultures were negative. Significant remarkable lab findings included C-reactive protein (CRP) of 10.5 ng/dl, erythrocyte sedimentation rate (ESR) of 60 mm/hr, and positive rheumatoid arthritis screen. Extensive rheumatological and hypercoagulable workup including anti-nuclear antibodies, complement levels, anti-thrombin III activity, protein C & S levels, homocysteine levels, and other procoagulant markers were within the normal range. Specific testing for systemic scleroderma, Sjogren’s, and polymyositis were also unremarkable. Confirmatory testing with anti-cyclic citrullinated protein showed levels of >250 units establishing the diagnosis of RA. The patient was treated with systemic oral anticoagulation and was initiated on steroids.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 31 years old, which is less than 50 years. Her heart rate is 98 bpm, which is less than 100 bpm. Her oxygen saturation is 98%, which is greater than or equal to 95%. She denies any hemoptysis. She is pregnant, so she is not using estrogen. She has no prior history of VTE. She does not report any unilateral leg swelling. She is a pregnant woman, so she is at risk for VTE due to her pregnancy status, but there is no specific mention of it in the note. Therefore, the criterion is considered not met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 37 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [35, 'years'], 'Heart Rate or Pulse': [80.0, 'beats per minute'], 'O₂ saturation percentage': [100.0, '%'], 'Hormone use': True, 'Previously Documented Pulmonary Embolism': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 35-year-old woman with Marfan syndrome was admitted at 37 weeks gestational age (GA). She was diagnosed with Marfan syndrome at 16 years of age. A previous pregnancy at 33 years of age culminated in a missed abortion at 6 weeks GA, for which a dilatation and curettage was performed at our hospital under monitored anesthesia with propofol and remifentanil. She underwent a Bentall operation due to aortic regurgitation at 20 years of age. She underwent a vitrectomy at 27 years of age for subluxation of the right lens. She had orthostatic headaches 3 years ago, and dural ectasia at the 5th lumbar and sacrum, which was identified on lumborsacral spine magnetic resonance myelography, was thought to be the cause of the symptoms. At the time of admission, she had a 35-mm abdominal aortic aneurysm for 8 years. The cardiac functions were stable because the previous aortic surgical procedures were well-maintained during the current pregnancy. She was medicated with verapamil, atenolol, and warfarin, which were switched to labetalol and enoxaparin during the pregnancy.\n",
      "She had the pathognomic body habitus of Marfan syndrome (height, 179 cm; weight, 76.2 kg; and arachnodactyly). A metallic click and systolic murmur were auscultated with a stethoscope. Her initial vital signs showed a blood pressure of 130/70 mmHg, a heart rate of 80/min, and an oxygen saturation of 100% on room air. A pre-operative echocardiography revealed a normal left ventricle ejection fraction (55-60%) and a well-functioning prosthetic aortic valve. Mild ectatic changes in the proximal descending thoracic aorta and distal abdominal aorta (32 × 36 and 34 × 31 mm, respectively) were confirmed with no interval changes compared to the last study checked 1 year ago.\n",
      "An elective cesarean section was recommended by the obstetricians, cardiologists, and anesthesiologists involved in the patient's care. Combined spinal-epidural anesthesia is the standard anesthetic choice for cesarean section at our hospital. However, the presence of dural ectasia at the 5th lumbar and sacrum, and a neurosurgeon's warning against spinal anesthesia for the possible recurrence of headache associated with CSF leakage, led us to decide on epidural anesthesia. Enoxaparin was discontinued one day before the scheduled cesarean section and unfractionated conventional heparin was administered until 6 hours before the operation.\n",
      "With the patient in the right lateral position, a 17-gauge Tuohy needle was inserted at the L3-4 interspace under sterile conditions using a midline approach with the loss-ofair resistance technique. Then, a 19-gauge epidural catheter (FlexTip Plus®; Arrow, USA) was inserted via the Tuohy needle and fixed at 9 cm. Eight ml of 2% lidocaine with epinephrine (1 : 200,000) and fentanyl (50 µg) were injected via an epidural catheter as a divided first dose, and the total 27 ml of 2% lidocaine with epinephrine (1 : 200,000) and fentanyl (100 µg) was injected incrementally over 10 minutes. Twenty minutes after the last epidural injection of lidocaine, the sensory block was sufficiently high (T4) for the cesarean section. The systolic blood pressure was decreased by 25% and 3 doses of phenylephrine (100 µg) and 1 dose of ephedrine (10 mg) were administered to maintain the blood pressure at 100/50 mmHg. She was sedated with propofol after the infant was delivered and transferred to the post-anesthesia care unit. The baby had been diagnosed prenatally with possible Marfan syndrome and was transferred to the neonatal intensive care unit. The patient's post-operative vital signs were stable with a blood pressure of 106/68 mmHg, a heart rate of 83/min, and an oxygen saturation of 100%. Heparin was re-infused 6 hours after the cesarean section. The post-operative pain was managed with patient-controlled epidural analgesia for 3 days post-operatively. The epidural catheter was removed 6 hours after stopping the continuous heparin injection on the 3rd post-operative day. She was transferred to the Cardiology Department for postpartum management and discharged without cardiovascular complications.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 84 years old, which is above 50, so criterion 1 is false. Heart rate is 90 bpm, which is below 100 bpm, so criterion 2 is true. Oxygen saturation is 98%, which is above 95%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 38 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['HR < 100', 'No estrogen use']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [9, 'years'], 'Heart Rate or Pulse': [118.0, 'beats per minute'], 'O₂ saturation percentage': [100.0, '%'], 'Unilateral Leg Swelling': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "We report the case of a 9-year-old Saudi male who presented at King Abdulaziz University Hospital with a 3-day history of pallor, lethargy, shortness of breath, and headache. Along with these manifestations, the family noticed a yellowish discoloration of the sclera. The patient was in optimal health, with no significant medical complaints, until 2 weeks prior to hospital admission, a time when he developed symptoms of upper respiratory tract infection (i.e., a sore throat, cough, and mild subjective fever). One week later, he developed diarrhea with a frequency greater than 5 times daily. The diarrhea was yellowish in color and without blood. Furthermore, the diarrhea was associated with epigastric pain and vomiting, and it resolved a few days later; however, the epigastric pain became more severe, and his vomiting continued. Due to this situation, the patient had been unable to maintain his usual appetite and had lost some weight. The patient also reported a decrease in the amount of his urine and a change of the urine's color, which was described by the mother as tea-colored. No rash or edema was reported.\n",
      "The patient was referred to our tertiary hospital by a dispensary after their results revealed red and granular casts in the urine and abnormal kidney function.\n",
      "An initial assessment revealed that the patient had a rapid but regular heart rate of 118 beats/min. His respiratory rate was 20/min, his blood pressure was 119/61 mmHg, and his oxygen saturation was 100%.\n",
      "Examination showed that the patient was conscious and oriented; he was pale and had yellowish sclera but exhibited no other significant signs (i.e., no periorbital or lower limb edema, skin rash, or petechia). His chest was clear, and the heart sounds were normal, with no additional sounds or murmurs. A neurological examination was unremarkable.\n",
      "Based on the initial assessment and the laboratory work-up, (Table ) hemolytic uremic syndrome was strongly suspected due to the presence of the classical triad of the disease. The diagnosis of PSGN was unlikely for several reasons, although the patient had a high ASO titer; this only confirmed a previous exposure and not an infection. Additionally, another more probable disease, i.e., HUS, better explained the abnormal kidney function and urine analysis. Unfortunately, we were unable to obtain a throat swab results and get an evidence of a streptococcal infection. Thus, PSGN could not be completely ruled out.\n",
      "There are few similar cases reported in the literature involving patients with SLE who initially present with HUS , , , , , . (Table )\n",
      "Surprisingly, the patient also exhibited a positive immune profile for SLE (i.e., ANA and dsDNA).So far, a clear diagnosis of the acute kidney injury was difficult to be made. For this reason, a kidney biopsy was indicated.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 22 years old, which is less than 50 years. Her heart rate is 90 bpm, which is less than 100 bpm. Her oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis. She is pregnant, so she is using estrogen. There is no mention of prior VTE. There is no mention of unilateral leg swelling. The patient is pregnant, so she is using estrogen, which is a risk factor for VTE. The patient's age, heart rate, and oxygen saturation meet the criteria, but her estrogen use and potential VTE risk do not meet the criteria.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 39 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [22, 'years'], 'Heart Rate or Pulse': [92.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 22-year-old female G2P0010 at 36 weeks gestation presented to an outside hospital with a 24-hour history of left flank pain and nausea. The pain was sharp, stabbing, constant, and radiated to the left mid-abdomen. She denied fever, chills, dysuria, hematuria, urinary frequency, or urgency. She underwent a CT scan that was concerning for adrenal hemorrhage [Figures and ]. She was noted to have blood pressure in the non-severe range. Later she developed severe range blood pressure and was found to have normal preeclampsia labs and negative urine spot. She was treated with antihypertensive medications including IV hydralazine 10 mg × 1, 20 mg × 2. She underwent an MRI that confirmed left adrenal hemorrhage []. Subsequently, she was transferred to our hospital.\n",
      "Upon transfer, the patient's vital signs were as follows: blood pressure 168/110 mmHg, heart rate 92 beats per minute, oxygen saturation 99% on room air, and respiratory rate 18 per minute. The abdomen was gravid, soft and non-tender to palpation. Her laboratory values were notable for a white blood cell count of 19,000/uL, hematocrit (Hct) of 30.8% and spot protein/creatinine ratio of 0.3 g/day. All other laboratory values including liver function and coagulation tests were within normal limits.\n",
      "A review of her history revealed an uneventful pregnancy without prior history of chronic hypertension, gestational hypertension, episodic hypertension, flushing, diarrhea, malignancy, endocrine dysfunction, coagulation disorder, family or personal history of a bleeding disorder, or blunt trauma to the abdomen. Her past medical history was notable only for migraine headaches and anxiety/depression not requiring pharmacological therapy. Her past surgical history included right laparoscopic oophorectomy for a large simple cyst.\n",
      "A plan was made for conservative management of her adrenal hemorrhage and blood pressure control. Based on severe-range blood pressure on intravenous antihypertensive therapy, a diagnosis of preeclampsia with severe features was made. The patient was offered an external cephalic version for fetal breech presentation, but she declined. A decision was made to proceed with cesarean delivery. A combined spinal-epidural anesthetic was provided without complication. The patient tolerated the surgery well and was discharged home 5 days later.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 52 years old, so criterion 1 is false. The heart rate is 90 bpm, so criterion 2 is true. The oxygen saturation is 96%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age is above 50 years, so criterion 1 is false. The patient's heart rate is below 100 bpm, so criterion 2 is true. The patient's oxygen saturation is above 95%, so criterion 3 is true. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 40 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'O₂ ≥ 95%', 'No prior VTE', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [29, 'years'], 'Heart Rate or Pulse': [110.0, 'beats per minute'], 'O₂ saturation percentage': [93.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Hemoptysis': False}\n",
      "\n",
      "Patient Note:\n",
      "Sudden-onset chest pain for 1 d.\n",
      "A 29-year-old man complained of sudden precordial pain with no remission for 1 d prior to hospital admission but denied hemoptysis, dyspnea, or syncope. He sought evaluation and was admitted for the purpose of intensive examination and treatment.\n",
      "The patient had been addicted to N2O for 1 year; as a result, peripheral neuropathy had occurred and was treated with vitamin B12 (Vit B12). His medical history included poor blood glucose control and anxiety. However, he had no history of thrombosis, malignant tumor, recent trauma, or prolonged air travel.\n",
      "The patient has smoked over 13 pack-years and did not have alcoholism or a positive family history.\n",
      "The initial assessment revealed that the patient was overweight and fragile, with a body mass index of 31.12 kg/m2, temperature of 36.3 °C, blood pressure of 110-120/70-80 mmHg, heart rate over 110 beats/min, respiratory rate over 30 breaths/min, and pulse oximetry of 93% when the fraction of inspired oxygen was 49%. Moreover, the physical examination indicated diminished breath sounds on both sides and the accentuation of pulmonic second sounds.\n",
      "Laboratory data showed a high leukocyte count and an increased hemoglobin level, suggested abnormal liver biochemistry and hyperlipidemia, and revealed HHcy (24.12 µmol/L), high Vit B12 (734 µmol/L), and normal folate (14.39 nmol/L). The results of the protein S, protein C, anti-thrombin III antibody, anti-cardiolipin antibody, lupus anticoagulant, anti-β2gp1 autoantibody, and other autoantibodies were within normal limits. The clotting profile was normal, other than the D-dimer value (1.13 mg/L), and thrombophilia screening was negative. As markers in the risk stratification of PE, the levels of brain natriuretic peptide (BNP) and cardiac troponin I (CTnI) were 533 pg/mL and 0.334 ng/mL, respectively. Arterial blood gas levels measured with an oxygen concentration of 49% showed the following: pH, 7.44; PaCO2, 30 mmHg; and PaO2, 74 mmHg.\n",
      "An electrocardiogram (ECG, Figure ) showed sinus tachycardia with typical changes on SIQIIITIII (S wave in the aVL lead, Q wave and T wave in the III lead). Ultrasonic cardiogram demonstrated right ventricular enlargement with left ventricular compression. Color Doppler scans were used to explore femoral, popliteal, and calf muscular venous thrombosis in the right extremity. Computed tomographic pulmonary angiography (CTPA) revealed occlusion of the pulmonary artery trunk, lobar artery, and arterial branches on both sides and signs of increased right heart load (Figure and ).\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 79 years old, which is above the age of 50. The heart rate is 78 bpm, which is less than 100 bpm. The oxygen saturation is 100%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient is not using estrogen. There is a history of lower extremity venous insufficiency, which is a form of VTE. The patient has bilateral leg swelling, not unilateral. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 41 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['No hemoptysis', 'No prior VTE']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [85, 'years'], 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [80.0, 'beats per minute'], 'Hemoptysis': True, 'O₂ saturation percentage': [99.0, '%'], 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "An 85-year-old male presented to our hospital with a 2-month history of a productive cough with white phlegm and a 2-day history of hemoptysis in October 2014. He reported no fever, chest pain, chills, night sweats, or dyspnea.\n",
      "On physical examination, the patient was afebrile. His heart rate was 80 beats per minute and regular, blood pressure 136/72 mm Hg, respiratory rate 20 breaths per minute, and oxygen saturation 99% while breathing ambient air. He was alert and not in acute distress. There was no lymphadenopathy in the neck. The lungs were clear and there were no heart murmurs. His abdomen was not tender, and there was no organomegaly. The neurological examination was unremarkable.\n",
      "The patient's white blood cell (WBC) count was 3430/mL, with 51.3% neutrophils, 32.9% lymphocytes, and 10.8% monocytes; his hemoglobin was 117 g/L; his hematocrit was 38.9%; and his platelet count was 207,000/mL. The patient's C-reactive protein (CRP) level was normal. Serum chemistry tests showed the following results: sodium, 142.3 mmol/L; potassium, 3.9 mmol/L; chloride, 106.2 mmol/L; blood urea nitrogen, 5.9 mmol/L; creatinine, 86.3 μmol/L; aspartate aminotransferase, 21 U/L (normal range 15–40 U/L); and alanine aminotransferase, 16 U/L (normal range 9–50 U/L). The international normalized ratio was 1.02, the partial-thromboplastin time was 27.1 seconds, and the d-dimer level was 180 μg/L. The brain natriuretic peptide was 17.0 pg/mL; tumor marker tests revealed: carcinoembryonic antigen, 2.32 ng/mL; squamous cell carcinoma antigen, 0.90 ng/mL; neuron-specific enolase, 6.24 ng/mL; and CY211, 2.25 μg/L.\n",
      "Computed tomography (CT) revealed a mass in the right lower lobe (Fig. A). Electrocardiography revealed sinus rhythm, with a ventricular rate of 79 beats per minute. No metastatic lesions were found on brain magnetic resonance imaging or in bone using emission CT.\n",
      "The hemoptysis was treated with 30 mg of ambroxol and 600 mg of p-aminomethyl benzoic acid daily. Sputum cultures were negative. Lung function tests after inhaling 400 μg of albuterol yielded an FEV1/FVC = 59.7% and FEV1 = 46.2%. Bronchoscopy showed stenosis in the posterior basal segment of the right lower lobe (Fig. ). A CT-guided transthoracic needle lung biopsy showed SCLC after histopathological and immunohistochemical examinations (Fig. ).\n",
      "Seven days after the transthoracic needle lung biopsy, the patient's temperature increased to 40°C and he developed a worsening cough with purulent sputum. Repeat laboratory tests showed a WBC count of 13,890/mL, with 87.0% neutrophils, 6.5% lymphocytes, and 0.9% monocytes; hemoglobin, 128 g/L; hematocrit, 38.70%; platelet count, 138,000/mL; and CRP, 88.0 mg/L. The patient was treated with cefuroxime (1.5 g) twice per day for 7 days and his WBC and CRP level normalized.\n",
      "He refused radiotherapy or chemotherapy. After obtaining consent, we treated the tumor with RFA. Before RFA, we evaluated the size and spatial relationships of the tumor using CT and determined the needle angle and depth via the shortest route from the surface to the mass. The puncture point was infiltrated with 5 mL of 2% lidocaine. The multipolar needle was directed to avoid bone, large blood vessels, and pulmonary bullae. A rapid biopsy of the lung tumor was performed. Heating was directed to an area within 0.5 to 1 cm of the tumor margin and to the needle track (Fig. B). After closing the puncture wound, repeat CT showed pneumothorax (Fig. C), which was treated with bed rest and inhaled oxygen. The patient had some chest pain the next day, but there was no fever or hemoptysis in the first week after RFA.\n",
      "At the 2-year follow-up examination, the efficacy of the RFA was evaluated as a partial response (PR) (Fig. D–G). The patient was last seen in January 2017, when he developed community-acquired pneumonia (Fig. H).\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 63 years old, which is above the age of 50. The heart rate is 65 bpm, which is less than 100 bpm. Oxygen saturation is 97%, which is greater than or equal to 95%. There is no mention of hemoptysis. The patient has a history of recurrent deep vein thrombosis, which indicates prior VTE. There is no mention of estrogen use. There is no mention of unilateral leg swelling. The patient has a history of VTE, which is a criterion for PERC.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 42 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [53, 'years'], 'Heart Rate or Pulse': [90.0, 'beats/minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 53-year-old man (height, 170 cm; weight, 89 kg) was admitted to the hospital because of a 1-year history of shortness of breath after exercise. The patient was a smoker, had a history of hypertension, and was taking captopril and nimodipine. Breathing was reduced in the left lung. However, neither rhonchus nor moist rales were heard during auscultation. Chest computed tomography revealed a GEB, and the left lung was compressed by about 95% with a right mediastinal shift (). An electrocardiogram showed normal findings, and echocardiography revealed that the heart was located in the right thoracic cavity. The left ventricular diastolic function was decreased, and the left ventricular ejection fraction was 64%. Laboratory tests showed no obvious abnormalities. Arterial blood gas analysis showed the following: pH: 7.43, PaCO2: 41 mmHg, PaO2: 94 mmHg, lactate: 1.4 mmol/L, potassium: 3.6 mmol/L, sodium: 138 mmol/L, calcium: 1.10 mmol/L, FiO2: 21%, and SpO2: 98%.\n",
      "On the day of surgery, the patient’s electrocardiogram, blood pressure, SpO2, and bispectral index were monitored upon entry into the operating room. A radial artery catheter and right internal jugular venous catheter were placed. The patient’s arterial blood pressure was 175/109 mmHg, heart rate was 90 beats/minute, and SpO2 was 94%. Before anesthesia, 40 µg of dexmedetomidine was infused within 10 minutes. The thoracic surgeon then created a small incision at the intersection of the sixth intercostal space and the left mid-axillary line to puncture the lung bulla and insert an indwelling catheter (14 Ga, 16 cm in length; Arrow International/Teleflex, Wayne, PA, USA) into the GEB to drain it for 15 minutes. The patient was preoxygenated with 100% oxygen at 6 L/minute for 5 minutes. Anesthesia was administered using 100 mg of propofol, 30 µg of sufentanil, and 50 mg of rocuronium. A 37-Fr right double-lumen endotracheal tube was inserted with the help of a visual laryngoscope, and single-lung ventilation was performed after proper alignment had been confirmed by fiberoptic bronchoscopy. The tidal volume was set at 5 to 6 mL/kg, the respiratory rate was 15 to 17 breaths/minute, the positive end-expiratory pressure was set at 5 cmH2O, and the inhalation:expiration ratio was 1:2. Propofol, remifentanil, and sevoflurane were used to maintain anesthesia. The intraoperative bispectral index was maintained at 40 to 50. After resecting the GEB (), one-lung ventilation was switched to two-lung ventilation and the lungs slowly expanded with a low tidal volume until complete lung re-expansion was observed. During the 3-hour surgery, the patient experienced 50 mL of blood loss, was administered 1300 mL of lactated Ringer’s solution, and excreted 500 mL of urine. After the operation, the double-lumen endotracheal tube was replaced with a single-lumen endotracheal tube and the patient was sent to the intensive care unit for monitoring and further treatment. Two hours after entering the intensive care unit, the patient was fully awake and the tracheal tube was smoothly removed. The following day, the patient was transferred to the thoracic surgery ward, where he recovered; he was discharged 12 days later. Postoperative chest computed tomography showed that the lungs were well inflated with no abnormalities ().\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 75 years old, which is above the age of 50. The heart rate is 68 bpm, which is less than 100 bpm. The oxygen saturation is 80%, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling. Therefore, the patient meets criteria 2, 4, 5, 6, and 7, but not criteria 1 and 3. The PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 43 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [32, 'years'], 'Hormone use': False, 'Unilateral Leg Swelling': False, 'Heart Rate or Pulse': [126.0, 'beats per minute'], 'O₂ saturation percentage': [95.0, '%'], 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A fit, physically active 32-year-old female with no underlying risk factors underwent a left knee anterior cruciate ligament (ACL) reconstruction and partial lateral meniscectomy. She was not taking oral contraceptives. She presented 19 days postoperatively with acute dyspnea, chest pain, tachycardia, and complaints of feeling light-headed of 5 days duration. In the emergency department, she had sinus tachycardia on electrocardiography, a heart rate of 126 bpm, blood pressure of 107/68 mmHg, respiratory rate of 18/min, and an oxygen saturation of 95% on room air. Her examination was noted to be otherwise unremarkable. There was no evidence of surgical site infection and no limb swelling noted. A complete blood count and electrolyte and metabolic panel were normal. Her troponin was 80 ng/L (normal 0–14 ng/L). A chest radiograph and D-dimer were not performed. Her pretest probability of pulmonary embolism was moderate based on Wells' criteria [].\n",
      "Computed tomography pulmonary angiogram (CTPA) reported the patient as having PTE. Findings included saddle PE, extensive clot extending into lobar and segmental branches of all lobes () as well as evidence of right heart strain with marked right atrial (RA) and RV dilation as well as flattening and deviation of the interventricular septum. The RV/LV ratio was 1.3. Unfractionated low-molecular-weight heparin was immediately initiated. Her simplified PE Severity Index (sPESI) was 1 (high risk, 8.9% mortality) [].\n",
      "The patient was admitted to the Internal Medicine service. On day 1, her clinical status was unchanged; laboratory indices were similar with a troponin level of 35 ng/L and NTpro-BNP of 3859 ng/L (normal 0–300). ICU was consulted on day 1 of admission, and a transthoracic echocardiogram (TTE) was immediately requested. This demonstrated a 3.3 cm maximum diameter multilobulated, mobile right atrial thrombus, which extended from the RV inlet through the pulmonic valve to the pulmonary artery (i.e., an RHTT). Intraventricular septal flattening and severe RV dilation with moderate systolic dysfunction and tricuspid regurgitation were also observed. McConnell's sign was present with apical hypercontractility and basal and mid-ventricular segmental hypokinesis. The right ventricular systolic pressure (RVSP) was 48.1 mmHg ().\n",
      "She was transferred to the intensive care unit (ICU) with a diagnosis of clinical submassive pulmonary embolism with clot in transit. Arterial blood gas was pH 7.52, pCO2 29 mmHg, PaO2 74 mmHg, O2 saturation 96%, and lactate 0.8 mmol/L. The case, as well as treatment options, was reviewed with a member of the pulmonary embolism response team (PERT). A decision was made to proceed with low-dose thrombolysis, despite the recent surgery, employing the regimen described in the MOPETT trial []. The potential benefits and risks were discussed with the patient who consented. She received a 10 mg recombinant tPA bolus followed by an additional 40 mg over two hours intravenously (IV). IV heparin was continuously infused at 10 U/kg/hr during the thrombolysis as well and for three hours afterwards at which time the heparin nomogram infusion of 18 U/kg/hr with serial adjustments based on PTT was re-introduced. Serial echocardiograms at 2 hours after thrombolysis and the next day () demonstrated improvement in her RV function. The RVSP was 27 mmHg at 2 hours and 26 mmHg the following day. The in-transit clot was no longer visible on the posttreatment echocardiograms. She was eventually discharged home on day 5 on tinzaparin for two weeks and then transitioned to rivaroxaban. She was continued on anticoagulation for 6 months.\n",
      "Seven months after discharge, she was doing very well. Her breathing had returned back to baseline, and she was rehabilitating well from her reconstruction. She had no bleeding complications from the rivaroxaban therapy. Her DASH score [] was 1 (3.9% annual risk of DVT recurrence), and her HERDOO2 score [] was 0 (3% risk of major recurrent venous thromboembolism per 100 patient years). The anticoagulation was discontinued. She had returned to the gym, though had not yet returned to more vigorous-intensity physical activities, such as basketball. A repeat echocardiogram at this time demonstrated normal left and right ventricular systolic function with no hemodynamically significant valvular disease. Serial D-dimers, every three months, for the following year were scheduled. Testing for inherited thrombophilia was negative.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 53 years old, which is above the age of 50. The heart rate is 90 bpm, which is below 100 bpm. The oxygen saturation is 94%, which is below 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, the patient meets 4 out of 7 criteria for the PERC score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 44 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['O₂ ≥ 95%', 'No hemoptysis', 'No prior VTE']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [75, 'years'], 'Heart Rate or Pulse': [124.0, 'beats/minute'], 'O₂ saturation percentage': [90.0, '%'], 'Hormone use': False, 'Recent surgery or trauma': False, 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 75-year-old woman, who was being treated with prednisolone 5 mg/day for polymyalgia rheumatica, presented with anorexia and general malaise for 3 days and then developed vomiting and diarrhea. She experienced difficulty moving her body, and her consciousness deteriorated. The patient was brought to our hospital on an ambulance. The consciousness level on admission, body temperature, blood pressure, pulse rate, respiratory rate, and peripheral oxygen saturation were E3V4M6, 39.5 °C, 153/88 mmHg, 124 beats/minute, 25 breaths/minute, and 90% (with oxygen mask 6 L/min), respectively. Her bulbar conjunctiva was congested on both sides, and coarse crackles were heard in the right lung field. Reticular dermatosis was found on both of her lower legs, and erythematous dermatosis was observed on the lower side of the back. Laboratory blood tests on admission showed elevated inflammatory markers (white blood cell count and C-reactive protein), creatine phosphokinase, and liver aminotransferase. Further, a rapid influenza diagnostic test was positive for influenza A (Table ). Chest computed tomography (CT) showed diffuse airspace opacification in the right middle lobe (Fig. ). Head CT demonstrated a slight fluid collection in the right upper sinus suggesting sinusitis.\n",
      "Her clinical signs and symptoms fulfilled three out of five clinical criteria of TSS with a fever of 38.9 °C or higher, diffuse erythroderma, and multisystem involvement (conjunctival congestion, gastrointestinal symptoms of vomiting and diarrhea, hepatic dysfunction, and disorientation). At this time point, she had not developed desquamation yet and had no hypotension. Therefore, the patient was clinically diagnosed with influenza with bacterial pneumonia and potential TSS, and her treatment was started with meropenem (1 g every 8 h), vancomycin (1 g every 12 h, therapeutic drug monitoring: ≥15 μg/mL), and clindamycin (600 mg every 8 h).\n",
      "The next day, S. simulans, a CoNS strain, was detected in both sets of blood cultures. Furthermore, pneumococci and methicillin-sensitive Staphylococcus aureus (MSSA) were identified in sputum cultures (Geckler 4 group) and pharyngeal cultures (small number of colonies), respectively. Exotoxins, such as TSST-1, and staphylococcal enterotoxins (type A, B, C, and D), which are known to cause TSS, were not detected in culture samples of MSSA and S. simulans. We used the reversed passive latex agglutination method to evaluate the exotoxins and enterotoxins; the minimum detection sensitivity of sensitized latex using this method was found to be 1–2 ng/mL. We changed the antimicrobial therapy to cefazolin (1 g q8h) and clindamycin (600 mg q8h), based on microbiologic test results, and this therapy was administered for 14 days. Finger desquamation appeared on the 8th day of hospitalization, fulfilling four out of five clinical criteria for TSS. Therefore, we diagnosed the case as probable TSS.\n",
      "Serum levels of inflammatory cytokines were high: neopterin 62 mmol/L (reference range, ≤5 mmol/L) and IL-6 38 pg/mL (reference range, ≤5 pg/mL). Lymphocyte subpopulation distribution was then analyzed in peripheral blood (Fig. ), showing prominent CD57 expression in CD8+ T cells, suggesting strong activation of this T lymphocyte subset.\n",
      "Furthermore, T cell receptor (TCR) Vβ repertoire distribution analysis was carried out (Fig. ). A specific subset of CD8+ T cells, including Vβ7.2 and Vβ14 cells, was increased, indicating the oligoclonal activation of CD8+ T cells likely due to antigen exposure. However, the distribution of CD4+ T cell TCR Vβ repertoire was normal. The activation of Vβ2+ population, which is characteristic for TSST-1, was not observed.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 68 years old, which is above 50, so criterion 1 is false. The heart rate is 100 bpm, which is not less than 100 bpm, so criterion 2 is false. The oxygen saturation is 96%, which is greater than or equal to 95%, so criterion 3 is true. The patient has hemoptysis, so criterion 4 is false. There is no mention of estrogen use, so criterion 5 is true. The patient has a history of lung cancer and is on LMWH, which indicates a prior VTE, so criterion 6 is false. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient has a total of 3 false criteria, so the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 45 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['O₂ ≥ 95%', 'No hemoptysis']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [43, 'years'], 'Heart Rate or Pulse': [79.0, 'beats per minute'], 'O₂ saturation percentage': [96.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 43-year-old Brazilian man arrived at the ED in May 2020 with a history of cough with hemoptoic sputum for more than 1 month, evolving to mild respiratory distress in the last 7 days. He did not show signs of a fever and other symptoms. He had a previous history of HIV/AIDS with no adherence to antiretroviral therapy, illicit drug abuse, and had generalized anxiety disorder. He had lost clinical and laboratory follow-up in the last 5 years. In 2015, the HIV viral load was 9,054 copies/mm3, and the T-CD4 cell count was 407/mm3. On physical examination, his weight was 55 kg, heart rate was 79 bpm, respiratory rate was 18 rpm, and SPO2 was 96%. No lymphadenopathy was observed. Blood cell count presented low hemoglobin (9.9 g/dL) and hematocrit levels (29.7%), and normal platelet and white cell count ranges. Lactate dehydrogenase and C-reactive protein levels were 312 U/L, above reference limits (140–271 U/L), and 52.3 mg/dL, respectively. The D-dimer level (0.6 mcg/mL) exceeded the normal range. Troponin, AST, ALT, and ferritin levels were in normal range.\n",
      "Chest CT revealed bilateral glass-ground opacities occupying approximately 25% of both lungs (). Respiratory secretion was collected with a nasopharyngeal swab and tested positive for SARS-CoV-2. Mycobacterium tuberculosis DNA was detected using PCR (GeneXpert MTB/RIF assay) without RIF resistance. Treatment was initiated with azithromycin (500 mg/day), HCQ (400 mg/day) for 5 days, and ceftriaxone (2 g/day). He was treated with isoniazid, ethambutol, pyrazinamide, and RIF. Antiretroviral therapy was not started to avoid complications with anti-TB treatment. The patient was clinically stable and discharged to home after 1 week. Currently, the patient is under follow-up and remains asymptomatic without developing relapses.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 20 years old, which is less than 50 years. The heart rate is 99 bpm, which is less than 100 bpm. The oxygen saturation is 85% on room air, which is less than 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the patient's history. Therefore, the PERC score is 1.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 46 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [40, 'years'], 'Heart Rate or Pulse': [100.0, 'beats per minute'], 'O₂ saturation percentage': [78.0, '%'], 'Unilateral Leg Swelling': True, 'Recent surgery or trauma': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "Mrs. A.O., a 40-year-old known SCD patient with hemoglobin SS genotype was referred to the pulmonary division on account of dry cough of 3 weeks, difficulty in breathing of 2 weeks, and bilateral leg swelling of 4 days. There was low-grade fever, no weight loss, and no contact with chronic cough index. Difficulty in breathing initially occurred on exertion but later occurred even at rest. There was orthopnea but no paroxysmal nocturnal dyspnea. There was bilateral leg swelling, which worsened progressively. No swelling in other parts of the body. No reduction in her urine volume. She was not a diagnosed asthmatic, hypertensive, or diabetic and she was not previously treated for tuberculosis or any other chronic lung diseases. She was only admitted for childbirth in her adulthood years. She had a single episode of blood transfusion when she was 6 years old. Afterwards, she has been crisis free for more than 20 years. She neither smokes cigarettes nor consumes alcoholic drinks. No history of exposure to cigarette smoke from others. She is married in a monogamous family with two girls and one boy. Her last childbirth was 15 years prior to presentation. She works as a secretary in the registration office of a state polytechnic. No history of exposure to occupational dust or fumes. No history of chronic drug use and no history of allergy.\n",
      "On general examination, she was a middle aged looking woman, conscious, dyspneic with central cyanosis, afebrile (Temperature=36.5), not pale, anicteric, not dehydrated, grade 3 digital clubbing, bilateral pitting pedal edema up to the lower third of the leg, weight=84 kg, height=1.65 m, and BMI=30.9 kg/m2. Oxygen saturation in room air was 78% and this increased to 92% on 5 L/min of oxygen via nasal prong.\n",
      "Respiratory examination revealed that she was in respiratory distress as evidenced by respiratory rate of 42/ min, flaring of alae nasi, and use of accessory muscles of respiration, and the trachea was central with symmetrical chest movement. Percussion note was resonant with coarse crepitations over the entire right lung and posterior lower zone of the left lung.\n",
      "Cardiovascular examination: pulse=100 beats/min, regular with premature beats, full volume; arterial wall was not thickened. No locomotor brachialis. BP was 105/60 mmHg. JVP was raised to the angle of the jaw. She had a right parasternal heave and apex beat was in the 5th left intercostal just lateral to the mid-clavicular line. Heart sounds were S1, S2, S3 gallop rhythm with loud pulmonary component of second heart sound.\n",
      "Abdomen – full, moves with respiration, liver was 4 cm below the costal margin, mildly tender, smooth surface, and span of 16 cm. Spleen and kidneys were not enlarged. No demonstrable ascites.\n",
      "Other systems were within normal limits.\n",
      "Her packed cell volume was 32% with a white blood cell count of 13.5 ×109/L (neutrophil=52%, lymphocyte=38%, other=9%) and erythrocyte sedimentation rate of 3 mm/h. Sputum examination for acid and alcohol fast bacilli was negative in three samples; sputum culture did not yield any growth. Chest X-ray showed widespread reticulonodular opacities involving the whole of the right lung field and left upper zone with an area of hyperluscency in the left mid and lower zones. Electrocardiography revealed sinus tachycardia of 120 beats/min, P pulmonale, and right ventricular hypertrophy with ventricular extrasystole. Echocardiography demonstrated tricuspid regurgitation with pulmonary hypertension. Spirometry showed severe restrictive pattern {FVC=1.13 L (36% of predicted); FEV1=0.84 L (35% of predicted) FEV1/FVC ratio=74.5% (92% of predicted)}. Chest CT demonstrated diffuse ground glass opacity with thickening of interlobar septa in the entire right lung field as well as left apex and part of the left lower region. There were multiple bullae with reduced attenuation (suggestive of compensatory emphysema of the remaining lung tissue) in the left lung field, sparing the apex. The pulmonary trunk was prominent and there was cardiomegaly [Figures –].\n",
      "She was admitted and managed initially in the intensive care unit with intranasal oxygen, cardiopulmonary monitoring, tablet levofloxacin 500 mg daily, intravenous frusemide 60 mg 8 hourly, tablet spironolactone 25 mg twice daily, and tablet aspirin 75 mg daily.\n",
      "The heart failure gradually improved but she continued to desaturate in room air. She was advised on domiciliary oxygen, which she initially rejected but later purchased a cylinder of oxygen (did not purchase oxygen concentrator because of poor power supply) and pulse oximeter. She was discharged home, on 1–3 L/min of domiciliary oxygen (to be titrated with the pulse oximeter readings), aspirin, and oral diuretics, after 1 month of hospitalization. She was re-admitted 1 week later with productive cough and features of right heart failure. She was managed with oxygen, diuretics, antibiotics, and aspirin. She improved and was discharged after 3 weeks. She has remained relatively stable at subsequent clinic visits. Her clinic oxygen saturation was 91-94% (off oxygen) during clinic visits.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 52 years old, which is above the age threshold of 50. His heart rate is 107 bpm, which is above the threshold of 100 bpm. His oxygen saturation is 93%, which is below the threshold of 95%. There is no mention of hemoptysis, estrogen use, prior VTE, or unilateral leg swelling in the note. Therefore, these criteria are considered met. The patient's age and heart rate are above the threshold, and his oxygen saturation is below the threshold, so these criteria are not met. The other criteria are met as there is no mention of them in the note.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 47 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['HR < 100', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [64, 'years'], 'Heart Rate or Pulse': [72.0, 'beats per minute'], 'O₂ saturation percentage': [100.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': True, 'Unilateral Leg Swelling': True, 'Hormone use': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 64-year-old male presented to the emergency department with a 10-day history of fatigue, shortness of breath, and peripheral oedema.\n",
      "His medical history included: bioprosthetic aortic valve replacement (AVR) and coronary artery bypass graft (CABG) surgery, 5 months prior, for critical aortic stenosis and significant coronary artery disease, hypertension, type-2 diabetes mellitus, hypercholesterolaemia, nephrotic syndrome, and pulmonary embolism. He was an active gentleman, often completing several rounds of golf per week.\n",
      "Medications included: warfarin, clopidogrel 75 mg OD, losartan 25 mg OD, atorvastatin 20 mg OD, prednisolone 60 mg OD, gliclazide 240 mg/40 mg BD, and linagliptin 5 mg OD.\n",
      "At presentation, his blood pressure was 110/60 mmHg, heart rate 72 b.p.m., respiratory rate 25 b.p.m., oxygen saturations 100% on air, and he had a temperature of 37.7°C. On physical examination, he appeared breathless on minimal exertion, had fine right basal crepitations, a pan-systolic and early diastolic murmur, and bilateral mild pitting oedema. Initial laboratory investigations revealed a haemoglobin of 117 g/L, white cell count of 11.57 × 109/L (neutrophil count 9.26 × 109/L), C-reactive protein 11 mg/L, and creatinine 96 μmol/L [estimated glomerular filtration rate (eGFR) 72 mL/min].\n",
      "The primary components of the admission differential diagnosis included: infective endocarditis, aortic valve dehiscence or thrombosis, congestive cardiac failure of alternative cause, and pneumonia.\n",
      "Urgent echocardiography was performed which demonstrated dehiscence of the aortic valve with mild aortic regurgitation. On 2D echo imaging, a hypoechoic tract could be visualized from the left ventricular outflow tract (LVOT) to the RA (Figure ). The suspicion of a Gerbode defect was confirmed on colour flow mapping, with a large jet demonstrated between the two chambers (Figure and C).\n",
      "Computerized tomography (CT) revealed a complex aortic root pseudoaneurysm with LVOT to RA fistulation and a large left-to-right shunt (Figure and B).\n",
      "Three peripheral blood cultures taken on admission returned positive for Staphylococcus warneri, a coagulase-negative Staphylococcus. Treatment with intravenous gentamicin, vancomycin, and rifampicin was initiated and after 10 days of therapy, he underwent a surgical aortic valve replacement and LV–RA fistula repair. After 1 month in hospital, he was discharged home, and 2 months later was back on the golf-course, albeit with a very limited swing on account of his recent sternotomy.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 75 years old, which is above 50, so criterion 1 is false. The heart rate is 124 bpm, which is above 100, so criterion 2 is false. The oxygen saturation is 90% with an oxygen mask, which is below 95%, so criterion 3 is false. There is no mention of hemoptysis, so criterion 4 is true. There is no mention of estrogen use, so criterion 5 is true. There is no mention of prior VTE, so criterion 6 is true. There is no mention of unilateral leg swelling, so criterion 7 is true. The patient's age, heart rate, and oxygen saturation are above the threshold, so the PERC score is 3.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 48 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [44, 'years'], 'Heart Rate or Pulse': [88.0, 'beats per minute'], 'O₂ saturation percentage': [92.0, '%'], 'Hormone use': False, 'Unilateral Leg Swelling': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 44-year-old Hispanic woman presented to the hospital with a six-month history of generalized weakness, weight loss of 40 pounds over a four-month period and a two-week history of progressively worsening dyspnea. She had had hypertension for five years for which she was being treated with lisinopril but had been noncompliant for over three years because of financial constraints. The patient denied any alcohol or illicit drug use and was a lifelong non-smoker.\n",
      "On admission, her blood pressure was 102/66 mm/Hg, her temperature was 37°C, her respiratory rate was 24 breaths/minute, her oxygen saturation level was 92% on room air and her pulse rate was 88 beats/minute. A physical examination revealed an ill-looking woman with mucosal pallor, generalized wasting and non-tender, rubbery axillary and inguinal lymphadenopathy. There was no evidence of cyanosis, digital clubbing, pitting edema, skin rash or joint deformities. Her abdomen was mildly distended but non-tender, with no organomegaly detected. Dullness to percussion and decreased breath sounds over the left base were noted on the respiratory system examination. The cardiovascular and neurological examinations were unremarkable.\n",
      "Initial laboratory investigations (Table ) revealed anemia, leukopenia, elevated blood urea nitrogen and elevated serum creatinine. Urinalysis showed trace proteinuria. Chest radiography revealed bilateral pleural effusions that were determined to be exudative in nature on the basis of thoracocentesis. There was a high index of suspicion for malignancy; however, the results of chest, abdomen and pelvis computed tomography scans and an axillary lymph node biopsy did not confirm this. Human immunodeficiency virus and tuberculin skin tests were negative.\n",
      "On day four of admission, she developed acute inflammatory arthritis of the elbows and knees. A serological workup revealed high anti-nuclear antibody, anti-double-stranded DNA antibody and anti-Smith antibody titers, with low complement 3 levels. An active sediment was noted on the basis of urinalysis (Table ). The patient's renal impairment persisted, and her glomerular filtration rate was estimated to be 53 ml/min/1.73 m2. A review of blood results since admission showed evidence of documented leukopenia on more than two occasions.\n",
      "On day 5 of admission, the patient experienced dyspnea and pleuritic chest pain. Reaccumulated pleural effusions were noted on a chest radiograph, and an echocardiogram showed evidence of pericardial effusion. Arterial blood gas interpreted in conjunction with a corresponding basal metabolic panel (Table ) revealed the presence of a non-anion gap hyperkalemic metabolic acidosis consistent with type 4 RTA. Analysis of morning serum sample showed a serum aldosterone level less than 1 ng/dl.\n",
      "The renal ultrasound obtained showed normal kidney morphology and no evidence of nephrolithiasis. A renal biopsy was done, which revealed diffuse global proliferative and membranous glomerulonephritis. This was consistent with lupus nephritis Renal Pathology Society/International Society of Nephrology 2003 class IV-G(A) and V, moderate activity index 9/24, minimal chronicity index 1/12; minimal tubulointerstitial fibrosis and acute tubular necrosis (Figure ).\n",
      "She was diagnosed with SLE complicated by a generalized lupus flare, with a SLEDAI score of 29. Overall during this single admission, she demonstrated six of the 11 American College of Rheumatology criteria used in the diagnosis of SLE.\n",
      "The patient was treated with a course of hydroxychloroquine and intravenous methylprednisone 1 g daily for three days. Thereafter she was placed on a prednisone, mycophenolate mofetil and hydroxychloroquine regimen. Complete resolution of the renal impairment (Figures and ) and type 4 RTA (Figure ) was achieved. She was discharged after 19 days to follow-up in the Rheumatology and Nephrology clinics. Her renal function remained normal at the one-month follow-up clinic visit.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 52 years old, so criterion 1 is false. Heart rate is 97 bpm, so criterion 2 is true. Oxygen saturation is 99%, so criterion 3 is true. The patient denies hemoptysis, so criterion 4 is true. The patient is male, so criterion 5 is true. The patient has no prior VTE, so criterion 6 is true. The patient has no unilateral leg swelling, so criterion 7 is true. The patient's PERC score is 1, indicating a low risk of pulmonary embolism.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 49 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 4 | Predicted: 4\n",
      "\n",
      "Parsed Entities:\n",
      "{'Hormone use': True, 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [122.0, 'beats per minute'], 'O₂ saturation percentage': [88.0, '%'], 'Recent surgery or trauma': True, 'age': [38, 'years'], 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 38-year-old G2P2 African American woman presented with 3-hour duration of severe abdominal pain, nausea, and vomiting. Her pain was acute in onset and constant in nature, radiated to both groins, and was progressively worsening. She denied any musculoskeletal pain. Her past medical history was significant for hypertension, fibroid uterus, and a cholecystectomy. She had worsening menorrhagia over the past two months. Her last gynecologic evaluation was three years prior to presentation. She reported tobacco use and denied alcohol or drug consumption. Physical examination revealed diffuse rebound tenderness and a palpable abdominal mass. Initial vital signs were as follows: temperature of 38.6°C, heart rate of 122 beats per minute, blood pressure of 48/37, and respiratory rate of 31 breaths per minute. Oxygen saturation was 88% and increased to 94% on 2 liters of nasal oxygen.\n",
      "Biochemical testing showed an elevated white blood cell count (13.5 K/μL), significant neutrophilia (94.8%), an elevatedcreatinine (3.8 mg/dL), low hemoglobin (8.9 g/dL), low potassium (3.2 mEq/L), and an elevated myoglobin (2140 ng/mL, normal range: 0–101 ng/mL). A cardiac and skeletal muscle enzyme panel was normal. Baseline creatinine from a prior admission was normal (0.6 mg/dL). Urinalysis showed trace blood and amorphous sediment. A computed tomography scan of the abdomen and pelvis without contrast showed a 24 cm × 13 cm × 13 cm complex mass occupying the pelvis and extending to the upper abdomen (). Both kidneys appeared normal in size without perinephric inflammation, hydronephrosis, or hydroureter. Renal sonography revealed normal echotexture and ureteral caliber.\n",
      "The working diagnosis was acute septic shock with associated acute renal failure. The patient had nonanion gap metabolic acidosis with a lactic acid level of 4.5 mmol/L (normal 0.4–2 mmol/L) and a pH of 7.40 with a compensatory decrease in PCO secondary to hyperventilation. Blood and urine cultures were obtained and the patient was started on intravenous fluid resuscitation, a bicarbonate drip, and broad-spectrum antibiotics. A norepinephrine infusion was used to maintain a normotensive state. The pelvic mass was thought to be the source of the patient's abdominal pain and represented a degenerating fibroid that was contributing to her critical presentation with worsening inflammation and myoglobinemia. Relevant tumor markers including CEA, AFP, CA-125, and inhibins A and B were normal.\n",
      "The patient's overall status continued to worsen the following day. She became obtunded with loss of consciousness, in sinus tachycardia, and hypotensive despite all aforementioned measures. Endotracheal intubation then followed. Furthermore, her renal function continued to deteriorate (creatinine of 7 mg/dL). Urine and blood cultures had still not yielded any bacterial growth. Continuous renal replacement therapy (CRRT) was initiated and the decision to perform an exploratory laparotomy and remove the pelvic mass followed, as it was attributed to the patient's worsening critical state.\n",
      "A large solitary fibroid was found within the left broad ligament that was densely adherent and contiguous with the uterus. The uterus and adnexal structures appeared significantly devitalized and edematous and were displacing the ureters without evidence of hydroureter. The bowels appeared normal. A total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed with an estimated blood loss of 150 mL. The patient remained intubated and returned to the surgical intensive care unit. The postoperative period was complicated by atrial fibrillation that responded to intravenous amiodarone in addition to anemia (Hg 6.7 g/dL) requiring blood transfusion.\n",
      "Dramatic biochemical improvement occurred over the next 48 hours with CRRT following surgery. Final blood and urine cultures were negative at 48 hours. Serum creatinine decreased to 1.4 mg/dL but however rebounded slowly over the following three days and peaked at 3.1 mg/dL. Serum myoglobin reached a nadir of 380.4 ng/mL by the fourth postoperative day (POD) and steadily increased and reached a plateau of 1074 ng/mL by POD-8 (). Clinical improvement followed with defervescence and normalization of vital signs by POD-3 and POD-5, respectively. Broad-spectrum antibiotics were discontinued at this time. The patient had normal sinus rhythm, was normotensive without any vasopressors, and was extubated uneventfully. The pathology reported a 29.4 × 20.8 × 19.7 cm large solitary leiomyoma weighing 3028 grams and showing extensive loss of nuclei from cells, stromal hyalinization, polymorphonuclear white blood cell infiltrate, and foci of calcifications reflecting various stages of early and late fibroid degenerative changes (). Both adnexal structures showed an extensive infiltrate of polymorphonuclear cells suggestive of severe and acute inflammation.\n",
      "The patient was discharged on POD-8 in a stable condition. Serum creatinine remained stable at 2.9 mg/dL, and myoglobin was 1074 ng/mL. She showed complete biochemical and clinical remission by her 4-week follow-up with a return to baseline serum creatinine (0.6 mg/dL) and a normal serum myoglobin of 25 ng/mL (). The patient was placed on oral estradiol for hormone replacement therapy and her care was released to her primary care physician.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 63 years old, which is above the age threshold of 50. The heart rate is 120 bpm, which is above the threshold of 100 bpm. Oxygen saturation is 88%, which is below the threshold of 95%. There is no mention of hemoptysis, estrogen use, or prior VTE. However, the patient has unilateral leg swelling due to deep vein thrombosis in the left radial artery. Therefore, the PERC score is 4.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 50 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['No prior VTE', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [52, 'years'], 'Heart Rate or Pulse': [97.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': True}\n",
      "\n",
      "Patient Note:\n",
      "History\n",
      "A 52-year-old African American male presented to the emergency department complaining of pleuritic, sharp pain in his right chest wall that had begun three days prior to arrival. The pain had since worsened in intensity, and did not radiate. He had taken acetaminophen without relief of his symptoms. The patient denied any fever, cough, shortness of breath, headache, or rash. His review of symptoms was otherwise negative. The patient had no significant past medical history and was taking no medications. He denied any recent history of surgery or trauma, but did note weight lifting two days prior to the onset of symptoms. Family history was negative for coagulopathies and autoimmune conditions.\n",
      "Exam findings\n",
      "Vital signs on arrival were blood pressure 146/97, heart rate 97, temperature 36.2°C, respiratory rate 20, and SpO2 99% on room air. He was alert and oriented, and in no acute distress. Lung sounds were clear bilaterally and heart sounds were normal. A raised cord was visible crossing from the epigastrium across the right breast toward the axilla, that was tender to palpation and mobile. There was no warmth, erythema, or rash overlying the cord. Head/eyes/ears/nose/throat, abdominal, and neurological examinations were unremarkable.\n",
      "Diagnostic evaluation\n",
      "Basic metabolic panel and troponin levels were normal, and a complete blood count and differential was unremarkable with platelets of 212 bil/L. Chest radiograph showed clear lung fields but did reveal remote right-sided posterior fractures of ribs five through eight. Given the pleuritic nature of the pain, a computed tomography pulmonary angiogram was ordered to rule out pulmonary embolism. As shown in Figure , it revealed a subtle density in the right chest wall over the area of the palpable cord, with no evidence of a pulmonary embolism. The diagnosis of superficial chest wall thrombophlebitis, or Mondor’s disease, was made.\n",
      "Patient course\n",
      "The patient was treated with ibuprofen in the emergency department and discharged with a naproxen prescription. He was referred to his primary care physician for further work-up. The pain improved in the days following his emergency department visit, resolving within a week of discharge. The patient was contacted two months after his emergency department visit. He noted that he was still able to appreciate a firm mass in his chest wall with some reduction in size since it was first diagnosed.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 65 years old, which is above the age of 50. His heart rate is 52 bpm, which is less than 100 bpm. His oxygen saturation is 98%, which is greater than or equal to 95%. There is no mention of hemoptysis, estrogen use, or prior VTE. However, he has unilateral leg swelling due to the renal vein thrombus. Therefore, the PERC score is 2.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 51 ---\n",
      "Model: Llama3-Med42-70B\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'O₂ ≥ 95%', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [63, 'years'], 'Heart Rate or Pulse': [92.0, 'beats per minute'], 'O₂ saturation percentage': [93.0, '%'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 63-year-old woman comes to the physician because of worsening shortness of breath, cough, and a 4-kg (8.8-lb) weight loss over the last year. She has no history of serious illness and takes no medications. She has smoked one pack of cigarettes daily for 35 years. Her temperature is 37°C (98.6°F), pulse is 92/min, respirations are 20/min, blood pressure is 124/78 mm Hg, and pulse oximetry on room air shows an oxygen saturation of 93%. Physical examination shows decreased breath sounds. A flow-volume loop obtained via pulmonary function testing is shown.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 46 years old, which is less than 50 years. The heart rate is 124 bpm, which is greater than 100 bpm. The oxygen saturation is 97.5%, which is greater than or equal to 95%. There is no mention of hemoptysis. There is no mention of estrogen use. There is no mention of prior VTE. The patient has unilateral leg swelling in the left thigh. The patient has a pulmonary vascular CTA with no obvious abnormalities, which suggests no pulmonary embolism.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 52 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [34, 'years'], 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [110.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 34-year-old woman is assaulted and suffers a number of stab wounds to her abdomen. Bystanders call paramedics and she is subsequently taken to the nearest hospital. On arrival to the emergency department, her vitals are T: 36 deg C, HR: 110 bpm, BP: 100/60, RR: 12, SaO2: 99%. A FAST and abdominal CT are promptly obtained which are demonstrated in Figures A and B, respectively. Her chart demonstrates no other medical problems and vaccinations/boosters up to date. The patient is diagnosed with a Grade V splenic laceration and is immediately brought to the OR for emergent splenectomy. The splenectomy is successfully performed with removal of the damaged spleen (Figure C).\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 75-year-old woman with exertional dyspnea, fever, and a diastolic heart murmur. She has no history of pet exposure, and her vital signs show a heart rate of 86/min and oxygen saturation of 92.2%. She has a history of valve replacement surgery due to infective endocarditis, and her blood tests show a low platelet count and elevated CRP. The patient has no history of estrogen use, prior VTE, or unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 53 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['HR < 100', 'No hemoptysis']\n",
      "Expected (Ground Truth): 4 | Predicted: 4\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [65, 'years'], 'Heart Rate or Pulse': [110.0, 'beats per minute'], 'O₂ saturation percentage': [85.0, '%'], 'Recent surgery or trauma': True, 'Unilateral Leg Swelling': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "Four days after undergoing a Whipple procedure for newly-diagnosed pancreatic cancer, a 65-year-old man has shortness of breath. His surgery was complicated by bleeding for which he required intraoperative transfusion with 4 units of packed red blood cells and 1 unit of platelets. His temperature is 38.8°C (101.8°F), pulse is 110/min, respirations are 26/min, and blood pressure is 95/55 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 85%. Cardiac examination shows normal heart sounds and no jugular venous distention. Auscultation of the lungs shows diffuse crackles bilaterally. The extremities are warm and there is no edema. Laboratory studies show a leukocyte count of 17,000/mm3 and hemoglobin concentration of 9.8 g/dL. Arterial blood gas on room air shows:\n",
      "pH 7.35\n",
      "PaO2 41 mm Hg\n",
      "PaCO2 38 mm Hg\n",
      "HCO3- 25 mEq/L\n",
      "The patient is intubated and mechanical ventilation is initiated. An x-ray of the chest is shown. Transthoracic echocardiography shows a normally contracting left ventricle.\n",
      "\n",
      "Reply:\n",
      "Based on the patient's history and clinical presentation, the most likely diagnosis is a pulmonary infection, possibly a bacterial or fungal infection, given the negative cultures and the patient's immunocompromised state.\n",
      "\n",
      "Now, let's calculate the PERC score for this patient:\n",
      "\n",
      "1. Age < 50 years: The patient is 58 years old, so this criterion is false.\n",
      "2. Heart rate < 100 bpm: The patient's heart rate is 57 bpm, so this criterion is true.\n",
      "3. Oxygen saturation ≥ 95%: The patient's oxygen saturation is 93% on room air, so this criterion is false.\n",
      "4. No hemoptysis: The patient has cough productive of brown sputum, which may indicate hemoptysis, so this criterion is false.\n",
      "5. No estrogen use: The patient is not on estrogen therapy, so this criterion is true.\n",
      "6. No prior venous thromboembolism (VTE): There is no mention of prior VTE in the patient's history, so this criterion is true.\n",
      "7. No unilateral leg swelling: There is no mention of leg swelling in the patient's history, so this criterion is true.\n",
      "\n",
      "PERC score: 4 (sum of false values)\n",
      "\n",
      "{\n",
      "  \"Explanation\": \"The patient is 58 years old, has a heart rate of 57 bpm, oxygen saturation of 93% on room air, cough productive of brown sputum, and no estrogen use, prior VTE, or unilateral leg swelling.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": false,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 54 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'No estrogen use']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [62, 'years'], 'Heart Rate or Pulse': [92.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Hemoptysis': False, 'Unilateral Leg Swelling': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 62-year-old woman presents to the emergency department after an episode of light-headedness. She was using the bathroom when she felt light-headed and fell to the floor. Her daughter found her and brought her into the emergency department right away. The patient has a past medical history of obesity and diabetes mellitus. She came to the emergency department 1 week ago for a similar complaint. The patient states that she has otherwise felt well with the exception of fatigue, constipation, an odd sensation in her chest, and a decreased appetite and desire to drink recently causing her to lose 10 pounds. Her temperature is 98.0°F (36.7°C), blood pressure is 122/88 mmHg, pulse is 92/min, respirations are 14/min, and oxygen saturation is 99% on room air. Physical exam reveals a cardiopulmonary exam within normal limits and stable gait. The patient has an obese abdomen with abdominal distension. Strength is 5/5 in the upper and lower extremities.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is an 18-year-old girl with abdominal pain, specifically in the right lower abdomen. She has a history of a similar episode last month, and her older brother had perforated appendicitis. The patient is sexually active with multiple partners and uses condoms inconsistently. The physical exam shows lower abdominal tenderness with guarding and tenderness of the right adnexa. The pelvic ultrasound reveals a small fluid collection in the cul-de-sac posterior to the uterus. The labs show a normal leukocyte count, hemoglobin, and platelet count. The beta-human chorionic gonadotropin result is pending.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 55 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['No unilateral leg swelling']\n",
      "Expected (Ground Truth): 4 | Predicted: 4\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [71, 'years'], 'Heart Rate or Pulse': [109.0, 'beats per minute'], 'O₂ saturation percentage': [100.0, '%'], 'Unilateral Leg Swelling': True, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 71-year-old male with a past medical history of hypertension presented to our community emergency department (ED) transported by emergency medical services (EMS) with the chief complaints of chest pain, difficulty breathing, back pain, and weakness of both lower extremities. He had an abrupt onset of chest pain, described as a sharp and stabbing pain, while using his rototiller in the garden, 6 h prior to arrival. His symptoms continued to progress to the point that he was having difficulty breathing and starting to have trouble walking for which EMS was called. Per EMS, they noted rapidly progressing symptoms while en route to the ED. Vitals on arrival to the ED are as follows: 94.5 °F, blood pressure of 91/64 mmHg, heart rate of 109 beats/min, respiratory rate of 22 breaths/min, and 100% pulse oximetry on room air. On physical exam, he was toxic appearing, in acute distress, and diaphoretic. Jugular venous distention was present. Cardiopulmonary exam was notable for tachycardia, distant heart sounds, and the presence of bibasilar rales. His skin/lower extremities were pale, mottled, and he was unable to move them. Carotid pulses were 2+ bilaterally, radial pules 1+ bilaterally, femoral pulses 1+ bilaterally, with absent popliteal pulses. On neurological exam, he had dysarthric speech, left-sided facial droop, and loss of strength and sensation in his lower extremities.\n",
      "The patient was placed on non-invasive positive pressure. Electrocardiography revealed sinus tachycardia with premature atrial complexes, a right bundle branch block, with non-specific ST/T wave changes in the anterior leads. Portable chest radiography taken in an upright position (Fig. ) demonstrated a widened mediastinum at about 10.5 cm. A bedside point of care cardiac ultrasound revealed a significant pericardial effusion. Computed tomography (CT) of the head without contrast was unremarkable for any acute process. Pertinent laboratory evaluation:\n",
      "Hemoglobin of 9.2 (13.5–17 g/dL) Arterial blood gas: pH 7.01, pCO2 45, p02 116, HCO3 12 Initial lactic acid of 8.3 (0.5–2.2 mmol/L) that increased to 14.8 Blood/urea/nitrogen of 42 (8–22 mg/dL) Creatinine of 3.06 (0.6–1.4 mg/dL).\n",
      "CT angiography of the chest, abdomen, and pelvis with and without intravenous contrast revealed a Stanford type A dissection with an intimal tear beginning at the level of the aortic root and extending throughout the course of the thoracic aorta and into the abdominal aorta (Figs. , , and ). Additional findings on CT included involvement of the origins of the great vessels (brachiocephalic trunk, left common carotid artery, left subclavian artery). Hemopericardium is visualized with high suspicion for pericardial tamponade. There is dilation of the ascending thoracic aorta measuring up to 5.2 cm. The dissection continues distally (Figs. and ) to involve the left common iliac artery and bilateral external iliac arteries.\n",
      "He was transferred emergently to a tertiary center and was taken immediately to the operating room for definitive repair. The patient underwent sternotomy, repair of Stanford type A dissection with right groin cannulation, and repair of the right femoral artery and vein. He arrived in the surgical intensive care unit in guarded condition, his sternotomy was left open secondary to severe coagulopathy intraoperatively, and he was on an epinephrine, norepinephrine, and vasopressin infusion. By day 2, continuous renal replacement therapy (CCRT) was initiated for acute tubular necrosis. Vascular surgery was consulted to evaluate a pulseless right lower extremity status post right femoral artery cannulation for cardiopulmonary bypass. Given the patient had an open sternotomy with five chest tubes with significant output requiring transfusion of multiple blood products throughout the night, vascular surgery could not perform a femoral-femoral bypass or axillofemoral bypass without heparinization.\n",
      "By day 3, he underwent mediastinal irrigation and sternal closure with cardiothoracic surgery. He was then taken for a right common femoral endarterectomy, iliofemoral and lower extremity embolectomy, and right lower extremity four-compartment fasciotomy secondary to acute ischemia of the right lower extremity. In addition, neurosurgery evaluated the patient because he was not spontaneously moving his extremities after surgery and there was concern that the dissection had caused an infarction of his thoracic spinal cord, resulting in paraplegia. By day 4, he remained stuporous off sedation and on maximum pressor support (norepinephrine infusion at 30 mcg/min, epinephrine infusion at 10 mcg/min, and a vasopressin infusion at 0.04 units/min). He continued to have upper extremity non-epileptic myoclonic jerks secondary to continued renal failure. CT of the head revealed multiple 1 to 2 cm foci consistent with likely subacute infarcts related to embolic disease. By day 5, a family discussion was had regarding a poor neurological prognosis for independent neurological recovery with likely permanent cognitive and motor deficits. His code status was subsequently changed to do not resuscitate (DNR) with no further escalation of care. The patient continued to deteriorate throughout the night, became asystolic, and expired.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 71-year-old man, which means he does not meet the first criterion (Age < 50 years). His heart rate is 116 beats per minute, which is higher than 100 bpm, so he does not meet the second criterion (Heart rate < 100 bpm). His peripheral oxygen saturation is 97% with a non-rebreathing mask, which is higher than 95%, so he meets the third criterion (Oxygen saturation ≥ 95%). There is no mention of hemoptysis in the patient's history or physical examination, so he meets the fourth criterion (No hemoptysis). The patient has a history of alcohol and nicotine abuse, but there is no mention of estrogen use, so he meets the fifth criterion (No estrogen use). There is no mention of prior venous thromboembolism (VTE) in the patient's history, so he meets the sixth criterion (No prior VTE). The patient has a wound on his right foot with maggots, which indicates unilateral leg swelling, so he does not meet the seventh criterion (No unilateral leg swelling).\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 4\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 56 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['O₂ ≥ 95%', 'No hemoptysis']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'Hormone use': False, 'Unilateral Leg Swelling': False, 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [153.0, 'beats per minute'], 'Hemoptysis': True, 'O₂ saturation percentage': [96.0, '%'], 'Recent surgery or trauma': False, 'age': [34, 'years'], 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 34-year-old male presented to our Emergency Department via emergency medical services complaining of palpitations, shortness of breath, and cough with one episode of hemoptysis that started earlier that day. The patient reported that his symptoms rapidly progressed a few hours prior to arrival shortly after smoking crystal methamphetamine. The patient reported chronic methamphetamine use for 10 years, becoming an everyday user 3 years ago. He admitted to occasional polysubstance use that included ketamine, ecstasy, and alcohol, although those were limited to a few times a month. Past medical history was significant for two remote spontaneous pneumothoraces, but the patient stated that his current symptoms felt unrelated. Past surgical history was noncontributory and he denied allergies or taking any prescribed medications. Reviews of systems were positive for myalgias and fatigue. The patient denied any chest pain, chest tightness or abdominal pain.\n",
      "Initial vital signs include the following: HR: 153 bpm, RR: 20, BP: 115/56 mmHg, Temp (O): 102.1 °F, and SpO2 96% (RA).\n",
      "The physical exam demonstrated a well-nourished, well-kept male appearing in his stated age in good physical shape. The patient appeared anxious and diaphoretic with dry mucus membranes and labored breathing. The patient was alert and oriented but found to have mild confusion upon detailed questioning. The rest of the neurologic exam was normal and the patient did not display any meningeal signs. Auscultation of the chest revealed rales at the lung bases. Cardiac exam demonstrated a regular, tachycardic rhythm without the presence of obvious murmurs, rubs, or gallops. There was no lower extremity edema present and patient displayed normal muscle tone. The rest of the physical exam was unremarkable.\n",
      "Upon the patient's initial presentation, orders for initial management were with a normal saline bolus of 2 liters, supplemental oxygen with 2 liters on nasal cannula, broad spectrum antibiotics (piperacillin/tazobactam and vancomycin), antipyretics, and multiple doses of IV lorazepam with the aim of treating his tachycardia with a mixed picture of sepsis, dehydration, and methamphetamine intoxication.\n",
      "Point-of-care ultrasound (POCUS) of the inferior vena cava (IVC), heart, and lungs was obtained. The IVC diameter measured 1.85 cm (max) in inspiration and 1.71 cm (min) in expiration (Images -, ). Cardiac views demonstrated gross biatrial and biventricular dilation on visual inspection with a severely reduced left ventricular ejection fraction (LVEF) and a small pericardial effusion (Images -, Videos -). Lung ultrasound demonstrated bilateral lung sliding anteriorly and B-lines in bilateral inferolateral lung fields (Images -, Videos -). With the information obtained via US, the decision was made to consult cardiology and to restrict IVF administration by giving the patient 1 liter of normal saline over the course of two hours instead of a 2-liter bolus.\n",
      "Electrocardiogram (ECG) revealed sinus tachycardia with a normal axis and without ST elevations, PR depressions, or significant T-wave inversions (). Chest X-ray demonstrated a right lower lobe consolidation with evidence of central pulmonary venous congestion and cephalization (). Significant laboratory findings included a WBC count of 21,000 with a neutrophilic predominance of 81%, lactic acid of 1.8 mmol/L, Pro-BNP of 1,741 pg/ml, and Troponin I < 0.04 ng/ml. The rest of the basic blood works including renal function and electrolytes were within normal limits for our institution. Computed tomography (CT) pulmonary angiogram was performed and demonstrated a right lower lobe consolidation and no evidence of pulmonary embolism. Also evident on CT were atrial and ventricular enlargement, central pulmonary venous congestion, and signs of early pulmonary edema (Images -).\n",
      "The patient was admitted to the ICU and was continued on broad-spectrum antibiotics and a normal saline infusion of 75 ml/hr. On day two, all IV fluids were discontinued and diuresis was employed for decompensated heart failure with developing hypoxia. The patient grew 2/2 positive blood cultures for Streptococcus pneumoniae and was found to be Influenza B positive. Comprehensive 2D Echocardiogram revealed dilated cardiomyopathy with LVEF of 16%, restrictive left ventricular filling pattern, elevated filling pressures with E/e'=30, moderate/severe mitral regurgitation, and severe tricuspid regurgitation.\n",
      "The patient improved during hospitalization and was discharged on day 9 with a diagnosis of severe sepsis, right lower lobe pneumonia, Streptococcus pneumoniae bacteremia, Influenza B, and Methamphetamine-Associated Cardiomyopathy.\n",
      "He was discharged on antibiotic therapy and a heart failure regimen consisting of lisinopril and metoprolol.\n",
      "His cardiac dysfunction improved with drug abstinence and medical therapy. A four-month echocardiogram demonstrated resolution of dilated atrial and ventricular chambers, with improvement of LVEF to 45% and improvement in valvular dysfunction to only trace mitral and tricuspid regurgitation.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 16-year-old girl with a history of psoriasis, presenting with fever, cough, and unintentional weight loss. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 16 years old, so this criterion is met (true).\n",
      "2. HR < 100: The patient's heart rate is 140 beats/min, which is above 100, so this criterion is not met (false).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 94% on room air, which is below 95%, so this criterion is not met (false).\n",
      "4. No hemoptysis: The patient denies hemoptysis, so this criterion is met (true).\n",
      "5. No estrogen use: There is no mention of estrogen use in the patient's history, so this criterion is met (true).\n",
      "6. No prior VTE: The patient has no history of venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: There is no mention of unilateral leg swelling in the patient's history, so this criterion is met (true).\n",
      "\n",
      "The PERC score is the sum of false values, which is 2 in this case.\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 57 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [33, 'years'], 'Heart Rate or Pulse': [114.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Hormone use': False, 'Unilateral Leg Swelling': False, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 33 years old Caucasian male presented to the emergency room of St.Vincent Mercy Medical Center at Toledo, Ohio with a history of intermittent hemetemesis for last couple of weeks which has increased in severity during the last 24 hours, progressing to 4 episodes of a cup full of blood. He also had complaints of light headedness and dizziness. He had no history of hemetochezia, melena, fever, chills, constipation, diarrhea, abdominal pain or nausea. He had no recent NSAIDs use, headache, chest pain, shortness of breath or palpitation.\n",
      "Patient had past history of Diabetes Mellitus type 1 and is on Insulin. Patient had history significant for Gallstone pancreatitis which resulted in Pseudocyst formation. Patient had undergone Cholecystectomy and Cystojejunostomy in 2007. He had history of Spinal Stenosis, right knee surgery and Tonsillectomy. Patient was allergic to Avandia, Fentanyl, and Metfromin. Patient was on Tramadol, Neurontin, Insulin, Zolpidem and Omeprazole. Patient had no history of Gastrointestinal (GI) disease in family. His father had diabetes and mother had COPD and pernicious anemia. Patient was a non smoker, non alcoholic and denied using any illicit drugs. His bowel and bladder functions were unaltered.\n",
      "On presentation his vitals were Temp: 36.3 °C, Pulse: 114/min, Blood pressure: 102/54 mm of Hg, Oxygen saturation: 99% on room air and Respiratory rate: 16/min. On physical examination he was conscious, coherent, pale looking and weak with warm and moist skin without dermatosis. No signs of Jaundice or generalized Lymphadenopathy were found. He had no obvious spinal or limb deformities. He had normal pulses in all extremities without any signs of cyanosis. His oral cavity was normal without ulcerations. His chest was symmetrically expanding with good breath sounds and without labored breathing. He had adynamic precordium with apex beat located in 5th intercostal space at midclavicular line. He had normal heart sounds without any murmur. His abdomen was soft and flat. He had tenderness in epigastric region. No organomegaly or masses were found and bowel sounds were normal. Patient had normal neurological examination with grossly intact cranial nerves and normal reflexes. Pupils were equal and reacting to light normally.\n",
      "His initial investigations were Hemoglobin 6.3 gm/dl, Hematocrit of 18.7%, MCV: 88.8 fL, White cell count 8.4 k/ul (Neutrophils 84, Lymphocytes 10, Monocytes 6, Eosinophils 0, Basophils 0), Platelet count: 327 k/ul, Sodium: 137 meq/l, Potassium: 4.7 mEq/l, Bicarbonate: 24.5 mEq/l, Chloride: 103 mEq/l, Blood Urea Nitrogen: 35 mg/dl, Creatinine: 0.59 mg/dl, Glucose: 231 mg/dl, Bilirubin: Direct: 0.12 and total 0.28 mg/dl, Proteins total: 4.4 g/dl, Albumin: 2.7 g/dl, AST: 31 units/L, ALT: 44 units/l, Calcium: 7.9 mEq/l, Alkaline phosphatase: 53 units/l, Lipase: 23 units/l, pCO2 46, pO2 84, pH 7.34, PTT: 23.4 (20.3-30.9 sec), Prothrombin time: 12.5 (9.7-12 sec), INR: 1.2, Fibrinogen: 420(140-420 mg/dl). Hepatitis serology and ANA screen were negative. He had undergone Liver biopsy was performed during surgery which was found normal without any changes of cirrhosis of liver ().\n",
      "On upper GI endoscopy (EGD) esophageal and stomach mucosa were found normal without any active sites of bleeding. Fundus was clearly seen without varices. Pylorus was patent and the duodenal bulb was normal. The major papilla was identified in the descending duodenum and had normal appearance. Just distal to the major papilla in the 2nd portion of duodenum, there was a large submucosal bulge suspicious for an ectopic duodenal varix (). On withdrawal of the scope findings were confirmed.\n",
      "Abdominal and pelvic CT scan with contrast showed massive gastric distention. Gastric outlet obstruction was suspected. Pancreatic Pseudocyst in the tail of the pancreas had significantly increased in size from the previous study. Changes of chronic pancreatitis were present.\n",
      "Mesenteric Arteriogram showed slow contrast filling of the superior mesenteric vein with significant limiting of flow. Superior Mesenteric Vein obstruction was suspected. Multiple venous varicosities around the distal stomach and the pancreatic head region were found (). Possibility of at least partial thrombosis of the Superior Mesenteric Vein (SMV) near the pancreatic head region was suspected secondary to pancreatitis. Splenic vein was found of normal caliber without any varicosities.\n",
      "Patient had undergone end to side Mesocaval Anastomosis with a Dacron 10 mm graft between the Superior Mesenteric Vein and the Inferior Vena Cava along with adhesionolysis and liver biopsy. During surgery no varicosities found in the gastric and esophageal region or no dilation found in the splenic or inferior mesenteric venous system. There were multiple adhesions found in the tail region of pancreas possibly because of previous Cystojejunostomy in that area. Similarly many adhesions found in the peripancreatic region most likely due to changes of chronic pancreatitis. Patient was discharged without any complications and found asymptomatic in the follow up visits with normal hemoglobin level and without any evidence of bleeding. Considering the young age of the patient and relatively absent varices at other sites Mesocaval shunt surgery was chosen as a treatment over Transjugular Intrahepatic Portosystemic Shunt (TIPS) and duodenal resection.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is an 85-year-old female with a history of atrial fibrillation and a pacemaker inserted 2 weeks prior. She presented with sudden onset substernal chest pain and dizziness. The following criteria were evaluated based on the provided information:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 58 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%', 'No estrogen use']\n",
      "Expected (Ground Truth): 3 | Predicted: 3\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [28, 'years'], 'Heart Rate or Pulse': [138.0, 'beats per minute'], 'O₂ saturation percentage': [86.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': True, 'Hormone use': False, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 28-year-old man was admitted in our hospital on Jul 13, 2018 because of recurrent cough and yellow-phlegm accompanied by fever for more than 10 months. The symptoms were repeated after routine symptomatic treatment. A chest computed tomography (CT) scan taken in January 2018 had showed that his right lung was spotted by small piece of shadow, accompanied by a cavity. The patient refused to initiate antitubercular therapy. The symptoms were improved after self-administration of cephalosporin as anti-infection treatment for 1 week. In May, the cough and sputum were aggravated, accompanied by fever in the afternoon, with body temperature around 38 °C. In the beginning of July, chest CT showed that the patchy shadow was scattered in two lungs with multiple cavities. The large consolidation in the right upper lung was significantly progressed compared with half a year ago. Considering combination of pulmonary tuberculosis and pulmonary infection, he was hospitalized.\n",
      "At admission, physical examination revealed the following: weight 53 kg; BMI 16.7, body temperature 38.7 °C, pulse 85/min, blood pressure 118/72 mmHg, finger oxygen saturation degree (FOSD) 98%. The lungs had lower breath sounds, with no obvious dry or wet rale. The auxiliary examination showed that the following test items were normal, including blood routine, biochemistry, coagulation, erythrocyte sedimentation rate, arterial blood gas analysis and echocardiography. D-dimer was 13.17 mg/L. Electrocardiogram showed sinus tachycardia. The details of chest CT was shown in Fig. . Acid-fast bacilli staining test for sputum sample was positive (4+/3+), which confirmed the diagnosis of pulmonary tuberculosis.\n",
      "Routine anti-tuberculosis regimen was initiated, including isoniazid (300 mg/day), rifampin (450 mg/day), pyrazinamide (1500 mg/day) and ethambutol (750 mg/day). After 3 days of treatment, the body temperature dropped down to the normal, and the cough was relieved. Respiratory symptoms were also improved after 15 days of treatment. At that time, the patient suddenly felt chest tightness, chest pain, and shortness of breath after increased activity (three times more than the usual). Physical examination revealed: heart beats 138/m, blood pressure 88/58 mmHg, FOSD 86%. Even after 6 L high-flow oxygen intake, FOSD was maintained at 90%. Arterial blood gas analysis without oxygen inhalation indicated: pH 7.44, PO2 48 mmHg, PCO2 33 mmHg, SPO2 86%, Oxygenation Index 228.57 mmHg, D-dimer 14.03 mg/L. Electrocardiogram showed atrial tachycardia, non-specific ST elevation. Taking together, all the data highly suggested PTE. Emergency computer tomography pulmonary angiography (CTPA) inspection showed signs of filling defects in the trunk and branches of the left pulmonary artery and the right lower pulmonary artery (Fig. ).\n",
      "According to the CTPA result, the patient was diagnosed as a large-scale PTE, and the risk stratification was medium-high. The patient was prescribed with low-molecular-weight heparin (LMWH) (0.1 mL/10 kg) for anticoagulation. Then, under pulmonary angiography, a combined thrombolytic therapy including mechanical thrombolysis, aspiration, and topical urokinase (300,000 U) was applied to the left pulmonary artery. Fortunately, as shown in Fig. , the filling defect of left pulmonary artery disappeared. After the interventional therapy, the patient received intravenous pumping of 20,000 U urokinase every 1 h for 24 h. The symptoms of chest tightness, chest pain and shortness of breath were significantly improved, while the blood oxygen saturation and blood pressure returned to normal, and the vital signs were stable. Neither hemoptysis nor gastrointestinal bleeding occurred during the period of thrombolysis. The deep vein B-ultrasound of double lower limbs was performed and found a flocculent echo in the superior cavity of the upper right femoral vein, and extended into the external iliac vein. Then protein C, protein S activity, coagulation factor V leiden mutation, prothrombin 20210A, lupus anticoagulant, homocysteine, were determined and no abnormality was found. Anti-tuberculosis and warfarin anticoagulant therapy were continued, and international normalized ratio (INR) value was monitored and adjusted between 2 and 3. The patient was discharged with self-administration of oral anti-TB drugs and anticoagulant drug. At follow-up after 20 days of discharge, B-ultrasound showed that the deep vein thrombosis (DVT) of right lower extremity of the patient disappeared. At follow-up of 4 months, the patient was re-examined with chest enhanced CT in the outpatient department of our hospital and no obvious emboli was found.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is 66 years old, which does not meet the first criterion (Age < 50). His heart rate is 120/min, which does not meet the second criterion (Heart rate < 100 bpm). His oxygen saturation is 98% on room air, which meets the third criterion (Oxygen saturation ≥ 95%). There is no mention of hemoptysis, so the fourth criterion (No hemoptysis) is met. The patient is taking insulin and metformin for diabetes, which does not meet the fifth criterion (No estrogen use). There is no mention of prior venous thromboembolism, so the sixth criterion (No prior VTE) is met. There is no mention of unilateral leg swelling, so the seventh criterion (No unilateral leg swelling) is met.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 3\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 59 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['No estrogen use']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [15, 'years'], 'Heart Rate or Pulse': [90.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': True, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Hemoptysis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 15-year-old female presented in preanesthetic checkup clinic for rush nail removal of femur. She was a known case of OI type I and history of recurrent fractures for which she had been operated three times uneventfully under general anesthesia. There was no history of OI in the family.\n",
      "On general examination, she was short statured with a height of 103 cm, weighing 49 kg, blue sclera, fragile bones, progressive hearing loss, kyphoscoliosis. Her blood pressure was 130/80 mmHg, and heart rate was 80 beats/min. There was no pallor, icterus, cyanosis, clubbing, lymphadenopathy, or pedal edema. Respiratory system revealed barrel-shaped chest with bilateral equal air entry, and cardiovascular system revealed normal heart sounds. Electrocardiogram (ECG), liver function test, renal function test, and coagulation profile were normal. Chest X-ray was normal except mediastinal widening; X-ray of the spine revealed dorsolumbar kyphoscoliosis to the left. Pulmonary function test was suggestive of mildly restrictive disease. Airway assessment showed acceptable flexion and extension at neck with adequate mouth opening and normal dentition, Mallampatti Class III. The patient was accepted for surgery as American Society of Anesthesiologists Grade III; in view odontoaxial dislocation and normal coagulation profile, we decided to proceed with a spinal anesthetic technique. Thorough operating room preparation was completed including difficult airway equipment, and measures made ready to deal with hyperthermias if any.\n",
      "The patient was positioned very carefully on the operation table, and pressure points were padded adequately. An 18-gauge intravenous (i.v.) cannula was inserted on the dorsum of the right hand. Monitors including ECG, sphygmomanometer, and SpO2 were placed on the patient.\n",
      "Her baseline blood pressure was 128/80 mmHg, heart rate was 90 beats/min, and O2 saturation on room air was 98%. An i.v. preload of 500 ml Ringer's lactate was administered. Despite the kyphoscoliosis, no difficulty was experienced in finding the subarachnoid space, and spinal anesthesia was given in the sitting position in the space L3–L4 space with 25-gauge Quincke needle with 2.5 ml of bupivacaine heavy 0.5%. The motor block was up to T 10 level. The operation lasted for 1 h and 45 min. There was no significant variation in the vitals, and the recovery was uneventful.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 24-year-old woman with chest pain and shortness of breath. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 24 years old, so this criterion is met (true).\n",
      "2. HR < 100: The patient's heart rate is 98/min, so this criterion is met (true).\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 99% on room air, so this criterion is met (true).\n",
      "4. No hemoptysis: The patient did not report any hemoptysis, so this criterion is met (true).\n",
      "5. No estrogen use: The patient uses a progesterone intrauterine device for contraception, which contains estrogen. Therefore, this criterion is not met (false).\n",
      "6. No prior VTE: The patient has no history of venous thromboembolism, so this criterion is met (true).\n",
      "7. No unilateral leg swelling: The patient did not report any unilateral leg swelling, so this criterion is met (true).\n",
      "\n",
      "The PERC score for this patient is 1, as only one criterion (estrogen use) is not met.\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 60 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'No estrogen use']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [65, 'years'], 'Heart Rate or Pulse': [52.0, 'beats per minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Recent surgery or trauma': False, 'Hormone use': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 65-year-old male presented with an abrupt onset of sharp, burning, constant right lower abdominal pain after previously been feeling well. There was no history of trauma, fever, vomiting, diarrhea, chest pain, shortness of breath, syncope, dysuria, hematuria or melena. His past medical history included hypertension, atrial flutter and cardiomyopathy, and he had an implantable cardioverter/defibrillator (ICD). There was no prior history of abdominal aortic aneurysm in the patient or in his family. His past surgical history included an inguinal hernia repair. His medications included aspirin, valsartan, metoprolol and atorvastatin. He did not smoke, use alcohol or illicit drugs.\n",
      "Physical exam showed vitals signs as follows: body temperature of 36.3°C, blood pressure of 140/82 mmHg, heart rate of 52 beats per minute, respiratory rate of 18 breaths per minute and pulsoximetry of 98% on room air. He was alert, but appeared in mild distress due to pain. His abdominal exam revealed tenderness to palpation in the right lower quadrant, with no rebound, guarding, distention or organomegaly. The remainder of the exam was normal.\n",
      "The initial emergency department evaluation included an electrocardiogram that showed atrial flutter with a 4:1 block. Laboratory assessment revealed trace hematuria, no leukocytosis, creatinine of 1.3 mg/dL (normal range, 0.7–1.4 mg/dL), mildly elevated lipase to 85 U/L (normal range, 12–70 U/L), mild hyperglycemia and mildly elevated aspartate aminotransferase to 46 U/L (normal range, 7–40 U/L). The lactate and coagulation profiles were within normal limits. Lactate dehydrogenase was not ordered at presentation, but obtained 2 days after admission, and was elevated at 1,479 U/L (normal range, 100–220 U/L). Lactate dehydrogenase is present in the renal tissue and elevates in serum after kidney insult, and it is unknown whether this level correlates to the severity of the infarct.\n",
      "Given the nature of the pain and the hematuria seen on urinalysis and the history of cardiomyopathy with atrial flutter, both nephrolithiasis and mesenteric ischemia were strongly considered as causes for this acute pain. Therefore, both non-contrast- and contrast-enhanced helical computed tomography (CT) images [Figures and ] were obtained, which showed extensive infarction involving the upper pole of the right kidney with multiple patchy infarcts into the lower pole, a patent right renal artery, but no visualization of the interparenchymal arterial branches within the mid and upper poles of the right kidney, suggesting arterial thromboembolic disease. There was poor opacification of the right renal vein, and, therefore, renal vein thrombus could not be ruled out. A 2-mm left renal calculus was also identified.\n",
      "The urology and vascular surgery services were consulted, and both recommended conservative treatment with anticoagulation. In addition to normal saline and dilaudid for pain control, a heparin bolus of 80 mg/kg was given and an infusion at 18 mg/kg/h was initiated, with the patient being admitted to the general medicine service.\n",
      "It was concluded his renal artery thrombosis was most likely embolic and a 2-D echocardiogram was ordered, which showed no intramural thrombus. He was discharged 5 days later, on coumadin. His creatinine, which was 1.3 mg/dL on admission, rose to 1.8 mg/dL and fell to 1.7 mg/dL by discharge. One month later, the creatinine levels had declined to 1.6 mg/dL.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 31-year-old woman at 35 weeks of gestation with a severe headache, intermittent blurred vision, and a blood pressure of 160/110 mmHg. The presence of protein in her urine suggests possible preeclampsia. Here's how each criterion applies to her case:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": false,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "Explanation:\n",
      "1. Age < 50: The patient is 31 years old, so this criterion is met.\n",
      "2. HR < 100: The patient's heart rate is 98/min, so this criterion is met.\n",
      "3. O₂ ≥ 95%: The patient's oxygen saturation is 98%, so this criterion is met.\n",
      "4. No hemoptysis: The patient denies any hemoptysis, so this criterion is met.\n",
      "5. No estrogen use: The patient is pregnant, which means she is using estrogen, so this criterion is not met.\n",
      "6. No prior VTE: The patient denies any prior VTE, so this criterion is met.\n",
      "7. No unilateral leg swelling: The patient denies any unilateral leg swelling, so this criterion is met.\n",
      "\n",
      "The PERC score for this patient is 1, as only one criterion (no estrogen use) is not met. However, it's important to note that the patient's symptoms and physical examination findings suggest possible preeclampsia, which is a serious condition that requires further evaluation and management.\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 61 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [22, 'years'], 'Heart Rate or Pulse': [92.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 22-year-old female G2P0010 at 36 weeks gestation presented to an outside hospital with a 24-hour history of left flank pain and nausea. The pain was sharp, stabbing, constant, and radiated to the left mid-abdomen. She denied fever, chills, dysuria, hematuria, urinary frequency, or urgency. She underwent a CT scan that was concerning for adrenal hemorrhage [Figures and ]. She was noted to have blood pressure in the non-severe range. Later she developed severe range blood pressure and was found to have normal preeclampsia labs and negative urine spot. She was treated with antihypertensive medications including IV hydralazine 10 mg × 1, 20 mg × 2. She underwent an MRI that confirmed left adrenal hemorrhage []. Subsequently, she was transferred to our hospital.\n",
      "Upon transfer, the patient's vital signs were as follows: blood pressure 168/110 mmHg, heart rate 92 beats per minute, oxygen saturation 99% on room air, and respiratory rate 18 per minute. The abdomen was gravid, soft and non-tender to palpation. Her laboratory values were notable for a white blood cell count of 19,000/uL, hematocrit (Hct) of 30.8% and spot protein/creatinine ratio of 0.3 g/day. All other laboratory values including liver function and coagulation tests were within normal limits.\n",
      "A review of her history revealed an uneventful pregnancy without prior history of chronic hypertension, gestational hypertension, episodic hypertension, flushing, diarrhea, malignancy, endocrine dysfunction, coagulation disorder, family or personal history of a bleeding disorder, or blunt trauma to the abdomen. Her past medical history was notable only for migraine headaches and anxiety/depression not requiring pharmacological therapy. Her past surgical history included right laparoscopic oophorectomy for a large simple cyst.\n",
      "A plan was made for conservative management of her adrenal hemorrhage and blood pressure control. Based on severe-range blood pressure on intravenous antihypertensive therapy, a diagnosis of preeclampsia with severe features was made. The patient was offered an external cephalic version for fetal breech presentation, but she declined. A decision was made to proceed with cesarean delivery. A combined spinal-epidural anesthetic was provided without complication. The patient tolerated the surgery well and was discharged home 5 days later.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 40-year-old Hispanic woman who presented with chest tightness, generalized weakness, and vomiting. She has a history of hyperthyroidism and hypertension but takes no medications. The patient's EKG showed sustained monomorphic ventricular tachycardia, which converted to normal sinus rhythm after treatment with lidocaine. In the ED, she was alert and complained of weakness in all four extremities. Neurological examination showed 2/6 strength and hypoactive reflexes in all four extremities. Initial laboratory tests showed a potassium level of 2.3 mEq/L, which later increased to 10.1 mEq/L. The patient was diagnosed with Thyrotoxic Periodic Paralysis (TPP) based on clinical presentation and laboratory results. Despite treatment, she developed episodes of ventricular fibrillation and died.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 62 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['No hemoptysis', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [85, 'years'], 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [80.0, 'beats per minute'], 'Hemoptysis': True, 'O₂ saturation percentage': [99.0, '%'], 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "An 85-year-old male presented to our hospital with a 2-month history of a productive cough with white phlegm and a 2-day history of hemoptysis in October 2014. He reported no fever, chest pain, chills, night sweats, or dyspnea.\n",
      "On physical examination, the patient was afebrile. His heart rate was 80 beats per minute and regular, blood pressure 136/72 mm Hg, respiratory rate 20 breaths per minute, and oxygen saturation 99% while breathing ambient air. He was alert and not in acute distress. There was no lymphadenopathy in the neck. The lungs were clear and there were no heart murmurs. His abdomen was not tender, and there was no organomegaly. The neurological examination was unremarkable.\n",
      "The patient's white blood cell (WBC) count was 3430/mL, with 51.3% neutrophils, 32.9% lymphocytes, and 10.8% monocytes; his hemoglobin was 117 g/L; his hematocrit was 38.9%; and his platelet count was 207,000/mL. The patient's C-reactive protein (CRP) level was normal. Serum chemistry tests showed the following results: sodium, 142.3 mmol/L; potassium, 3.9 mmol/L; chloride, 106.2 mmol/L; blood urea nitrogen, 5.9 mmol/L; creatinine, 86.3 μmol/L; aspartate aminotransferase, 21 U/L (normal range 15–40 U/L); and alanine aminotransferase, 16 U/L (normal range 9–50 U/L). The international normalized ratio was 1.02, the partial-thromboplastin time was 27.1 seconds, and the d-dimer level was 180 μg/L. The brain natriuretic peptide was 17.0 pg/mL; tumor marker tests revealed: carcinoembryonic antigen, 2.32 ng/mL; squamous cell carcinoma antigen, 0.90 ng/mL; neuron-specific enolase, 6.24 ng/mL; and CY211, 2.25 μg/L.\n",
      "Computed tomography (CT) revealed a mass in the right lower lobe (Fig. A). Electrocardiography revealed sinus rhythm, with a ventricular rate of 79 beats per minute. No metastatic lesions were found on brain magnetic resonance imaging or in bone using emission CT.\n",
      "The hemoptysis was treated with 30 mg of ambroxol and 600 mg of p-aminomethyl benzoic acid daily. Sputum cultures were negative. Lung function tests after inhaling 400 μg of albuterol yielded an FEV1/FVC = 59.7% and FEV1 = 46.2%. Bronchoscopy showed stenosis in the posterior basal segment of the right lower lobe (Fig. ). A CT-guided transthoracic needle lung biopsy showed SCLC after histopathological and immunohistochemical examinations (Fig. ).\n",
      "Seven days after the transthoracic needle lung biopsy, the patient's temperature increased to 40°C and he developed a worsening cough with purulent sputum. Repeat laboratory tests showed a WBC count of 13,890/mL, with 87.0% neutrophils, 6.5% lymphocytes, and 0.9% monocytes; hemoglobin, 128 g/L; hematocrit, 38.70%; platelet count, 138,000/mL; and CRP, 88.0 mg/L. The patient was treated with cefuroxime (1.5 g) twice per day for 7 days and his WBC and CRP level normalized.\n",
      "He refused radiotherapy or chemotherapy. After obtaining consent, we treated the tumor with RFA. Before RFA, we evaluated the size and spatial relationships of the tumor using CT and determined the needle angle and depth via the shortest route from the surface to the mass. The puncture point was infiltrated with 5 mL of 2% lidocaine. The multipolar needle was directed to avoid bone, large blood vessels, and pulmonary bullae. A rapid biopsy of the lung tumor was performed. Heating was directed to an area within 0.5 to 1 cm of the tumor margin and to the needle track (Fig. B). After closing the puncture wound, repeat CT showed pneumothorax (Fig. C), which was treated with bed rest and inhaled oxygen. The patient had some chest pain the next day, but there was no fever or hemoptysis in the first week after RFA.\n",
      "At the 2-year follow-up examination, the efficacy of the RFA was evaluated as a partial response (PR) (Fig. D–G). The patient was last seen in January 2017, when he developed community-acquired pneumonia (Fig. H).\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 79-year-old African American female who presented with shortness of breath and bilateral lower limb edema. The following criteria were evaluated based on the provided information:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 63 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['HR < 100', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [68, 'years'], 'Heart Rate or Pulse': [100.0, 'beats per minute'], 'O₂ saturation percentage': [96.0, '%'], 'Hormone use': False, 'Hemoptysis': False, 'Recent surgery or trauma': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 68-year-old man attended the Accident and Emergency department with increasing breathlessness but no chest pain, sputum production or haemoptysis. He had recently returned from holiday in Spain and his general practitioner prescribed amoxicillin for a presumed chest infection. He was a diet-controlled type 2 diabetic on treatment for hypertension. He had a 40-pack-year smoking history and had lost 4 kg in weight. Examination revealed an obese man with normal blood pressure, sinus tachycardia at 100 beats⋅min−1, with a respiratory rate of 26 breaths⋅min−1. His oxygen saturation was 96% on air. His white cell count was 11×109 cells⋅L−1 and C-reactive protein was 92 mg⋅L−1. Renal function and coagulation studies were normal.\n",
      "The admitting medical team felt that there was a “complete whiteout” of the left hemithorax and initially treated him for suspected severe community-­acquired pneumonia with intravenous antibiotics and fluids, while arranging a respiratory opinion. Prophylactic low molecular weight ­heparin (LMWH) was also started. The respiratory team felt that an underlying malignancy may have been responsible for the radiographic appearances of left upper lobe collapse and suggested a ­computed tomography (CT) scan of the thorax. shows a “veil-like” opacity projected over the left lung field, a raised left hemidiaphragm with blunting of the left costophrenic angle consistent with left upper lobe collapse, volume loss and an associated pleural effusion.\n",
      "The CT scan showed a large left hilar mass coalescing with the left upper lobe collapse. There were associated large para-aortic, subcarinal, mediastinal and supraclavicular nodes, a single liver metastasis and a second separate mass in the right lung. Lung cancer staging was T4N3M1b.\n",
      "It was interesting to note that a separate mass was present in the right lung (c). He did have metastatic disease but this might represent a synchronous primary, although by strict definition, to diagnose this, we needed to prove that the second mass was of different histology to the primary mass or that it was of the same histology but with no mediastinal or metastatic spread [].\n",
      "While awaiting a bronchoscopy, the patient coughed up ∼600 mL of fresh blood in 12 h, with worsening hypoxia. Repeat full blood count and coagulation studies were normal.\n",
      "The patient was having massive haemoptysis, defined as coughing up anything between 100 mL and 600 mL of fresh blood in 24 h [].\n",
      "He was seen by the on-call medical team and sat upright. Two large-bore cannulae were inserted in case of exsanguination. Sitting upright runs the risk of the blood spilling over into the normal lung. “Drowning” by filling up the bronchial tree with blood tends to occur before any true haemodynamic instability due to volume loss. As such, the mainstay of treatment in massive haem­optysis is to protect the normal lung and try to stop the bleeding [, ].\n",
      "The respiratory team felt that a palliative approach was too premature, but it was explained to him that his prognosis was poor with limited treatment options available. He agreed to a “do not resuscitate” plan. A treatment escalation plan was agreed to ensure his treatment was limited to level 2 care. Hypoxia precluded a bronchoscopy or transfer to the local cardiothoracic centre. Bronchoscopic strategies to control pulmonary haemorrhage include balloon tamponade, iced saline lavage, administration of a topical vasoconstrictor or coagulant, laser therapy and electrocautery [].\n",
      "The patient pointed to his left hemithorax when asked which side he felt the bleeding was coming from. Anecdotal experience suggests that patients with haemoptysis can often accurately indicate the side of the bleeding lesion. He was therefore positioned on his left side and tranexamic acid was administered intravenously. A pilot study evaluating the effect of tranexamic acid and the related antifibrinolytic agent aminocaproic acid included three patients with haemoptysis due to lung cancer []. All three patients experienced cessation of bleeding within 1–4 days without any recurrence. Patients received 1.5 g of intravenous tranexamic acid initially, followed by 1 g three times per day for a week after cessation of bleeding. The use of tranexamic acid in bleeding has been recognised for a long time [] and tranexamic acid may reduce both the duration and volume of bleeding, with low risk of short-term thromboembolic complications [].\n",
      "His haemoptysis and hypoxia improved over the ensuing days, and at bronchoscopy an organised clot was visualised in the left upper lobe bronchus with no endobronchial masses and a normal right bronchial tree. Left upper lobe lavage revealed no malignant cells on cytology. At endobronchial ultrasound examination, a large paratracheal node was sampled and histology demonstrated a poorly differentiated necrotic squamous cell carcinoma.\n",
      "The patient’s clinical condition slowly improved until 15 days into his admission, when overnight he developed acute dyspnoea with tachycardia at 120 beats⋅min−1. Arterial blood gas sampling measured his arterial oxygen tension (PaO) at 7.0 kPa on high flow oxygen via a reservoir bag, and an arterial carbon dioxide tension (PaCO) of 5.1 kPa. A repeat chest radiograph showed no change.\n",
      "The PA–aO is a measure of the difference between the alveolar concentration (A) of oxygen and the arterial (a) concentration of oxygen. In room air (inspiratory oxygen fraction of 0.21) at sea level (atmospheric pressure of 760 mmHg) assuming 100% humidity in the alveoli, a simplified version of the equation is 21−((PaCO/0.8)−PaO), 0.8 being the respiratory quotient.\n",
      "High flow oxygen delivers ∼85% oxygen, so 85−(5.1/0.8)−7=71.625, which is significantly raised. While his PA–aO was likely to be raised due to his cancer/effusion, such a disparity and the clinical picture points towards the possibility of a pulmonary embolus. The use of the PA–aO is a useful adjunct in diagnosis []. There are numerous case reports about tranexamic acid increasing the risk of pulmonary emboli [, ]. In this case, the patient had other significant risk factors such as disseminated malignancy and a prolonged period of immobility.\n",
      "The patient understood that if left untreated, a large pulmonary embolus may prove fatal, but by treating it with anticoagulation, a major fatal haemoptysis was also more likely. He agreed to receive LMWH together with morphine for symptoms of dyspnoea and agitation. 6 h later, he had improved clinically and was able to safely lie flat briefly for a CT pulmonary angiogram. This confirmed large right-sided pulmonary emboli with associated right heart strain with reflux of contrast into the venous circulation (). The option of inferior vena cava filter insertion to prevent further embolic events was not available in our hospital, and he was too unstable to be transferred to an appropriate tertiary hospital. Over the following 2 days, urgent palliative radiotherapy to the left-sided tumour was arranged. After he had received a single fraction, further large volume haemoptysis recurred. LMWH was stopped and tranexamic acid restarted. The bleeding settled once more and he completed five fractions of radiotherapy. Slowly his oxygen saturations improved to 93% on air and he was discharged home on long-term full-dose LMWH with no recurrence of the haem­optysis.\n",
      "He presented 3 weeks later with progressive respiratory failure and his symptoms were palliated according to his wishes.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 57-year-old woman with recurrent fever and painful ulcers on her legs. She has a history of sensorineural deafness in her left ear, gingival hypertrophy, and granulomatous hepatic lesions. The patient has been treated with antibiotics, ibuprofen, prednisone, and azathioprine. The following criteria are evaluated based on the patient's history and physical examination findings.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 64 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'O₂ ≥ 95%', 'No prior VTE']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [53, 'years'], 'Heart Rate or Pulse': [90.0, 'beats/minute'], 'O₂ saturation percentage': [98.0, '%'], 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 53-year-old man (height, 170 cm; weight, 89 kg) was admitted to the hospital because of a 1-year history of shortness of breath after exercise. The patient was a smoker, had a history of hypertension, and was taking captopril and nimodipine. Breathing was reduced in the left lung. However, neither rhonchus nor moist rales were heard during auscultation. Chest computed tomography revealed a GEB, and the left lung was compressed by about 95% with a right mediastinal shift (). An electrocardiogram showed normal findings, and echocardiography revealed that the heart was located in the right thoracic cavity. The left ventricular diastolic function was decreased, and the left ventricular ejection fraction was 64%. Laboratory tests showed no obvious abnormalities. Arterial blood gas analysis showed the following: pH: 7.43, PaCO2: 41 mmHg, PaO2: 94 mmHg, lactate: 1.4 mmol/L, potassium: 3.6 mmol/L, sodium: 138 mmol/L, calcium: 1.10 mmol/L, FiO2: 21%, and SpO2: 98%.\n",
      "On the day of surgery, the patient’s electrocardiogram, blood pressure, SpO2, and bispectral index were monitored upon entry into the operating room. A radial artery catheter and right internal jugular venous catheter were placed. The patient’s arterial blood pressure was 175/109 mmHg, heart rate was 90 beats/minute, and SpO2 was 94%. Before anesthesia, 40 µg of dexmedetomidine was infused within 10 minutes. The thoracic surgeon then created a small incision at the intersection of the sixth intercostal space and the left mid-axillary line to puncture the lung bulla and insert an indwelling catheter (14 Ga, 16 cm in length; Arrow International/Teleflex, Wayne, PA, USA) into the GEB to drain it for 15 minutes. The patient was preoxygenated with 100% oxygen at 6 L/minute for 5 minutes. Anesthesia was administered using 100 mg of propofol, 30 µg of sufentanil, and 50 mg of rocuronium. A 37-Fr right double-lumen endotracheal tube was inserted with the help of a visual laryngoscope, and single-lung ventilation was performed after proper alignment had been confirmed by fiberoptic bronchoscopy. The tidal volume was set at 5 to 6 mL/kg, the respiratory rate was 15 to 17 breaths/minute, the positive end-expiratory pressure was set at 5 cmH2O, and the inhalation:expiration ratio was 1:2. Propofol, remifentanil, and sevoflurane were used to maintain anesthesia. The intraoperative bispectral index was maintained at 40 to 50. After resecting the GEB (), one-lung ventilation was switched to two-lung ventilation and the lungs slowly expanded with a low tidal volume until complete lung re-expansion was observed. During the 3-hour surgery, the patient experienced 50 mL of blood loss, was administered 1300 mL of lactated Ringer’s solution, and excreted 500 mL of urine. After the operation, the double-lumen endotracheal tube was replaced with a single-lumen endotracheal tube and the patient was sent to the intensive care unit for monitoring and further treatment. Two hours after entering the intensive care unit, the patient was fully awake and the tracheal tube was smoothly removed. The following day, the patient was transferred to the thoracic surgery ward, where he recovered; he was discharged 12 days later. Postoperative chest computed tomography showed that the lungs were well inflated with no abnormalities ().\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 40-year-old male with a history of COVID-19, who presented with fevers, shortness of breath, and multi-focal consolidation on chest X-ray. He required mechanical ventilation and ECMO support. The PERC score is calculated based on the following criteria:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": false,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 65 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [32, 'years'], 'Hormone use': False, 'Unilateral Leg Swelling': False, 'Heart Rate or Pulse': [126.0, 'beats per minute'], 'O₂ saturation percentage': [95.0, '%'], 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A fit, physically active 32-year-old female with no underlying risk factors underwent a left knee anterior cruciate ligament (ACL) reconstruction and partial lateral meniscectomy. She was not taking oral contraceptives. She presented 19 days postoperatively with acute dyspnea, chest pain, tachycardia, and complaints of feeling light-headed of 5 days duration. In the emergency department, she had sinus tachycardia on electrocardiography, a heart rate of 126 bpm, blood pressure of 107/68 mmHg, respiratory rate of 18/min, and an oxygen saturation of 95% on room air. Her examination was noted to be otherwise unremarkable. There was no evidence of surgical site infection and no limb swelling noted. A complete blood count and electrolyte and metabolic panel were normal. Her troponin was 80 ng/L (normal 0–14 ng/L). A chest radiograph and D-dimer were not performed. Her pretest probability of pulmonary embolism was moderate based on Wells' criteria [].\n",
      "Computed tomography pulmonary angiogram (CTPA) reported the patient as having PTE. Findings included saddle PE, extensive clot extending into lobar and segmental branches of all lobes () as well as evidence of right heart strain with marked right atrial (RA) and RV dilation as well as flattening and deviation of the interventricular septum. The RV/LV ratio was 1.3. Unfractionated low-molecular-weight heparin was immediately initiated. Her simplified PE Severity Index (sPESI) was 1 (high risk, 8.9% mortality) [].\n",
      "The patient was admitted to the Internal Medicine service. On day 1, her clinical status was unchanged; laboratory indices were similar with a troponin level of 35 ng/L and NTpro-BNP of 3859 ng/L (normal 0–300). ICU was consulted on day 1 of admission, and a transthoracic echocardiogram (TTE) was immediately requested. This demonstrated a 3.3 cm maximum diameter multilobulated, mobile right atrial thrombus, which extended from the RV inlet through the pulmonic valve to the pulmonary artery (i.e., an RHTT). Intraventricular septal flattening and severe RV dilation with moderate systolic dysfunction and tricuspid regurgitation were also observed. McConnell's sign was present with apical hypercontractility and basal and mid-ventricular segmental hypokinesis. The right ventricular systolic pressure (RVSP) was 48.1 mmHg ().\n",
      "She was transferred to the intensive care unit (ICU) with a diagnosis of clinical submassive pulmonary embolism with clot in transit. Arterial blood gas was pH 7.52, pCO2 29 mmHg, PaO2 74 mmHg, O2 saturation 96%, and lactate 0.8 mmol/L. The case, as well as treatment options, was reviewed with a member of the pulmonary embolism response team (PERT). A decision was made to proceed with low-dose thrombolysis, despite the recent surgery, employing the regimen described in the MOPETT trial []. The potential benefits and risks were discussed with the patient who consented. She received a 10 mg recombinant tPA bolus followed by an additional 40 mg over two hours intravenously (IV). IV heparin was continuously infused at 10 U/kg/hr during the thrombolysis as well and for three hours afterwards at which time the heparin nomogram infusion of 18 U/kg/hr with serial adjustments based on PTT was re-introduced. Serial echocardiograms at 2 hours after thrombolysis and the next day () demonstrated improvement in her RV function. The RVSP was 27 mmHg at 2 hours and 26 mmHg the following day. The in-transit clot was no longer visible on the posttreatment echocardiograms. She was eventually discharged home on day 5 on tinzaparin for two weeks and then transitioned to rivaroxaban. She was continued on anticoagulation for 6 months.\n",
      "Seven months after discharge, she was doing very well. Her breathing had returned back to baseline, and she was rehabilitating well from her reconstruction. She had no bleeding complications from the rivaroxaban therapy. Her DASH score [] was 1 (3.9% annual risk of DVT recurrence), and her HERDOO2 score [] was 0 (3% risk of major recurrent venous thromboembolism per 100 patient years). The anticoagulation was discontinued. She had returned to the gym, though had not yet returned to more vigorous-intensity physical activities, such as basketball. A repeat echocardiogram at this time demonstrated normal left and right ventricular systolic function with no hemodynamically significant valvular disease. Serial D-dimers, every three months, for the following year were scheduled. Testing for inherited thrombophilia was negative.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 63-year-old woman with worsening shortness of breath, cough, and weight loss. She has a history of smoking and decreased breath sounds on physical examination. The flow-volume loop from pulmonary function testing is not provided, but we can still evaluate the PERC criteria based on the information given.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 66 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'Hormone use': False, 'Previously Documented Pulmonary Embolism': False, 'Heart Rate or Pulse': [101.0, 'beats per minute'], 'Hemoptysis': False, 'O₂ saturation percentage': [99.0, '%'], 'Recent surgery or trauma': False, 'age': [39, 'years'], 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 39-year-old male with a medical history of diabetes mellitus presented to the emergency room for the evaluation of jaundice. He complained of fever for the last seven days that was associated with nausea, intermittent headache, and dry cough. He also had diffuse arthralgia. The patient took over-the-counter antipyretic and analgesic but did not get any relief. The initial evaluation revealed a temperature of 100°F, blood pressure of 110/70 mmHg, heart rate of 101 beats per minute, respiratory rate of 20 per minute, and oxygen saturation of 99% on room air. The physical examination showed severe jaundice with the icteric sclera. He had diffuse arthralgia with tenderness. Cardiac and chest examination was normal. The abdomen was soft with normal bowel sounds and no organomegaly.\n",
      "Initial laboratory analysis is shown in Tables and 2. The patient’s platelet count, hemoglobin, and hematocrit were within the normal ranges, except white blood cells. His serum metabolic panel was unremarkable, except for elevated total bilirubin and creatinine.\n",
      "Extensive workup for severe jaundice involved serum iron studies, cytomegalovirus (CMV) antibody, and antinuclear antibody (ANA), all of which were negative. Common causes of hyperbilirubinemia such as hepatitis A, B, and, C were negative. His low-density lipoprotein (LDL) was 50 mg/dL, high-density lipoprotein (HDL) was 55 mg/dL, serum cholesterol was 180 mg/dL, and serum triglyceride was 152 mg/dL.\n",
      "On abdominal ultrasound, the liver, gall bladder, and spleen were normal in size and texture. CT of thorax and abdomen was performed, which revealed diffuse pulmonary and hilar infiltrates in both lung bases. It was suspected that the patient had a possible chest infection, and he was started on intravenous ampicillin-sulbactam. The patient’s kidney function was concerning due to high creatinine, but creatinine improved to 2.0 mg/dL on the third hospital day.\n",
      "On further investigation, the patient reported that he visited Connecticut, USA, one week ago. He had no history of tick bite. Peripheral smear examination of blood was performed, which revealed no abnormality in the morphology of blood cells. Serologic tests for Lyme disease were performed. He was treated with doxycycline at a dose of 100 mg twice a day on the third hospital day. The radiograph of the joints revealed no abnormality.\n",
      "His total bilirubin remained high during the hospital stay in the beginning, and his bilirubin was 12.0 mg/dL (direct: 10.3 mg/dL) on the third hospital day (Figure ). His white blood cell count remained elevated at 18 × 103/µL. However, his liver enzymes remained normal (Figure ).\n",
      "The patient’s fever resolved on hospital day 4, and joint pain also got better. Repeat ultrasound of the abdomen was conducted due to the worsening of laboratory results, which revealed no mass or calcification, except few changes in liver echotexture suggesting the possible fatty/fibrotic change. The gallbladder was thin-walled and anechoic, with no stones. Portal vein appeared red-orange, and the hepatic artery was yellow (indicating higher flow velocity). The decision was made for invasive workups such as biopsy and magnetic resonance cholangiopancreatography (MRCP), but the patient denied it.\n",
      "Serum ELISA (enzyme-linked immunosorbent assay) for Lyme disease was performed. The results of ELISA screen were positive for Lyme disease, which was further confirmed by Western blot. He continued on doxycycline. His bilirubin gradually improved. He was discharged with outpatient follow-up. The patient remained afebrile and symptom-free throughout his hospital stay, without any significant pulmonary or gastrointestinal symptoms. His bilirubin was 9.0 mg/dL on the day of discharge from the hospital.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is an 84-year-old woman with a 1-week history of abdominal pain and appetite loss. She has no history of cough, sputum, fever, chills, weight loss, or night sweats. She has no history of tobacco smoking, tuberculosis, or exposure to individuals with tuberculosis. She does not have a history of malignancy, diabetes mellitus, cytotoxic therapy, or corticosteroid use. Her family history is unremarkable. Physical examination revealed a heart rate of 90 beats/min, blood pressure of 157/76 mmHg, respiratory rate of 24 breaths/min, temperature of 37.8 °C, and oxygen saturation of 98% on room air. Respiratory, cardiac, and abdominal examinations were unremarkable. Chest radiograph showed multiple small nodules in both lung fields, and chest CT showed diffuse micronodules in random patterns in both lung lobes, cardiomegaly, and bilateral pleural effusion. White blood cell count, C-reactive protein, and procalcitonin levels were 2800 /μl, 7.50 mg/dl, and 0.373 ng/ml, respectively. Serum carcinoembryonic antigen, carbohydrate antigen 19–9, and soluble IL-2 receptor were elevated. Angiotensin-converting enzyme, mycoplasma antibody, and blood sugar were within normal ranges. Serum QuantiFERON testing was positive. CD4/8 ratio, CD4 count, and CD8 count were 1.73, 422 /μl, and 244 /μl, respectively. IgG, IgA, and IgM were 998 mg/dl, 128 mg/dl, and 59 mg/dl, respectively. Testing for human immunodeficiency virus infection was negative. Expectorated sputum smears were negative for bacteria and acid-fast bacilli. Urinary antigen testing for Streptococcus pneumoniae and Legionella pneumophila was negative. Abdominal CT and magnetic resonance imaging showed no abnormalities. Liver, skin, and bone marrow biopsies showed epithelioid cell granuloma without caseous necrosis. Gastric aspirate smear was positive for acid-fast bacilli, and polymerase chain reaction was positive for Mycobacterium tuberculosis. Gastric aspirate culture was positive for M. tuberculosis after 1 week of culture. After a 2-month treatment course, chest radiograph showed gradual improvement, and oral EB was discontinued. The patient was discharged. After a 6-month treatment course, chest radiograph showed new multiple nodules in the right middle lung field. Chest CT showed that a right S6 small nodule, presumed to be miliary tuberculosis, had increased, and new multiple nodules appeared in the right lower lobe. The patient’s white blood cell count and C-reactive protein at this time were 2400 /μl and 0.09 mg/dl, respectively. Flexible fiberoptic bronchoscopy was subsequently performed. Microbiological testing of bronchial lavage fluids did not reveal any bacteria, mycobacteria, or fungi. However, cytology showed a small number of Periodic acid-Schiff-positive bodies, suggesting Cryptococcus species. Moreover, serum cryptococcal antigen testing was positive. According to these findings, pulmonary cryptococcosis was diagnosed, although the culture was negative. Oral fluconazole was subsequently initiated. After a 6-month treatment course, chest radiograph showed gradual improvement, and oral FLCZ was discontinued. The patient received a total of 12 months of antimycobacterial therapy. On follow-up, she has remained asymptomatic with respect to pulmonary disease, with no recurrence.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 67 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100', 'O₂ ≥ 95%']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [29, 'years'], 'Heart Rate or Pulse': [100.0, 'beats per minute'], 'O₂ saturation percentage': [95.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Unilateral Leg Swelling': False, 'Hemoptysis': False, 'Recent surgery or trauma': True, 'Previously documented Deep Vein Thrombosis': False}\n",
      "\n",
      "Patient Note:\n",
      "A 29-year-old male presented to the Emergency Department with a penetrating stab wound to the anterior left second intercostal space, 2 cm medial to the mid-clavicular line. Previous medical history consisted of a right tibia-fibula fracture with intra-medullary nailing 7 years prior.\n",
      "The patient presented haemodynamically unstable, in grade 3 haemorrhagic shock and after resuscitation, improved as a transient fluid responder. A left-sided intercostal drain was inserted for a large haemothorax. Vital signs after resuscitation: heart rate 100; respiratory rate 14; saturating at 95% on room air; blood pressure 101/64. Post-resuscitation, no angina was reported. On examination: no features of cardiac failure, central cyanosis, bruits, or murmurs were elicited. No ST or other rhythm abnormalities were noted on electrocardiogram (). Pertinent findings were that of chronic septic hardware of the right lower limb which on further enquiry, had not been formally assessed by an orthopaedic service. Microbiological workup of the local septic limb was deferred until after haemodynamic stabilization.\n",
      "A preliminary diagnosis of local septic hardware led to screening for methicillin-resistant Staphylococcus aureus, and antibiotic prophylaxis with broad-spectrum coverage.\n",
      "Focused Assessment with Sonography for Trauma scan demonstrated a 1 cm pericardial effusion. A contrasted computed tomographical scan of the chest and cardiac TTE was ordered.\n",
      "Computed tomographical findings () demonstrated a right ventricular outflow tract (RVOT) injury at the level of the pulmonary valve and an associated suspected thrombus. A small aortic root injury with a small pseudo-aneurysm and intimal flap was also observed. The injury tract extended to the medial superior vena cava (SVC) and a high index of suspicion for an SVC injury was entertained.\n",
      "Transthoracic cardiac ECHO () findings did not demonstrate valvulopathies, clear flow reversal or shunting, regional wall motion abnormalities, tamponade, or features of infective endocarditis. The patient had a preserved left ventricular ejection fraction. A large dense lesion was noted immediately beneath the pulmonary valve which demonstrated beat to beat movement and was noted to be highly suggestive of a clot.\n",
      "Pertinent laboratory findings showed that the patient had normal renal and liver function with a normocytic normochromic anaemia (haemoglobin = 10.9) and no coagulation abnormalities (normal prothrombin and partial thromboplastin time).\n",
      "The patient was intubated under general anaesthesia with a single lumen endotracheal tube (). Femoral cardiopulmonary bypass was initiated via the left groin. A median sternotomy was performed and no active bleeding was seen.\n",
      "The aorta was then clamped and the heart arrested with cold blood cardioplegia administered into the aortic root. Cardioplegia was given every 20 min throughout the procedure.\n",
      "A large clot was found within a defect in the medial wall of the RVOT, abutting the ascending aorta, and was subsequently removed. The RVOT was repaired with continuous 3/0 prolene sutures.\n",
      "The aorta was opened via a transverse ‘J’ incision (). There was a 0.5 cm laceration in the aortic wall, ∼1 mm left of the right coronary ostium which was repaired primarily. The plane between the main pulmonary artery (PA) and ascending aorta was dissected and opened. The right coronary artery was not injured. The contralateral side of the ascending aorta (right side) also had a defect through it and there was a small point injury to the base of the SVC which were both primarily repaired.\n",
      "Pre-operative radiological findings had a good correlation with the intra-operative findings and no other intra-operative injuries were noted.\n",
      "The patient was weaned off of cardiopulmonary bypass and closure of the femoral cannulation site, and sternum was performed successfully. The patient remained intubated and was transported to intensive care unit.\n",
      "A complete recovery was made with no residual thrombus or intracardiac shunt at early follow-up. There was no cardiac, respiratory, or neurological sequelae at 30-day follow-up.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 75-year-old male who underwent elective right hip arthroplasty and developed dyspnea, polypnea, and low arterial oxygen saturation on the fourth postoperative day. The patient's physical examination, laboratory findings, and imaging studies led to a diagnosis of pulmonary embolism. The patient's age, heart rate, oxygen saturation, and other factors will be evaluated against the PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": false,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 68 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [43, 'years'], 'Heart Rate or Pulse': [210.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Hormone use': False, 'Hemoptysis': False, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 43-year-old man presented to the emergency department reporting sudden-onset feeling of palpitations and near syncope after strenuous heavy lifting. He was pale and diaphoretic; blood pressure was measured 90/70 mmHg, oxygen level 99%, heart-rate 210–230 b.p.m., and body temperature 36.6°C. Past medical history was clear for cardiac disease, syncope, or pre-syncope. No history of sudden cardiac death (SCD) or cardiomyopathy into his family was stated. He denied recent flu-like symptoms, smoking, illicit drug use, or excessive alcohol consumption. Physical examination was unremarkable. Initial electrocardiogram (ECG) depicted an irregularly irregular, broad QRS complex tachycardia (). No previous ECG recordings were handed. Direct current (DC) cardioversion restored sinus rhythm with manifest ventricular pre-excitation and clear ‘delta’ waves () confirming our initial clinical suspicion for underlying WPW syndrome. Shortest pre-excited RR interval (SPERRI) during AF was estimated at 160 ms (), indicating an AP with extremely short antegrade effective refractory period (ERP) at risk for mediating SCD. Echocardiography ruled out abnormalities associated with WPW, including Ebstein’s anomaly, valve lesions, cardiac hypertrophy, atrial aneurysms, and septal defects. Cardiac ischaemia was also excluded on the basis of clinical, electrocardiographic, echocardiographic, and laboratory data. The patient was put on enoxaparin 80 mg b.i.d. and propafenone 150 mg t.i.d. and his clinical course remained uneventful. Electrophysiological study (EPS) was performed at a tertiary centre on Day 10 post-diagnosis; programmed atrial stimulation induced pre-excited AF with markedly increased SPERRI = 264 ms and a left anterolateral AP with antegrade only conduction properties was ablated (). The patient was scheduled for routine cardiologic follow-up and advised to abstain from intense physical activity for at least 1-month post-discharge. In case of palpitations, ECG and 24-h Holter monitoring were suggested. CHA2DS2-VASc Score was calculated zero, so 1 month of rivaroxaban 20 mg daily was deemed sufficient post-ablation. Family members were also screened for pre-excitation. The patient remained symptom free without pre-excitation on surface ECG on his latest follow-up visit 3 months after the procedure.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 53-year-old man with a history of shortness of breath after exercise, smoking, hypertension, and taking captopril and nimodipine. The patient's breathing was reduced in the left lung, and chest computed tomography revealed a giant emphysematous bulla (GEB) with 95% compression of the left lung and right mediastinal shift. The patient underwent surgery to resect the GEB. The following criteria were evaluated based on the provided information:\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 69 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['HR < 100']\n",
      "Expected (Ground Truth): 2 | Predicted: 2\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [63, 'years'], 'Hormone use': False, 'Previously Documented Pulmonary Embolism': True, 'Heart Rate or Pulse': [65.0, 'beats per minute'], 'O₂ saturation percentage': [97.0, '%'], 'Previously documented Deep Vein Thrombosis': True}\n",
      "\n",
      "Patient Note:\n",
      "A 63-year-old Caucasian male with a past history of supraventricular tachycardia and recurrent deep vein thrombosis, who had been non-compliant with his daily Rivaroxaban® 20 mg, presented with pleuritic chest pain and was found to have a right lower lobe pulmonary embolus. The patient was subsequently restarted on Rivaroxaban® and discharged. He presented again 5 days later with left arm weakness and was found to have multiple areas of punctuate infarctions of both cerebral and cerebellar hemispheres, more confluent within the right frontal lobe on magnetic resonance imaging (MRI) of the brain ( and ). He has been compliant with his Rivaroxaban® since the previous hospital discharge 5 days prior. The patient was admitted and subsequently started on unfractionated heparin. On admission, his vital signs were blood pressure 138/93, heart rate 65 beats per minute, respiratory rate 16, and oxygen saturation 97% on room air. Cardiopulmonary examination revealed regular rate and rhythm, without murmurs, rubs, or gallops and clear lungs on auscultation. Neurologic examination revealed intact cranial nerves, preserved strength in all extremities with an exception of mild dysmetria in the left upper extremity and an NIH score of 1. Electrocardiogram revealed normal sinus rhythm, non-specific ST changes, and a premature ventricular contraction. Transthoracic echocardiogram was notable for normal left ventricular function with mild tricuspid regurgitation and stage 1 diastolic dysfunction. Transesophageal echocardiogram was negative for intracardiac thrombus. The echocardiography with agitated saline contrast revealed microbubbles of moderate opacity entering the left atrium from the left lower pulmonary vein indicative of a grade 2 intra-pulmonary arteriovenous shunt (). There was no atrial septal defect or patent foramen ovale. Unfractionated heparin was continued, and the patient was transferred to a tertiary care center for embolization of the shunt. There, he developed recurrent cerebral infarctions while anticoagulation was temporarily held. Computed tomography of the abdomen and pelvis was done for persistent abdominal pain, and noted an omental mass, and subsequent exploratory laparotomy revealed an adenocarcinoma within the omentum with nodular peritoneal implants. The patient was placed on weight-based Enoxaparin® and discharged home with scheduled outpatient chemotherapy. Embolotherapy of the intrapulmonary shunt was deferred given this new diagnosis of malignancy.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 52-year-old male with a history of CLL and Richter transformation. He presented with abdominal pain and weakness, and his vital signs showed a heart rate of 107 bpm and oxygen saturation of 93%. The patient has been taking high doses of vitamin D, which led to vitamin D poisoning, hypercalcemia, and acute renal failure. He underwent hemodialysis and was admitted to the hematology clinic.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": false,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 2\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 70 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'HR < 100']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [21, 'years'], 'Heart Rate or Pulse': [121.0, 'beats per minute'], 'O₂ saturation percentage': [100.0, '%'], 'Hemoptysis': False, 'Previously Documented Pulmonary Embolism': False, 'Previously documented Deep Vein Thrombosis': False, 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False}\n",
      "\n",
      "Patient Note:\n",
      "A 21-year-old woman presented to the ED with complaint of chest pain and shortness of breath. Prior to arrival to the ED she had an episode of near syncope. Her previous medical history included development of diffuse erythematous rash following a course of minocycline prescribed for acne three months prior to ED presentation. The minocycline was discontinued, and she was treated with 30 milligrams (mg) daily oral prednisone with improvement of the rash. Initial vitals included blood pressure of 81/68 millimeters of mercury (mmHg), heart rate of 121 beats per minute (bpm), and respiratory rate of 18 breaths per minute. She was afebrile (36.7ºC oral temperature) and had pulse oximetry (SpO2) of 100% on room air. Physical exam was within normal limits. Electrocardiogram (ECG) showed right bundle branch block and normal ST-T segments, but no previous ECG was available.\n",
      "While in the ED the patient had an episode of syncope during peripheral venous catheter placement, and intravenous (IV) fluids were administered due to concern of vasovagal event. She was also administered 5 mg IV dexamethasone due to possibility of adrenal suppression from steroid use. Her systolic pressure improved. However, the patient complained of worsening chest pain and then became unresponsive with pulseless electrical activity arrest (PEA). Cardiopulmonary resuscitation (CPR) and Advanced Cardiac Life Support were initiated. She received two doses of 1 mg IV epinephrine with return of spontaneous circulation (ROSC) in normal sinus rhythm of 70 bpm and blood pressure of 72/48 mmHg. Due to persistent hypotension, norepinephrine infusion was administered with improvement of blood pressure to 88/56 mmHg. She was intubated for airway protection.\n",
      "Due to concern for massive pulmonary embolus, computed tomography chest angiography was performed but was unremarkable. Point-of-care echocardiogram demonstrated no right heart strain and grossly reduced heart function. Telemetry demonstrated QRS widening and increasing bradycardia to 41 bpm. The patient then developed a second PEA arrest with ROSC after CPR and one dose of 1 mg IV epinephrine. She remained hypotensive with blood pressure of 60/40 mmHg despite norepinephrine infusion. Initial troponin-T measured was 8.56 nanograms/milliliter (ng/mL) (reference range 0.0–0.02 ng/mL) and complete blood count with differential showed leukocytosis of 17.5 × 103 cells/mL (reference range 4.0–10.0 × 103 cells/mL) and eosinophilia of 1.6 × 103 cells/mL r (reference range 0.0–0.4 × 103 cells/mL). The cardiology service was consulted and a formal echocardiogram demonstrated a severely reduced ejection fraction of 15% (normal range 55–70%).\n",
      "The dermatology service was also consulted at bedside in the ED; concern for ANEM in setting of DRESS given the rapidity of onset of her cardiac dysfunction was discussed. Also, the differential diagnoses included coronary vasculitis, viral myocarditis, infiltrative cardiomyopathy, and sepsis. (She was administered 4.5 g piperacillin/tazobactam and 20 milligrams/kilogram (mg/kg) vancomycin, and 500 mg azithromycin IV.)\n",
      "While in the ED the patient developed further hypotension with blood pressure of 61/40 mmHg despite multiple vasopressors (IV vasopressin and norepinephrine infusions) and had severe acidemia and hypoxemia despite high ventilator support. Ventilator settings were tidal volume of 360mL, positive end-expiratory pressure of 20 centimeters of water (cmH2O), and fraction of inspired oxygen of 100%, and respiratory rate of 28 breaths per minute. Arterial blood gas (ABG) revealed respiratory acidosis with pH of 7.06, carbon dioxide partial pressure (pCO2) of 78 mmHg (reference range 33–43 mmHg), low arterial oxygen (PaO2) of 61 mmHg (reference range 80–100 mmHg), and normal bicarbonate. Basal metabolic panel was within normal limits. Due to continued decline, she received cannulation for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) within the ED. ECMO cannulation occurred within three hours of initial cardiac arrest. Once placed on ECMO she had significant improvement in her acidosis and hypoxemia on repeat ABG (pH 7.39, pCO2 41 mmHg, PaO2 135 mmHg) and was rapidly weaned from her vasopressors.\n",
      "The patient was admitted to the cardiac intensive care unit (ICU) for further management. Due to concern of DRESS-induced myocarditis, dexamethasone with a dose of 1 mg/kg/day was administered intravenously. On hospital day (HD) eight, cardiac biopsy demonstrated diffuse active myocarditis with coagulative myocyte necrosis and mixed infiltrate including eosinophils consistent with DRESS myocarditis. She was decannulated from ECMO on HD 16. She was eventually discharged after 20 days in the ICU and 62 total days in the hospital with a life vest and continued cardiac follow-up. An echocardiogram performed three months later demonstrated improved ejection fraction of 34%.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 52-year-old African American male with pleuritic chest pain. We will evaluate each of the 7 PERC criteria to determine the score.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": false,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": true\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n",
      "\n",
      "--- Correct Answer with Wrong Criteria 71 ---\n",
      "Model: Med42-Qwen2.5-72B-v3-bi\n",
      "Wrong Criteria: ['Age < 50', 'No unilateral leg swelling']\n",
      "Expected (Ground Truth): 1 | Predicted: 1\n",
      "\n",
      "Parsed Entities:\n",
      "{'age': [57, 'years'], 'Heart Rate or Pulse': [78.0, 'beats per minute'], 'O₂ saturation percentage': [99.0, '%'], 'Unilateral Leg Swelling': False, 'Hormone use': False, 'Recent surgery or trauma': False, 'Hemoptysis': False, 'Previously documented Deep Vein Thrombosis': False, 'Previously Documented Pulmonary Embolism': False}\n",
      "\n",
      "Patient Note:\n",
      "A 57-year-old woman presented to the rheumatology clinic with recurrent fever and painful ulcers on her legs since two months. Eight months prior to current presentation, she developed vertigo and decreased hearing in her left ear which she felt was “full of air” all the time. She was found to have sensorineural deafness in her left ear. Two weeks later, she developed fever with chills. A chest radiograph revealed infiltrates in her right lung and an elevated ESR. She was treated with oral antibiotics which relieved her symptoms. Then she developed gingival hypertrophy and a CT scan of the paranasal sinuses revealed subcutaneous soft tissue thickening of the right buccal area suggestive of an inflammatory process. She was treated with ibuprofen and felt better. Her past medical history was notable for hypothyroidism for 20 years and she as well was maintained on 50 mcg of thyroxin daily. She had undergone hysterectomy for uterine fibroids 15 years ago. She reported no recent travel history. Of note, she revealed contact with sick animals. She nursed her paralyzed pet dog and also had cats. She was treated with antibiotics yet continued to spike fever and came to our center for comprehensive evaluation. On examination, she appeared weak and ill. The temperature was 37.5°C, the blood pressure 139/69 mm Hg, the pulse 78 beats per minute, and the respiratory rate 16 breaths per minute, with 99% oxygen saturation at room air. Erythematous tender nodules were noticed on bilateral lower extremities ().\n",
      "The remainder of the examination was unremarkable. Her complete blood count revealed normocytic, normochromic anemia with normal white cell and platelet count. Her biochemistry showed normal kidney and liver function. No active sediment was present on urinalysis. Her three sets of blood cultures and one urine culture reported no growth. The test for latent tuberculosis by interferon gamma release assay (IGRA) was also negative. Serology for Brucella abortus and melitensis also came negative. Tests for chronic viral hepatitis B and C were also normal. Serological tests for connective tissue disease were negative as was the serum angiotensin converting enzyme level. Other relevant investigations are outlined in . An upper abdominal ultrasound showed hypoechoic, cystic lesions scattered across both lobes of the liver (). A subsequent CT scan of the abdomen with contrast showed multiple oval hypoattenuating lesions in both lobes of the liver ().\n",
      "On liver biopsy there was evidence of cholestasis and multiple large irregular areas of necrosis, palisaded by epitheloid cells with associated granulomatous inflammation with a number of plasma cells ().\n",
      "Acid-fast bacilli culture of liver biopsy specimen after six weeks came out negative. Meanwhile, the patient continued to spike fever with maximum temperature of 101°F. Leg lesions were becoming worse with central necrosis and purulent discharge (Figures and ).\n",
      "Pus cultures were negative for bacterial, fungal, and mycobacterial growth. A biopsy of the skin was performed. Pathological examination of frozen sections revealed surface ulceration with fibrinoid necrosis and vasculitis involving superficial and deep dermal vessels along with granuloma formation, neutrophilic infiltration, and debris ().\n",
      "Immunohistochemical testing was performed on biopsy specimen using immune-alkaline phosphatase technique which came negative for mycobacterial species. Real-time PCR for mycobacterial species also turned out to be negative. It was concluded from the skin biopsy that the patient had cutaneous granulomatous vasculitis. Treatment was commenced with prednisone 1 mg/kg/day and the patient was offered induction with cyclophosphamide which she refused due to associated toxicities. Meanwhile, azathioprine 2 mg/kg/day was added to prednisone. After seven weeks on prednisone and six weeks of azathioprine her lesions had healed almost completely (). She was maintained on prednisone 5 mg bid and azathioprine 50 mg bid with healing lesions. A repeat CT scan of the abdomen revealed normal architecture of hepatic parenchyma.\n",
      "Therefore, considering a chronic inflammatory process characterized by hearing loss, gingival hypertrophy, granulomatous hepatic lesions, and cutaneous ulcers with necrotizing granulomatous inflammation on skin biopsy, a unifying diagnosis of granulomatosis with polyangiitis (GPA) was made.\n",
      "\n",
      "Reply:\n",
      "{\n",
      "  \"Explanation\": \"The patient is a 12-year-old girl with fatigue, dyspnea, and mild chest pain on exertion for 1 week. She does not have a fever or a rash. She had an upper respiratory infection 3 weeks ago. She returned from summer camp in Colorado 3 days ago. Her temperature is 36.9°C (98.4°F), heart rate is 96/min, and blood pressure is 106/74 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 96%. Physical examination reveals jugular venous distention and 1+ pitting edema on both ankles. A few scattered inspiratory crackles are heard in the thorax and an S3 is heard at the apex. Abdominal examination is unremarkable. Her hemoglobin concentration is 11.6 g/dL, leukocyte count is 8900/mm3, and ESR is 10 mm/hr. An x-ray of the chest shows mild cardiac enlargement.\",\n",
      "  \"Criteria\": {\n",
      "    \"Age < 50\": true,\n",
      "    \"HR < 100\": true,\n",
      "    \"O₂ ≥ 95%\": true,\n",
      "    \"No hemoptysis\": true,\n",
      "    \"No estrogen use\": true,\n",
      "    \"No prior VTE\": true,\n",
      "    \"No unilateral leg swelling\": false\n",
      "  },\n",
      "  \"Answer\": 1\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "print_correct_with_wrong_criteria(parsed_json, perc_df)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7c0a5481",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Evaluating model: Llama-3.3-70B-Instruct ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Summary Table ===\n",
      "                 model_id  wrong  correct  invalid  total  accuracy\n",
      "0  Llama-3.3-70B-Instruct     99       34        0    133     0.256\n"
     ]
    }
   ],
   "source": [
    "sys_instruct = (\n",
    "    \"You are a clinical decision support assistant. You always follow structured clinical decision rules and explain your reasoning before giving a final structured JSON answer.\\n\"\n",
    ")\n",
    "invalid_outputs, wrong_outputs, results_df,parsed_json = await run_models_with_output(\n",
    "    sys_instruct = sys_instruct\n",
    "    ,prompt= \"Your task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\\n\"\n",
    "    \"\\n\"\n",
    "    \"There are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\\n\"\n",
    "    \"\\n\"\n",
    "    \"PERC Criteria:\\n\"\n",
    "    \"1. Age < 50 years\\n\"\n",
    "    \"2. Heart rate < 100 bpm\\n\"\n",
    "    \"3. Oxygen saturation ≥ 95%\\n\"\n",
    "    \"4. No hemoptysis\\n\"\n",
    "    \"5. No estrogen use\\n\"\n",
    "    \"6. No prior venous thromboembolism (VTE)\\n\"\n",
    "    \"7. No unilateral leg swelling\\n\"\n",
    "    \"\\n\"\n",
    "    \"After your output return a **single JSON object*.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Format:\\n\"\n",
    "\n",
    "    \"First explain the decision making process , interpret and analyze the patient's note\"\n",
    "\n",
    "    \"After you reach your answer, put your final decision in the output below:\"\n",
    "    \"{\\n\"\n",
    "    \"  \\\"Explanation\\\": \\\"<A short explanation of how each criterion was evaluated>\\\",\\n\"\n",
    "    \"  \\\"Criteria\\\": {\\n\"\n",
    "    \"    \\\"Age < 50\\\": true or false,\\n\"\n",
    "    \"    \\\"HR < 100\\\": true or false,\\n\"\n",
    "    \"    \\\"O₂ ≥ 95%\\\": true or false,\\n\"\n",
    "    \"    \\\"No hemoptysis\\\": true or false,\\n\"\n",
    "    \"    \\\"No estrogen use\\\": true or false,\\n\"\n",
    "    \"    \\\"No prior VTE\\\": true or false,\\n\"\n",
    "    \"    \\\"No unilateral leg swelling\\\": true or false\\n\"\n",
    "    \"  },\\n\"\n",
    "    \"  \\\"Answer\\\": <sum of false values>\\n\"\n",
    "    \"}\\n\",\n",
    "    model_ids=[\"Llama-3.3-70B-Instruct\"],\n",
    "    include_relevant_entities=False,\n",
    "    full_df=True\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "78170c1f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Evaluating model: Llama-3.3-70B-Instruct ===\n",
      "\n",
      "Batch Progress: 100.0% (133/133)\n",
      "Parsing: 100.0% (133/133)\n",
      "Done ✅\n",
      "\n",
      "=== Summary Table ===\n",
      "                 model_id  wrong  correct  invalid  total  accuracy\n",
      "0  Llama-3.3-70B-Instruct    103       30        0    133     0.226\n"
     ]
    }
   ],
   "source": [
    "sys_instruct = (\n",
    "    \"You are a clinical decision support assistant. You always follow structured clinical decision rules and explain your reasoning before giving a final structured JSON answer.\\n\"\n",
    "    \"Your task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\\n\"\n",
    "    \"\\n\"\n",
    "    \"There are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\\n\"\n",
    "    \"\\n\"\n",
    "    \"PERC Criteria:\\n\"\n",
    "    \"1. Age < 50 years\\n\"\n",
    "    \"2. Heart rate < 100 bpm\\n\"\n",
    "    \"3. Oxygen saturation ≥ 95%\\n\"\n",
    "    \"4. No hemoptysis\\n\"\n",
    "    \"5. No estrogen use\\n\"\n",
    "    \"6. No prior venous thromboembolism (VTE)\\n\"\n",
    "    \"7. No unilateral leg swelling\\n\"\n",
    "    \"\\n\"\n",
    "    \"After your output return a **single JSON object*.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Format:\\n\"\n",
    "\n",
    "    \"First explain the decision making process , interpret and analyze the patient's note\"\n",
    "\n",
    "    \"After you reach your answer, put your final decision in the output below:\"\n",
    "    # \"{\\n\"\n",
    "    # \"  \\\"Explanation\\\": \\\"<A short explanation of how each criterion was evaluated>\\\",\\n\"\n",
    "    # \"  \\\"Criteria\\\": {\\n\"\n",
    "    # \"    \\\"Age < 50\\\": true or false,\\n\"\n",
    "    # \"    \\\"HR < 100\\\": true or false,\\n\"\n",
    "    # \"    \\\"O₂ ≥ 95%\\\": true or false,\\n\"\n",
    "    # \"    \\\"No hemoptysis\\\": true or false,\\n\"\n",
    "    # \"    \\\"No estrogen use\\\": true or false,\\n\"\n",
    "    # \"    \\\"No prior VTE\\\": true or false,\\n\"\n",
    "    # \"    \\\"No unilateral leg swelling\\\": true or false\\n\"\n",
    "    # \"  },\\n\"\n",
    "    \"  {\\\"Answer\\\": <sum of false criteria>}\\n\"\n",
    ")\n",
    "invalid_outputs, wrong_outputs, results_df,parsed_json = await run_models_with_output(\n",
    "    sys_instruct = sys_instruct\n",
    "    ,prompt= \"Your task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\\n\"\n",
    "    \"\\n\"\n",
    "    \"There are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\\n\"\n",
    "    \"\\n\"\n",
    "    \"PERC Criteria:\\n\"\n",
    "    \"1. Age < 50 years\\n\"\n",
    "    \"2. Heart rate < 100 bpm\\n\"\n",
    "    \"3. Oxygen saturation ≥ 95%\\n\"\n",
    "    \"4. No hemoptysis\\n\"\n",
    "    \"5. No estrogen use\\n\"\n",
    "    \"6. No prior venous thromboembolism (VTE)\\n\"\n",
    "    \"7. No unilateral leg swelling\\n\"\n",
    "    \"\\n\"\n",
    "    \"After your output return a **single JSON object*.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Format:\\n\"\n",
    "\n",
    "    \"First explain the decision making process , interpret and analyze the patient's note\"\n",
    "\n",
    "    \"After you reach your answer, put your final decision in the output below:\"\n",
    "    \"{\\n\"\n",
    "    \"  \\\"Explanation\\\": \\\"<A short explanation of how each criterion was evaluated>\\\",\\n\"\n",
    "    \"  \\\"Criteria\\\": {\\n\"\n",
    "    \"    \\\"Age < 50\\\": true or false,\\n\"\n",
    "    \"    \\\"HR < 100\\\": true or false,\\n\"\n",
    "    \"    \\\"O₂ ≥ 95%\\\": true or false,\\n\"\n",
    "    \"    \\\"No hemoptysis\\\": true or false,\\n\"\n",
    "    \"    \\\"No estrogen use\\\": true or false,\\n\"\n",
    "    \"    \\\"No prior VTE\\\": true or false,\\n\"\n",
    "    \"    \\\"No unilateral leg swelling\\\": true or false\\n\"\n",
    "    \"  },\\n\"\n",
    "    \"  \\\"Answer\\\": <sum of false criteria>}\\n\"\n",
    "    \"}\\n\",\n",
    "    model_ids=[\"Llama-3.3-70B-Instruct\"],\n",
    "    include_relevant_entities=True,\n",
    "    full_df=True\n",
    ")\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c034a9ac",
   "metadata": {},
   "source": [
    "### Using Jinja"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1be3bb2c",
   "metadata": {},
   "outputs": [],
   "source": [
    "from jinja2 import Environment, DictLoader\n",
    "\n",
    "template_str = \"\"\"\n",
    "{% if include_relevant_entities %}\n",
    "Relevant Entities:\n",
    "{{ entities }}\n",
    "\n",
    "{% endif %}\n",
    "Patient Note:\n",
    "{{ note }}\n",
    "\n",
    "{{ prompt }}\n",
    "\"\"\"\n",
    "\n",
    "env = Environment(loader=DictLoader({'perc_prompt': template_str}))\n",
    "template = env.get_template('perc_prompt')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "id": "4e39ad7b",
   "metadata": {},
   "outputs": [],
   "source": [
    "''' A function that runs models with output.\n",
    "It takes a system instruction, a list of model IDs, and optional parameters for including relevant entities,\n",
    "sampling, and full DataFrame usage.\n",
    "It returns invalid outputs, wrong outputs, a summary DataFrame, and parsed results per model.'''\n",
    "async def run_models_with_output_with_jinja(\n",
    "    sys_instruct,\n",
    "    model_ids: List[str],\n",
    "    include_relevant_entities=True,\n",
    "    sample=10,\n",
    "    full_df=False,\n",
    "    prompt=\"Calculate PERC score for this patient.\"\n",
    "):\n",
    "    results = []\n",
    "    wrong_outputs = []\n",
    "    invalid_outputs = []\n",
    "    parsed_results_per_model = {model_id: [] for model_id in model_ids}\n",
    "\n",
    "    subset_df = perc_df.head(sample)\n",
    "    iterate_df = perc_df if full_df else subset_df\n",
    "\n",
    "    for model_id in model_ids:\n",
    "        print(f\"\\n=== Evaluating model: {model_id} ===\\n\")\n",
    "        wrong = invalid = correct = 0\n",
    "        total = len(iterate_df)\n",
    "        prompts = []\n",
    "\n",
    "        for idx, row in iterate_df.iterrows():\n",
    "            entities = entities = ast.literal_eval(row[\"Relevant Entities\"]) if include_relevant_entities else None\n",
    "            user_instruction = template.render(\n",
    "                note=row[\"Patient Note\"],\n",
    "                entities=row[\"Parsed Entities\"],\n",
    "                include_relevant_entities=include_relevant_entities,\n",
    "                prompt=prompt\n",
    "            )\n",
    "            prompts.append(user_instruction)\n",
    "\n",
    "\n",
    "        results_async = await run_batch(\n",
    "            model=model_id,\n",
    "            system_instruction=sys_instruct,\n",
    "            prompts=prompts\n",
    "        )\n",
    "\n",
    "        for i, reply in enumerate(results_async):\n",
    "            progress = (i + 1) / len(results_async) * 100\n",
    "            print(f\"\\rParsing: {progress:.1f}% ({i + 1}/{len(results_async)})\", end=\"\", flush=True)\n",
    "\n",
    "            row = iterate_df.iloc[i]\n",
    "            entities = row[\"Parsed Entities\"]\n",
    "            ground_truth = row[\"Ground Truth Answer\"]\n",
    "\n",
    "            parsed = extract_json_from_text(reply)\n",
    "            if parsed is None or \"Answer\" not in parsed:\n",
    "                # parsed = extract_score_from_text(reply) \n",
    "                if parsed is None or \"Answer\" not in parsed:\n",
    "                    invalid += 1\n",
    "                    invalid_outputs.append({\n",
    "                        \"model\": model_id,\n",
    "                        \"note\": row[\"Patient Note\"],\n",
    "                        \"entities\": entities if include_relevant_entities else None,\n",
    "                        \"reply\": reply,\n",
    "                        \"reason\": \"Invalid JSON or missing 'Answer'\"\n",
    "                    })\n",
    "                    parsed_results_per_model[model_id].append({\n",
    "                        \"note\": row[\"Patient Note\"],\n",
    "                        \"entities\": entities if include_relevant_entities else None,\n",
    "                        \"ground_truth\": ground_truth,\n",
    "                        \"parsed_criteria\": None,\n",
    "                        \"predicted\": None,\n",
    "                        \"raw_reply\": reply,\n",
    "                        \"valid\": False,\n",
    "                        \"correct\": False\n",
    "                    })\n",
    "                    continue\n",
    "\n",
    "            predicted_score = parsed.get(\"Answer\")\n",
    "\n",
    "            # Extract all criteria booleans except the 'Answer'\n",
    "            criteria = {k: v for k, v in parsed.items() if k != \"Answer\"}\n",
    "\n",
    "            if predicted_score == ground_truth:\n",
    "                correct += 1\n",
    "            else:\n",
    "                wrong += 1\n",
    "                wrong_outputs.append({\n",
    "                    \"model\": model_id,\n",
    "                    \"note\": row[\"Patient Note\"],\n",
    "                    \"entities\": entities if include_relevant_entities else None,\n",
    "                    \"reply\": reply,\n",
    "                    \"expected\": ground_truth,\n",
    "                    \"predicted\": predicted_score\n",
    "                })\n",
    "\n",
    "            parsed_results_per_model[model_id].append({\n",
    "                \"note\": row[\"Patient Note\"],\n",
    "                \"entities\": entities if include_relevant_entities else None,\n",
    "                \"ground_truth\": ground_truth,\n",
    "                \"parsed_criteria\": criteria,\n",
    "                \"predicted\": predicted_score,\n",
    "                \"raw_reply\": reply,\n",
    "                \"valid\": True,\n",
    "                \"correct\": predicted_score == ground_truth\n",
    "            })\n",
    "\n",
    "        valid = correct + wrong\n",
    "        accuracy = correct / valid if valid > 0 else 0\n",
    "\n",
    "        results.append({\n",
    "            \"model_id\": model_id,\n",
    "            \"wrong\": wrong,\n",
    "            \"correct\": correct,\n",
    "            \"invalid\": invalid,\n",
    "            \"total\": total,\n",
    "            \"accuracy\": round(accuracy, 3)\n",
    "        })\n",
    "\n",
    "        print(\"\\nDone ✅\")\n",
    "\n",
    "    results_df = pd.DataFrame(results)\n",
    "    print(\"\\n=== Summary Table ===\")\n",
    "    print(results_df)\n",
    "\n",
    "    return invalid_outputs, wrong_outputs, results_df, parsed_results_per_model\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "id": "fb04067f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== Evaluating model: Llama-3.3-70B-Instruct ===\n",
      "\n",
      "Batch Progress: 57.1% (76/133)"
     ]
    },
    {
     "ename": "TimeoutError",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mCancelledError\u001b[0m                            Traceback (most recent call last)",
      "File \u001b[0;32m~/Documents/ai_paper_tool/.venv/lib/python3.9/site-packages/aiohttp/client_reqrep.py:532\u001b[0m, in \u001b[0;36mClientResponse.start\u001b[0;34m(self, connection)\u001b[0m\n\u001b[1;32m    531\u001b[0m     protocol \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_protocol\n\u001b[0;32m--> 532\u001b[0m     message, payload \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m protocol\u001b[38;5;241m.\u001b[39mread()  \u001b[38;5;66;03m# type: ignore[union-attr]\u001b[39;00m\n\u001b[1;32m    533\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m http\u001b[38;5;241m.\u001b[39mHttpProcessingError \u001b[38;5;28;01mas\u001b[39;00m exc:\n",
      "File \u001b[0;32m~/Documents/ai_paper_tool/.venv/lib/python3.9/site-packages/aiohttp/streams.py:672\u001b[0m, in \u001b[0;36mDataQueue.read\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m    671\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 672\u001b[0m     \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_waiter\n\u001b[1;32m    673\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m (asyncio\u001b[38;5;241m.\u001b[39mCancelledError, asyncio\u001b[38;5;241m.\u001b[39mTimeoutError):\n",
      "\u001b[0;31mCancelledError\u001b[0m: ",
      "\nThe above exception was the direct cause of the following exception:\n",
      "\u001b[0;31mTimeoutError\u001b[0m                              Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[130], line 36\u001b[0m\n\u001b[1;32m      1\u001b[0m sys_instruct \u001b[38;5;241m=\u001b[39m (\n\u001b[1;32m      2\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mYou are a clinical decision support assistant. You always follow structured clinical decision rules and explain your reasoning before giving a final structured JSON answer.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m      3\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mYour task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     34\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m  \u001b[39m\u001b[38;5;124m{\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mAnswer\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: <sum of false criteria>}\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     35\u001b[0m )\n\u001b[0;32m---> 36\u001b[0m invalid_outputs, wrong_outputs, results_df,parsed_json \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m run_models_with_output_with_jinja(\n\u001b[1;32m     37\u001b[0m     sys_instruct \u001b[38;5;241m=\u001b[39m sys_instruct\n\u001b[1;32m     38\u001b[0m     ,prompt\u001b[38;5;241m=\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mYour task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     39\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     40\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mThere are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     41\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     42\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mPERC Criteria:\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     43\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m1. Age < 50 years\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     44\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m2. Heart rate < 100 bpm\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     45\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m3. Oxygen saturation ≥ 95\u001b[39m\u001b[38;5;124m%\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     46\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m4. No hemoptysis\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     47\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m5. No estrogen use\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     48\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m6. No prior venous thromboembolism (VTE)\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     49\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m7. No unilateral leg swelling\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     50\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     51\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mAfter your output return a **single JSON object*.\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     52\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     53\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mFormat:\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     54\u001b[0m \n\u001b[1;32m     55\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mFirst explain the decision making process , interpret and analyze the patient\u001b[39m\u001b[38;5;124m'\u001b[39m\u001b[38;5;124ms note\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     56\u001b[0m \n\u001b[1;32m     57\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mAfter you reach your answer, put your final decision in the output below:\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     58\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m{\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     59\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m  \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mExplanation\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m<A short explanation of how each criterion was evaluated>\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m,\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     60\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m  \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mCriteria\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: \u001b[39m\u001b[38;5;124m{\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     61\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m    \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mAge < 50\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: true or false,\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     62\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m    \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mHR < 100\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: true or false,\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     63\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m    \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mO₂ ≥ 95\u001b[39m\u001b[38;5;124m%\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: true or false,\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     64\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m    \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mNo hemoptysis\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: true or false,\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     65\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m    \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mNo estrogen use\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: true or false,\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     66\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m    \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mNo prior VTE\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: true or false,\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     67\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m    \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mNo unilateral leg swelling\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: true or false\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     68\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m  },\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     69\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m  \u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124mAnswer\u001b[39m\u001b[38;5;130;01m\\\"\u001b[39;00m\u001b[38;5;124m: <sum of false criteria>}\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m     70\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m}\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124m\"\u001b[39m,\n\u001b[1;32m     71\u001b[0m     model_ids\u001b[38;5;241m=\u001b[39m[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mLlama-3.3-70B-Instruct\u001b[39m\u001b[38;5;124m\"\u001b[39m],\n\u001b[1;32m     72\u001b[0m     include_relevant_entities\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m,\n\u001b[1;32m     73\u001b[0m     full_df\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[1;32m     74\u001b[0m )\n",
      "Cell \u001b[0;32mIn[129], line 38\u001b[0m, in \u001b[0;36mrun_models_with_output_with_jinja\u001b[0;34m(sys_instruct, model_ids, include_relevant_entities, sample, full_df, prompt)\u001b[0m\n\u001b[1;32m     29\u001b[0m     user_instruction \u001b[38;5;241m=\u001b[39m template\u001b[38;5;241m.\u001b[39mrender(\n\u001b[1;32m     30\u001b[0m         note\u001b[38;5;241m=\u001b[39mrow[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mPatient Note\u001b[39m\u001b[38;5;124m\"\u001b[39m],\n\u001b[1;32m     31\u001b[0m         entities\u001b[38;5;241m=\u001b[39mrow[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mParsed Entities\u001b[39m\u001b[38;5;124m\"\u001b[39m],\n\u001b[1;32m     32\u001b[0m         include_relevant_entities\u001b[38;5;241m=\u001b[39minclude_relevant_entities,\n\u001b[1;32m     33\u001b[0m         prompt\u001b[38;5;241m=\u001b[39mprompt\n\u001b[1;32m     34\u001b[0m     )\n\u001b[1;32m     35\u001b[0m     prompts\u001b[38;5;241m.\u001b[39mappend(user_instruction)\n\u001b[0;32m---> 38\u001b[0m results_async \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m run_batch(\n\u001b[1;32m     39\u001b[0m     model\u001b[38;5;241m=\u001b[39mmodel_id,\n\u001b[1;32m     40\u001b[0m     system_instruction\u001b[38;5;241m=\u001b[39msys_instruct,\n\u001b[1;32m     41\u001b[0m     prompts\u001b[38;5;241m=\u001b[39mprompts\n\u001b[1;32m     42\u001b[0m )\n\u001b[1;32m     44\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m i, reply \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28menumerate\u001b[39m(results_async):\n\u001b[1;32m     45\u001b[0m     progress \u001b[38;5;241m=\u001b[39m (i \u001b[38;5;241m+\u001b[39m \u001b[38;5;241m1\u001b[39m) \u001b[38;5;241m/\u001b[39m \u001b[38;5;28mlen\u001b[39m(results_async) \u001b[38;5;241m*\u001b[39m \u001b[38;5;241m100\u001b[39m\n",
      "Cell \u001b[0;32mIn[111], line 43\u001b[0m, in \u001b[0;36mrun_batch\u001b[0;34m(model, system_instruction, prompts)\u001b[0m\n\u001b[1;32m     40\u001b[0m completed \u001b[38;5;241m=\u001b[39m \u001b[38;5;241m0\u001b[39m\n\u001b[1;32m     42\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m coro \u001b[38;5;129;01min\u001b[39;00m asyncio\u001b[38;5;241m.\u001b[39mas_completed(tasks):\n\u001b[0;32m---> 43\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m coro\n\u001b[1;32m     44\u001b[0m     results\u001b[38;5;241m.\u001b[39mappend(result)\n\u001b[1;32m     45\u001b[0m     completed \u001b[38;5;241m+\u001b[39m\u001b[38;5;241m=\u001b[39m \u001b[38;5;241m1\u001b[39m\n",
      "File \u001b[0;32m/Library/Developer/CommandLineTools/Library/Frameworks/Python3.framework/Versions/3.9/lib/python3.9/asyncio/tasks.py:614\u001b[0m, in \u001b[0;36mas_completed.<locals>._wait_for_one\u001b[0;34m()\u001b[0m\n\u001b[1;32m    611\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m f \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[1;32m    612\u001b[0m     \u001b[38;5;66;03m# Dummy value from _on_timeout().\u001b[39;00m\n\u001b[1;32m    613\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m exceptions\u001b[38;5;241m.\u001b[39mTimeoutError\n\u001b[0;32m--> 614\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mf\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mresult\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n",
      "Cell \u001b[0;32mIn[111], line 22\u001b[0m, in \u001b[0;36mget_chat_completion\u001b[0;34m(session, sem, model, system_instruction, user_instruction)\u001b[0m\n\u001b[1;32m     10\u001b[0m payload \u001b[38;5;241m=\u001b[39m {\n\u001b[1;32m     11\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmodel\u001b[39m\u001b[38;5;124m\"\u001b[39m: model,\n\u001b[1;32m     12\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmessages\u001b[39m\u001b[38;5;124m\"\u001b[39m: [\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     18\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmax_tokens\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;241m2000\u001b[39m\n\u001b[1;32m     19\u001b[0m }\n\u001b[1;32m     21\u001b[0m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mwith\u001b[39;00m sem:\n\u001b[0;32m---> 22\u001b[0m     \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mwith\u001b[39;00m session\u001b[38;5;241m.\u001b[39mpost(BASE_URL, headers\u001b[38;5;241m=\u001b[39mHEADERS, json\u001b[38;5;241m=\u001b[39mpayload) \u001b[38;5;28;01mas\u001b[39;00m response:\n\u001b[1;32m     23\u001b[0m         response\u001b[38;5;241m.\u001b[39mraise_for_status()\n\u001b[1;32m     24\u001b[0m         result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m response\u001b[38;5;241m.\u001b[39mjson()\n",
      "File \u001b[0;32m~/Documents/ai_paper_tool/.venv/lib/python3.9/site-packages/aiohttp/client.py:1482\u001b[0m, in \u001b[0;36m_BaseRequestContextManager.__aenter__\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m   1481\u001b[0m \u001b[38;5;28;01masync\u001b[39;00m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21m__aenter__\u001b[39m(\u001b[38;5;28mself\u001b[39m) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m _RetType:\n\u001b[0;32m-> 1482\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_resp: _RetType \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_coro\n\u001b[1;32m   1483\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mawait\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_resp\u001b[38;5;241m.\u001b[39m\u001b[38;5;21m__aenter__\u001b[39m()\n",
      "File \u001b[0;32m~/Documents/ai_paper_tool/.venv/lib/python3.9/site-packages/aiohttp/client.py:770\u001b[0m, in \u001b[0;36mClientSession._request\u001b[0;34m(self, method, str_or_url, params, data, json, cookies, headers, skip_auto_headers, auth, allow_redirects, max_redirects, compress, chunked, expect100, raise_for_status, read_until_eof, proxy, proxy_auth, timeout, verify_ssl, fingerprint, ssl_context, ssl, server_hostname, proxy_headers, trace_request_ctx, read_bufsize, auto_decompress, max_line_size, max_field_size, middlewares)\u001b[0m\n\u001b[1;32m    767\u001b[0m     handler \u001b[38;5;241m=\u001b[39m _connect_and_send_request\n\u001b[1;32m    769\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 770\u001b[0m     resp \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m handler(req)\n\u001b[1;32m    771\u001b[0m \u001b[38;5;66;03m# Client connector errors should not be retried\u001b[39;00m\n\u001b[1;32m    772\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m (\n\u001b[1;32m    773\u001b[0m     ConnectionTimeoutError,\n\u001b[1;32m    774\u001b[0m     ClientConnectorError,\n\u001b[1;32m    775\u001b[0m     ClientConnectorCertificateError,\n\u001b[1;32m    776\u001b[0m     ClientConnectorSSLError,\n\u001b[1;32m    777\u001b[0m ):\n",
      "File \u001b[0;32m~/Documents/ai_paper_tool/.venv/lib/python3.9/site-packages/aiohttp/client.py:748\u001b[0m, in \u001b[0;36mClientSession._request.<locals>._connect_and_send_request\u001b[0;34m(req)\u001b[0m\n\u001b[1;32m    746\u001b[0m resp \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mawait\u001b[39;00m req\u001b[38;5;241m.\u001b[39msend(conn)\n\u001b[1;32m    747\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 748\u001b[0m     \u001b[38;5;28;01mawait\u001b[39;00m resp\u001b[38;5;241m.\u001b[39mstart(conn)\n\u001b[1;32m    749\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mBaseException\u001b[39;00m:\n\u001b[1;32m    750\u001b[0m     resp\u001b[38;5;241m.\u001b[39mclose()\n",
      "File \u001b[0;32m~/Documents/ai_paper_tool/.venv/lib/python3.9/site-packages/aiohttp/client_reqrep.py:547\u001b[0m, in \u001b[0;36mClientResponse.start\u001b[0;34m(self, connection)\u001b[0m\n\u001b[1;32m    545\u001b[0m         \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_continue \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[1;32m    546\u001b[0m             set_result(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_continue, \u001b[38;5;28;01mTrue\u001b[39;00m)\n\u001b[0;32m--> 547\u001b[0m             \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_continue \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m    549\u001b[0m \u001b[38;5;66;03m# payload eof handler\u001b[39;00m\n\u001b[1;32m    550\u001b[0m payload\u001b[38;5;241m.\u001b[39mon_eof(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_response_eof)\n",
      "File \u001b[0;32m~/Documents/ai_paper_tool/.venv/lib/python3.9/site-packages/aiohttp/helpers.py:685\u001b[0m, in \u001b[0;36mTimerContext.__exit__\u001b[0;34m(self, exc_type, exc_val, exc_tb)\u001b[0m\n\u001b[1;32m    683\u001b[0m         \u001b[38;5;28;01mif\u001b[39;00m enter_task\u001b[38;5;241m.\u001b[39muncancel() \u001b[38;5;241m>\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_cancelling:\n\u001b[1;32m    684\u001b[0m             \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[0;32m--> 685\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m asyncio\u001b[38;5;241m.\u001b[39mTimeoutError \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mexc_val\u001b[39;00m\n\u001b[1;32m    686\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "\u001b[0;31mTimeoutError\u001b[0m: "
     ]
    }
   ],
   "source": [
    "sys_instruct = (\n",
    "    \"You are a clinical decision support assistant. You always follow structured clinical decision rules and explain your reasoning before giving a final structured JSON answer.\\n\"\n",
    "    \"Your task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\\n\"\n",
    "    \"\\n\"\n",
    "    \"There are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\\n\"\n",
    "    \"\\n\"\n",
    "    \"PERC Criteria:\\n\"\n",
    "    \"1. Age < 50 years\\n\"\n",
    "    \"2. Heart rate < 100 bpm\\n\"\n",
    "    \"3. Oxygen saturation ≥ 95%\\n\"\n",
    "    \"4. No hemoptysis\\n\"\n",
    "    \"5. No estrogen use\\n\"\n",
    "    \"6. No prior venous thromboembolism (VTE)\\n\"\n",
    "    \"7. No unilateral leg swelling\\n\"\n",
    "    \"\\n\"\n",
    "    \"After your output return a **single JSON object*.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Format:\\n\"\n",
    "\n",
    "    \"First explain the decision making process , interpret and analyze the patient's note\"\n",
    "\n",
    "    \"After you reach your answer, put your final decision in the output below:\"\n",
    "    # \"{\\n\"\n",
    "    # \"  \\\"Explanation\\\": \\\"<A short explanation of how each criterion was evaluated>\\\",\\n\"\n",
    "    # \"  \\\"Criteria\\\": {\\n\"\n",
    "    # \"    \\\"Age < 50\\\": true or false,\\n\"\n",
    "    # \"    \\\"HR < 100\\\": true or false,\\n\"\n",
    "    # \"    \\\"O₂ ≥ 95%\\\": true or false,\\n\"\n",
    "    # \"    \\\"No hemoptysis\\\": true or false,\\n\"\n",
    "    # \"    \\\"No estrogen use\\\": true or false,\\n\"\n",
    "    # \"    \\\"No prior VTE\\\": true or false,\\n\"\n",
    "    # \"    \\\"No unilateral leg swelling\\\": true or false\\n\"\n",
    "    # \"  },\\n\"\n",
    "    \"  {\\\"Answer\\\": <sum of false criteria>}\\n\"\n",
    ")\n",
    "invalid_outputs, wrong_outputs, results_df,parsed_json = await run_models_with_output_with_jinja(\n",
    "    sys_instruct = sys_instruct\n",
    "    ,prompt= \"Your task is to calculate the PERC (Pulmonary Embolism Rule-out Criteria) score for a patient using the note and extracted entities provided.\\n\"\n",
    "    \"\\n\"\n",
    "    \"There are 7 criteria. Each one is evaluated as either true (criterion met) or false (criterion not met). Each false criterion adds 1 point to the PERC score.\\n\"\n",
    "    \"\\n\"\n",
    "    \"PERC Criteria:\\n\"\n",
    "    \"1. Age < 50 years\\n\"\n",
    "    \"2. Heart rate < 100 bpm\\n\"\n",
    "    \"3. Oxygen saturation ≥ 95%\\n\"\n",
    "    \"4. No hemoptysis\\n\"\n",
    "    \"5. No estrogen use\\n\"\n",
    "    \"6. No prior venous thromboembolism (VTE)\\n\"\n",
    "    \"7. No unilateral leg swelling\\n\"\n",
    "    \"\\n\"\n",
    "    \"After your output return a **single JSON object*.\\n\"\n",
    "    \"\\n\"\n",
    "    \"Format:\\n\"\n",
    "\n",
    "    \"First explain the decision making process , interpret and analyze the patient's note\"\n",
    "\n",
    "    \"After you reach your answer, put your final decision in the output below:\"\n",
    "    \"{\\n\"\n",
    "    \"  \\\"Explanation\\\": \\\"<A short explanation of how each criterion was evaluated>\\\",\\n\"\n",
    "    \"  \\\"Criteria\\\": {\\n\"\n",
    "    \"    \\\"Age < 50\\\": true or false,\\n\"\n",
    "    \"    \\\"HR < 100\\\": true or false,\\n\"\n",
    "    \"    \\\"O₂ ≥ 95%\\\": true or false,\\n\"\n",
    "    \"    \\\"No hemoptysis\\\": true or false,\\n\"\n",
    "    \"    \\\"No estrogen use\\\": true or false,\\n\"\n",
    "    \"    \\\"No prior VTE\\\": true or false,\\n\"\n",
    "    \"    \\\"No unilateral leg swelling\\\": true or false\\n\"\n",
    "    \"  },\\n\"\n",
    "    \"  \\\"Answer\\\": <sum of false criteria>}\\n\"\n",
    "    \"}\\n\",\n",
    "    model_ids=[\"Llama-3.3-70B-Instruct\"],\n",
    "    include_relevant_entities=True,\n",
    "    full_df=True\n",
    ")\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
